10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________________________

FORM 10-K

(Mark One)
x	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2016
or
o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from  to

Commission File Number:    001-31911

______________________________________________

American Equity Investment Life Holding Company

(Exact name of registrant as specified in its charter)

Iowa (State or other jurisdiction of Incorporation)	42-1447959 (I.R.S. Employer Identification No.)
6000 Westown Parkway West Des Moines, Iowa (Address of principal executive offices)	50266 (Zip Code)
Registrant's telephone number, including area code:    (515) 221-0002
Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Name of each exchange on which registered
Common stock, par value $1	New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: Common Stock, par value $1

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x    No o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o    No x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x    No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x    No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer x Accelerated filer o Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.) Yes o    No x

Aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was $1,133,734,418 based on the closing price of $14.25 per share, the closing price of the common stock on the New York Stock Exchange on June 30, 2016.

Shares of common stock outstanding as of February 22, 2017: 88,279,845

Documents incorporated by reference: Portions of the registrant's definitive proxy statement for the annual meeting of shareholders to be held June 1, 2017, which will be filed within 120 days after December 31, 2016, are incorporated by reference into Part III of this report.

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2016

TABLE OF CONTENTS

PART I.
Item 1.	Business	1
Item 1A.	Risk Factors	8
Item 1B.	Unresolved Staff Comments	16
Item 2.	Properties	16
Item 3.	Legal Proceedings	16
Item 4.	Mine Safety Disclosures	16
PART II.
Item 5.	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	16
Item 6.	Selected Consolidated Financial Data	17
Item 7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	19
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	45
Item 8.	Consolidated Financial Statements and Supplementary Data	47
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	47
Item 9A.	Controls and Procedures	47
Item 9B.	Other Information	48
PART III.
	The information required by Items 10 through 14 is incorporated by reference from our definitive proxy statement to be filed with the Commission pursuant to Regulation 14A within 120 days after December 31, 2016.	48
PART IV.
Item 15.	Exhibits, Financial Statement Schedules	48
SIGNATURES		49
Index to Consolidated Financial Statements and Schedules		F-1
Exhibit Index
Exhibit 12.1	Ratio of Earnings to Fixed Charges
Exhibit 21.2	Subsidiaries of American Equity Investment Life Holding Company
Exhibit 23.1	Consent of Independent Registered Public Accounting Firm
Exhibit 31.1	Certification
Exhibit 31.2	Certification
Exhibit 32.1	Certification
Exhibit 32.2	Certification

PART I

Item 1.    Business

Introduction

We are a leader in the development and sale of fixed index and fixed rate annuity products. We were incorporated in the state of Iowa on December 15, 1995. We issue fixed annuity and life insurance products through our wholly-owned life insurance subsidiaries, American Equity Investment Life Insurance Company ("American Equity Life"), American Equity Investment Life Insurance Company of New York and Eagle Life Insurance Company ("Eagle Life"). We have one business segment which represents our core business comprised of the sale of fixed index and fixed rate annuities. Our business strategy is focused on growing our policyholder funds and earning predictable returns by managing investment spreads and investment risk. We are licensed to sell our products in 50 states and the District of Columbia. Throughout this report, unless otherwise specified or the context otherwise requires, all references to "American Equity", the "Company", "we", "our" and similar references are to American Equity Investment Life Holding Company and its consolidated subsidiaries.

Investor related information, including periodic reports filed on Forms 10-K, 10-Q and 8-K and any amendments may be found on our internet website at www.american-equity.com as soon as reasonably practicable after such reports are filed with the Securities and Exchange Commission ("SEC"). In addition, we have available on our website our: (i) code of business conduct and ethics; (ii) audit committee charter; (iii) compensation committee charter; (iv) nominating and corporate governance committee charter and (v) corporate governance guidelines. The information incorporated herein by reference is also electronically accessible from the SEC's website at www.sec.gov.

Annuity Market Overview

Our target market includes the group of individuals ages 45-75 who are seeking to accumulate tax-deferred savings or create guaranteed lifetime income. We believe that significant growth opportunities exist for annuity products because of favorable demographic and economic trends. According to the U.S. Census Bureau, there were approximately 39 million Americans age 65 and older in 2010, representing 13% of the U.S. population and this group has grown to 44.7 million in 2013. By 2030, this sector of the population is expected to increase to 20% of the total population. Our fixed index and fixed rate annuity products are particularly attractive to this group due to their principal protection, competitive rates of credited interest, tax-deferred growth, guaranteed lifetime income and alternative payout options. Our competitive fixed index and fixed rate annuity products have enabled us to enjoy favorable growth in recent years and since our formation.

According to Wink's Sales and Market Report published by Wink, Inc., total industry sales of fixed index annuities increased 19.8% to $44.9 billion for the first three quarters of 2016 from $37.5 billion for the first three quarters of 2015. Total industry sales of fixed index annuities have increased 64% over the five year period from 2010 to 2015 (data provided in the following table according to Wink's Sales and Market Report published by Wink, Inc.), which we believe is attributable to more Americans reaching retirement age and seeking products that will provide principal protection and guaranteed lifetime income.

	For the Year Ended December 31,
	2015			2014			2013			2012			2011
	(Dollars in thousands)
Total industry sales of fixed index annuities	$	53,069,850		$	46,896,350		$	38,646,864		$	33,975,442		$	32,387,045
Increase from prior year	6,173,500			8,249,486			4,671,422			1,588,397			41,481
Increase from prior year	13.2		%	21.3		%	13.7		%	4.9		%	0.1		%

Strategy

Key elements of executing our strategy include the following:

Expand and Enhance our Distribution Network.  We currently distribute through a number of distribution channels, including independent agents, broker/dealers, banks and registered investment advisors. American Equity Life has relationships with approximately 35 national marketing organizations, through which nearly 25,000 independent agents are under contract. Our objective is to improve the productivity and efficiency of our independent agent distribution channel by focusing our marketing and recruiting efforts on those independent agents capable of selling $1 million or more of annuity premium annually. We will also be alert for opportunities to establish relationships with successful national marketing organizations and agents not presently associated with us. We continue to grow distribution through broker/dealers, banks and registered investment advisors. According to Wink's Sales and Market Report published by Wink, Inc., sales of fixed index annuities through broker/dealers and banks represented almost 35% of industry sales in the third quarter of 2016. Eagle Life is focused solely on the broker/dealer, bank and registered investment advisor channel and is developing a network of broker/dealers, banks and registered investment advisors that have the ability to distribute fixed index and fixed rate annuity products in large volume. We also offer broker/dealer and bank friendly products for those broker/dealers and banks that choose to associate with us through American Equity Life. We continue to strive to provide all of our distribution partners with the highest quality service possible.

1

Continue to Introduce Innovative and Competitive Products.  We intend to be at the forefront of the fixed index and fixed rate annuity industry in developing and introducing innovative and competitive products. We were one of the first companies to offer a fixed index annuity that allows a choice among interest crediting strategies including both equity and bond indices as well as a traditional fixed rate strategy. We were one of the first companies to include a lifetime income benefit rider with our fixed index annuities and first to have a lifetime income benefit rider with gender-based income payments. We believe that our continued focus on anticipating and being responsive to the product needs of the ever-growing population of retirees will lead to increased customer loyalty, revenues and profitability.

Use our Expertise to Achieve Targeted Spreads on Annuity Products.  We have had a successful track record in achieving the targeted spreads on our annuity products. This historical success has been challenged in the current extended low interest rate environment. However, we intend to continue to leverage our experience and expertise in managing the investment spread during a range of interest rate environments to achieve, or work towards achieving, our targeted spreads.

Maintain our Profitability Focus and Improve Operating Efficiency.  We are committed to improving our profitability by advancing the scope and sophistication of our investment management and spread capabilities and continuously seeking out efficiencies within our operations. The expanded use of technological resources will continue to allow us to improve our processes, scalability and response times.

Take Advantage of the Growing Popularity of Index Products.  We believe that the growing popularity of fixed index annuity products that allow equity and bond market participation without the risk of loss of the premium deposit presents an attractive opportunity to grow our business. The popularity of fixed index annuity products has increased in recent years with the availability of lifetime income benefit riders that provide an attractive alternative for converting accumulated retirement savings into lifetime income. We intend to capitalize on our reputation as a leading provider of fixed index annuities in this expanding segment of the annuity market.

Focus on High Quality Service to Agents and Policyholders.  We have maintained high quality personal service as one of our highest priorities since the inception of our company and continue to strive for an unprecedented level of timely and accurate service to both our agents and policyholders. Examples of our high quality service include a live person answering phone calls and issuing policies within 24 hours of receiving the application if the paperwork is in good order. We believe high quality service is one of our strongest competitive advantages.

Be Proactive in the Changing Regulatory Environment. We have been a strong and vocal defender of our products and our industry through continued regulatory challenges and have long been an advocate for appropriate regulation. We intend to remain flexible and responsive to the ever changing regulatory environment and will continue to engage with our key regulators to ensure policyholder protections are in place and adequate while permitting continued access to our much needed retirement products.

Products

Annuities offer our policyholders a tax-deferred means of accumulating retirement savings, as well as a reliable source of income during the payout period. When our policyholders deposit cash to annuities, we account for these receipts as policy benefit reserves in the liability section of our consolidated balance sheet. The annuity deposits collected, by product type, during the three most recent fiscal years are as follows:

	Year Ended December 31,
	2016				2015				2014
Product Type	Deposits Collected		Deposits as a % of Total		Deposits Collected		Deposits as a % of Total		Deposits Collected		Deposits as a % of Total
	(Dollars in thousands)
Fixed index annuities	$	5,724,758	80	%	$	6,791,689	96	%	$	3,999,439	96	%
Annual reset fixed rate annuities	64,317		1	%	45,182		1	%	57,273		1	%
Multi-year fixed rate annuities	1,303,273		18	%	214,356		3	%	103,293		2	%
Single premium immediate annuities	35,851		1	%	32,752		—	%	24,580		1	%
	$	7,128,199	100	%	$	7,083,979	100	%	$	4,184,585	100	%

Fixed Index Annuities

Fixed index annuities allow policyholders to earn index credits based on the performance of a particular index without the risk of loss of their principal. Most of these products allow policyholders to transfer funds once a year among several different crediting strategies, including one or more index based strategies and a traditional fixed rate strategy. Approximately 88%, 89% and 89% of our fixed index annuity sales for the years ended December 31, 2016, 2015 and 2014, respectively, were "premium bonus" products. The initial annuity deposit on these policies is increased at issuance by a specified premium bonus ranging from 3% to 10%. Generally, the surrender charge and bonus vesting provisions of our policies are structured such that we have comparable protection from early termination between bonus and non-bonus products.

2

The annuity contract value is equal to the sum of premiums paid, premium bonuses and interest credited ("index credits" for funds allocated to an index based strategy), which is based upon an overall limit (or "cap") or a percentage (the "participation rate") of the annual appreciation (based in certain situations on monthly averages or monthly point-to-point calculations) in a recognized index or benchmark. Caps and participation rates limit the amount of annual interest the policyholder may earn in any one contract year and may be adjusted by us annually subject to stated minimums. Caps generally range from 1% to 12% and participation rates range from 10% to 100%. In addition, some products have a spread or "asset fee" generally ranging from 0.75% to 4.0%, which is deducted from annual interest to be credited. For products with asset fees, if the annual appreciation in the index does not exceed the asset fee, the policyholder's index credit is zero. The minimum guaranteed surrender values are equal to no less than 87.5% of the premium collected plus interest credited at an annual rate ranging from 1% to 3%.

Fixed Rate Annuities

Fixed rate deferred annuities include annual reset and multi-year rate guaranteed products. Our annual reset fixed rate annuities have an annual interest rate (the "crediting rate") that is guaranteed for the first policy year. After the first policy year, we have the discretionary ability to change the crediting rate once annually to any rate at or above a guaranteed minimum rate. Our multi-year rate guaranteed annuities are similar to our annual reset products except that the initial crediting rate is guaranteed for up to seven years before it may be changed at our discretion. The minimum guaranteed rate on our annual reset fixed rate deferred annuities ranges from 1% to 4% and the initial guaranteed rate on our multi-year rate guaranteed policies ranges from 1.7% to 3.75%.

The initial crediting rate is largely a function of the interest rate we can earn on invested assets acquired with new annuity deposits and the rates offered on similar products by our competitors. For subsequent adjustments to crediting rates, we take into account the yield on our investment portfolio, annuity surrender and withdrawal assumptions and crediting rate history for particular groups of annuity policies with similar characteristics. As of December 31, 2016, crediting rates on our outstanding fixed rate deferred annuities generally ranged from 1.0% to 4.0%. The average crediting rates on our outstanding annual reset and multi-year rate guaranteed fixed rate deferred annuities at December 31, 2016 were 1.99% and 2.74%, respectively.

We also sell single premium immediate annuities ("SPIAs"). Our SPIAs are designed to provide a series of periodic payments for a fixed period of time or for life, according to the policyholder's choice at the time of issue. The amounts, frequency and length of time of the payments are fixed at the outset of the annuity contract. SPIAs are often purchased by persons at or near retirement age who desire a steady stream of payments over a future period of years. The implicit interest rate on SPIAs is based on market conditions when the policy is issued. The implicit interest rate on our outstanding SPIAs averaged 2.61% at December 31, 2016.

Withdrawal Options—Fixed Index and Fixed Rate Annuities

Policyholders are typically permitted penalty-free withdrawals up to 10% of the contract value in each year after the first year, subject to limitations. Withdrawals in excess of allowable penalty-free amounts are assessed a surrender charge during a penalty period which ranges from 6 to 17 years for fixed index annuities and 5 to 15 years for fixed rate annuities from the date the policy is issued. This surrender charge initially ranges from 7% to 20% for fixed index annuities and 8% to 20% for fixed rate annuities of the contract value and generally decreases by approximately one-half to two percentage points per year during the surrender charge period. For certain policies, the premium bonus is considered in the establishment of the surrender charge percentages. For other policies, there is a vesting schedule ranging from 10 to 14 years that applies to the premium bonus and any interest earned on that premium bonus. Surrender charges and bonus vesting are set at levels aimed at protecting us from loss on early terminations and reducing the likelihood of policyholders terminating their policies during periods of increasing interest rates. This practice enhances our ability to maintain profitability on such policies. Policyholders may elect to take the proceeds of the annuity either in a single payment or in a series of payments for life, for a fixed number of years or a combination of these payment options. Information on surrender charge protection and net account values are as follows:

	For the Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Annuity Surrender Charges:
Average years at issue	13.5			13.7			13.8
Average years remaining	8.6			9.1			9.2
Average surrender charge percentage remaining	13.8		%	14.3		%	14.7		%
Annuity Account Value (net of coinsurance)	$	45,204,015		$	41,249,647		$	35,363,041

Beginning in July 2007, substantially all of our fixed index annuity policies and many of our annual reset fixed rate deferred annuities were issued with a lifetime income benefit rider. This rider provides an additional liquidity option to policyholders. With the lifetime income benefit rider, a policyholder can elect to receive guaranteed payments for life from their contract without requiring them to annuitize their contract value. The amount of the living income benefit available is determined by the growth in the policy's income account value as defined in the rider (3.0% to 8.0%), which is selected by the policyholder at the time of purchase, and the policyholder's age at the time the policyholder elects to begin receiving living income benefit payments. Lifetime income benefit payments may be stopped and restarted at the election of the policyholder. During 2013, we introduced new versions of our lifetime income benefit rider that had an optional wellbeing benefit or optional death benefit. Policyholders have the choice of selecting a rider with a base level of benefit for no explicit fee or paying a fee for a rider that has a higher level of benefits, and beginning in 2013 we introduced products where the addition of a rider to the policy is completely optional. Rider fees range from 0.30% to 1.00% of the policy's income account value.

3

Life Insurance

These products include traditional ordinary and term, universal life and other interest-sensitive life insurance products. We have approximately $2.0 billion of life insurance in force as of December 31, 2016. Premiums related to this business accounted for less than 1% of revenues for the years ended December 31, 2016, 2015 and 2014.

Investments/Spread Management

Investment activities are an integral part of our business, and net investment income is a significant component of our total revenues. Profitability of our annuity products is significantly affected by spreads between interest yields on investments, the cost of options to fund the annual index credits on our fixed index annuities and rates credited on our fixed rate annuities and the fixed rate strategy in our fixed index annuities. We manage the index-based risk component of our fixed index annuities by purchasing call options on the applicable indices to fund the annual index credits on these annuities and by adjusting the caps, participation rates and asset fees on policy anniversary dates to reflect the change in the cost of such options which varies based on market conditions. All options are purchased on the respective policy anniversary dates, and new options are purchased on each of the anniversary dates to fund the next annual index credits. All credited rates on annual reset fixed rate deferred annuities and the fixed rate strategy in fixed index annuities may be changed annually, subject to minimum guarantees. Changes in caps, participation rates and asset fees on fixed index annuities and crediting rates on fixed rate and fixed index annuities may not be sufficient to maintain targeted investment spreads in all economic and market environments. In addition, competition and other factors, including the potential for increases in surrenders and withdrawals, may limit our ability to adjust or to maintain caps, participation rates, asset fees and crediting rates at levels necessary to avoid narrowing of spreads under certain market conditions.

For additional information regarding the composition of our investment portfolio and our interest rate risk management, see Management's Discussion and Analysis of Financial Condition and Results of Operations—Financial Condition—Investments, Quantitative and Qualitative Disclosures About Market Risk and Note 3 to our audited consolidated financial statements.

Marketing/Distribution

We market our products through a variable cost distribution network including, independent agents through national marketing organizations, broker/dealers, banks and registered investment advisors. We emphasize high quality service to our agents and policyholders along with the prompt payment of commissions to our agents. We believe this has been significant in building excellent relationships with our distribution network.

Our independent agents and agencies range in profile from national sales organizations to personal producing general agents. We actively recruit new agents and terminate those agents who have not produced business for us in recent periods and are unlikely to sell our products in the future. In our recruitment efforts, we emphasize that agents have direct access to our executive officers, giving us an edge in recruiting over larger and foreign-owned competitors. We also emphasize our products, service and our focused fixed rate and fixed index annuity expertise. We also have favorable relationships with our national marketing organizations, which have enabled us to efficiently sell through an expanded number of independent agents.

The independent agent distribution system is comprised of insurance brokers and marketing organizations. We are pursuing a strategy to increase the efficiency of our independent agent distribution network by strengthening our relationships with key national and regional marketing organizations and are alert for opportunities to establish relationships with organizations not presently associated with us. These organizations typically recruit agents for us by advertising our products and our commission structure through direct mail advertising or seminars for insurance agents and brokers. These organizations bear most of the cost incurred in marketing our products. We compensate marketing organizations by paying them a percentage of the commissions earned on new annuity policy sales generated by the agents recruited by such organizations. We also conduct incentive programs for marketing organizations and agents from time to time. We generally do not enter into exclusive arrangements with these marketing organizations.

Agents contracted with us through two national marketing organizations accounted for more than 29% of the annuity deposits and insurance premiums collected during 2016 by American Equity Life, and we expect these organizations to continue as marketers for American Equity Life with a focus on selling our products. The states with the largest share of direct premium collected during 2016 were: Florida (9.6%), California (8.6%), Texas (7.2%), Pennsylvania (6.1%) and North Carolina (5.3%).

Eagle Life's fixed index and fixed rate annuities are distributed pursuant to selling agreements with the applicable broker/dealers, banks and registered investment advisors. Relationships with these firms are facilitated by wholesalers who promote Eagle Life and are compensated based upon the sales of the firms that they have contracted with Eagle Life. At December 31, 2016, we had 53 selling agreements in place with broker/dealers. Fourteen of these selling agreements are with broker/dealers affiliated with banks. American Equity Life also is selling through broker/dealers and we have introduced products specifically for this distribution channel.

Competition and Ratings

We operate in a highly competitive industry. Our annuity products compete with fixed index, fixed rate and variable annuities sold by other insurance companies and also with mutual fund products, traditional bank products and other investment and retirement funding alternatives offered by asset managers, banks, and broker/dealers. Our insurance products compete with products of other insurance companies, financial intermediaries and other institutions based on a number of features, including crediting rates, index options, policy terms and conditions, service provided to distribution channels and policyholders, ratings, reputation and distributor compensation.

4

The sales agents for our products use the ratings assigned to an insurer by independent rating agencies as one factor in determining which insurer's annuity to market. The degree to which ratings adjustments have affected and will affect our sales and persistency is unknown. Following is a summary of American Equity Life's financial strength ratings:

	Financial Strength Rating	Outlook Statement
A.M. Best Company
January 2011—current	A-	Stable
Standard & Poor's
August 2015—current	A-	Stable
June 2013—August 2015	BBB+	Positive
October 2011—June 2013	BBB+	Stable
Fitch Ratings
May 2013—Current	BBB+	Stable

Financial strength ratings generally involve quantitative and qualitative evaluations by rating agencies of a company's financial condition and operating performance. Generally, rating agencies base their ratings upon information furnished to them by the insurer and upon their own investigations, studies and assumptions. Ratings are based upon factors of concern to policyholders, agents and intermediaries and are not directed toward the protection of investors and are not recommendations to buy, sell or hold securities.

In addition to the financial strength ratings, rating agencies use an "outlook statement" to indicate a medium or long-term trend which, if continued, may lead to a rating change. A positive outlook indicates a rating may be raised and a negative outlook indicates a rating may be lowered. A stable outlook is assigned when ratings are not likely to be changed. Outlook statements should not be confused with expected stability of the insurer's financial or economic performance. A rating may have a "stable" outlook to indicate that the rating is not expected to change, but a "stable" outlook does not preclude a rating agency from changing a rating at any time without notice.

In December 2016, A.M. Best changed its rating outlook on the U.S. life/annuity sector from stable to negative citing increased volatility across economic and regulatory fronts, which includes continuing interest rate pressures. In January 2016, Standard & Poor's affirmed its outlook on the U.S. life insurance sector as stable. The rating agencies have heightened the level of scrutiny they apply to insurance companies, increased the frequency and scope of their credit reviews and may adjust upward the capital and other requirements employed in the rating agency models for maintenance of certain ratings levels.

A.M. Best Company ratings currently range from "A++" (Superior) to "F" (In Liquidation), and include 16 separate ratings categories. Within these categories, "A++" (Superior) and "A+" (Superior) are the highest, followed by "A" (Excellent) and "A-" (Excellent) then followed by "B++" (Good) and "B+" (Good). Publications of A.M. Best Company indicate that the "A-" rating is assigned to those companies that, in A.M. Best Company's opinion, have demonstrated an excellent ability to meet their ongoing obligations to policyholders.

Standard & Poor's insurer financial strength ratings currently range from "AAA (extremely strong)" to "R (under regulatory supervision)", and include 21 separate ratings categories, while "NR" indicates that Standard & Poor's has no opinion about the insurer's financial strength. Within these categories, "AAA" and "AA" are the highest, followed by "A" and "BBB". Publications of Standard & Poor's indicate that an insurer rated "A-" is regarded as having strong financial security characteristics, but is somewhat more likely to be affected by adverse business conditions than are higher rated insurers.

Fitch Rating's insurer financial strength ratings currently range from "AAA (exceptionally strong)" to "C (distressed)." Ratings of "BBB-" and higher are considered to be "secure," and those of "BB+" and lower are considered to be "vulnerable."

A.M. Best Company, Standard & Poor's and Fitch review their ratings of insurance companies from time to time. There can be no assurance that any particular rating will continue for any given period of time or that it will not be changed or withdrawn entirely if, in their judgment, circumstances so warrant. If our ratings were to be negatively adjusted for any reason, we could experience a material decline in the sales of our products and the persistency of our existing business, as well as an increase in the cost of debt or equity financing.

5

Reinsurance

We follow the industry practice of reinsuring a portion of our annuity risks with unaffiliated reinsurers. Our reinsurance agreements play a part in managing our regulatory capital.

Coinsurance

American Equity Life has three coinsurance agreements with Athene Life Re Ltd. ("Athene"), an unauthorized life reinsurer domiciled in Bermuda. One agreement ceded 20% of certain of American Equity Life's fixed index annuities issued from January 1, 2009 through March 31, 2010. The business reinsured under this agreement is not eligible for recapture until the end of the month following seven years after the date of issuance of the policy. The second agreement ceded 80% of American Equity Life's multi-year rate guaranteed annuities issued from July 1, 2009 through December 31, 2013 and 80% of Eagle Life's multi-year rate guaranteed annuities issued from November 20, 2013 through December 31, 2013. The business reinsured under this agreement may not be recaptured. The third agreement cedes 80% of American Equity Life's and Eagle Life's multi-year rate guaranteed annuities issued on or after January 1, 2014, 80% of Eagle Life's fixed index annuities issued on or after January 1, 2014 and 80% of certain of American Equity Life's fixed index annuities issued from August 1, 2016 through December 31, 2016. The reinsurance agreement specifies that the coinsurance percentage for Eagle Life's fixed index annuities decreases to 50% for policies issued between January 1, 2017 and December 31, 2018, and to 20% for policies issued on or after January 1, 2019. The business reinsured under this agreement may not be recaptured. American Equity Life is an intermediary for reinsurance of Eagle Life's business ceded to Athene. American Equity Life and Eagle Life remain liable to policyholders with respect to the policy liabilities ceded to Athene should Athene fail to meet the obligations it has coinsured. The annuity deposits that have been ceded to Athene are held in trusts and American Equity Life is named as the sole beneficiary of the trusts. The assets in the trusts are required to remain at a value that is sufficient to support the current balance of policy benefit liabilities of the ceded business on a statutory basis. If the value of the trust accounts would ever be less than the amount of the ceded policy benefit liabilities on a statutory basis, Athene is required to either establish a letter of credit or deposit securities in the trusts for the amount of any shortfall. None of the coinsurance deposits with Athene are deemed by management to be uncollectible.

American Equity Life has two coinsurance agreements with EquiTrust Life Insurance Company ("EquiTrust"), covering 70% of certain of American Equity Life's fixed index and fixed rate annuities issued from August 1, 2001 through December 31, 2001, 40% of those contracts issued during 2002 and 2003, and 20% of those contracts issued from January 1, 2004 to July 31, 2004. The business reinsured under these agreements may not be recaptured. We remain liable to policyholders with respect to the policy liabilities ceded to EquiTrust should EquiTrust fail to meet the obligations it has coinsured. EquiTrust has received a financial strength rating of "B++" (Good) with a stable outlook from A.M. Best Company. None of the coinsurance deposits with EquiTrust are deemed by management to be uncollectible.

Financing Arrangements

American Equity Life has a reinsurance agreement with Hannover Life Reassurance Company of America, ("Hannover"), which is treated as reinsurance under statutory accounting practices and as a financing arrangement under U.S. generally accepted accounting principles ("GAAP"). The statutory surplus benefit under this agreement is eliminated under GAAP and the associated charges are recorded as risk charges and included in other operating costs and expenses in the consolidated statements of operations. The agreement became effective July 1, 2013 and is a yearly renewable term reinsurance agreement for statutory purposes covering 45.6% of waived surrender charges related to penalty free withdrawals, deaths and lifetime income benefit rider payments as well as lifetime income benefit rider payments in excess of policy fund values on certain business. We may recapture the risks reinsured under this agreement as of the end of any quarter after December 31, 2020 and the agreement, as amended, makes it punitive to us if we do not recapture the business ceded by the first quarter of 2021.

Indemnity Reinsurance

Consistent with the general practice of the life insurance industry, American Equity Life enters into agreements of indemnity reinsurance with other insurance companies in order to reinsure portions of the coverage provided by its annuity, life and accident and health insurance products. Indemnity reinsurance agreements are intended to limit a life insurer's maximum loss on a large or unusually hazardous risk or to diversify its risks. Indemnity reinsurance does not discharge the original insurer's primary liability to the insured.

The maximum loss retained by us on any one life insurance policy we have issued was $0.1 million or less as of December 31, 2016. American Equity Life's reinsured business under indemnity reinsurance agreements is primarily ceded to two reinsurers. Reinsurance related to life and accident and health insurance that was ceded by us to these reinsurers was immaterial.

We believe the assuming companies will be able to honor all contractual commitments, based on our periodic review of their financial statements, insurance industry reports and reports filed with state insurance departments.

For more information regarding reinsurance, see Note 7 to our audited consolidated financial statements. For risks involving reinsurance see "Item 1A. Risk Factors - Our reinsurance program involves risks because we remain liable with respect to the liabilities ceded to reinsurers if the reinsurers fail to meet the obligations assumed by them."

6

Regulation

Life insurance companies are subject to regulation and supervision by the states in which they transact business. State insurance laws establish supervisory agencies with broad regulatory authority, including the power to:

• grant and revoke licenses to transact business;

• regulate and supervise trade practices and market conduct;

• establish guaranty associations;

• license agents;

• approve policy forms;

• approve premium rates for some lines of business;

• establish reserve requirements;

• prescribe the form and content of required financial statements and reports;

• determine the reasonableness and adequacy of statutory capital and surplus;

• perform financial, market conduct and other examinations;

• define acceptable accounting principles for statutory reporting;

• regulate the type and amount of permitted investments; and

• limit the amount of dividends and surplus note payments that can be paid without obtaining regulatory approval.

Our life subsidiaries are subject to periodic examinations by state regulatory authorities. In 2015, the Iowa Insurance Division completed financial examinations of American Equity Life and Eagle Life for the five year period ending December 31, 2013. There were no adjustments to American Equity Life's or Eagle Life's statutory financial statements as a result of these examinations. The New York Insurance Department is currently conducting a financial examination of American Equity Investment Life Insurance Company of New York for the three year period ending December 31, 2013.

The payment of dividends or the distributions, including surplus note payments, by our life subsidiaries is subject to regulation by each subsidiary's state of domicile's insurance department. Currently, American Equity Life may pay dividends or make other distributions without the prior approval of the Iowa Insurance Commissioner, unless such payments, together with all other such payments within the preceding twelve months, exceed the greater of (1) American Equity Life's statutory net gain from operations for the preceding calendar year, or (2) 10% of American Equity Life's statutory surplus at the preceding December 31. For 2017, up to $272.7 million can be distributed as dividends by American Equity Life without prior approval of the Iowa Insurance Commissioner. In addition, dividends and surplus note payments may be made only out of earned surplus, and all surplus note payments are subject to prior approval by regulatory authorities. American Equity Life had $1.4 billion of statutory earned surplus at December 31, 2016.

Most states have also enacted regulations on the activities of insurance holding company systems, including acquisitions, extraordinary dividends, the terms of surplus notes, the terms of affiliate transactions and other related matters. We are registered pursuant to such legislation in Iowa. A number of state legislatures have also considered or have enacted legislative proposals that alter and, in many cases, increase the authority of state agencies to regulate insurance companies and holding company systems.

Most states, including Iowa and New York where our life subsidiaries are domiciled, have enacted legislation or adopted administrative regulations affecting the acquisition of control of insurance companies as well as transactions between insurance companies and persons controlling them. The nature and extent of such legislation and regulations currently in effect vary from state to state. However, most states require administrative approval of the direct or indirect acquisition of 10% or more of the outstanding voting securities of an insurance company incorporated in the state. The acquisition of 10% of such securities is generally deemed to be the acquisition of "control" for the purpose of the holding company statutes and requires not only the filing of detailed information concerning the acquiring parties and the plan of acquisition, but also administrative approval prior to the acquisition. In many states, the insurance authority may find that "control" in fact does not exist in circumstances in which a person owns or controls more than 10% of the voting securities.

Historically, the federal government has not directly regulated the business of insurance. However, federal legislation and administrative policies in several areas, including pension regulation, age and sex discrimination, financial services regulation, securities regulation and federal taxation can significantly affect the insurance business. Additionally, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the "Dodd-Frank Act") generally provides for enhanced federal supervision of financial institutions, including insurance companies in certain circumstances, and financial activities that represent a systemic risk to financial stability or the U.S. economy. Under the Dodd-Frank Act, a Federal Insurance Office has been established within the U.S. Treasury Department to monitor all aspects of the insurance industry and its authority may extend to our business, although the Federal Insurance Office is not empowered with any general regulatory authority over insurers. The director of the Federal Insurance Office serves in an advisory capacity to the Financial Stability Oversight Council ("FSOC") and has the ability to recommend that an insurance company be subject to heightened prudential standards by the Federal Reserve, if it is determined that financial distress at the company could pose a threat to financial stability in the U.S. The Dodd-Frank Act also provides for the preemption of state laws when inconsistent with certain international agreements.

On April 6, 2016, the U.S. Department of Labor released a final regulation which substantially expands the range of activities that will be considered fiduciary advice under the Employee Retirement Income Security Act of 1974 and the Internal Revenue Code of 1986. If the regulation is not overturned by pending lawsuits or otherwise delayed, repealed or revised, implementation is scheduled to phase in beginning April 10, 2017. The success of efforts to overturn, delay, repeal or revise the regulation cannot be predicted. We believe it could materially impact our business and have an adverse effect on sales of annuity products to individual retirement account (“IRAs”) holders, particularly index annuity products sold in the independent insurance agent distribution channel. A significant portion of our annuity sales are to IRAs. The new regulation deems advisors, including independent insurance agents, who sell fixed index annuities to IRAs, IRA rollovers or 401(k) plans fiduciaries and

7

prohibits them from receiving compensation unless they comply with a prohibited transaction exemption. Although the precise impact of the final regulation is difficult to assess, compliance with the prohibited transaction exemptions will likely result in increased regulatory burdens, decreases in sales, changes to our compensation practices and product offerings and increased litigation risk, which could negatively impact our business, results of operations or financial condition.

State insurance regulators and the National Association of Insurance Commissioners ("NAIC") are continually reexamining existing laws and regulations and developing new legislation for passage by state legislatures and new regulations for adoption by insurance authorities. Proposed laws and regulations or those still under development pertain to insurer solvency and market conduct and in recent years have focused on:

• insurance company investments;

• risk-based capital ("RBC") guidelines, which consist of regulatory targeted surplus levels based on the relationship of statutory capital and surplus, with prescribed adjustments, to the sum of stated percentages of each element of a specified list of company risk exposures;

• the implementation of non-statutory guidelines and the circumstances under which dividends may be paid;

• principles-based reserving;

• own risk solvency and enterprise risk management assessment;

• cybersecurity assessments;

• product approvals;

• agent licensing;

• underwriting and suitability practices; and

• life insurance and annuity sales practices.

The NAIC's RBC requirements are intended to be used by insurance regulators as an early warning tool to identify deteriorating or weakly capitalized insurance companies for the purpose of initiating regulatory action. The RBC formula defines a minimum capital standard which supplements low, fixed minimum capital and surplus requirements previously implemented on a state-by-state basis. Such requirements are not designed as a ranking mechanism for adequately capitalized companies.

The NAIC's RBC requirements provide for four levels of regulatory attention depending on the ratio of a company's total adjusted capital to its RBC. Adjusted capital is defined as the total of statutory capital and surplus, asset valuation reserve and certain other adjustments. Calculations using the NAIC formula at December 31, 2016, indicated that American Equity Life's ratio of total adjusted capital to the highest level at which regulatory action might be initiated was 342%.

Our life subsidiaries also may be required, under the solvency or guaranty laws of most states in which they do business, to pay assessments up to certain prescribed limits to fund policyholder losses or liabilities of insolvent insurance companies. These assessments may be deferred or forgiven under most guaranty laws if they would threaten an insurer's financial strength and, in certain instances, may be offset against future premium taxes.

Federal Income Tax

The annuity and life insurance products that we market generally provide the policyholder with a federal income tax advantage, as compared to certain other savings investments such as certificates of deposit and taxable bonds, in that federal income taxation on any increases in the contract values (i.e., the "inside build-up") of these products is deferred until it is received by the policyholder. With other savings investments, the increase in value is generally taxed each year as it is realized. Additionally, life insurance death benefits are generally exempt from income tax.

From time to time, various tax law changes have been proposed that could have an adverse effect on our business, including the elimination of all or a portion of the income tax advantage described above for annuities and life insurance. If legislation were enacted to eliminate the tax deferral for annuities, such a change would have an adverse effect on our ability to sell non-qualified annuities. Non-qualified annuities are annuities that are not sold to an individual retirement account or other qualified retirement plan.

Since 2013, distributions from non-qualified annuity policies are considered "investment income" for purposes of the Medicare tax on investment income contained in the Health Care and Education Reconciliation Act of 2010. As a result, in certain circumstances a 3.8% tax ("Medicare Tax") may be applied to some or the entire taxable portion of distributions from non-qualified annuities to individuals whose income exceeds certain threshold amounts. This tax may have an adverse effect on our ability to sell non-qualified annuities to individuals whose income exceeds these threshold amounts.

Employees

As of December 31, 2016, we had 530 full-time employees. We have experienced no work stoppages or strikes and consider our relations with our employees to be excellent. None of our employees are represented by a union.

Item 1A.    Risk Factors

We are exposed to significant financial and capital risk, including changing interest rates and credit spreads which may have an adverse effect on sales of our products, profitability, investment portfolio and reported book value per share.

Future changes in interest rates and credit spreads may result in fluctuations in the income derived from our investments. These and other factors could have a material adverse effect on our financial condition, results of operations or cash flows.

8

Interest rate and credit spread risk. Our interest rate risk is related to market price and changes in cash flow. Substantial and sustained increases and decreases in market interest rates can materially and adversely affect the profitability of our products, our ability to earn predictable returns, the fair value of our investments and the reported value of stockholders' equity. A rise in interest rates, in the absence of other countervailing changes, will decrease the unrealized gain position of our investment portfolio and may result in an unrealized loss position. With respect to our available for sale fixed maturity securities, such declines in value (net of income taxes and certain adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements) reduce our reported stockholders' equity and book value per share.

If interest rates rise dramatically within a short period of time, our business may be exposed to disintermediation risk. Disintermediation risk is the risk that our policyholders may surrender all or part of their contracts in a rising interest rate environment, which may require us to sell assets in an unrealized loss position. Alternatively, we may increase crediting rates to retain business and reduce the level of assets that may need to be sold at a loss. However, such action would reduce our investment spread and net income.

Due to the long-term nature of our annuity liabilities, sustained declines in long-term interest rates may result in increased redemptions of our fixed maturity securities that are subject to call redemption prior to maturity by the issuer or prepayments of commercial mortgage loans and expose us to reinvestment risk. If we are unable to reinvest the proceeds from such redemptions into investments with credit quality and yield characteristics of the redeemed or prepaid investments, our net income and overall financial performance may be adversely affected. We have a certain ability to mitigate this risk by lowering crediting rates on our products subject to certain restrictions as discussed below.

Our exposure to credit spreads is related to market price and changes in cash flows related to changes in credit spreads. If credit spreads widen significantly it could result in greater investment income on new investments but would also indicate growing concern about the ability of credit issuers to service their debt which could result in additional other than temporary impairments. If credit spreads tighten significantly it could result in reduced net investment income from new purchases of fixed maturity securities or fundings of commercial mortgage loans.

Credit risk. We are subject to the risk that the issuers of our fixed maturity securities and other debt securities and borrowers on our commercial mortgages, will default on principal and interest payments, particularly if a major downturn in economic activity occurs. An increase in defaults on our fixed maturity securities and commercial mortgage loan portfolios could harm our financial strength and reduce our profitability.

Credit and cash flow assumption risk is the risk that issuers of securities, mortgagees on mortgage loans or other parties, including derivatives counterparties, default on their contractual obligations or experience adverse changes to their contractual cash flow streams. We attempt to minimize the adverse impact of this risk by monitoring portfolio diversification and exposure by asset class, creditor, industry, and by complying with investment limitations governed by state insurance laws and regulations as applicable. We also consider all relevant objective information available in estimating the cash flows related to residential and commercial mortgage backed securities.

We use derivative instruments to fund the annual credits on our fixed index annuities. We purchase derivative instruments, consisting primarily of one-year call options, from a number of counterparties. Our policy is to acquire such options only from counterparties rated "A-"or better by a nationally recognized rating agency and the maximum credit exposure to any single counterparty is subject to concentration limits. In addition, we have entered into credit support agreements with our counterparties which allow us to require our counterparties to post collateral to secure their obligations to us under the derivative instruments. If our counterparties fail to honor their obligations under the derivative instruments, our revenues may not be sufficient to fund the annual index credits on our fixed index annuities. Any such failure could harm our financial strength and reduce our profitability.

Liquidity risk. We could have difficulty selling our private placement securities and commercial mortgage loans because they are less liquid than our publicly traded securities. If we require significant amounts of cash on short notice, we may have difficulty selling these securities and loans at attractive prices or in a timely manner, or both.

Fluctuations in interest rates and investment spread could adversely affect our financial condition, results of operations and cash flows.

A key component of our net income is the investment spread. A narrowing of investment spreads may adversely affect operating results. Although we have the right to adjust interest crediting rates (cap, participation or asset fee rates for fixed index annuities) on most products, changes to crediting rates may not be sufficient to maintain targeted investment spreads in all economic and market environments. In general, our ability to lower crediting rates is subject to minimum crediting rates filed with and approved by state regulators. In addition, competition and other factors, including the potential for increases in surrenders and withdrawals, may limit our ability to adjust or maintain crediting rates at levels necessary to avoid the narrowing of spreads under certain market conditions. Our policy structure generally provides for resetting of policy crediting rates at least annually and imposes withdrawal penalties for withdrawals during the first 5 to 17 years a policy is in force.

Managing the investment spread on our fixed index annuities is more complex than it is for fixed rate annuity products. We manage the index-based risk component of our fixed index annuities by purchasing call options on the applicable indices to fund the annual index credits on these annuities and by adjusting the caps, participation rates and asset fees on policy anniversary dates to reflect changes in the cost of such options which varies based on market conditions. The price of such options generally increases with increases in the volatility in both the indices and interest rates, which may either narrow the spread or cause us to lower caps or participation rates. Thus, the volatility of the cost of the indices adds an additional degree of uncertainty to the profitability of the index products. We attempt to mitigate this risk by resetting caps, participation rates and asset fees annually on the policy anniversaries.

9

Persistent environment of low interest rates affects and may continue to negatively affect our results of operations and financial condition.

Prolonged periods of low interest rates may have a negative impact on our ability to sell our fixed index annuities as consumers look for other financial instruments with potentially higher yields to fund retirement. In times of low interest rates, such as we have been experiencing since 2010 and which we may continue to experience in 2017, it is difficult to offer attractive rates and benefits to customers while maintaining profitability, which may limit sales growth of interest sensitive products.

Sustained declines in interest rates may subject us to lower returns on our invested assets, and we have had to and may have to continue to invest the cash we receive from premiums and interest or return of principal on our investments in instruments with yields less than those we currently own. This may reduce our future net investment income and compress the spread on our annuity products. Further, borrowers may prepay fixed maturity securities and commercial mortgage loans in order to borrow at lower market rates. Any related prepayment fees are recorded in net investment income and may create income statement volatility.

An environment of rising interest rates may materially affect our liquidity and financial condition.

Periods of rising interest rates may cause increased policy surrenders and withdrawals as policyholders seek financial instruments with higher returns, commonly referred to as disintermediation. This may lead to net cash outflows and the resulting liquidity demands may require us to sell investment assets when the prices of those assets are adversely affected by the increase in interest rates, which may result in realized investment losses. Further, a portion of our investment portfolio consists of commercial mortgage loans and privately placed securities, which are relatively illiquid, thus increasing our liquidity risk in the event of disintermediation. We may also be required to accelerate the amortization of deferred policy acquisition costs and deferred sales inducements related to surrendered contracts, which would adversely affect our results of operations.

During such times, we may offer higher crediting rates on new sales of annuity products and increase crediting rates on existing annuity products to maintain or enhance product competitiveness. We may not be able to purchase enough higher yielding assets necessary to fund higher crediting rates and maintain our desired spread, which could result in lower profitability on our business. Alternatively, if we seek to maintain profitability of our products in rising interest rate environments it may be difficult to position our products to offer attractive rates and benefits to customers which may limit sales growth of interest sensitive products.

Our valuation of fixed maturity securities may include methodologies, estimates and assumptions which are subject to differing interpretations and could result in changes to investment valuations that may materially adversely affect our results of operations or financial condition.

Fixed maturity securities are reported at fair value in our consolidated balance sheets. During periods of market disruption including periods of significantly rising or high interest rates, rapidly widening credit spreads or illiquidity, it may be difficult to value certain of our securities if trading becomes less frequent and/or market data becomes less observable. Prices provided by independent broker quotes or independent pricing services that are used in the determination of fair value can vary significantly for a particular security. There may be certain asset classes that were in active markets with significant observable data that become illiquid due to the current financial environment. As such, valuations may include inputs and assumptions that are less observable or require greater judgment as well as valuation methods that require greater judgment. Further, rapidly changing and unprecedented credit conditions could materially impact the valuation of securities as reported in our consolidated financial statements and the period-to-period changes in value could vary significantly. Decreases in value may have a material adverse effect on our results of operations or financial condition.

Defaults on commercial mortgage loans and volatility in performance may adversely affect our business, financial condition and results of operations.

Commercial mortgage loans have the potential to face heightened delinquency and default risk depending on economic conditions which could have a negative impact on the performance of the underlying collateral, resulting in declining values and an adverse impact on the obligors of such instruments. An increase in the default rate of our commercial mortgage loan investments could have an adverse effect on our business, financial condition and results of operations.

In addition, the carrying value of commercial mortgage loans is negatively impacted by such factors. The carrying value of commercial mortgage loans is stated as outstanding principal less any loan loss allowances recognized. Considerations in determining allowances include, but are not limited to, the following: (i) declining debt service coverage ratios and increasing loan to value ratios; (ii) bankruptcy filings of major tenants or affiliates of the borrower on the property; (iii) catastrophic events at the property; and (iv) other subjective events or factors, including whether the terms of the debt will be restructured. There can be no assurance that management's assessment of loan loss allowances on commercial mortgage loans will not change in future periods, which could lead to investment losses.

Conditions in the U.S. and global capital markets and economies could deteriorate in the near future and affect our financial position and our level of earnings from our operations.

The U.S. government has continued to keep interest rates low as a strategy to stimulate the economy. While these strategies have appeared to be successful, any future economic downturn or market disruption could negatively impact our ability to invest funds. Specifically, if market conditions deteriorate in 2017 or beyond:

10

• our investment portfolio could incur additional other than temporary impairments;

• our commercial mortgage loans could experience a greater amount of loss;

• due to potential downgrades in our investment portfolio, we could be required to raise additional capital to sustain our current business in force and new sales of our annuity products, which may be difficult in a distressed market. If capital would be available, it may be at terms that are not favorable to us;

• we may be required to limit growth in sales of our annuity products; and/or

• our liquidity could be negatively affected and we could be forced to limit our operations and our business could suffer, as we need liquidity to pay our policyholder benefits, operating expenses, dividends on our capital stock, and to service our debt obligations.

The principal sources of our liquidity are annuity deposits, investment income and proceeds from the sale, maturity and call of investments. Sources of additional capital in normal markets include the issuance by us of a variety of short and long-term instruments, including equity, debt or other types of securities.

We face competition from companies that have greater financial resources, broader arrays of products and higher ratings, which may impair our ability to retain existing customers, attract new customers and maintain our profitability and financial strength.

We operate in a highly competitive industry. Many of our competitors are substantially larger and enjoy substantially greater financial resources, higher ratings by rating agencies, broader and more diversified product lines and more widespread agency relationships. Our annuity products compete with fixed index, fixed rate and variable annuities sold by other insurance companies and also with mutual fund products, traditional bank products and other retirement funding alternatives offered by asset managers, banks and broker/dealers. Our insurance products compete with those of other insurance companies, financial intermediaries and other institutions based on a number of factors, including premium rates, policy terms and conditions, service provided to distribution channels and policyholders, ratings by rating agencies, reputation and distributor compensation.

While we compete with numerous other companies, we view the following as our most significant competitors:

• Allianz Life Insurance Company of North America;

• Security Benefit Life;

• Great American Life Insurance Company;

• AIG Companies;

• Athene USA Corp; and

• Midland National Life Insurance Company.

Our ability to compete depends in part on returns and other benefits we make available to our policyholders through our annuity contracts. We will not be able to accumulate and retain assets under management for our products if our investment results underperform the market or the competition, since such underperformance likely would result in lower rates to policyholders which could lead to withdrawals and reduced sales.

We compete for distribution sources for our products. We believe that our success in competing for distributors depends on our financial strength, the services we provide to and the relationships we develop with these distributors, as well as offering competitive commission structures. Our distributors are generally free to sell products from whichever providers they wish, which makes it important for us to continually offer distributors products and services they find attractive. If our products or services fall short of distributors' needs, we may not be able to establish and maintain satisfactory relationships with distributors of our products. Our ability to compete in the past has also depended in part on our ability to develop innovative new products and bring them to market more quickly than our competitors. In order for us to compete in the future, we will need to continue to bring innovative products to market in a timely fashion. Otherwise, our revenues and profitability could suffer.

Our reinsurance program involves risks because we remain liable with respect to the liabilities ceded to reinsurers if the reinsurers fail to meet the obligations assumed by them.

Our life insurance subsidiaries cede certain policies to other insurance companies through reinsurance agreements. American Equity Life has three coinsurance agreements with Athene covering $3.9 billion of policy benefit reserves at December 31, 2016 and American Equity Life has entered into two coinsurance agreements with EquiTrust covering $0.7 billion of policy benefit reserves at December 31, 2016. Since Athene is an unauthorized reinsurer, the annuity deposits that have been ceded to Athene are held in trusts and American Equity Life is named as the sole beneficiary of the trusts. The assets in the trusts are required to remain at a value that is sufficient to support the current balance of policy benefit liabilities of the ceded business on a statutory basis. If the value of the assets in the trusts would ever be less than the amount of the ceded policy benefit liabilities on a statutory basis, Athene is required to either establish a letter of credit or deposit securities in the trusts for the amount of any shortfall. We remain liable with respect to the policy liabilities ceded to EquiTrust and Athene should either fail to meet the obligations assumed by them.

In addition, we have entered into other types of reinsurance contracts including indemnity reinsurance and financing arrangements. Should any of these reinsurers fail to meet the obligations assumed under such contracts, we remain liable with respect to the liabilities ceded.

Any disruption in our ability to maintain our reinsurance program may hinder our ability to manage our regulatory capital.

No assurances can be made that reinsurance will remain continuously available to us to the same extent and on the same terms as are currently available. If we were unable to maintain our current level of reinsurance or purchase new reinsurance protection in amounts that we consider sufficient and at prices that we consider acceptable, we would have to accept an increase in our net liability exposure or a decrease in our statutory surplus, reduce the amount of business we write or develop other alternatives to reinsurance.

11

We may experience volatility in net income due to the application of fair value accounting to our derivative instruments.

All of our derivative instruments, including certain derivative instruments embedded in other contracts, are recognized in the balance sheet at their fair values and changes in fair value are recognized immediately in earnings. This impacts certain revenues and expenses we report for our fixed index annuity business as follows:

• We must present the call options purchased to fund the annual index credits on our fixed index annuity products at fair value. The fair value of the call options is based upon the amount of cash that would be required to settle the call options obtained from the counterparties adjusted for the nonperformance risk of the counterparty. We record the change in fair value of these options as a component of our revenues. The change in fair value of derivatives includes the gains or losses recognized at expiration of the option term or upon early termination and changes in fair value for open positions.

• The contractual obligations for future annual index credits are treated as a "series of embedded derivatives" over the expected life of the applicable contracts. Increases or decreases in the fair value of embedded derivatives generally correspond to increases or decreases in equity market performance and changes in the interest rates used to discount the excess of the projected policy contract values over the projected minimum guaranteed contract values. We record the change in fair value of these embedded derivatives as a component of our benefits and expenses in our consolidated statements of operations.

The application of fair value accounting for derivatives and embedded derivatives in future periods to our fixed index annuity business may cause substantial volatility in our reported net income.

Our results of operations and financial condition depend on the accuracy of management assumptions and estimates.

Assumptions and estimates are made regarding expenses and interest rates, tax liability, contingent liabilities, investment performance and other factors related to our business and anticipated results. We rely on these assumptions and estimates when determining period end accruals, future earnings and various components of our consolidated balance sheet. All assumptions and estimates utilized incorporate many factors, none of which can be predicted with certainty. Our actual experiences, as well as changes in estimates, are used to prepare our consolidated statement of operations. To the extent our actual experience and changes in estimates differ from original estimates, our results of operations and financial condition could be materially adversely affected.

The calculations we use to estimate various components of our consolidated balance sheet and consolidated statement of operations are necessarily complex and involve analyzing and interpreting large quantities of data. The assumptions and estimates required for these calculations involve judgment and by their nature are imprecise and subject to changes and revisions over time. Accordingly, our results may be adversely affected from time to time by actual results differing from assumptions, by changes in estimates and by changes resulting from implementing more sophisticated administrative systems and procedures that facilitate the calculation of more precise estimates.

We may face unanticipated losses if there are significant deviations from our assumptions regarding the probabilities that our annuity contracts will remain in force from one period to the next and our assumptions regarding policyholders' utilization of lifetime income benefit riders.

The expected future profitability of our annuity products is based in part upon expected patterns of premiums, expenses and benefits using a number of assumptions, including those related to the probability that a policy or contract will remain in force, or persistency, and mortality. Since no insurer can precisely determine persistency or mortality, actual results could differ significantly from assumptions, and deviations from estimates and assumptions could have a material adverse effect on our business, financial condition or results of operations. For example, actual persistency that is lower than our assumptions could have an adverse impact on future profitability, especially in the early years of a policy or contract primarily because we would be required to accelerate the amortization of expenses we deferred in connection with the acquisition of the policy.

In addition, we set initial crediting rates for our annuity products based upon expected claims and payment patterns, using assumptions for, among other factors, mortality rates of our policyholders. The long-term profitability of these products depends upon how our actual experience compares with our pricing assumptions. For example, if mortality rates are lower than our pricing assumptions, we could be required to make more payments under certain annuity contracts in addition to what we had projected.

In determining the liability from period to period of our lifetime income benefit riders, we must make significant assumptions such as expected index credits, the age when a policyholder may begin to utilize the rider and the number of policyholders that may not utilize the rider at all. Changes in these assumptions can be material. Our experience regarding policyholder activity is limited as we began issuing policies with this rider in 2007. Accordingly, our results of operations could be adversely affected from time to time by actual index credits being different than expected, actual policyholder behavior varying from what we have assumed in determining the liability associated with these riders and by changes in estimates based on this policyholder behavior.

12

If our estimated gross profits decrease significantly from initial expectations we may be required to expense our deferred policy acquisition costs and deferred sales inducements in an accelerated manner, which would reduce our profitability.

Deferred policy acquisition costs are costs that vary with and primarily relate to the acquisition of new business. Deferred sales inducements are contract enhancements such as first-year premium and interest bonuses that are credited to policyholder account balances. These costs are capitalized when incurred and are amortized over the life of the contracts. Current amortization of these costs is generally in proportion to expected gross profits from interest margins and, to a lesser extent, from surrender charges and rider fees. Unfavorable experience with regard to expected expenses, investment returns, mortality or withdrawals may cause acceleration of the amortization of these costs resulting in an increase of expenses and lower profitability.

If we do not manage our growth effectively, our financial performance could be adversely affected; our historical growth rates may not be indicative of our future growth.

We have experienced rapid growth since our formation in December 1995. We intend to continue to grow and further growth will impose significant added responsibilities on our management, including the need to identify, recruit, maintain and integrate additional employees, including management. There can be no assurance that we will be successful in expanding our business or that our systems, procedures and controls will be adequate to support our operations as they expand. In addition, due to our rapid growth and resulting increased size, it may be necessary to expand the scope of our investing activities to asset classes in which we historically have not invested or have not had significant exposure. If we are unable to adequately manage our investments in these classes, our financial condition or operating results in the future could be less favorable than in the past. Further, we have utilized reinsurance in the past to support our growth. The future availability and cost of reinsurance is uncertain. Our failure to manage growth effectively, or our inability to recruit, maintain and integrate additional qualified employees and independent agents, could have a material adverse effect on our business, financial condition or results of operations. In addition, our historical growth rates are not likely to accurately reflect our future growth rates or our growth potential. We cannot assure you that our future revenues will increase or that we will continue to be profitable.

Our operations support complex transactions and are highly dependent on the proper functioning of information technology and communication systems. Any failure of our information technology or communications systems may result in a materially adverse effect on our results of operations and corporate reputation.

While systems and processes are designed to support complex transactions and avoid systems failure, fraud, information security failures, processing errors and breaches of regulation, any failure could lead to a materially adverse effect on our results of operations and corporate reputation. In addition, we must commit significant resources to maintain and enhance our existing systems in order to keep pace with industry standards and customer preferences. If we fail to keep up-to-date information systems, we may not be able to rely on information for product pricing, risk management and underwriting decisions. In addition, even though backup and recovery systems and contingency plans are in place, we cannot assure investors that interruptions, failures or breaches in security of these processes and systems will not occur, or if they do occur, that they can be remediated promptly. The occurrence of any of these events could have a materially adverse effect on our business, results of operations and financial condition.

An information technology failure or security breach may disrupt our business, damage our reputation and adversely affect our results of operations, financial condition and cash flows.

We use information technology ("IT") to store, retrieve, evaluate and utilize customer and company data and information. Our business is highly dependent on our ability to access IT systems to perform necessary business functions such as providing customer support, making changes to existing policies, filing and paying claims, managing our investment portfolios and producing financial statements. While we have policies, procedures, automation and backup plans, and a broad range of information security technical controls designed to prevent or limit the effect of failure, our IT may be vulnerable to disruptions or breaches as a result of natural disasters, man-made disasters, criminal activity, pandemics or other events beyond our control. The failure of our IT for any reason could disrupt our operations, result in the loss of customers and may adversely affect our business, results of operations and financial condition.

We retain confidential information within our IT, and we rely on sophisticated commercial technologies to maintain the security of those systems. Anyone who is able to circumvent our security measures and penetrate our IT could access, view, misappropriate, alter, or delete any information in the systems, including personally identifiable policyholder information and proprietary business information. In addition, an increasing number of states require that persons be notified if a security breach results in the disclosure of personally identifiable customer information. Any compromise of the security of our computer systems that results in inappropriate disclosure of personally identifiable customer information could damage our reputation in the marketplace, deter people from purchasing our products, subject us to significant civil and criminal liability and require us to incur significant technical, legal and other expenses. While there have been attempts to penetrate our IT defenses, there is evidence that the attacks have been blocked and there is no evidence that an IT breach has occurred.

13

If we are unable to attract and retain national marketing organizations, independent agents, broker/dealers, banks and registered investment advisors, sales of our products may be reduced.

We must attract and retain marketing organizations and distributors, including agents to sell our products. Insurance companies compete vigorously for productive agents. We compete with other life insurance companies for marketers and agents primarily on the basis of our financial position, support services, compensation and product features. Such marketers and agents may promote products offered by other life insurance companies that may offer a larger variety of products than we do. Our competitiveness for such marketers and agents also depends upon the long-term relationships we develop with them. We are developing a network of broker/dealers, banks and registered investment advisors to distribute our products. If we are unable to attract and retain sufficient marketers, agents, broker/dealers, banks and registered investment advisors to sell our products, our ability to compete and our sales would suffer.

We may require additional capital to support our business and sustain future growth which may not be available when needed or may be available only on unfavorable terms.

Our long-term strategic capital requirements will depend on many factors including the accumulated statutory earnings of our life insurance subsidiaries and the relationship between the statutory capital and surplus of our life insurance subsidiaries and various elements of required capital. For the purpose of supporting long-term capital requirements, we may need to increase or maintain the statutory capital and surplus of our life insurance subsidiaries through additional financings, which could include debt, equity, financing arrangements and/or other surplus relief transactions. Adverse market conditions have affected and continue to affect the availability and cost of capital. Such financings, if available at all, may be available only on terms that are not favorable to us. If we cannot maintain adequate capital, we may be required to limit growth in sales of new annuity products, and such action could adversely affect our business, financial condition or results of operations.

Changes in state and federal regulation may affect our profitability.

We are subject to regulation under applicable insurance statutes, including insurance holding company statutes, in the various states in which our life insurance subsidiaries transact business. Our life insurance subsidiaries are domiciled in Iowa and New York. We are currently licensed to sell our products in 50 states and the District of Columbia. Insurance regulation is intended to provide safeguards for policyholders rather than to protect shareholders of insurance companies or their holding companies. As increased scrutiny has been placed upon the insurance regulatory framework, a number of state legislatures have considered or enacted legislative proposals that alter, and in many cases increase, state authority to regulate insurance companies and holding company systems.

Regulators oversee matters relating to trade practices, policy forms, claims practices, guaranty funds, types and amounts of investments, reserve adequacy, insurer solvency, minimum amounts of capital and surplus, transactions with related parties, changes in control and payment of dividends.

The NAIC and state insurance regulators continually reexamine existing laws and regulations. The NAIC may develop and recommend adoption of new or modify existing Model Laws and Regulations. State insurance regulators may impose those recommended changes, or others, in the future.

Our life insurance subsidiaries are subject to state insurance regulations based on the NAIC's risk-based capital requirements which are intended to be used by insurance regulators as an early warning tool to identify deteriorating or weakly capitalized insurance companies for the purpose of initiating regulatory action. Our life insurance subsidiaries also may be required, under solvency or guaranty laws of most states in which they do business, to pay assessments up to certain prescribed limits to fund policyholder losses or liabilities for insolvent insurance companies.

Although the federal government does not directly regulate the insurance business, federal legislation and administrative policies in several areas, including pension regulation, age and sex discrimination, financial services regulation, securities regulation and federal taxation, can significantly affect the insurance business. In addition, legislation has been enacted which could result in the federal government assuming some role in the regulation of the insurance industry.

In July 2010, the Dodd-Frank Act was enacted and signed into law. The Dodd-Frank Act made extensive changes to the laws regulating the financial services industry and requires various federal agencies to adopt a broad range of new rules and regulations. Among other things, the Dodd-Frank Act imposes a comprehensive new regulatory regime on the over-the-counter ("OTC") derivatives marketplace. It also requires central clearing for certain derivatives transactions that the U.S. Commodities Futures Trading Commission ("CFTC") determines must be cleared and are accepted for clearing by a "derivatives clearing organization" (subject to certain exceptions) and provides the CFTC with authority to impose position limits across markets. The Dodd-Frank Act and any such regulations may subject us to additional restrictions on our hedging positions which may have an adverse effect on our ability to hedge risks associated with our business, including our fixed index annuity business, or on the cost of our hedging activity.

The Dodd-Frank Act also created Financial Stability Oversight Council ("FSOC"). The FSOC may designate whether certain insurance companies and insurance holding companies pose a grave threat to the financial stability of the United States, in which case such companies would become subject to prudential regulation by the Board of Governors of the U.S. Federal Reserve. The Dodd-Frank Act also established a Federal Insurance Office under the U.S. Treasury Department to monitor all aspects of the insurance industry other than certain health insurance, certain long-term care insurance and crop insurance. It is not possible at this time to assess the impact on our business of the establishment of the Federal Insurance Office and the FSOC. However, the regulatory framework at the state and federal level applicable to our insurance products is evolving. The changing regulatory framework could affect the design of such products and our ability to sell certain products. Any changes in these laws and regulations could materially and adversely affect our business, financial condition or results of operations.

14

On April 6, 2016, the U.S. Department of Labor released a final regulation which substantially expands the range of activities that will be considered to be fiduciary advice under the Employee Retirement Income Security Act of 1974 and the Internal Revenue Code of 1986.  If the regulation is not overturned by pending lawsuits or otherwise delayed, repealed or revised, implementation will phase in beginning April 10, 2017. The success of efforts to overturn, delay, repeal or revise the regulation cannot be predicted. We believe it could materially impact our business and have an adverse effect on sales of annuity products to individual retirement account (“IRA”) holders, particularly index annuity products sold in the independent insurance agent distribution channel.  A significant portion of our annuity sales are to IRAs.  The new regulation deems advisors, including independent insurance agents, who sell fixed index annuities to IRAs, IRA rollovers or 401(k) plans fiduciaries and prohibits them from receiving compensation unless they comply with a prohibited transaction exemption. Although the precise impact of the final regulation is difficult to assess, compliance with the prohibited transaction exemptions will likely result in increased regulatory burdens, decreases in sales, changes to our compensation practices and product offerings and increased litigation risk, which could negatively impact our business, results of operations or financial condition.

The regulatory framework at the state and federal level applicable to our insurance products is evolving. The changing regulatory framework could affect the design of such products and our ability or the ability of our agents to sell certain products. Any changes in these laws and regulations could materially and adversely affect our business, financial condition or results of operations.

Changes in federal income taxation laws, including any reduction in individual income tax rates, may affect sales of our products and profitability.

The annuity and life insurance products that we market generally provide the policyholder with certain federal income tax advantages. For example, federal income taxation on any increases in non-qualified annuity contract values (i.e., the "inside build-up") is deferred until it is received by the policyholder. With other savings instruments, such as certificates of deposit and taxable bonds, the increase in value is generally taxed each year as it is realized. Additionally, life insurance death benefits are generally exempt from income tax. Decreases in individual income tax rates would decrease the advantage of deferring the inside build-up.

From time to time, various tax law changes have been proposed that could have an adverse effect on our business, including the elimination of all or a portion of the income tax advantages described above for annuities and life insurance. If legislation were enacted to eliminate all or a portion of the tax deferral for annuities, such a change would have an adverse effect on our ability to sell non-qualified annuities. Non-qualified annuities are annuities that are not sold to a qualified retirement plan.

Beginning in 2013, distributions from non-qualified annuity policies are now considered "investment income" for purposes of the Medicare tax on investment income contained in the Health Care and Education Reconciliation Act of 2010. As a result, in certain circumstances a 3.8% tax (“Medicare Tax”) may be applied to some or all of the taxable portion of distributions from non-qualified annuities to individuals whose income exceeds certain threshold amounts. This tax may have an adverse effect on our ability to sell non-qualified annuities to individuals whose income exceeds these threshold amounts.

We face risks relating to litigation and regulatory examination, including the costs of such litigation or examination, management distraction and the potential for damage awards, fines, penalties or other required remediation, which may adversely impact our business.

We are occasionally involved in litigation, both as a defendant and as a plaintiff. In addition, state regulatory bodies, such as state insurance departments, the SEC, the Financial Industry Regulatory Authority, Inc. ("FINRA"), the Department of Labor and other regulatory bodies regularly make inquiries and conduct examinations or investigations concerning our compliance with, among other things, insurance laws, securities laws, the Employee Retirement Income Security Act of 1974, as amended, and laws governing the activities of broker/dealers. Companies in the life insurance and annuity business have faced litigation, including class action lawsuits, alleging improper product design, improper sales practices and similar claims.

A downgrade in our credit or financial strength ratings may increase our future cost of capital, reduce new sales, adversely affect relationships with distributors and increase policy surrenders and withdrawals.

Currently, our senior unsecured indebtedness carries, a "BBB-" rating with a stable outlook from Standard & Poor's, a BBB- rating with a stable outlook from Fitch Ratings, and a "bbb-" rating with a stable outlook from A.M. Best Company. Our ability to maintain such ratings is dependent upon the results of operations of our subsidiaries and our financial strength. If we fail to preserve the strength of our balance sheet and to maintain a capital structure that rating agencies deem suitable, it could result in a downgrade of the ratings applicable to our senior unsecured indebtedness. A downgrade would likely reduce the fair value of the common stock and may increase our future cost of capital.

Financial strength ratings are important factors in establishing the competitive position of life insurance and annuity companies. In recent years, the market for annuities has been dominated by those insurers with the highest ratings. A ratings downgrade, or the potential for a ratings downgrade, could have a number of adverse effects on our business. For example, distributors and sales agents for life insurance and annuity products use the ratings as one factor in determining which insurer's annuities to market. A ratings downgrade could cause those distributors and agents to seek alternative carriers. In addition, a ratings downgrade could materially increase the number of policy or contract surrenders we experience, as well as our ability to obtain reinsurance or obtain reasonable pricing on reinsurance.

Financial strength ratings are measures of an insurance company's ability to meet contractholder and policyholder obligations and generally involve quantitative and qualitative evaluations by rating agencies of a company's financial condition and operating performance. Generally, rating agencies base their ratings upon information furnished to them by the insurer and upon their own investigations, studies and assumptions. Ratings are based upon factors of concern to agents, policyholders and intermediaries and are not directed toward the protection of investors and are not recommendations to buy, sell or hold securities.

15

Item 1B.    Unresolved Staff Comments

None.

Item 2.    Properties

We lease commercial office space in two buildings in West Des Moines, Iowa, one for our principal offices under an operating lease that expires on November 30, 2026 and one for our investment operations under a lease that expires on March 31, 2023. We also lease our office in Pell City, Alabama, pursuant to an operating lease that expires on December 31, 2017. We are fully utilizing these facilities and believe these locations to be sufficient to house our operations for the foreseeable future.

Item 3.    Legal Proceedings

See Note 13 to our audited consolidated financial statements.

Item 4.    Mine Safety Disclosures

None

PART II

Item 5.    Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our common stock is traded on the New York Stock Exchange ("NYSE") under the symbol AEL. The following table sets forth the high and low sales prices of our common stock for each quarterly period within the two most recent fiscal years as quoted on the NYSE.

	High	Low
2016
First Quarter	$23.65	$12.65
Second Quarter	$16.96	$12.77
Third Quarter	$18.32	$13.07
Fourth Quarter	$23.41	$15.39
2015
First Quarter	$29.62	$25.46
Second Quarter	$29.90	$25.06
Third Quarter	$30.02	$22.36
Fourth Quarter	$28.30	$22.55

As of December 31, 2016, there were approximately 14,100 holders of our common stock. In 2016 and 2015, we paid an annual cash dividend of $0.24 and $0.22, respectively, per share on our common stock. We intend to continue to pay an annual cash dividend on such shares so long as we have sufficient capital and/or future earnings to do so. However, we anticipate retaining most of our future earnings, if any, for use in our operations and the expansion of our business. Any further determination as to dividend policy will be made by our board of directors and will depend on a number of factors, including our future earnings, capital requirements, financial condition and future prospects and such other factors as our board of directors may deem relevant.

Since we are a holding company, our ability to pay cash dividends depends in large measure on our subsidiaries' ability to make distributions of cash or property to us. Iowa insurance laws restrict the amount of distributions American Equity Life and Eagle Life can pay to us without the approval of the Iowa Insurance Commissioner. See Management's Discussion and Analysis of Financial Condition and Results of Operations and Note 12 to our audited consolidated financial statements, which are incorporated by reference in this Item 5.

Issuer Purchases of Equity Securities

There were no issuer purchases of equity securities for the quarter ended December 31, 2016.

16

Item 6.    Selected Consolidated Financial Data

The summary consolidated financial and other data should be read in conjunction with Management's Discussion and Analysis of Financial Condition and Results of Operations and our audited consolidated financial statements and related notes appearing elsewhere in this report. The results for past periods are not necessarily indicative of results that may be expected for future periods.

	Year ended December 31,
	2016			2015			2014			2013			2012
	(Dollars in thousands, except per share data)
Consolidated Statements of Operations Data:
Revenues
Premiums and other considerations	$	43,767		$	36,048		$	32,623		$	45,347		$	76,675
Annuity product charges	173,579			136,168			118,990			103,591			89,006
Net investment income	1,849,872			1,692,192			1,531,667			1,383,927			1,286,923
Change in fair value of derivatives	164,219			(336,146		)	504,825			1,076,015			221,138
Net realized gains (losses) on investments, excluding other than temporary impairment ("OTTI") losses	11,524			10,211			(4,003		)	40,561			(6,454		)
Net OTTI losses recognized in operations	(22,679		)	(19,536		)	(2,627		)	(6,234		)	(14,932		)
Total revenues	2,220,282			1,518,937			2,168,973			2,610,692			1,652,356
Benefits and expenses
Insurance policy benefits and change in future policy     benefits	52,483			45,458			41,815			53,071			81,481
Interest sensitive and index product benefits	725,472			968,053			1,473,700			1,272,867			808,479
Change in fair value of embedded derivatives	543,465			(464,698		)	32,321			133,968			286,899
Amortization of deferred sales inducements and policy acquisition costs	625,178			495,504			294,997			618,581			252,076
Interest expense on notes and loan payable and subordinated debentures	41,206			41,088			48,492			50,958			41,937
Other operating costs and expenses	102,231			96,218			81,584			91,915			95,495
Total benefits and expenses	2,090,035			1,181,623			1,972,909			2,221,360			1,566,367
Income before income taxes	130,247			337,314			196,064			389,332			85,989
Income tax expense	47,004			117,484			70,041			136,049			28,191
Net income	$	83,243		$	219,830		$	126,023		$	253,283		$	57,798
Per Share Data:
Earnings per common share	$	0.98		$	2.78		$	1.69		$	3.86		$	0.94
Earnings per common share—assuming dilution	0.97			2.72			1.58			3.38			0.89
Dividends declared per common share	0.24			0.22			0.20			0.18			0.15
Non-GAAP Financial Measures (a):
Reconciliation of net income to operating income:
Net income	$	83,243		$	219,830		$	126,023		$	253,283		$	57,798
Net realized investment (gains) losses, including OTTI	7,188			5,737			4,429			(18,170		)	13,397
Change in fair value of derivatives and embedded derivatives - index annuities	56,634			(44,055		)	79,053			(153,267		)	48,406
Change in fair value of derivatives and embedded derivatives - debt	(1,265		)	1,296			104			(2,038		)	4,983
Extinguishment of debt	—			—			12,503			32,515			—
Litigation reserve	(1,957		)	—			(1,418		)	30			14,876
Income taxes	(21,499		)	13,012			(30,048		)	51,067			(29,273		)
Operating income (a non-GAAP financial measure)	$	122,344		$	195,820		$	190,646		$	163,420		$	110,187
Operating income per common share	$	1.44		$	2.48		$	2.56		$	2.49		$	1.80
Operating income per common share—assuming dilution	1.43			2.42			2.39			2.18			1.69

17

	As of and for the Year Ended December 31,
	2016		2015		2014		2013		2012
	(Dollars in thousands, except per share data)
Consolidated Balance Sheet Data:
Total investments	$	44,757,568	$	39,570,332	$	35,981,858	$	30,346,654	$	27,537,210
Total assets	56,053,472		49,029,392		43,976,689		39,605,843		35,122,673
Policy benefit reserves	51,637,026		45,495,431		39,802,861		35,789,655		31,773,988
Notes and loan payable	493,755		393,227		413,805		539,639		304,473
Subordinated debentures	241,853		241,452		241,072		240,713		240,460
Accumulated other comprehensive income ("AOCI")	339,966		201,663		721,401		46,196		686,807
Total stockholders' equity	2,291,595		1,944,535		2,139,876		1,384,687		1,720,237
Other Data:
Life subsidiaries' statutory capital and surplus and asset valuation reserve	2,933,193		2,593,472		2,327,335		1,995,658		1,741,638
Life subsidiaries' statutory net gain from operations before income taxes and realized capital gains (losses)	144,159		227,865		467,923		305,628		182,057
Life subsidiaries' statutory net income	80,699		132,723		344,666		205,112		79,644
Book value per share (b)	26.04		23.83		27.93		19.40		27.46
Book value per share, excluding AOCI (b)	22.17		21.36		18.52		18.75		16.49

(a) In addition to net income, we have consistently utilized operating income, operating income per common share and operating income per common share—assuming dilution, non-GAAP financial measures commonly used in the life insurance industry, as economic measures to evaluate our financial performance. Operating income equals net income adjusted to eliminate the impact of items that fluctuate from year to year in a manner unrelated to core operations and we believe measures excluding their impact are useful in analyzing operating trends. The most significant adjustments to arrive at operating income eliminate the impact of fair value accounting for our fixed index annuity business and are not economic in nature bur rather impact the timing of reported results. We believe the combined presentation and evaluation of operating income together with net income provides information that may enhance an investor's understanding of our underlying results and profitability. The amounts included in the reconciliation of net income to operating income are presented net of related adjustments to amortization of deferred sales inducements and deferred policy acquisition costs.

(b) Book value per share and book value per share excluding AOCI, non-GAAP financial measures, are calculated as total stockholders' equity and total stockholders' equity excluding AOCI divided by the total number of shares of common stock outstanding. Since AOCI fluctuates from year to year due to unrealized changes in the fair value of available for sale investments, we believe these non-GAAP financial measures provide useful supplemental information. Common shares outstanding include shares held by the NMO Deferred Compensation Trust and exclude unallocated shares held by our employee stock ownership plan—see Note 11 to our audited consolidated financial statements.

18

Item 7.    Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's discussion and analysis reviews our consolidated financial position at December 31, 2016 and 2015, and our consolidated results of operations for the three years in the period ended December 31, 2016, and where appropriate, factors that may affect future financial performance. This analysis should be read in conjunction with our audited consolidated financial statements, notes thereto and selected consolidated financial data appearing elsewhere in this report.

Cautionary Statement Regarding Forward-Looking Information

All statements, trend analyses and other information contained in this report and elsewhere (such as in filings by us with the SEC, press releases, presentations by us or our management or oral statements) relative to markets for our products and trends in our operations or financial results, as well as other statements including words such as "anticipate", "believe", "plan", "estimate", "expect", "intend" and other similar expressions, constitute forward-looking statements. We caution that these statements may and often do vary from actual results and the differences between these statements and actual results can be material. Accordingly, we cannot assure you that actual results will not differ materially from those expressed or implied by the forward-looking statements. Factors that could contribute to these differences include, among other things:

• general economic conditions and other factors, including prevailing interest rate levels and stock and credit market performance which may affect (among other things) our ability to sell our products, our ability to access capital resources and the costs associated therewith, the fair value of our investments, which could result in impairments and other than temporary impairments, and certain liabilities, and the lapse rate and profitability of policies;

• customer response to new products and marketing initiatives;

• changes in Federal income tax laws and regulations which may affect the relative income tax advantages of our products;

• increasing competition in the sale of annuities;

• regulatory changes or actions, including those relating to regulation of financial services affecting (among other things) bank sales and underwriting of insurance products and regulation of the sale, underwriting and pricing of products; and

• the risk factors or uncertainties listed from time to time in our filings with the SEC.

For a detailed discussion of these and other factors that might affect our performance, see Item 1A of this report.

Executive Summary

Excellent customer service teamed with our ability to offer innovative insurance products that provide principal protection and lifetime income continued to result in significant sales of our annuity products. In 2016, our sales increased 1% to $7.1 billion which has resulted in cash and investments in excess of $45 billion at December 31, 2016. Our sales for the last five years have ranged from $3.9 billion to $7.1 billion and we have exceeded $4 billion in sales in four of those years. We have applied a conservative investment strategy to the annuity deposits we continue to manage which has provided reliable returns on our invested assets. Our profitability has also been driven by maintaining an efficient operation.

The economic and personal investing environments continued to be conducive for high sales levels as retirees and others look to put their money in instruments that will protect their principal and provide them with consistent cash flow sources in their retirement years. However, our sales slowed in the last half of 2016 as competition in our distribution channels escalated and rates from several of our competitors were appreciably above prior levels. Sales of our products by independent agents may come under pressure during 2017 if the U.S. Department of Labor fiduciary rule is not delayed, repealed, revised or overturned through litigation.

We are currently in the midst of an unprecedented period of low interest rates and low yields for investments with the credit quality we prefer which presents a strong headwind to achieving our target rate for investment spread. In response to this persistent low interest rate environment, we have been reducing policyholder crediting rates for new annuities and existing annuities since the fourth quarter of 2011. Spread results for 2016, 2015 and 2014 reflect the benefit from these reductions; however, the reductions in cost of money have been less than and were offset by continued lower yields from investment purchases.

In August 2015, we completed an underwritten public offering of 9,890,000 shares of our common stock at a public offering price of $25.25 per share, of which 5,590,000 shares were subject to forward sale agreements. We physically settled the forward sales agreements on August 1, 2016 by delivery of those shares of our common stock and contributed the $134.7 million in net proceeds from the settlement to the capital and surplus of American Equity Life to support continued growth and maintain desired financial strength ratings.

On September 30, 2016, we entered into a credit agreement providing for a $100 million term loan that matures on September 30, 2019 and a $150 million unsecured revolving line of credit that matures on September 30, 2021. The $100 million of loan proceeds were contributed to the capital and surplus of American Equity Life on October 3, 2016.

19

Our Business and Profitability

We specialize in the sale of individual annuities (primarily deferred annuities) and, to a significantly lesser extent, we also sell life insurance policies. Under U.S. generally accepted accounting principles ("GAAP"), premium collections for deferred annuities are reported as deposit liabilities instead of as revenues. Similarly, cash payments to policyholders are reported as decreases in the liabilities for policyholder account balances and not as expenses. Sources of revenues for products accounted for as deposit liabilities are net investment income, surrender charges assessed against policy withdrawals and fees deducted from policyholder account balances for lifetime income benefit riders, net realized gains (losses) on investments and changes in fair value of derivatives. Components of expenses for products accounted for as deposit liabilities are interest sensitive and index product benefits (primarily interest credited to account balances), changes in fair value of embedded derivatives, amortization of deferred sales inducements and deferred policy acquisition costs, other operating costs and expenses and income taxes.

Our business model contemplates continued growth in invested assets and operating income while maintaining a high quality investment portfolio that will not experience significant losses from impairments of invested assets. We are committed to maintaining a high quality investment portfolio with limited exposure to below investment grade securities and other riskier assets. Growth in invested assets is predicated on a continuation of our high sales achievements of the last five years while at the same time maintaining a high level of retention of the funds received.

Our profitability depends in large part upon:

• the amount of assets under our management,

• investment spreads we earn on our policyholder account balances,

• our ability to manage our investment portfolio to maximize returns and minimize risks such as interest rate changes and defaults or impairment of investments,

• our ability to manage interest rates credited to policyholders and costs of the options purchased to fund the annual index credits on our fixed index annuities,

• our ability to manage the costs of acquiring new business (principally commissions to agents and bonuses credited to policyholders), and

• our ability to manage our operating expenses.

Earnings from products accounted for as deposit liabilities are primarily generated from the excess of net investment income earned over the interest credited or the cost of providing index credits to the policyholder, or the "investment spread." Our investment spread is summarized as follows:

	Year Ended December 31,
	2016	2015	2014
Average yield on invested assets	4.51%	4.73%	4.90%
Aggregate cost of money	1.90%	1.96%	2.10%
Aggregate investment spread	2.61%	2.77%	2.80%
Impact of:
Investment yield - additional prepayment income	0.06%	0.08%	0.07%
Cost of money benefit from over-hedging	0.01%	0.04%	0.03%

The cost of money for fixed index annuities and average crediting rates for fixed rate annuities are computed based upon policyholder account balances and do not include the impact of amortization of deferred sales inducements. See Critical Accounting Policies—Deferred Policy Acquisition Costs and Deferred Sales Inducements. With respect to our fixed index annuities, the cost of money includes the average crediting rate on amounts allocated to the fixed rate strategy, expenses we incur to fund the annual index credits and where applicable, minimum guaranteed interest credited. Proceeds received upon expiration or early termination of call options purchased to fund annual index credits are recorded as part of the change in fair value of derivatives, and are largely offset by an expense for interest credited to annuity policyholder account balances. See Critical Accounting Policies—Policy Liabilities for Fixed Index Annuities and Financial Condition—Derivative Instruments.

Renewal rate adjustments covering $16 - 17 billion of policyholder account values began on September 1, 2016, and should lower the overall cost of money by 8 basis points when fully implemented. In addition, we began applying renewal rate adjustments on $7.4 billion of policyholder account values beginning on December 6, 2016. These adjustments will be implemented over the next 12 to 15 months on policy anniversary dates and are expected to reduce a portion of the 0.49% cost of money differential between existing rates and guaranteed minimum rates we had at December 31, 2016.

We reduced new money rates on many of our fixed index annuity products by approximately 10 basis points in April 2016 and reduced new money rates on many of our non-bonus fixed index annuity products by approximately 10-25 basis points in August 2016. We also reduced rates three times on our multi-year rate guaranteed annuity products for a total of 55-85 basis points during the second and third quarters of 2016. Investment yields available to us in the third and fourth quarters of 2016 were significantly lower than the first six months of the year. Investment yields at these levels will continue to put downward pressure on our investment spread and product returns.

20

Results of Operations for the Three Years Ended December 31, 2016

Annuity deposits by product type collected during 2016, 2015 and 2014, were as follows:

	Year Ended December 31,
Product Type	2016		2015		2014
	(Dollars in thousands)
Fixed index annuities	$	5,724,758	$	6,791,689	$	3,999,439
Annual reset fixed rate annuities	64,317		45,182		57,273
Multi-year fixed rate annuities	1,303,273		214,356		103,293
Single premium immediate annuities	35,851		32,752		24,580
Total before coinsurance ceded	7,128,199		7,083,979		4,184,585
Coinsurance ceded	1,736,054		471,822		171,124
Net after coinsurance ceded	$	5,392,145	$	6,612,157	$	4,013,461

Annuity deposits before coinsurance ceded increased 1% during 2016 compared to 2015 and increased 69% during 2015 compared to 2014. Over these years, we have remained consistently in the top three companies for sales of fixed index annuities according to Wink's Sales and Market Report published by Wink, Inc. We attribute the continuing significant sales to our attractive product offerings, our consistent presence in the fixed index annuity market, our continued strong relationships with and excellent service provided to our distribution partners, the increased attractiveness of safe money products in volatile markets and lower interest rates on competing products such as bank certificates of deposit. 2016 sales levels were supported by sales of multi-year rate guaranteed (MYGA) fixed annuity products. These products are often emphasized by banks which are an expanding source of distribution for Eagle Life. Our rates on these products were more competitive during the first half of 2016 and together with the larger number of bank distribution relationships, translated into a significant increase in sales of those products.

Annuity deposits before coinsurance ceded from fixed index annuities decreased 16% as compared to 2015. We had robust sales of fixed index annuities by independent agents during the final three quarters of 2015 following the withdrawal in the first quarter of 2015 of a competitor’s guaranteed income product that had been the source of significant competition. This competitor has returned to the market in 2016 and in general the market in the independent agent distribution channel has been more competitive in 2016. Declines in fixed index annuity sales from independent agents has been partially offset by increases in sales from banks and broker-dealers which were up 65% in 2016 to $610.6 million. These increases were attributable to an expansion in the number of distribution relationships selling Eagle Life's fixed index annuities from 42 relationships as of December 31, 2015 to 53 relationships as of December 31, 2016 and increased sales from many of the relationships that were selling Eagle Life's fixed index annuities in both periods.

We coinsure 80% of the premiums received from (1) MYGA fixed annuity products, (2) fixed index annuities sold by Eagle Life through broker/dealers and banks and (3) certain non-bonus fixed index annuity products sold by American Equity Life from August 1, 2016 through December 31, 2016. The increases in coinsurance ceded premiums are attributable to the increases in premiums from these sources. The premiums ceded for American Equity Life's non-bonus fixed index annuities issued from August 1, 2016 through December 31, 2016 were $198.1 million.

Net income, in general, has been positively impacted by the growth in the volume of business in force and the investment spread earned on this business. The average amount of annuity account balances outstanding (net of annuity liabilities ceded under coinsurance agreements) increased 14% to $43.5 billion for the year ended December 31, 2016 compared to $38.1 billion in 2015 and 14% for the year ended December 31, 2015 compared to $33.4 billion in 2014. Our investment spread measured in dollars was $1.0 billion, $924.8 million, and $809.5 million for the years ended December 31, 2016, 2015 and 2014, respectively. As previously mentioned, our investment spread has been negatively impacted by the extended low interest rate environment (see Net investment income).

Net income is also impacted by the change in fair value of derivatives and embedded derivatives which fluctuates from year to year based upon changes in fair values of call options purchased to fund the annual index credits for fixed index annuities and changes in interest rates used to discount the embedded derivative liability. Net income for the years ended December 31, 2016 and 2014 was negatively impacted by decreases in the discount rates used to estimate our embedded derivative liabilities, while net income for the year ended December 31, 2015 was positively impacted by increases in the discount rates used to estimate our embedded derivative liabilities. Net income for the year ended December 31, 2014 was also positively impacted by revisions of assumptions used in determining fixed index annuity embedded derivatives that were made in the second quarter of 2014. These revisions, which consisted of changes in the lapse and expected costs of annual call options assumptions, decreased the change in the fair value of embedded derivatives for the year ended December 31, 2014 by $62.6 million, which after related adjustments to deferred sales inducements and deferred policy acquisition costs and income taxes, increased net income for the year ended December 31, 2014 by $14.8 million (see Change in fair value of embedded derivatives).

21

We periodically revise the key assumptions used in the calculation of amortization of deferred policy acquisition costs and deferred sales inducements retrospectively through an unlocking process when estimates of current or future gross profits/margins (including the impact of realized investment gains and losses) to be realized from a group of products are revised. In addition, we periodically revise the assumptions used in determining reserves held for lifetime income benefit riders as experience develops that is different from our assumptions.

Net income includes effects from unlocking and revisions to assumptions used in determining reserves for lifetime income benefit riders as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Increase (decrease) in amortization of deferred sales inducements	$	35,760		$	(5,612	)	$	(12,595	)
Increase (decrease) in amortization of deferred policy acquisition costs	48,164			(10,970		)	(35,527		)
Increase in interest sensitive and index product benefits	42,002			18,313			12,428
Increase (decrease) in net income	(81,224		)	(1,117		)	22,986

We review these assumptions quarterly and as a result of these reviews, we made adjustments to assumptions used in the calculation of amortization of deferred policy acquisition costs and deferred sales inducements in the first and third quarters of 2016. During the first quarter of 2016, we made adjustments to lower future spread assumptions after comparing investment spread assumptions to actual investment spreads earned in the three months ended December 31, 2015 and March 31, 2016 and determining that decreases in the average yield earned on invested assets resulting from the continued low interest rate environment were creating shortfalls in investment spread and gross profits. During the third quarter of 2016, we made adjustments to extend the period of time in which we assume investment spread will grade up to our long-term spread targets by an additional two years as yields obtained on investments purchased in the third quarter of 2016 were much lower than we had anticipated as a result of the overall decline in investment yields that followed the Brexit vote. In addition, during the third quarter of 2016, revisions to assumptions used in determining reserves held for lifetime income benefit riders described below resulted in a decrease in estimated future gross profits.

The most significant revisions to assumptions used in the calculation of deferred policy acquisition costs and deferred sales inducements in 2015 and 2014 were account balance true-ups, which were favorable to us due to stronger equity market performance than we assumed, favorable adjustments to lapse assumptions to reflect better persistency experienced than assumed and unfavorable adjustments to investment spread to reflect lower spreads being earned than assumed. In 2015, the favorable impact of the account balance true-up and lapse assumption change was largely offset by reductions in estimated future gross profits attributable to revisions to the assumptions for the lifetime income benefit rider liability described below.

The 2016, 2015 and 2014 revisions to reserves for lifetime income benefit riders were consistent with unlocking for deferred policy acquisition costs and deferred sales inducements described above. The 2016 revisions were primarily due to actual index credits on policies being lower than projected over the past four quarters. The most significant assumption change generating the 2015 negative impact on net income was an increase to the primary election age to begin receiving lifetime income from 67 to 70 as our experience has shown that age 70 is the most popular age at which policyholders elect to begin receiving lifetime income benefit payments. The lifetime income benefit payments are determined by applying a payout factor to the rider's benefit base. The payout factors vary by the age at the time the lifetime income is elected. In early versions of the rider, the age band for payout factors was 10 years (i.e. 60-69; 70-79). As a result, policyholders have an incentive to defer their lifetime income election until age 70, when the payout factor stepped up. Subsequent versions of the rider reduced the age bands between payout factors to five years and the rider we currently sell has a different payout factor for every age. With these structures, assumption revisions from any further developments in our experience for primary election age should have a smaller impact than what was experienced in 2015.

In 2014, we retired $138 million aggregate principal amount of two issues of convertible notes. The loss on retirement was $12.5 million ($11.5 million after income taxes). In connection with the retirement of the 2015 notes, we entered into early termination agreements for a corresponding amount of the related 2015 notes hedges and the 2015 warrants. The impact of these partial unwinds decreased the change in fair value of derivatives and net income for the year ended December 31, 2014 by $6.3 million and $3.7 million, respectively (see Note 5 to our audited consolidated financial statements).

Operating income, a non-GAAP financial measure (see reconciliation to net income in Item 6. Selected Consolidated Financial Data) decreased 38% to $122.3 million in 2016 and increased 3% to $195.8 million in 2015 from $190.6 million in 2014.

In addition to net income, we have consistently utilized operating income, a non-GAAP financial measure commonly used in the life insurance industry, as an economic measure to evaluate our financial performance. Operating income equals net income adjusted to eliminate the impact of items that fluctuate from year to year in a manner unrelated to core operations, and we believe measures excluding their impact are useful in analyzing operating trends. The most significant adjustments to arrive at operating income eliminate the impact of fair value accounting for our fixed index annuity business and are not economic in nature but rather impact the timing of reported results. We believe the combined presentation and evaluation of operating income together with net income provides information that may enhance an investor's understanding of our underlying results and profitability.

22

Operating income is not a substitute for net income determined in accordance with GAAP. The adjustments made to derive operating income are important to understanding our overall results from operations and, if evaluated without proper context, operating income possesses material limitations. As an example, we could produce a low level of net income in a given period, despite strong operating performance, if in that period we experience significant net realized losses from our investment portfolio. We could also produce a high level of net income in a given period, despite poor operating performance, if in that period we generate significant net realized gains from our investment portfolio. As an example of another limitation of operating income, it does not include the decrease in cash flows expected to be collected as a result of credit loss OTTI. Therefore, our management reviews net realized investment gains (losses) and analyses of our net investment income, including impacts related to OTTI write-downs, in connection with their review of our investment portfolio. In addition, our management examines net income as part of their review of our overall financial results.

Operating income in 2016, 2015 and 2014 includes effects from unlocking and revisions to assumptions used in determining reserves for living income benefit riders as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Increase (decrease) in amortization of deferred sales inducements	$	36,127		$	(478	)	$	(10,713	)
Increase (decrease) in amortization of deferred policy acquisition costs	47,765			(4,260		)	(33,027		)
Increase in interest sensitive and index product benefits	42,002			18,313			12,428
Increase (decrease) in operating income	(81,202		)	(8,756		)	20,165

Annuity product charges (surrender charges assessed against policy withdrawals and fees deducted from policyholder account balances for lifetime income benefit riders) increased 27% to $173.6 million in 2016 and 14% to $136.2 million in 2015 from $119.0 million in 2014. The components of annuity product charges are set forth in the table that follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Surrender charges	$	51,577		$	46,614		$	47,500
Lifetime income benefit riders (LIBR) fees	122,002			89,554			71,490
	$	173,579		$	136,168		$	118,990
Withdrawals from annuity policies subject to surrender charges	$	429,090		$	373,166		$	387,274
Average surrender charge collected on withdrawals subject to surrender charges	12.0		%	12.5		%	12.3		%
Fund values on policies subject to LIBR fees	$	17,809,659		$	14,296,046		$	12,250,068
Weighted average per policy LIBR fee	0.69		%	0.63		%	0.58		%

The increases in annuity product charges were primarily attributable to increases in fees assessed for lifetime income benefit riders due to a larger volume of business in force subject to the fee and and an increase in the average fees being charged as compared to prior periods. See Interest sensitive and index product benefits below for corresponding expense recognized on lifetime income benefit riders. Surrender charges increased in 2016 due to an increase in withdrawals from annuity policies subject to surrender charges. Surrender charges decreased in 2015 as withdrawals from annuity policies subject to surrender charges decreased as compared to 2014.

Net investment income increased 9% to $1.8 billion in 2016 and 10% to $1.7 billion in 2015 from $1.5 billion in 2014. The increases were principally attributable to the growth in our annuity business and corresponding increases in our invested assets. Average invested assets excluding derivative instruments (on an amortized cost basis) increased 15% to $41.1 billion in 2016 and 14% to $35.9 billion in 2015 compared to $31.3 billion in 2014. The average yield earned on average invested assets was 4.51%, 4.73% and 4.90% for 2016, 2015 and 2014, respectively.

The decrease in yield earned on average invested assets in 2016, 2015 and 2014 was attributable to investment of new premiums and portfolio cash flows during those periods and 2013 at rates below the overall portfolio yield and higher cash balances. The average yield on fixed income securities purchased and commercial mortgage loans funded was 3.66%, 3.87% and 4.22% for the years ended December 31, 2016, 2015 and 2014, respectively. The average balance for cash and short-term investments was $0.9 billion, $0.3 billion and $0.4 billion in 2016, 2015 and 2014, respectively. The average yield on our cash and short-term investments was 0.05%, 0.07% and 0.07% in 2016, 2015 in 2014, respectively. The unfavorable impact from these items was partially offset by prepayment and fee income received resulting in additional net investment income of $23.8 million, $26.9 million and $22.3 million, in 2016, 2015 and 2014, respectively.

23

Change in fair value of derivatives consists of call options purchased to fund annual index credits on fixed index annuities, the 2015 notes hedges related to our 2015 notes and an interest rate swap and interest rate caps that hedge our floating rate subordinated debentures. The components of change in fair value of derivatives are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Call options:
Gain (loss) on option expiration	$	(282,574	)	$	(464,027	)	$	707,520
Change in unrealized gains/losses	447,603			136,106			(185,573		)
2015 notes hedges	—			(4,516		)	(8,934		)
Interest rate swap	(482		)	(2,341		)	(4,863		)
Interest rate caps	(328		)	(1,368		)	(3,325		)
	$	164,219		$	(336,146	)	$	504,825

The differences between the change in fair value of derivatives between years for call options are primarily due to the performance of the indices upon which our call options are based. A substantial portion of our call options are based upon the S&P 500 Index with the remainder based upon other equity and bond market indices. The range of index appreciation (after applicable caps, participation rates and asset fees) for options expiring during these years is as follows:

	Year Ended December 31,
	2016	2015	2014
S&P 500 Index
Point-to-point strategy	0.0 - 8.2%	0.0 - 8.9%	1.0 - 11.5%
Monthly average strategy	0.0 - 8.3%	0.0 - 9.0%	0.8 - 11.1%
Monthly point-to-point strategy	0.0 - 5.0%	0.0 - 12.1%	0.0 - 19.9%
Fixed income (bond index) strategies	0.0 - 10.0%	0.0 - 10.0%	0.0 - 10.0%

The change in fair value of derivatives is also influenced by the aggregate costs of options purchased. The aggregate cost of options has increased primarily due to an increased amount of fixed index annuities in force. The aggregate cost of options is also influenced by the amount of policyholder funds allocated to the various indices and market volatility which affects option pricing. See Critical Accounting Policies - Policy Liabilities for Fixed Index Annuities.

Our 2015 notes matured and were extinguished on September 15, 2015, and the 2015 notes hedges expired on that same date. The fair value of the 2015 notes hedges changed based upon changes in the price of our common stock, interest rates, stock price volatility, dividend yield and the time to expiration of the 2015 notes hedges. Similarly, the fair value of the conversion option obligation to the holders of the 2015 notes changed based upon these same factors and the conversion option obligation was accounted for as an embedded derivative liability with changes in fair value reported in the Change in fair value of embedded derivatives. The amount of the change in fair value of the 2015 notes hedges was typically equal to the amount of the change in the related embedded derivative liability and there typically was an offsetting expense in the change in fair value of embedded derivatives. Due to the partial unwind agreements we entered into in 2014, the decrease in the change in the fair value of the 2015 notes embedded derivative conversion liability exceeded the decrease in the fair value of the 2015 notes hedges by $10.1 million for the year ended December 31, 2014. See Note 5 to our audited consolidated financial statements for a discussion of the unwind agreements, the 2015 notes hedges and the 2015 notes embedded derivative conversion liability.

Net realized gains (losses) on investments, excluding OTTI losses include gains and losses on the sale of securities and impairment losses on mortgage loans on real estate which fluctuate from year to year due to changes in the interest rate and economic environment and the timing of the sale of investments, as well as gains (losses) recognized on real estate owned due to any sales and impairments on long-lived assets. See Note 3 to our audited consolidated financial statements for a detailed presentation of the types of investments that generated the gains (losses).

Losses on available for sale fixed maturity securities were realized primarily due to strategies to reposition the fixed maturity security portfolio that resulted in improved net investment income, risk or duration profiles as they pertain to our asset liability management. Securities were sold at losses in 2016 and 2015 due to our long-term fundamental concern with the issuers' ability to meet their future financial obligations. See Note 4 to our audited consolidated financial statements for additional discussion of allowance for credit losses recognized on mortgage loans on real estate.

Net OTTI losses recognized in operations increased to $22.7 million in 2016 and increased to $19.5 million in 2015 from $2.6 million in 2014. The impairments recognized in 2016 were primarily on three corporate securities with exposure to the telecommunications, materials and energy sectors and two asset-backed securities with exposure to the energy sector. The impairments recognized in 2015 were primarily on two corporate securities with exposure to the metals and mining sector and one asset-backed security with exposure to the energy sector. The impairments recognized in 2014 were on residential mortgage backed securities and were principally due to changes of assumptions regarding loss severity of a number of securities we hold which affected our ongoing analysis of expected cash flow projections. See Financial Condition—Investments and Note 3 to our audited consolidated financial statements for additional discussion of write downs of securities for other than temporary impairments.

24

Interest sensitive and index product benefits decreased 25% to $0.7 billion in 2016 and decreased 34% to $1.0 billion in 2015 from $1.5 billion in 2014. The components of interest sensitive and index product benefits are summarized as follows:

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands)
Index credits on index policies	$	267,995	$	587,705	$	1,096,504
Interest credited (including changes in minimum guaranteed interest for fixed index annuities)	276,032		258,870		284,577
Lifetime income benefit riders	181,445		121,478		92,619
	$	725,472	$	968,053	$	1,473,700

The changes in index credits were attributable to changes in the level of appreciation of the underlying indices (see discussion above under Change in fair value of derivatives) and the amount of funds allocated by policyholders to the respective index options. Total proceeds received upon expiration of the call options purchased to fund the annual index credits were $272.3 million, $602.4 million and $1.1 billion for the years ended December 31, 2016, 2015 and 2014, respectively. The increase in interest credited in 2016 was primarily due to an increase in the total account value of annuity liabilities outstanding receiving a fixed rate of interest. The decrease in interest credited in 2015 was primarily due to a decrease in the average rate credited to the annuity liabilities outstanding receiving a fixed rate of interest. The average amount of annuity liabilities outstanding (net of annuity liabilities ceded under coinsurance agreements) increased 14% to $43.5 billion in 2016 and 14% to $38.1 billion in 2015 from $33.4 billion in 2014. The increases in benefits recognized for lifetime income benefit riders were due to increases in the number of policies with lifetime income benefit riders and correlates to the increase in fees discussed in Annuity product charges, and the impact of revisions to assumptions used in determining reserves held for lifetime income benefit riders. See Net income above for discussion of the impact of changes in the assumptions used in determining reserves for lifetime income benefit riders for the years ended December 31, 2016, 2015 and 2014.

The reserve (net of coinsurance ceded) held for lifetime income benefit riders was $533.4 million and $352.0 million at December 31, 2016 and 2015, respectively.

Amortization of deferred sales inducements, in general, has been increasing each year due to growth in our annuity business and the deferral of sales inducements incurred with respect to sales of premium bonus annuity products. Bonus products represented 88%, 89% and 89% of our net annuity deposits during 2016, 2015 and 2014, respectively. The increases in amortization from these factors have been affected by amortization associated with (1) fair value accounting for derivatives and embedded derivatives utilized in our fixed index annuity business, (2) net realized gains (losses) on investments and net OTTI losses recognized in operations and (3) changes in litigation reserves. Fair value accounting for derivatives and embedded derivatives utilized in our fixed index annuity business creates differences in the recognition of revenues and expenses from derivative instruments including the embedded derivative liabilities in our fixed index annuity contracts. The change in fair value of the embedded derivatives will not correspond to the change in fair value of the derivatives (purchased call options), because the purchased call options are one-year options while the options valued in the fair value of embedded derivatives cover the expected lives of the contracts which typically exceed ten years. Amortization of deferred sales inducements is summarized as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Amortization of deferred sales inducements before gross profit adjustments	$	274,309		$	209,051		$	174,799
Gross profit adjustments:
Fair value accounting for derivatives and embedded derivatives	(21,678		)	1,976			(42,865		)
Net realized gains (losses) on investments, net OTTI losses recognized in operations      and changes in litigation reserves	(1,465		)	(1,637		)	(515		)
Amortization of deferred sales inducements after gross profit adjustments	$	251,166		$	209,390		$	131,419

See Net income and Operating income, a non-GAAP financial measure, above for discussion of the impact of unlocking on amortization of deferred sales inducements for the years ended December 31, 2016, 2015 and 2014. See Critical Accounting Policies—Deferred Policy Acquisition Costs and Deferred Sales Inducements.

25

Change in fair value of embedded derivatives includes changes in the fair value of our fixed index annuity embedded derivatives and changes in the fair value of the embedded derivative related to the conversion option of our 2015 notes and, in 2014, our 2029 notes (see Notes 5 and 9 to our audited consolidated financial statements). The components of change in fair value of embedded derivatives are as follows:

	Year Ended December 31,
	2016		2015			2014
	(Dollars in thousands)
Fixed index annuities—embedded derivatives	$	145,045	$	(825,668	)	$	(532,337	)
Other changes in difference between policy benefit reserves computed using derivative accounting vs. long-duration contracts accounting	398,420		365,486			579,885
2015 notes embedded conversion derivative	—		(4,516		)	(19,036		)
2029 notes embedded conversion derivative	—		—			3,809
	$	543,465	$	(464,698	)	$	32,321

The change in fair value of the fixed index annuity embedded derivatives resulted from (i) changes in the expected index credits on the next policy anniversary dates, which are related to the change in fair value of the call options acquired to fund those index credits discussed above in Change in fair value of derivatives; (ii) changes in discount rates used in estimating our embedded derivative liabilities; and (iii) the growth in the host component of the policy liability. The amounts presented as "Other changes in difference between policy benefit reserves computed using derivative accounting vs. long-duration contracts accounting" represents the total change in the difference between policy benefit reserves for fixed index annuities computed under the derivative accounting standard and the long-duration contracts accounting standard at each balance sheet date, less the change in fair value of our fixed index annuities embedded derivative. See Critical Accounting Policies—Policy Liabilities for Fixed Index Annuities. The primary reasons for the increase in the change in fair value of the fixed index annuity embedded derivatives for 2016 were decreases in the discount rates used in estimating our embedded derivative liabilities and increases in the expected index credits on the next policy anniversary dates resulting from increases in the fair value of the call options acquired to fund these index credits during 2016 as compared to 2015. The primary reasons for the decrease in the change in fair value of the fixed index annuity embedded derivatives for 2015 were increases in the discount rates used in estimating our embedded derivative liabilities and decreases in the expected index credits on the next policy anniversary dates resulting from decreases in the fair value of the call options acquired to fund these index credits during 2015 as compared to 2014. The discount rates used in estimating our embedded derivative liabilities fluctuate from year to year based on changes in the general level of interest rates. See Net income above for discussion of the impact of assumption changes for the fixed index annuity embedded derivatives in 2014.

As discussed above under Change in fair value of derivatives, the fair value of the 2015 notes embedded conversion derivative changes based upon the same factors effecting the changes in the 2015 notes hedges and, in general, the amount for the change in the fair value of the 2015 notes embedded conversion derivative was equal to the amount for the change in fair value of the 2015 notes hedges. See discussion above for explanation of the difference in these amounts for 2014. Prior to November 2014, the conversion option in the 2029 convertible notes was expected to be settled in net shares of our common stock and the conversion option in the 2029 notes was accounted for as equity. In November 2014, we issued a notice of mandatory redemption of all of the 2029 notes that were outstanding at the time the notice was issued and amended the terms of the indenture governing the 2029 notes to provide the holders with the option of receiving the conversion value of their notes entirely in cash rather than cash for the principal amount and net shares for the portion of the conversion value that exceeds the principal amount. As a result of this mandatory redemption and the change in terms, $32.1 million principal amount of the 2029 notes was converted into $69.4 million in cash and $24.6 million in shares of our common stock (897,548 shares). The amendment to the conversion terms resulted in a reclassification of the fair value of the conversion premium for the 2029 notes from equity to an embedded conversion derivative liability. The fair value of the conversion premium on the date of reclassification was $58.1 million. We applied fair value accounting to the embedded derivative liability from the date of reclassification to the dates of settlement of the conversions of the 2029 notes and recognized as expense the $3.8 million increase in the fair value of the embedded derivative liability.

Interest expense on notes and loan payable decreased 2% to $28.2 million in 2016 and decreased 21% to $28.8 million in 2015 from $36.4 million in 2014. The decreases in 2016 and 2015 are primarily attributable to the extinguishment of $22 million and $138 million aggregate principal amount of our convertible senior notes in 2015 and 2014, respectively, which was partially offset in 2016 by interest expense on the $100 million variable rate term loan originated on September 30, 2016. See Note 9 to our audited consolidated financial statements.

Amortization of deferred policy acquisition costs, in general, has been increasing each year due to the growth in our annuity business and the deferral of policy acquisition costs incurred with respect to sales of annuity products. The increases in amortization from these factors have been affected by amortization associated with (1) fair value accounting for derivatives and embedded derivatives utilized in our fixed index annuity business, (2) net realized gains (losses) on investments and net OTTI losses recognized in operations and (3) changes in litigation reserves. As discussed above, fair value accounting for derivatives and embedded derivatives utilized in our fixed index annuity business creates differences in the recognition of revenues and expenses from derivative instruments including the embedded derivative liabilities in our fixed index annuity contracts. Amortization of deferred policy acquisition costs is summarized as follows:

26

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Amortization of deferred policy acquisition costs before gross profit adjustments	$	387,089		$	293,676		$	239,369
Gross profit adjustments:
Fair value accounting for derivatives and embedded derivatives	(11,447		)	(5,611		)	(74,900		)
Net realized gains (losses) on investments, net OTTI losses recognized in operations      and changes in litigation reserves	(1,630		)	(1,951		)	(891		)
Amortization of deferred policy acquisition costs after gross profit adjustments	$	374,012		$	286,114		$	163,578

See Net income and Operating income, a non-GAAP financial measure, above for discussion of the impact of unlocking on amortization of deferred policy acquisition costs for the years ended December 31, 2016, 2015 and 2014. See Critical Accounting Policies—Deferred Policy Acquisition Costs and Deferred Sales Inducements.

Other operating costs and expenses increased 6% to $102.2 million in 2016 and increased 18% to $96.2 million in 2015 from $81.6 million in 2014 and are summarized as follows:

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands)
Salary and benefits	$	53,479	$	48,328	$	43,018
Risk charges	28,276		21,950		17,159
Other	20,476		25,940		21,407
Total other operating costs and expenses	$	102,231	$	96,218	$	81,584

Salary and benefits expense increased in 2016 as compared to 2015 as a result of increase in salary and benefits of $6.6 million due to an increased number of employees related to our growth as well as an expense of $2.6 million related to assumption changes and the execution of an amended and restated retirement agreement with our Executive Chairman. These 2016 increases were offset by a decrease of $3.9 million related to expense recognized under our short-term incentive compensation program and other bonus programs during 2016 as compared to 2015 primarily as a result of the short-term incentive compensation program being paid out at a lower percentage of target in 2016 than in 2015. Salary and benefits expense increased in 2015 as compared to 2014 as a result of an increase in salary and benefits of $2.9 million due to an increased number of employees related to our growth. In addition, salary and benefits expense increased in 2015 as compared to 2014 as a result of an increase of $3.0 million related to expense recognized under our short-term incentive compensation program and other bonus programs primarily as a result of the short-term incentive compensation program being paid out at a higher percentage of target in 2015 than in 2014. These 2015 increases were offset by a decrease of $0.8 million related to compensation costs that vary based on the Company's stock price.

The increases in reinsurance risk charges expense during 2016 and 2015 were due to the growth in our policyholder liabilities subject to a reinsurance agreement pursuant to which we cede excess regulatory reserves to an unaffiliated reinsurer. The regulatory reserves ceded at December 31, 2016, 2015 and 2014 were $638.1 million, $480.7 million and $322.5 million, respectively.

Other expenses decreased in 2016 as compared to 2015 as 2016 benefited from the release of a litigation liability of $2.8 million and the release of a guaranty fund assessment liability of $2.3 million.

Other expenses increased in 2015 as compared to 2014 due to an increase in general expenses related to our growth and strong sales levels achieved in 2015. In addition, 2015 other expenses increased as compared to 2014, as 2014 benefited from reductions in accrued liabilities for litigation and guaranty fund assessment accruals of $3.2 million.

Income tax expense decreased in 2016 and increased in 2015 primarily because of the changes in income before income taxes. The effective income tax rates were 36.1%, 34.8% and 35.7% for 2016, 2015 and 2014, respectively.

Income tax expense and the resulting effective tax rate are based upon two components of income before income taxes ("pretax income") that are taxed at different tax rates. Life insurance income is generally taxed at an effective rate of approximately 35.4% reflecting the absence of state income taxes for substantially all of the states that the life insurance subsidiaries do business in. The income (loss) for the parent company and other non-life insurance subsidiaries is generally taxed at an effective tax rate of 41.5% reflecting the combined federal / state income tax rates. The effective tax rates resulting from the combination of the income tax provisions for the life / non-life sources of income (loss) vary from year to year based primarily on the relative size of pretax income (loss) from the two sources. The effective income tax rate increased in 2016 because the portion of total taxable income from non-life insurance subsidiaries increased significantly, as well as tax exempt investment income decreasing significantly from the prior two years. The effective income tax rate decreased in 2015 because a portion of the 2014 parent company's loss on extinguishment of debt was not deductible resulting in an effective tax rate on the parent company's pretax loss that was less than 41.5%.

27

Financial Condition

Investments

Our investment strategy is to maintain a predominantly investment grade fixed income portfolio, provide adequate liquidity to meet our cash obligations to policyholders and others and maximize current income and total investment return through active investment management. Consistent with this strategy, our investments principally consist of fixed maturity securities and mortgage loans on real estate.

Insurance statutes regulate the type of investments that our life subsidiaries are permitted to make and limit the amount of funds that may be used for any one type of investment. In light of these statutes and regulations and our business and investment strategy, we generally seek to invest in United States government and government-sponsored agency securities, corporate securities, residential and commercial mortgage backed securities, other asset backed securities and United States municipalities, states and territories securities rated investment grade by established nationally recognized statistical rating organizations ("NRSRO's") or in securities of comparable investment quality, if not rated and commercial mortgage loans on real estate.

The composition of our investment portfolio is summarized as follows:

	December 31,
	2016				2015
	Carrying Amount		Percent		Carrying Amount		Percent
	(Dollars in thousands)
Fixed maturity securities:
United States Government full faith and credit	$	11,805	—	%	$	471,256	1.2	%
United States Government sponsored agencies	1,344,787		3.0	%	1,398,611		3.5	%
United States municipalities, states and territories	3,926,950		8.8	%	3,755,367		9.5	%
Foreign government obligations	232,233		0.5	%	212,565		0.5	%
Corporate securities	27,195,351		60.8	%	23,879,016		60.3	%
Residential mortgage backed securities	1,254,835		2.8	%	1,462,072		3.7	%
Commercial mortgage backed securities	5,365,235		12.0	%	4,174,396		10.5	%
Other asset backed securities	1,806,123		4.0	%	1,145,178		2.9	%
Total fixed maturity securities	41,137,319		91.9	%	36,498,461		92.1	%
Mortgage loans on real estate	2,480,956		5.5	%	2,435,257		6.2	%
Derivative instruments	830,519		1.9	%	337,256		0.9	%
Other investments	308,774		0.7	%	299,358		0.8	%
	$	44,757,568	100.0	%	$	39,570,332	100.0	%

Fixed Maturity Securities

Our fixed maturity security portfolio is managed to minimize risks such as interest rate changes and defaults or impairments while earning a sufficient and stable return on our investments. The largest portion of our fixed maturity securities are in investment grade (NAIC designation 1 or 2) publicly traded or privately placed corporate securities.

A summary of our fixed maturity securities by NRSRO ratings is as follows:

	December 31,
	2016				2015
Rating Agency Rating	Carrying Amount		Percent of Fixed Maturity Securities		Carrying Amount		Percent of Fixed Maturity Securities
	(Dollars in thousands)
Aaa/Aa/A	$	26,431,700	64.3	%	$	23,724,648	65.0	%
Baa	13,002,964		31.6	%	11,491,609		31.5	%
Total investment grade	39,434,664		95.9	%	35,216,257		96.5	%
Ba	1,048,379		2.5	%	657,760		1.8	%
B	155,619		0.4	%	68,712		0.2	%
Caa	79,763		0.2	%	91,998		0.3	%
Ca and lower	418,894		1.0	%	463,734		1.2	%
Total below investment grade	1,702,655		4.1	%	1,282,204		3.5	%
	$	41,137,319	100.0	%	$	36,498,461	100.0	%

28

The NAIC's Securities Valuation Office ("SVO") is responsible for the day-to-day credit quality assessment and the valuation of fixed maturity securities owned by state regulated insurance companies. The purpose of such assessment and valuation is for determining regulatory capital requirements and regulatory reporting. Insurance companies report ownership to the SVO when such securities are eligible for regulatory filings. The SVO conducts credit analysis on these securities for the purpose of assigning a NAIC designation and/or unit price. Typically, if a security has been rated by a NRSRO, the SVO utilizes that rating and assigns a NAIC designation based upon the following system:

NAIC Designation	NRSRO Equivalent Rating
1	Aaa/Aa/A
2	Baa
3	Ba
4	B
5	Caa
6	Ca and lower

For most of the bonds held in our portfolio the NAIC designation matches the NRSRO equivalent rating. However, for certain loan-backed and structured securities, as defined by the NAIC, the NAIC rating is not always equivalent to the NRSRO rating presented in the previous table. The NAIC has adopted revised rating methodologies for certain loan-backed and structured securities comprised of non-agency residential mortgage backed securities ("RMBS") and commercial mortgage backed securities ("CMBS"). The NAIC’s objective with the revised rating methodologies for these structured securities is to increase the accuracy in assessing expected losses and use the improved assessment to determine a more appropriate capital requirement for such structured securities. The revised methodologies reduce regulatory reliance on rating agencies and allow for greater regulatory input into the assumptions used to estimate expected losses from structured securities.

The use of this process by the SVO may result in certain non-agency RMBS and CMBS being assigned a NAIC designation that is higher than the equivalent NRSRO rating. The NAIC designations for non-agency RMBS and CMBS are based on security level expected losses as modeled by an independent third party (engaged by the NAIC) and the statutory carrying value of the security, including any purchase discounts or impairment charges previously recognized. Evaluation of non-agency RMBS and CMBS held by insurers using the revised NAIC rating methodologies is performed on an annual basis.

As stated previously, our fixed maturity security portfolio is managed to minimize risks such as defaults or impairments while earning a sufficient and stable return on our investments. Our strategy has been to invest primarily in investment grade fixed maturity securities. Investment grade is NAIC 1 and 2 securities and Baa3/BBB- and better securities on the NRSRO scale. This strategy meets the objective of minimizing risk while also managing asset capital charges on a regulatory capital basis.

A summary of our fixed maturity securities by NAIC designation is as follows:

	December 31, 2016								December 31, 2015
NAIC Designation	Amortized Cost		Fair Value		Carrying Amount		Percentage of Total Carrying Amount		Amortized Cost		Fair Value		Carrying Amount		Percentage of Total Carrying Amount
	(Dollars in thousands)								(Dollars in thousands)
1	$	25,607,268	$	26,507,798	$	26,507,798	64.5	%	$	23,363,259	$	24,207,801	$	24,207,801	66.3	%
2	13,037,592		13,295,648		13,295,648		32.3	%	11,709,730		11,589,325		11,589,325		31.8	%
3	1,201,059		1,155,702		1,163,761		2.8	%	758,531		643,293		654,538		1.8	%
4	154,226		137,188		137,188		0.3	%	60,480		44,312		44,312		0.1	%
5	17,475		24,664		24,664		0.1	%	—		—		—		—	%
6	13,160		8,260		8,260		—	%	8,332		2,485		2,485		—	%
	$	40,030,780	$	41,129,260	$	41,137,319	100.0	%	$	35,900,332	$	36,487,216	$	36,498,461	100.0	%

The amortized cost and fair value of fixed maturity securities at December 31, 2016, by contractual maturity are presented in Note 3 to our audited consolidated financial statements in this Form 10-K, which is incorporated by reference in this Item 7.

29

Unrealized Losses

The amortized cost and fair value of fixed maturity securities that were in an unrealized loss position were as follows:

	Number of Securities	Amortized Cost		Unrealized Losses			Fair Value
	(Dollars in thousands)
December 31, 2016
Fixed maturity securities, available for sale:
United States Government full faith and credit	3	$	7,693	$	(288	)	$	7,405
United States Government sponsored agencies	18	1,042,461		(46,913		)	995,548
United States municipalities, states and territories	113	485,802		(22,393		)	463,409
Foreign government obligations	4	54,626		(5,080		)	49,546
Corporate securities:
Finance, insurance and real estate	208	2,501,744		(88,911		)	2,412,833
Manufacturing, construction and mining	315	3,407,651		(148,526		)	3,259,125
Utilities and related sectors	170	1,871,090		(69,263		)	1,801,827
Wholesale/retail trade	48	469,190		(15,172		)	454,018
Services, media and other	90	1,036,586		(46,901		)	989,685
Residential mortgage backed securities	25	87,169		(3,554		)	83,615
Commercial mortgage backed securities	407	3,266,304		(117,014		)	3,149,290
Other asset backed securities	112	918,403		(20,703		)	897,700
	1,513	$	15,148,719	$	(584,718	)	$	14,564,001
Fixed maturity securities, held for investment:
Corporate security:
Insurance	1	$	76,825	$	(8,059	)	$	68,766
December 31, 2015
Fixed maturity securities, available for sale:
United States Government full faith and credit	4	$	38,029	$	(299	)	$	37,730
United States Government sponsored agencies	21	971,462		(14,409		)	957,053
United States municipalities, states and territories	76	273,297		(8,628		)	264,669
Foreign government obligations	6	69,364		(10,935		)	58,429
Corporate securities:
Finance, insurance and real estate	145	2,201,597		(74,462		)	2,127,135
Manufacturing, construction and mining	334	4,271,655		(377,459		)	3,894,196
Utilities and related sectors	216	2,499,341		(161,505		)	2,337,836
Wholesale/retail trade	43	537,720		(25,988		)	511,732
Services, media and other	101	1,112,071		(43,010		)	1,069,061
Residential mortgage backed securities	34	172,697		(3,489		)	169,208
Commercial mortgage backed securities	222	2,796,286		(105,281		)	2,691,005
Other asset backed securities	43	523,592		(19,880		)	503,712
	1,245	$	15,467,111	$	(845,345	)	$	14,621,766
Fixed maturity securities, held for investment:
Corporate security:
Insurance	1	$	76,622	$	(11,245	)	$	65,377

Unrealized losses decreased $263.8 million from $856.6 million at December 31, 2015 to $592.8 million at December 31, 2016. The decrease in unrealized losses was primarily due to price improvements in the energy and metals & mining securities during the year ended December 31, 2016. The 10-year U.S. Treasury yield rates at December 31, 2016 and 2015 were 2.45% and 2.27%, respectively.

30

The following table sets forth the composition by credit quality (NAIC designation) of fixed maturity securities with gross unrealized losses:

NAIC Designation	Carrying Value of Securities with Gross Unrealized Losses		Percent of Total		Gross Unrealized Losses			Percent of Total
	(Dollars in thousands)
December 31, 2016
1	$	8,754,856	59.8	%	$	(330,920	)	55.8	%
2	5,091,437		34.8	%	(176,557		)	29.8	%
3	657,549		4.5	%	(60,689		)	10.3	%
4	119,986		0.8	%	(17,786		)	3.0	%
5	8,744		0.1	%	(1,920		)	0.3	%
6	8,254		—	%	(4,905		)	0.8	%
	$	14,640,826	100.0	%	$	(592,777	)	100.0	%
December 31, 2015
1	$	8,278,102	56.3	%	$	(280,209	)	32.7	%
2	5,813,570		39.6	%	(436,543		)	51.0	%
3	560,199		3.8	%	(117,814		)	13.7	%
4	44,041		0.3	%	(16,168		)	1.9	%
5	—		—	%	—			—	%
6	2,476		—	%	(5,856		)	0.7	%
	$	14,698,388	100.0	%	$	(856,590	)	100.0	%

Our investments' gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities (consisting of 1,514 and 1,246 securities, respectively) have been in a continuous unrealized loss position at December 31, 2016 and 2015, along with a description of the factors causing the unrealized losses is presented in Note 3 to our audited consolidated financial statements in this Form 10-K, which is incorporated by reference in this Item 7.

31

The amortized cost and fair value of fixed maturity securities in an unrealized loss position and the number of months in a continuous unrealized loss position (fixed maturity securities that carry an NRSRO rating of BBB/Baa or higher are considered investment grade) were as follows:

	Number of Securities	Amortized Cost		Fair Value		Gross Unrealized Losses
		(Dollars in thousands)
December 31, 2016
Fixed maturity securities:
Investment grade:
Less than six months	1,265	$	12,767,396	$	12,374,177	$	(393,219	)
Six months or more and less than twelve months	69	669,022		621,784		(47,238		)
Twelve months or greater	90	970,424		901,674		(68,750		)
Total investment grade	1,424	14,406,842		13,897,635		(509,207		)
Below investment grade:
Less than six months	15	132,087		126,236		(5,851		)
Six months or more and less than twelve months	10	80,535		72,830		(7,705		)
Twelve months or greater	65	606,080		536,066		(70,014		)
Total below investment grade	90	818,702		735,132		(83,570		)
	1,514	$	15,225,544	$	14,632,767	$	(592,777	)
December 31, 2015
Fixed maturity securities
Investment grade:
Less than six months	588	$	7,395,125	$	7,193,059	$	(202,066	)
Six months or more and less than twelve months	484	6,799,113		6,388,844		(410,268		)
Twelve months or greater	44	592,600		484,646		(107,954		)
Total investment grade	1,116	14,786,838		14,066,549		(720,288		)
Below investment grade:
Less than six months	87	297,879		279,947		(17,933		)
Six months or more and less than twelve months	15	175,603		148,337		(27,266		)
Twelve months or greater	28	283,413		192,310		(91,103		)
Total below investment grade	130	756,895		620,594		(136,302		)
	1,246	$	15,543,733	$	14,687,143	$	(856,590	)

32

The amortized cost and fair value of fixed maturity securities (excluding United States Government and United States Government sponsored agency securities) segregated by investment grade (NRSRO rating of BBB/Baa or higher) and below investment grade that had unrealized losses greater than 20% and the number of months in a continuous unrealized loss position were as follows:

	Number of Securities	Amortized Cost		Fair Value		Gross Unrealized Losses
		(Dollars in thousands)
December 31, 2016
Investment grade:
Less than six months	—	$	—	$	—	$	—
Six months or more and less than twelve months	—	—		—		—
Twelve months or greater	—	—		—		—
Total investment grade	—	—		—		—
Below investment grade:
Less than six months	1	19,930		15,961		(3,969		)
Six months or more and less than twelve months	—	—		—		—
Twelve months or greater	10	85,831		58,436		(27,395		)
Total below investment grade	11	105,761		74,397		(31,364		)
	11	$	105,761	$	74,397	$	(31,364	)
December 31, 2015
Investment grade:
Less than six months	37	$	460,894	$	339,047	$	(121,847	)
Six months or more and less than twelve months	13	122,794		82,149		(40,645		)
Twelve months or greater	1	2,856		1,999		(857		)
Total investment grade	51	586,544		423,195		(163,349		)
Below investment grade:
Less than six months	13	73,412		44,976		(28,436		)
Six months or more and less than twelve months	13	145,886		88,308		(57,578		)
Twelve months or greater	3	30,930		14,213		(16,717		)
Total below investment grade	29	250,228		147,497		(102,731		)
	80	$	836,772	$	570,692	$	(266,080	)

33

The amortized cost and fair value of fixed maturity securities, by contractual maturity, that were in an unrealized loss position are shown below. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. All of our mortgage and other asset backed securities provide for periodic payments throughout their lives, and are shown below as a separate line.

	Available for sale				Held for investment
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
	(Dollars in thousands)
December 31, 2016
Due in one year or less	$	—	$	—	$	—	$	—
Due after one year through five years	177,550		172,375		—		—
Due after five years through ten years	4,943,504		4,806,216		—		—
Due after ten years through twenty years	2,736,298		2,621,945		—		—
Due after twenty years	3,019,491		2,832,860		76,825		68,766
	10,876,843		10,433,396		76,825		68,766
Residential mortgage backed securities	87,169		83,615		—		—
Commercial mortgage backed securities	3,266,304		3,149,290		—		—
Other asset backed securities	918,403		897,700		—		—
	$	15,148,719	$	14,564,001	$	76,825	$	68,766
December 31, 2015
Due in one year or less	$	—	$	—	$	—	$	—
Due after one year through five years	257,994		247,957		—		—
Due after five years through ten years	6,111,139		5,802,168		—		—
Due after ten years through twenty years	2,816,752		2,693,742		—		—
Due after twenty years	2,788,651		2,513,974		76,622		65,377
	11,974,536		11,257,841		76,622		65,377
Residential mortgage backed securities	172,697		169,208		—		—
Commercial mortgage backed securities	2,796,286		2,691,005		—		—
Other asset backed securities	523,592		503,712		—		—
	$	15,467,111	$	14,621,766	$	76,622	$	65,377

Energy and Metals & Mining

The tables below summarize our publicly issued corporate fixed maturity securities in the energy and metals & mining sectors. Our privately placed available for sale fixed maturity securities at December 31, 2016 total $169.6 million fair value ($172.2 million amortized cost) in Energy and $41.9 million fair value ($43.1 million amortized cost) in Metals & Mining and are not included in the following tables.

	December 31, 2016
Sector and Subsector	Amortized Cost		Fair Value		Unrealized Gain (Loss)			Average Credit Rating
	(Dollars in thousands)
Energy
Independent	$	510,403	$	509,599	$	(804	)	Baa
Integrated	507,277		520,721		13,444			A
Oil field services	403,265		386,865		(16,400		)	Baa
Refining	119,537		123,131		3,594			Baa
Midstream	775,709		792,578		16,869			Baa
Government owned no guarantee	308,684		318,805		10,121			A
Metals & Mining	559,162		574,473		15,311			Baa
Total Energy and Metals & Mining	$	3,184,037	$	3,226,172	$	42,135		Baa

34

	Amortized Cost at December 31, 2016
	Energy
NRSRO Rating	Independent		Integrated		Oil field services		Refining		Midstream		Government Owned No Guarantee		Metals & Mining		Total
	(Dollars in thousands)
Aaa	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Aa	—		228,203		—		—		—		19,918		—		248,121
A	94,496		94,732		90,629		12,091		90,820		238,946		76,596		698,310
Baa	369,692		149,138		185,217		107,446		656,099		25,266		287,800		1,780,658
Ba	46,215		35,204		58,311		—		28,790		—		129,914		298,434
B	—		—		60,491		—		—		24,554		54,051		139,096
Below B	—		—		8,617		—		—		—		10,801		19,418
	$	510,403	$	507,277	$	403,265	$	119,537	$	775,709	$	308,684	$	559,162	$	3,184,037

	Fair Value at December 31, 2016
	Energy
NRSRO Rating	Independent		Integrated		Oil field services		Refining		Midstream		Government Owned No Guarantee		Metals & Mining		Total
	(Dollars in thousands)
Aaa	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Aa	—		236,662		—		—		—		21,002		—		257,664
A	96,301		96,198		95,508		12,612		96,116		252,015		79,824		728,574
Baa	369,032		153,685		181,876		110,519		668,128		25,401		295,751		1,804,392
Ba	44,266		34,176		52,670		—		28,334		—		128,825		288,271
B	—		—		49,745		—		—		20,387		50,382		120,514
Below B	—		—		7,066		—		—		—		19,691		26,757
	$	509,599	$	520,721	$	386,865	$	123,131	$	792,578	$	318,805	$	574,473	$	3,226,172

International Exposure

We hold fixed maturity securities with international exposure. As of December 31, 2016, 18% of the carrying value of our fixed maturity securities was comprised of corporate debt securities of issuers based outside of the United States and debt securities of foreign governments. Our investment professionals analyze each holding for credit risk by economic and other factors of each country and industry. The following table presents our international exposure in our fixed maturity portfolio by country or region:

	December 31, 2016
	Amortized Cost		Fair Value		Percent of Total Fair Value
	(Dollars in thousands)
GIIPS (1)	$	245,327	$	262,272	0.6	%
Asia/Pacific	434,249		443,717		1.1	%
Non-GIIPS Europe	2,978,930		3,043,505		7.4	%
Latin America	261,516		254,276		0.6	%
Non-U.S. North America	1,277,542		1,293,018		3.2	%
Australia & New Zealand	711,576		712,207		1.7	%
Other	1,288,879		1,299,827		3.2	%
	$	7,198,019	$	7,308,822	17.8	%

(1) Greece, Ireland, Italy, Portugal and Spain continue to cause credit risk as economic conditions in these countries continue to be volatile, especially within the financial and banking sectors. All of our exposure in GIIPS are corporate securities with issuers domiciled in these countries. None of our foreign government obligations were held in any of these countries.

35

All of the securities presented in the table above are denominated in U.S. dollars and all are investment grade (NAIC designation of either 1 or 2), except for the following:

	December 31, 2016
	Amortized Cost		Carrying Amount/ Fair Value
	(Dollars in thousands)
GIIPS (1)	$	28,746	$	29,267
Asia/Pacific	11,499		9,768
Non-GIIPS Europe	98,302		93,411
Latin America	55,640		44,449
Non-U.S. North America	120,524		115,832
	$	314,711	$	292,727

Watch List

At each balance sheet date, we identify invested assets which have characteristics (i.e. significant unrealized losses compared to amortized cost and industry trends) creating uncertainty as to our future assessment of an other than temporary impairment. As part of this assessment we review not only a change in current price relative to its amortized cost but the issuer's current credit rating and the probability of full recovery of principal based upon the issuer's financial strength. Specifically for corporate issues we evaluate the financial stability and quality of asset coverage for the securities relative to the term to maturity for the issues we own. A security which has a 25% or greater change in market price relative to its amortized cost and a possibility of a loss of principal will be included on a list which is referred to as our watch list. We exclude from this list securities with unrealized losses which are related to market movements in interest rates and which have no factors indicating that such unrealized losses may be other than temporary as we do not intend to sell these securities and it is more likely than not we will not have to sell these securities before a recovery is realized. In addition, we exclude our residential and commercial mortgage backed securities as we monitor all of our residential and commercial mortgage backed securities on a quarterly basis for changes in default rates, loss severities and expected cash flows for the purpose of assessing potential other than temporary impairments and related credit losses to be recognized in operations. At December 31, 2016, the amortized cost and fair value of securities on the watch list (all fixed maturity securities) are as follows:

General Description	Number of Securities	Amortized Cost		Unrealized Losses			Fair Value		Months in Continuous Unrealized Loss Position	Months Unrealized Losses Greater Than 20%
		(Dollars in thousands)
Below investment grade
Corporate securities:
Energy	6	$	53,615	$	(10,278	)	$	43,337	18 - 44	0 - 24
Industrials	1	4,982		(2,076		)	2,906		26	17
Materials	4	29,703		(1,724		)	27,979		18 - 47	—
Telecommunications	1	2,324		(442		)	1,882		30	—
Utilities	1	4,423		(797		)	3,626		16	5
Other asset backed securities:
Financials	2	6,845		(4,244		)	2,601		43 - 69	20 - 24
Utilities	1	1,830		—			1,830		4	4
	16	$	103,722	$	(19,561	)	$	84,161

We have determined that the unrealized losses of the securities on the watch list are temporary as we do not intend to sell these securities and it is more likely than not we will not have to sell these securities before recovery of their amortized cost. Our analysis of these securities and their credit performance at December 31, 2016 is as follows:

Corporate securities:

Energy, Industrials and Materials: The decline in the value of these securities relates to ongoing operational issues related to the decline in certain commodity prices specific to their businesses. The decline in these commodity prices creates financial challenges as the industries realign to accommodate the lower prices. These issuers will be stressed greater than the average company due to their price sensitivity and the specific position they hold in the chain of supply. We recognized an other than temporary impairment on one security during the third quarter of 2016 due to our evaluation of the operating performance and the credit worthiness of the issuer. While the remaining issuers have seen their financial and profitability profile weakened, we have determined that the remaining securities were not other than temporarily impaired due to our evaluation of the operating performance and the credit worthiness of the issuer.

36

Telecommunications:  The decline in the value of this security is the result of regional economic recessionary pressure in Brazil and an increase in competition in the markets it operates. This issuer has seen weakened performance and heightened risk. We recognized an other than temporary impairment on this security during the first quarter of 2016 due to our evaluation of the operating performance and the credit worthiness of the issuer.

Utilities: The decline in the value of this security is due to the company's parent announcing a strategic decision to attempt to become a fully regulated utility by 2018. This issuer is part of the unregulated business of the parent and concerns have arisen about its ability to become regulated. This uncertainty has stressed market prices for this bond. Due to the company's parent announcing that it is committed to exiting the power generation business and could potentially enter the facility into bankruptcy, we recognized an other than temporary impairment on this security during the fourth quarter of 2016.

Other asset backed securities:

Financials:  The decline in value of one of the asset backed securities is due to poor performance in the underlying pool of student loans. The investment is backed by a guarantee from the for-profit education services provider. We have determined that this security was not other than temporarily impaired, because the guarantee is in good standing and all required payments have been made, including hyper-amortization payments triggered by the performance of the student loan portfolio. The decline in value of the the other asset backed security is related directly to the decline in oil prices and the financial stability of its operator. The issuer has direct exposure to the oil market as its primary business is deep water drilling. As oil prices have declined the operator of the deep water vessel has experienced financial pressure on its balance sheet. We recognized other than temporary impairments on this security during the second quarter of 2016 and the third quarter of 2015.

Utilities:  The decline in the value of this security is due to the company's parent announcing a strategic decision to attempt to become a fully regulated utility by 2018.  This issuer is part of the unregulated business of the parent and concerns have arisen about its ability to become regulated.  This uncertainty has stressed market prices for this bond.  Due to the company's parent announcing that it is committed to exiting the power generation business and could potentially enter the facility into bankruptcy, we recognized an other than temporary impairment on this security during the fourth quarter of 2016.

Other Than Temporary Impairments

We have a policy and process to identify securities in our investment portfolio for which we should recognize impairments. See Critical Accounting Policies—Evaluation of Other Than Temporary Impairments. During the years ended December 31, 2016, 2015 and 2014, we recognized other than temporary impairment on corporate securities, residential mortgage backed securities, commercial mortgage backed securities and other asset backed securities, all of which are available for sale fixed maturity securities. In addition, in all periods presented we recognized credit losses on residential mortgage backed securities, and on one other asset backed security in 2016, that resulted in a reclassification of OTTI loss from accumulated other comprehensive income to net income.

In 2016, we recognized a $3.9 million OTTI loss in operations due to our concern regarding a corporate security issued by a Brazilian telecommunications company as developments in 2016 led us to the conclusion that we will not be able to fully recover our amortized cost basis due to liquidity concerns. A $3.0 million OTTI loss was recognized in operations due to our concern regarding a corporate security issued by a Brazilian metals and mining company as developments during 2016 led us to the conclusion that we will not be able to fully recover our amortized cost basis. We recognized a $9.2 million OTTI loss in operations on a corporate security and an other asset backed security as a result of the parent of both entities announcement that it is committed to exiting the power generation business and could potentially enter the facilities into bankruptcy. In 2016, we recognized an additional impairment of $3.5 million on an other asset backed security due to the asset supporting the cash flows being taken out of production which was first impaired during 2015. The OTTI that we recognized in 2016 on commercial mortgage backed securities were due to our intent to sell the securities, which were in an unrealized loss position at the reporting date of the period in which the decision to sell these securities was made.

In 2015, we recognized a $4.9 million OTTI loss in operations on an other asset backed security due to the asset supporting the cash flows being taken out of production. A total of $12.4 million was recognized as OTTI loss in operations on corporate securities issued by a company in iron ore production that had long standing contract issues that gave us concern as to their future cash flow and liquidity.

Several factors led us to believe that full recovery of amortized cost is not expected on the securities for which we recognized credit losses and reclassified OTTI from accumulated other comprehensive income to net income. A discussion of these factors, our policy and process to identify securities that could potentially have impairment that is other than temporary and a summary of OTTI is presented in Note 3 to our audited consolidated financial statements in this Form 10-K, which is incorporated by reference in this Item 7.

37

Mortgage Loans on Real Estate

Our commercial mortgage loan portfolio consists of mortgage loans collateralized by the related properties and diversified as to property type, location and loan size. Our mortgage lending policies establish limits on the amount that can be loaned to one borrower and other criteria to attempt to reduce the risk of default. Our commercial mortgage loans on real estate are reported at cost, net of loan loss allowances and deferred prepayment fees. At December 31, 2016 and 2015, the largest principal amount outstanding for any single mortgage loan was $20.9 million and $17.9 million, respectively, and the average loan size was $3.2 million and $2.9 million, respectively. In addition, the average loan to value ratio for the overall portfolio was 53.7% at both December 31, 2016 and 2015, respectively, based upon the underwriting and appraisal at the time the loan was made. This loan to value is indicative of our conservative underwriting policies and practices for making commercial mortgage loans and may not be indicative of collateral values at the current reporting date. Our current practice is to only obtain market value appraisals of the underlying collateral at the inception of the loan unless we identify indicators of impairment in our ongoing analysis of the portfolio, in which case, we either calculate a value of the collateral using a capitalization method or obtain a third party appraisal of the underlying collateral. The commercial mortgage loan portfolio is summarized by geographic region and property type in Note 4 of our audited consolidated financial statements of this Form 10-K, which is incorporated by reference in this Item 7.

In the normal course of business, we commit to fund commercial mortgage loans up to 90 days in advance. At December 31, 2016, we had commitments to fund commercial mortgage loans totaling $75.5 million, with fixed interest rates ranging from 3.90% to 4.88%. During 2016 and 2015, due to historically low interest rates, the commercial mortgage loan industry has been very competitive. This competition has resulted in a number of borrowers refinancing with other lenders. For the year ended December 31, 2016, we received $301.7 million in cash for loans being paid in full compared to $371.0 million for the year ended December 31, 2015. Some of the loans being paid off have either reached their maturity or are nearing maturity; however, some borrowers are paying the prepayment fee and refinancing at a lower rate.

See Note 4 to our audited consolidated financial statements for a presentation of our specific and general loan loss allowances, impaired loans, foreclosure activity and troubled debt restructure analysis.

We have a process by which we evaluate the credit quality of each of our commercial mortgage loans. This process utilizes each loan's debt service coverage ratio as a primary metric. A summary of our portfolio by debt service coverage ratio (based on most recent information collected) follows:

	December 31, 2016				December 31, 2015
	Principal Outstanding		Percent of Total Principal Outstanding		Principal Outstanding		Percent of Total Principal Outstanding
	(Dollars in thousands)				(Dollars in thousands)
Debt Service Coverage Ratio:
Greater than or equal to 1.5	$	1,781,928	71.5	%	$	1,772,226	72.3	%
Greater than or equal to 1.2 and less than 1.5	517,697		20.8	%	414,482		16.9	%
Greater than or equal to 1.0 and less than 1.2	122,115		4.9	%	141,799		5.8	%
Less than 1.0	68,879		2.8	%	121,402		5.0	%
	$	2,490,619	100.0	%	$	2,449,909	100.0	%

All of our mortgage loans (based on principal outstanding) that have a debt service coverage ratio of less than 1.0 are performing under the original contractual loan terms at December 31, 2016.

Mortgage loans summarized in the following table represent all loans that we are either not currently collecting or those we feel it is probable we will not collect all amounts due according to the contractual terms of the loan agreements (all loans that we have worked with the borrower to alleviate short-term cash flow issues, loans delinquent for 60 days or more at the reporting date, loans we have determined to be collateral dependent and loans that we have recorded specific impairments on that we feel may continue to have performance issues).

	December 31,
	2016			2015
	(Dollars in thousands)
Impaired mortgage loans with an allowance	$	4,640		$	21,277
Impaired mortgage loans with no related allowance	1,591			8,859
Allowance for probable loan losses	(1,327		)	(7,842		)
Net carrying value of impaired mortgage loans	$	4,904		$	22,294

At December 31, 2016, we had no commercial mortgage loans that were delinquent (60 days or more past due at the reporting date) in their principal and interest payments.

38

Derivative Instruments

Our derivative instruments primarily consist of call options purchased to provide the income needed to fund the annual index credits on our fixed index annuity products. The fair value of the call options is based upon the amount of cash that would be required to settle the call options obtained from the counterparties adjusted for the nonperformance risk of the counterparty. The nonperformance risk for each counterparty is based upon its credit default swap rate. We have no performance obligations related to the call options.

None of our derivatives qualify for hedge accounting, thus, any change in the fair value of the derivatives that are not classified as equity is recognized immediately in the consolidated statements of operations. A presentation of our derivative instruments along with a discussion of the business strategy involved with our derivatives is included in Note 5 to our audited consolidated financial statements in this Form 10-K, which is incorporated by reference in this Item 7.

Liabilities

Our liability for policy benefit reserves increased to $51.6 billion at December 31, 2016 compared to $45.5 billion at December 31, 2015, primarily due to additional annuity sales as discussed above. Substantially all of our annuity products have a surrender charge feature designed to reduce the risk of early withdrawal or surrender of the policies and to compensate us for our costs if policies are withdrawn early. Notwithstanding these policy features, the withdrawal rates of policyholder funds may be affected by changes in interest rates and other factors.

See Note 9 to our audited consolidated financial statements in this Form 10-K, which is incorporated by reference in this Item 7 for discussion of our notes and loan payable and borrowings under repurchase agreements.

See Note 10 to our audited consolidated financial statements for additional information concerning our subordinated debentures payable to, and the preferred securities issued by, our subsidiary trusts.

Liquidity and Capital Resources

Liquidity for Insurance Operations

Our insurance subsidiaries' primary sources of cash flow are annuity deposits, investment income, and proceeds from the sale, maturity and calls of investments. The primary uses of funds are investment purchases, payments to policyholders in connection with surrenders and withdrawals, policy acquisition costs and other operating expenses.

Liquidity requirements are met primarily by funds provided from operations. Our life subsidiaries generally receive adequate cash flow from annuity deposits and investment income to meet their obligations. Annuity and life insurance liabilities are generally long-term in nature. However, a primary liquidity concern is the risk of an extraordinary level of early policyholder withdrawals. We include provisions within our annuity policies, such as surrender charges and bonus vesting, that help limit and discourage early withdrawals. At December 31, 2016, approximately 94% of our annuity liabilities were subject to penalty upon surrender, with a weighted average remaining surrender charge period of 8.6 years and a weighted average surrender charge percentage of 13.8%.

Our insurance subsidiaries continue to have adequate cash flows from annuity deposits and investment income to meet their policyholder and other obligations. Net cash flows from annuity deposits and funds returned to policyholders as surrenders, withdrawals and death claims were $3.2 billion for the year ended December 31, 2016 compared to $4.7 billion for the year ended December 31, 2015 with the decrease attributable to a $1.2 billion decrease in net annuity deposits after coinsurance and a $236.3 million (after coinsurance) increase in funds returned to policyholders. We continue to invest the net proceeds from policyholder transactions and investment activities in high quality fixed maturity securities and fixed rate commercial mortgage loans.

Liquidity of Parent Company

We, as the parent company, are a legal entity separate and distinct from our subsidiaries, and have no business operations. We need liquidity primarily to service our debt (senior notes, term loan and subordinated debentures issued to subsidiary trusts), pay operating expenses and pay dividends to stockholders. Our assets consist primarily of the capital stock and surplus notes of our subsidiaries. Accordingly, our future cash flows depend upon the availability of dividends, surplus note interest payments and other statutorily permissible payments from our subsidiaries, such as payments under our investment advisory agreements and tax allocation agreement with our subsidiaries. These sources provide adequate cash flow for us to meet our current and reasonably foreseeable future obligations and we expect they will be adequate to fund our parent company cash flow requirements in 2017.

The ability of our life insurance subsidiaries to pay dividends or distributions, including surplus note payments, will be limited by applicable laws and regulations of the states in which our life insurance subsidiaries are domiciled, which subject our life insurance subsidiaries to significant regulatory restrictions. These laws and regulations require, among other things, our insurance subsidiaries to maintain minimum solvency requirements and limit the amount of dividends these subsidiaries can pay.

39

Currently, American Equity Life may pay dividends or make other distributions without the prior approval of the Iowa Insurance Commissioner, unless such payments, together with all other such payments within the preceding twelve months, exceed the greater of (1) American Equity Life's net gain from operations for the preceding calendar year, or (2) 10% of American Equity Life's statutory capital and surplus at the preceding December 31. For 2017, up to $272.7 million can be distributed as dividends by American Equity Life without prior approval of the Iowa Insurance Commissioner. In addition, dividends and surplus note payments may be made only out of statutory earned surplus, and all surplus note payments are subject to prior approval by regulatory authorities in the life subsidiary's state of domicile. American Equity Life had $1.4 billion of statutory earned surplus at December 31, 2016.

The maximum distribution permitted by law or contract is not necessarily indicative of an insurer's actual ability to pay such distributions, which may be constrained by business and regulatory considerations, such as the impact of such distributions on surplus, which could affect the insurer's ratings or competitive position, the amount of premiums that can be written and the ability to pay future dividends or make other distributions. Further, state insurance laws and regulations require that the statutory surplus of our life subsidiaries following any dividend or distribution must be reasonable in relation to their outstanding liabilities and adequate for their financial needs. Along with solvency regulations, the primary driver in determining the amount of capital used for dividends is the level of capital needed to maintain desired financial strength ratings from A.M. Best and Standard and Poor's. Both regulators and rating agencies could become more conservative in their methodology and criteria, including increasing capital requirements for our insurance subsidiaries which, in turn, could negatively affect the cash available to us from insurance subsidiaries. As of December 31, 2016, we estimate American Equity Life has sufficient statutory capital and surplus, combined with capital available to the holding company, to meet this rating objective. However, this capital may not be sufficient if significant future losses are incurred or a rating agency modifies its rating criteria and access to additional capital could be limited.

The transfer of funds by American Equity Life is also restricted by a covenant in our line of credit agreement which requires American Equity Life to maintain a minimum risk-based capital ratio of 275% and a minimum level of statutory surplus equal to the sum of 1) 80% of statutory surplus at June 30, 2016, 2) 50% of the statutory net income for each fiscal quarter ending after June 30, 2016, and 3) 50% of all capital contributed to American Equity Life after June 30, 2016. American Equity Life's risk-based capital ratio was 342% at December 31, 2016. Under this agreement, we are also required to maintain a maximum ratio of adjusted debt to total adjusted capital of 0.35.

In August 2015, we completed an underwritten public offering of 9,890,000 shares of our common stock at a public offering price of $25.25 per share, of which 5,590,000 shares were subject to forward sale agreements. During the third quarter of 2015, we contributed $120 million to the capital and surplus of American Equity Life which included $104.5 million of initial net proceeds from the issuance of 4.3 million shares of common stock in our August 2015 public stock offering. We settled the forward sale agreements on August 1, 2016, and issued 5,590,000 shares of our common stock and received $134.7 million in net proceeds which was contributed to the capital and surplus of American Equity Life.

In 2015 and 2014, we retired $344 million aggregate principal amount of three convertible note issues. The total consideration paid to retire the convertible notes included $486 million of cash and 9.45 million shares of our common stock. We have now extinguished all of our convertible notes.

Cash and cash equivalents of the parent holding company at December 31, 2016, were $36.4 million. In addition, as discussed in Note 9 to our audited consolidated financial statements we have a $150 million revolving line of credit agreement. This revolving line of credit terminates on September 30, 2021, and borrowings are available for general corporate purposes of the parent company and its subsidiaries. We also have the ability to issue equity, debt or other types of securities through one or more methods of distribution under a currently effective shelf registration statement on Form S-3. The terms of any offering would be established at the time of the offering, subject to market conditions.

On August 5, 2015, Standard & Poor's raised its counterparty credit rating on American Equity Investment Life Holding Company to BBB- from BB+ and its financial strength rating on American Equity Life to A- from BBB+. On August 7, 2015, Fitch Ratings upgraded the issuer default rating of American Equity Investment Life Holding Company to BBB- from BB+.

Statutory accounting practices prescribed or permitted for our life subsidiaries differ in many respects from those governing the preparation of financial statements under GAAP. Accordingly, statutory operating results and statutory capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. Information as to statutory capital and surplus and statutory net income for our life subsidiaries as of December 31, 2016 and 2015 and for the years ended December 31, 2016, 2015 and 2014 is included in Note 12 to our audited consolidated financial statements.

40

In the normal course of business, we enter into financing transactions, lease agreements, or other commitments. These commitments may obligate us to certain cash flows during future periods. The following table summarizes such obligations as of December 31, 2016.

	Payments Due by Period
	Total		Less Than 1 year		1–3 Years		4–5 Years		After 5 Years
	(Dollars in thousands)
Annuity and single premium universal life products (1)	$	51,628,372	$	2,872,877	$	11,385,699	$	7,625,528	$	29,744,268
Notes and loan payable, including interest payments (2)	628,428		29,537		158,419		440,472		—
Subordinated debentures, including interest payments (3)	550,997		12,575		25,152		25,152		488,118
Operating leases	16,871		1,890		3,813		3,704		7,464
Mortgage loan funding and other investments	158,248		118,822		25,626		13,800		—
Total	$	52,982,916	$	3,035,701	$	11,598,709	$	8,108,656	$	30,239,850

(1) Amounts shown in this table are projected payments through the year 2036 which we are contractually obligated to pay to our annuity policyholders. The payments are derived from actuarial models which assume a level interest rate scenario and incorporate assumptions regarding mortality and persistency, when applicable. These assumptions are based on our historical experience.

(2) Period that principal amounts are due is determined by the earliest of the call/put date or the maturity date of each note payable.

(3) Amount shown is net of equity investments in the capital trusts due to the contractual right of offset upon repayment of the notes.

Inflation

Inflation does not have a significant effect on our consolidated balance sheet. We have minimal investments in property, equipment or inventories. To the extent that interest rates may change to reflect inflation or inflation expectations, there would be an effect on our balance sheet and operations. It is not possible to calculate the effect such changes in interest rates, if any, have had on our operating results.

Critical Accounting Policies

The increasing complexity of the business environment and applicable authoritative accounting guidance require us to closely monitor our accounting policies. We have identified six critical accounting policies that are complex and require significant judgment. The following summary of our critical accounting policies is intended to enhance your ability to assess our financial condition and results of operations and the potential volatility due to changes in estimates.

Valuation of Investments

Our fixed maturity securities (bonds and redeemable preferred stocks maturing more than one year after issuance) and equity securities classified as available for sale are reported at fair value. Unrealized gains and losses, if any, on these securities are included directly in stockholders' equity as a component of accumulated other comprehensive income (loss), net of income taxes and certain adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements. Unrealized gains and losses represent the difference between the amortized cost or cost basis and the fair value of these investments. We use significant judgment within the process used to determine fair value of these investments.

GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. We categorize our investments into three levels of fair value hierarchy based on the priority of inputs used in determining fair value. The hierarchy defines the highest priority inputs (Level 1) as quoted prices in active markets for identical assets or liabilities. The lowest priority inputs (Level 3) are our own assumptions about what a market participant would use in determining fair value such as estimated future cash flows. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, a financial instrument's level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument.

41

We categorize investments recorded at fair value in the consolidated balance sheets as follows:

Level 1 — Quoted prices are available in active markets for identical financial instruments as of the reporting date. We do not adjust the quoted price for these financial instruments, even in situations where we hold a large position and a sale could reasonably impact the quoted price.

Level 2 — Quoted prices in active markets for similar financial instruments, quoted prices for identical or similar financial instruments in markets that are not active; and models and other valuation methodologies using inputs other than quoted prices that are observable.

Level 3 — Models and other valuation methodologies using significant inputs that are unobservable for financial instruments and include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in Level 3 are securities for which no market activity or data exists and for which we used discounted expected future cash flows with our own assumptions about what a market participant would use in determining fair value.

The following table presents the fair value of fixed maturity and equity securities, available for sale, by pricing source and hierarchy level as of December 31, 2016 and 2015, respectively:

	Quoted Prices in Active Markets for Identical Assets (Level 1)			Significant Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)			Total
	(Dollars in thousands)
December 31, 2016
Priced via third party pricing services	$	5,387		$	41,016,054		$	—		$	41,021,441
Priced via independent broker quotations	—			36,436			—			36,436
Priced via matrices	—			—			—			—
Priced via other methods	—			10,617			—			10,617
	$	5,387		$	41,063,107		$	—		$	41,068,494
% of Total	—		%	100.0		%	—		%	100.0		%
December 31, 2015
Priced via third party pricing services	$	438,719		$	35,785,649		$	—		$	36,224,368
Priced via independent broker quotations	—			164,314			—			164,314
Priced via matrices	—			—			—			—
Priced via other methods	—			40,985			—			40,985
	$	438,719		$	35,990,948		$	—		$	36,429,667
% of Total	1.2		%	98.8		%	—		%	100.0		%

Management's assessment of all available data when determining fair value of our investments is necessary to appropriately apply fair value accounting.

We utilize independent pricing services in estimating the fair values of investment securities. The independent pricing services incorporate a variety of observable market data in their valuation techniques, including:

• reported trading prices,

• benchmark yields,

• broker-dealer quotes,

• benchmark securities,

• bids and offers,

• credit ratings,

• relative credit information, and

• other reference data.

The independent pricing services also take into account perceived market movements and sector news, as well as a security's terms and conditions, including any features specific to that issue that may influence risk and marketability. Depending on the security, the priority of the use of observable market inputs may change as some observable market inputs may not be relevant or additional inputs may be necessary.

42

The independent pricing services provide quoted market prices when available. Quoted prices are not always available due to market inactivity. When quoted market prices are not available, the third parties use yield data and other factors relating to instruments or securities with similar characteristics to determine fair value for securities that are not actively traded. We generally obtain one value from our primary external pricing service. In situations where a price is not available from this service, we may obtain further quotes or prices from additional parties as needed. In addition, for our callable United States Government sponsored agencies we obtain multiple broker quotes and take the average of the broker prices received. Market indices of similar rated asset class spreads are considered for valuations and broker indications of similar securities are compared. Inputs used by the broker include market information, such as yield data and other factors relating to instruments or securities with similar characteristics. Valuations and quotes obtained from third party commercial pricing services are non-binding and do not represent quotes on which one may execute the disposition of the assets.

We validate external valuations at least quarterly through a combination of procedures that include the evaluation of methodologies used by the pricing services, analytical reviews and performance analysis of the prices against trends, and maintenance of a securities watch list. Additionally, as needed we utilize discounted cash flow models or perform independent valuations on a case-by-case basis using inputs and assumptions similar to those used by the pricing services. Although we do identify differences from time to time as a result of these validation procedures, we did not make any significant adjustments as of December 31, 2016 and 2015.

Evaluation of Other Than Temporary Impairments and Allowance for Loan Loss

The evaluation of investments for other than temporary impairments involves significant judgment and estimates by management. We review and analyze all investments on an ongoing basis for changes in market interest rates and credit deterioration. This review process includes analyzing our ability to recover the amortized cost or cost basis of each investment that has a fair value that is materially lower than its amortized cost and requires a high degree of management judgment and involves uncertainty. The evaluation of securities for other than temporary impairments is a quantitative and qualitative process, which is subject to risks and uncertainties.

We have a policy and process to identify securities that could potentially have an impairment that is other than temporary. This process involves monitoring market events and other items that could impact issuers. The evaluation includes but is not limited to such factors as:

• the length of time and the extent to which the fair value has been less than amortized cost or cost;

• whether the issuer is current on all payments and all contractual payments have been made as agreed;

• the remaining payment terms and the financial condition and near-term prospects of the issuer;

• the lack of ability to refinance due to liquidity problems in the credit market;

• the fair value of any underlying collateral;

• the existence of any credit protection available;

• our intent to sell and whether it is more likely than not we would be required to sell prior to recovery for debt securities;

• our assessment in the case of equity securities including perpetual preferred stocks with credit deterioration that the security cannot recover to cost in a reasonable period of time;

• our intent and ability to retain equity securities for a period of time sufficient to allow for recovery;

• consideration of rating agency actions; and

• changes in estimated cash flows of mortgage and asset backed securities.

We determine whether other than temporary impairment losses should be recognized for debt and equity securities by assessing all facts and circumstances surrounding each security. Where the decline in fair value of debt securities is attributable to changes in market interest rates or to factors such as market volatility, liquidity and spread widening, and we anticipate recovery of all contractual or expected cash flows, we do not consider these investments to be other than temporarily impaired because we do not intend to sell these investments and it is not more likely than not we will be required to sell these investments before a recovery of amortized cost, which may be maturity. For equity securities, we recognize an impairment charge in the period in which we do not have the intent and ability to hold the securities until recovery of cost or we determine that the security will not recover to book value within a reasonable period of time. We determine what constitutes a reasonable period of time on a security-by-security basis by considering all the evidence available to us, including the magnitude of any unrealized loss and its duration.

Other than temporary impairment losses on equity securities are recognized in operations. If we intend to sell a debt security or if it is more likely than not that we will be required to sell a debt security before recovery of its amortized cost basis, other than temporary impairment has occurred and the difference between amortized cost and fair value will be recognized as a loss in operations.

If we do not intend to sell and it is not more likely than not we will be required to sell the debt security but also do not expect to recover the entire amortized cost basis of the security, an impairment loss would be recognized in operations in the amount of the expected credit loss. We determine the amount of expected credit loss by calculating the present value of the cash flows expected to be collected discounted at each security's acquisition yield based on our consideration of whether the security was of high credit quality at the time of acquisition. The difference between the present value of expected future cash flows and the amortized cost basis of the security is the amount of credit loss recognized in operations. The remaining amount of the other than temporary impairment is recognized in other comprehensive income.

43

The determination of the credit loss component of a mortgage backed security is based on a number of factors. The primary consideration in this evaluation process is the issuer's ability to meet current and future interest and principal payments as contractually stated at time of purchase. Our review of these securities includes an analysis of the cash flow modeling under various default scenarios considering independent third party benchmarks, the seniority of the specific tranche within the structure of the security, the composition of the collateral and the actual default, loss severity and prepayment experience exhibited. With the input of third party assumptions for default projections, loss severity and prepayment expectations, we evaluate the cash flow projections to determine whether the security is performing in accordance with its contractual obligation.

We utilize the models from a leading structured product software specialist serving institutional investors. These models incorporate each security's seniority and cash flow structure. In circumstances where the analysis implies a potential for principal loss at some point in the future, we use our "best estimate" cash flow projection discounted at the security's effective yield at acquisition to determine the amount of our potential credit loss associated with this security. The discounted expected future cash flows equates to our expected recovery value. Any shortfall of the expected recovery when compared to the amortized cost of the security will be recorded as the credit loss component of an other than temporary impairment.

The cash flow modeling is performed on a security-by-security basis and incorporates actual cash flows on the residential mortgage backed securities through the current period, as well as the projection of remaining cash flows using a number of assumptions including default rates, prepayment rates and loss severity rates. The default curves we use are tailored to the Prime or Alt-A residential mortgage backed securities that we own, which assume lower default rates and loss severity for Prime securities versus Alt-A securities. These default curves are scaled higher or lower depending on factors such as current underlying mortgage loan performance, rating agency loss projections, loan to value ratios, geographic diversity, as well as other appropriate considerations.

The determination of the credit loss component of a corporate bond (including redeemable preferred stocks) is based on the underlying financial performance of the issuer and their ability to meet their contractual obligations. Considerations in our evaluation include, but are not limited to, credit rating changes, financial statement and ratio analysis, changes in management, significant changes in credit spreads, breaches of financial covenants and a review of the economic outlook for the industry and markets in which they trade. In circumstances where an issuer appears unlikely to meet its future obligation, or the security's price decline is deemed other than temporary, an estimate of credit loss is determined. Credit loss is calculated using default probabilities as derived from the credit default swaps markets in conjunction with recovery rates derived from independent third party analysis or a best estimate of credit loss. This credit loss rate is then incorporated into a present value calculation based on an expected principal loss in the future discounted at the yield at the date of purchase and compared to amortized cost to determine the amount of credit loss associated with the security.

In addition, for debt securities which we do not intend to sell and it is not more likely than not we will be required to sell, but our intent changes due to changes or events that could not have been reasonably anticipated, an other than temporary impairment charge is recognized in net income and amortized cost is written down to fair value. Once an impairment charge has been recorded, we then continue to review the other than temporarily impaired securities for appropriate valuation on an ongoing basis. Unrealized losses may be recognized in future periods through a charge to earnings should we later conclude that the decline in fair value below amortized cost is other than temporary pursuant to our accounting policy described above. The use of different methodologies and assumptions to determine the fair value of investments and the timing and amount of impairments may have a material effect on the amounts presented in our consolidated financial statements.

We evaluate our mortgage loan portfolio for the establishment of a loan loss allowance by specific identification of impaired loans and the measurement of an estimated loss for each individual loan identified. A mortgage loan is impaired when it is probable that we will be unable to collect all amounts due according to the contractual terms of the loan agreement.If we determine that the value of any specific mortgage loan is impaired, the carrying amount of the mortgage loan will be reduced to its fair value, based upon the present value of expected future cash flows from the loan discounted at the loan's effective interest rate, or the fair value of the underlying collateral less estimated costs to sell.

In addition, we analyze the mortgage loan portfolio for the need of a general loan allowance for probable losses on all other loans on a quantitative and qualitative basis. The amount of the general loan allowance is based upon management's evaluation of the collectability of the loan portfolio, historical loss experience, delinquencies, credit concentrations, underwriting standards and national and local economic conditions.

We rate each of the mortgage loans in our portfolio based on factors such as historical operating performance, loan to value ratio and economic outlook, among others. We calculate a loss factor to apply to each rating based on historical losses we have recognized in our mortgage loan portfolio. We apply the loss factors to the total principal outstanding within each rating category to determine an appropriate estimate of the general loan loss allowance. We also assess the portfolio quantitatively and apply a loss rate to all loans without a specific allowance based on management's assessment of economic conditions, and we apply an additional amount of loss allowance to a group of loans that we have identified as having higher risk of loss.

Policy Liabilities for Fixed Index Annuities

We offer a variety of fixed index annuities with crediting strategies linked to the S&P 500 Index and other equity and bond market indices. We purchase call options on the applicable indices as an investment to provide the income needed to fund the annual index credits on the index products. See Financial Condition—Derivative Instruments. Certain derivative instruments embedded in the fixed index annuity contracts are recognized in the consolidated balance sheet at their fair values and changes in fair value are recognized immediately in our consolidated statements of operations in accordance with accounting standards for derivative instruments and hedging activities.

Accounting for derivatives prescribes that the contractual obligations for future annual index credits are treated as a "series of embedded derivatives" over the expected life of the applicable contracts. Policy liabilities for fixed index annuities are equal to the sum of the "host" (or guaranteed) component and the embedded derivative component for each fixed index annuity policy. The host value is established at inception of the contract and accreted over the policy's life at a constant rate of interest. We estimate the fair value of the embedded derivative component at each valuation date by (i) projecting policy contract values and minimum guaranteed contract values over the expected lives of the contracts and (ii) discounting the excess of the projected contract value amounts at the applicable risk free interest rates adjusted for our nonperformance risk related to those liabilities. The projections of policy contract values are based on our best estimate assumptions for future policy growth and future policy decrements. Our best estimate assumptions for future policy growth include assumptions for the expected index credits on the next policy anniversary date which are derived from the fair values of the underlying call options purchased to fund such index credits and the expected costs of annual call options we will purchase in the future to fund index credits beyond the next policy anniversary. The projections of minimum guaranteed contract values include the same best estimate assumptions for policy decrements as were used to project policy contract values. The amounts reported in the consolidated statements of operations as "Interest sensitive and index product benefits" represent amounts credited to policy liabilities pursuant to accounting by insurance companies for certain long-duration contracts which include index credits through the most recent policy anniversary. The amounts reported in the consolidated statements of operations as "Changes in fair value of embedded derivatives" equal the change in the difference between policy benefit reserves for fixed index annuities computed under the derivative accounting standard and the long-duration contracts accounting standard at each balance sheet date.

In general, the change in the fair value of the embedded derivatives will not correspond to the change in fair value of the purchased call options because the purchased call options are one year options while the options valued in the embedded derivatives represent the rights of the contract holder to receive index credits over the entire period the fixed index annuities are expected to be in force, which typically exceeds 10 years.

The most sensitive assumption in determining policy liabilities for fixed index annuities is the rates used to discount the excess projected contract values. As indicated above, the discount rate reflects our nonperformance risk. If the discount rates used to discount the excess projected contract values at December 31, 2016 were to increase by 100 basis points, our reserves for fixed index annuities would decrease by $451.4 million recorded through operations as a decrease in the change in fair value of embedded derivatives and there would be a corresponding decrease of $276.4 million to our combined balance for deferred policy acquisition costs and deferred sales inducements recorded through operations as an increase in amortization of deferred policy acquisition costs and deferred sales inducements. A decrease by 100 basis points in the discount rate used to discount the excess projected contract values would increase our reserves for fixed index annuities by $504.5 million recorded through operations as an increase in the change in fair value of embedded derivatives and increase our combined balance for deferred policy acquisition costs and deferred sales inducements by $299.5 million recorded through operations as a decrease in amortization of deferred policy acquisition costs and deferred sales inducements.

Liability for Lifetime Income Benefit Riders

Beginning in July 2007, substantially all of our fixed index annuity policies and many of our annual reset fixed rate deferred annuities were issued with a lifetime income benefit rider.

The liability for lifetime income benefit riders is based on estimates of the value of benefit payments expected to be paid in excess of projected policy values recognizing the excess over the expected lives of the underlying policies based on actual and expected assessments including spreads and product charges and fees. The inputs used in the calculation of the liability for lifetime income benefit riders include actual policy values, actual income account values, actual payout factors, actual roll-up rates and our best estimate assumptions for future policy growth, future policy decrements, the ages at which policyholders are expected to elect to begin to receive lifetime income benefit payments, the percentage of policyholders who elect to receive lifetime income benefit payments and the type of income benefit payments selected upon election. The assumptions are reviewed quarterly and revisions to the assumptions are made based on historical results and our best estimates of future experience. The liability for lifetime income benefit riders is included in policy benefit reserves in the consolidated balance sheets and the change in the liability is included in interest sensitive and index product benefits in the consolidated statements of operations. See Results of Operations for the Three Years Ended December 31, 2016in this Item 7. for a discussion and presentation of the actual effects of assumption revisions.

Deferred Policy Acquisition Costs and Deferred Sales Inducements

Costs relating to the successful production of new business are not expensed when incurred but instead are capitalized as deferred policy acquisition costs or deferred sales inducements. Only costs which are expected to be recovered from future policy revenues and gross profits may be deferred.

Deferred policy acquisition costs and deferred sales inducements are subject to loss recognition testing on a quarterly basis or when an event occurs that may warrant loss recognition. Deferred policy acquisition costs consist principally of commissions and certain costs of policy issuance. Deferred sales inducements consist of premium and interest bonuses credited to policyholder account balances.

44

For annuity products, these costs are being amortized generally in proportion to expected gross profits from investment spreads, including the cost of hedging the fixed indexed annuity obligations, and, to a lesser extent, from product charges net of expected excess payments for lifetime income benefit riders, and mortality and expense margins. Current and future period gross profits/margins for fixed index annuities also include the impact of amounts recorded for the change in fair value of derivatives and the change in fair value of embedded derivatives. Current period amortization is adjusted retrospectively through an unlocking process when estimates of current or future gross profits/margins (including the impact of realized investment gains and losses) to be realized from a group of products are revised. Our estimates of future gross profits/margins are based on actuarial assumptions related to the underlying policies terms, lives of the policies, yield on investments supporting the liabilities and level of expenses necessary to maintain the polices over their entire lives. Revisions are made based on historical results and our best estimates of future experience. See Results of Operations for the Three Years Ended December 31, 2016 in this Item 7. for a discussion and presentation of the actual effects of unlocking.

Estimated future gross profits vary based on a number of sources including investment spread margins, surrender charge income, policy persistency, policy administrative expenses and realized gains and losses on investments including credit related other than temporary impairment losses. Estimated future gross profits are most sensitive to changes in investment spread margins which are the most significant component of gross profits. If estimated gross profits for all future years on business in force at December 31, 2016 were to increase by 10%, our combined balance for deferred policy acquisition costs and deferred sales inducements at December 31, 2016 would increase by $182.2 million recorded through operations as a decrease to amortization of deferred policy acquisition costs and deferred sales inducements. Correspondingly, a 10% decrease in estimated gross profits for all future years would result in a $202.7 million decrease in the combined December 31, 2016 balances recorded through operations as an increase to amortization of deferred policy acquisition costs and deferred sales inducements.

Deferred Income Taxes

We account for income taxes using the liability method. This method provides for the tax effects of transactions reported in the audited consolidated financial statements for both taxes currently due and deferred. Deferred income taxes reflect the impact of temporary differences between the amount of assets and liabilities recognized for financial reporting purposes and such amounts recognized for tax purposes. A temporary difference is a transaction, or amount of a transaction, that is recognized currently for financial reporting purposes but will not be recognized for tax purposes until a future tax period, or is recognized currently for tax purposes but will not be recognized for financial reporting purposes until a future reporting period. Deferred income taxes are measured by applying enacted tax rates for the years in which the temporary differences are expected to be recovered or settled to the amount of each temporary difference.

The realization of deferred income tax assets is primarily based upon management's estimates of future taxable income. Valuation allowances are established when management estimates, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination, consideration is given to, among other things, the following:

• future taxable income of the necessary character exclusive of reversing temporary differences and carryforwards;

• future reversals of existing taxable temporary differences;

• taxable income in prior carryback years; and

• tax planning strategies.

Actual realization of deferred income tax assets and liabilities may materially differ from these estimates as a result of changes in tax laws as well as unanticipated future transactions impacting related income tax balances.

The realization of deferred income tax assets related to unrealized losses on our available for sale fixed maturity securities is also based upon our intent to hold these securities for a period of time sufficient to allow for a recovery in fair value and not realize the unrealized loss.

New Accounting Pronouncements

See Note 1 to our audited consolidated financial statements in this Form 10-K beginning on page F-9, which is incorporated by reference in this Item 7, for new accounting pronouncement disclosures.

Item 7A.    Quantitative and Qualitative Disclosures About Market Risk

We seek to invest our available funds in a manner that will maximize shareholder value and fund future obligations to policyholders and debtors, subject to appropriate risk considerations. We seek to meet this objective through investments that: (i) consist substantially of investment grade fixed maturity securities, (ii) have projected returns which satisfy our spread targets and (iii) have characteristics which support the underlying liabilities. Many of our products incorporate surrender charges, market interest rate adjustments or other features to encourage persistency.

We seek to maximize the total return on our available for sale investments through active investment management. Accordingly, we have determined that our available for sale portfolio of fixed maturity securities is available to be sold in response to: (i) changes in market interest rates; (ii) changes in relative values of individual securities and asset sectors; (iii) changes in prepayment risks; (iv) changes in credit quality outlook for certain securities; (v) liquidity needs; and (vi) other factors.

45

Interest rate risk is our primary market risk exposure. Substantial and sustained increases and decreases in market interest rates can affect the profitability of our products, the fair value of our investments and the amount of interest we pay on our floating rate term loan and subordinated debentures. See Note 9 to our consolidated financial statements, which is incorporated by reference to this Item 7A, for information regarding the floating interest rate on our term loan. Our floating rate trust preferred securities bear interest at the three month LIBOR plus 3.50% - 4.00%. Our outstanding balance of floating rate trust preferred securities was $164.5 million at December 31, 2016, of which $85.5 million has been swapped to a fixed rate which began in March 2014 and $79.0 million has been capped for a term of seven years which began in July 2014 (See Note 5 to our consolidated financial statements in this Form 10-K). The profitability of most of our products depends on the spreads between interest yield on investments and rates credited on insurance liabilities. We have the ability to adjust crediting rates (caps, participation rates or asset fee rates for fixed index annuities) on substantially all of our annuity liabilities at least annually (subject to minimum guaranteed values). In addition, substantially all of our annuity products have surrender and withdrawal penalty provisions designed to encourage persistency and to help ensure targeted spreads are earned. However, competitive factors, including the impact of the level of surrenders and withdrawals, may limit our ability to adjust or maintain crediting rates at levels necessary to avoid narrowing of spreads under certain market conditions.

A major component of our interest rate risk management program is structuring the investment portfolio with cash flow characteristics consistent with the cash flow characteristics of our insurance liabilities. We use models to simulate cash flows expected from our existing business under various interest rate scenarios. These simulations enable us to measure the potential gain or loss in fair value of our interest rate-sensitive financial instruments, to evaluate the adequacy of expected cash flows from our assets to meet the expected cash requirements of our liabilities and to determine if it is necessary to lengthen or shorten the average life and duration of our investment portfolio. The "duration" of a security is the time weighted present value of the security's expected cash flows and is used to measure a security's sensitivity to changes in interest rates. When the durations of assets and liabilities are similar, exposure to interest rate risk is minimized because a change in value of assets should be largely offset by a change in the value of liabilities.

If interest rates were to increase 10% (31 basis points) from levels at December 31, 2016, we estimate that the fair value of our fixed maturity securities would decrease by approximately $1.0 billion. The impact on stockholders' equity of such decrease (net of income taxes and certain adjustments for changes in amortization of deferred policy acquisition costs and deferred sales inducements) would be a decrease of $291.7 million in accumulated other comprehensive income and a decrease in stockholders' equity. The models used to estimate the impact of a 10% change in market interest rates incorporate numerous assumptions, require significant estimates and assume an immediate and parallel change in interest rates without any management of the investment portfolio in reaction to such change. Consequently, potential changes in value of our financial instruments indicated by the simulations will likely be different from the actual changes experienced under given interest rate scenarios, and the differences may be material. Because we actively manage our investments and liabilities, our net exposure to interest rates can vary over time. However, any such decreases in the fair value of our fixed maturity securities (unless related to credit concerns of the issuer requiring recognition of an other than temporary impairment) would generally be realized only if we were required to sell such securities at losses prior to their maturity to meet our liquidity needs, which we manage using the surrender and withdrawal provisions of our annuity contracts and through other means. See Financial Condition—Liquidity for Insurance Operations for a further discussion of the liquidity risk.

At December 31, 2016, 35% of our fixed income securities have call features, of which 0.1% ($55.7 million) were subject to call redemption. Another 3.1% ($1.3 billion) will become subject to call redemption during 2017. Approximately 70% of our fixed income securities that have call features are not callable until within six months of their stated maturities. During the years ended December 31, 2016 and 2015, we received $1.2 billion and $0.7 billion, respectively, in net redemption proceeds related to the exercise of such call options. We have reinvestment risk related to these redemptions to the extent we cannot reinvest the net proceeds in assets with credit quality and yield characteristics similar to the redeemed bonds. Such reinvestment risk typically occurs in a declining rate environment. Should rates decline to levels which tighten the spread between our average portfolio yield and average cost of interest credited on annuity liabilities, we have the ability to reduce crediting rates (caps, participation rates or asset fees for index annuities) on most of our annuity liabilities to maintain the spread at our targeted level. At December 31, 2016, approximately 98% of our annuity liabilities were subject to annual adjustment of the applicable crediting rates at our discretion, limited by minimum guaranteed crediting rates specified in the policies.

We purchase call options on the applicable indices to fund the annual index credits on our fixed index annuities. These options are primarily one-year instruments purchased to match the funding requirements of the underlying policies. Fair value changes associated with those investments are substantially offset by an increase or decrease in the amounts added to policyholder account balances for fixed index products. The difference between proceeds received at expiration of these options and index credits, as shown in the following table, is primarily due to over-hedging as a result of policyholder behavior being different than our expectations.

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands)
Annual index credits to policyholders on their anniversaries	$	267,995	$	587,705	$	1,096,504
Proceeds received at expiration of options related to such credits	272,277		602,436		1,103,710

On the anniversary dates of the index policies, we purchase new one-year call options to fund the next annual index credits. The risk associated with these prospective purchases is the uncertainty of the cost, which will determine whether we are able to earn our spread on our index business. We manage this risk through the terms of our fixed index annuities, which permit us to change caps, participation rates and asset fees, subject to contractual features. By modifying caps, participation rates or asset fees, we can limit option costs to budgeted amounts, except in cases where the contractual features would prevent further modifications. Based upon actuarial testing which we conduct as a part of the design of our index products and on an ongoing basis, we believe the risk that contractual features would prevent us from controlling option costs is not material.

46

Item 8.    Consolidated Financial Statements and Supplementary Data

The audited consolidated financial statements are included as a part of this report on Form 10-K on pages F-1 through F-54.

Item 9.    Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A.    Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures.

In accordance with the Securities Exchange Act Rules 13a-15(e) and 15d-15(e), our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report on Form 10-K. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2016.

(b) Management's Report on Internal Control over Financial Reporting.

The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f). Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

The Company's management assessed the effectiveness of the Company's internal control over financial reporting as of December 31, 2016 based upon criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on the assessment, management has determined that we maintained effective internal control over financial reporting as of December 31, 2016.

The Company's independent registered public accounting firm, KPMG LLP, who audited the consolidated financial statements included in this annual report on Form 10-K, has issued an attestation report on the effectiveness of management's internal control over financial reporting as of December 31, 2016. This report appears on page F-2 of this annual report on Form 10-K.

(c) Changes in Internal Control over Financial Reporting.

Other than the remediation described below, there were no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2016, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

(d) Remediation of the Material Weakness in Internal Control Over Financial Reporting.

A material weakness is defined as a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company's annual or interim financial statements will not be prevented or detected on a timely basis. As previously reported, we did not have adequate controls designed and in place to ensure that we correctly implemented changes made to the calculation of lifetime income benefit reserves in the third quarter of 2015. Specifically, the design of our control relating to the review of the implementation of code changes to reflect revised assumptions and the impact of those changes (the “review control”) on the lifetime income benefit reserves was not modified given the complex nature and volume of code changes we made as part of the third quarter review. As a result, we failed to identify an immaterial after-tax calculation error. This amount was corrected in the fourth quarter of 2015 prior to issuing our consolidated financial statements. The control deficiency related to the lifetime income benefit reserves created a reasonable possibility that a material misstatement to the consolidated financial statements would not be prevented or detected on a timely basis and therefore we concluded that the deficiency represented a material weakness in the Company's internal control over financial reporting as of December 31, 2015.

With the oversight of our audit committee, we took corrective steps during 2016 to remediate the underlying causes of the material weakness. The corrective steps we have taken, which are intended to ensure that code changes to the lifetime income benefit reserves calculation function as intended, are:

- The “review control” over the implementation of code changes to our lifetime income benefit reserves was enhanced to ensure that all code changes are reviewed by an individual who is not responsible for the implementation of the code changes.

- The scope of the “review control” over the implementation of code changes to our lifetime income benefit reserves was expanded to include detailed testing of our lifetime income benefit reserves calculation to ensure any code changes are implemented accurately.

The enhanced “review control” as described above was implemented during the fourth quarter of 2015. During the fourth quarter of 2016 and prior to the issuance of our consolidated financial statements for the year ended December 31, 2016, we completed sufficient instances of

47

testing of the operating effectiveness of the enhanced “review control” and concluded that the above identified material weakness in our internal controls over financial reporting has been fully remediated.

Item 9B.    Other Information

There is no information required to be disclosed on Form 8-K for the quarter ended December 31, 2016 which has not been previously reported.

PART III

The information required by Part III is incorporated by reference from our definitive proxy statement for our annual meeting of shareholders to be held June 1, 2017 to be filed with the Commission pursuant to Regulation 14A within 120 days after December 31, 2016.

PART IV

Item 15.    Exhibits and Financial Statement Schedules

Financial Statements and Financial Statement Schedules.    See Index to Consolidated Financial Statements and Schedules on page F-1 for a list of financial statements and financial statement schedules included in this report.

All other schedules to the audited consolidated financial statements required by Article 7 of Regulation S-X are omitted because they are not applicable, not required, or because the information is included elsewhere in the audited consolidated financial statements or notes thereto.

Exhibits.    See Exhibit Index immediately preceding the Exhibits for a list of Exhibits filed with this report.

48

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, this 27th day of February 2017.

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
By:	/s/ JOHN M. MATOVINA
	John M. Matovina, Chief Executive Officer and President

Pursuant to the requirements of the Securities Exchange Act of 1934, this registration statement has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:

Signature	Title (Capacity)	Date
/s/ JOHN M. MATOVINA	Chief Executive Officer, President and Director (Principal Executive Officer)	February 27, 2017
John M. Matovina
/s/ TED M. JOHNSON	Chief Financial Officer and Treasurer (Principal Financial Officer)	February 27, 2017
Ted M. Johnson
/s/ SCOTT A. SAMUELSON	Vice President—Controller (Principal Accounting Officer)	February 27, 2017
Scott A. Samuelson
/s/ D.J. NOBLE	Chairman of the Board and Director	February 27, 2017
D.J. Noble
/s/ JOYCE A. CHAPMAN	Director	February 27, 2017
Joyce A. Chapman
/s/ ALEXANDER M. CLARK	Director	February 27, 2017
Alexander M. Clark
/s/ JAMES M. GERLACH	Director	February 27, 2017
James M. Gerlach
/s/ ROBERT L. HOWE	Director	February 27, 2017
Robert L. Howe
/s/ WILLIAM R. KUNKEL	Director	February 27, 2017
William R. Kunkel
/s/ ALAN D. MATULA	Director	February 27, 2017
Alan D. Matula
/s/ DAVID S. MULCAHY	Director	February 27, 2017
David S. Mulcahy
/s/ GERARD D. NEUGENT	Director	February 27, 2017
Gerard D. Neugent
/s/ DEBRA J. RICHARDSON	Director	February 27, 2017
Debra J. Richardson
/s/ A.J. STRICKLAND, III	Director	February 27, 2017
A.J. Strickland, III

49

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND SCHEDULES

YEARS ENDED DECEMBER 31, 2016, 2015 and 2014

Reports of Independent Registered Public Accounting Firm	F-2
Consolidated Financial Statements:
Consolidated Balance Sheets	F-3
Consolidated Statements of Operations	F-4
Consolidated Statements of Comprehensive Income (Loss)	F-5
Consolidated Statements of Changes in Stockholders' Equity	F-6
Consolidated Statements of Cash Flows	F-7
Notes to Consolidated Financial Statements
Note 1.  Significant Accounting Policies	F-9
Note 2.  Fair Value of Financial Instruments	F-13
Note 3.  Investments	F-18
Note 4.  Mortgage Loans on Real Estate	F-25
Note 5.  Derivative Instruments	F-30
Note 6.  Deferred Policy Acquisition Costs and Deferred Sales Inducements	F-33
Note 7. Reinsurance and Policy Provisions	F-33
Note 8. Income Taxes	F-35
Note 9. Notes and Loan Payable and Amounts Due Under Repurchase Agreements	F-36
Note 10. Subordinated Debentures	F-37
Note 11. Retirement and Share-based Compensation Plans	F-38
Note 12. Statutory Financial Information and Dividend Restrictions	F-41
Note 13. Commitments and Contingencies	F-42
Note 14. Earnings Per Share and Stockholders' Equity	F-43
Note 15. Quarterly Financial Information (Unaudited)	F-44
Schedules:
Schedule I—Summary of Investments—Other Than Investments in Related Parties	F-45
Schedule II—Condensed Financial Information of Registrant	F-46
Schedule III—Supplementary Insurance Information	F-50
Schedule IV—Reinsurance	F-51
Schedule V—Valuation and Qualifying Accounts	F-52

F-1

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

American Equity Investment Life Holding Company:

We have audited the accompanying consolidated balance sheets of American Equity Investment Life Holding Company and subsidiaries (the Company) as of December 31, 2016 and 2015, and the related consolidated statements of operations, comprehensive income (loss), changes in stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2016. In connection with our audits of the consolidated financial statements, we also have audited the financial statement schedules listed in the Index on page F-1. We also have audited the Company’s internal control over financial reporting as of December 31, 2016, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for these consolidated financial statements and financial statement schedules, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedules and an opinion on the Company’s internal control over financial reporting based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the consolidated financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the American Equity Investment Life Holding Company and subsidiaries as of December 31, 2016 and 2015, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2016, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the related financial statement schedules, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly, in all material respects, the information set forth therein. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2016, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

/s/ KPMG LLP

Des Moines, Iowa

February 27, 2017

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except share and per share data)

	December 31,
	2016		2015
Assets
Investments:
Fixed maturity securities:
Available for sale, at fair value (amortized cost: 2016 - $39,953,955; 2015 - $35,823,710)	$	41,060,494	$	36,421,839
Held for investment, at amortized cost (fair value: 2016 - $68,766; 2015 - $65,377)	76,825		76,622
Mortgage loans on real estate	2,480,956		2,435,257
Derivative instruments	830,519		337,256
Other investments	308,774		299,358
Total investments	44,757,568		39,570,332
Cash and cash equivalents	791,266		397,749
Coinsurance deposits	4,639,492		3,187,470
Accrued investment income	397,773		362,104
Deferred policy acquisition costs	2,905,377		2,905,136
Deferred sales inducements	2,208,218		2,232,148
Deferred income taxes	168,578		232,683
Income taxes recoverable	11,474		29,599
Other assets	173,726		112,171
Total assets	$	56,053,472	$	49,029,392
Liabilities and Stockholders' Equity
Liabilities:
Policy benefit reserves	$	51,637,026	$	45,495,431
Other policy funds and contract claims	298,347		324,850
Notes and loan payable	493,755		393,227
Subordinated debentures	241,853		241,452
Other liabilities	1,090,896		629,897
Total liabilities	53,761,877		47,084,857
Stockholders' equity:
Preferred stock, par value $1 per share, 2,000,000 shares authorized, 2016 and 2015 - no shares issued and outstanding	—		—
Common stock, par value $1 per share, 200,000,000 shares authorized; issued and outstanding: 2016 - 88,001,130 shares (excluding 2,887,082 treasury shares); 2015 - 81,354,079 shares (excluding 3,448,750 treasury shares)	88,001		81,354
Additional paid-in capital	770,344		630,367
Accumulated other comprehensive income	339,966		201,663
Retained earnings	1,093,284		1,031,151
Total stockholders' equity	2,291,595		1,944,535
Total liabilities and stockholders' equity	$	56,053,472	$	49,029,392

See accompanying notes to consolidated financial statements.

F-3

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Dollars in thousands, except per share data)

	Year Ended December 31,
	2016			2015			2014
Revenues:
Premiums and other considerations	$	43,767		$	36,048		$	32,623
Annuity product charges	173,579			136,168			118,990
Net investment income	1,849,872			1,692,192			1,531,667
Change in fair value of derivatives	164,219			(336,146		)	504,825
Net realized gains (losses) on investments, excluding other than temporary impairment ("OTTI") losses	11,524			10,211			(4,003		)
OTTI losses on investments:
Total OTTI losses	(21,349		)	(25,547		)	—
Portion of OTTI losses recognized in (from) other comprehensive income	(1,330		)	6,011			(2,627		)
Net OTTI losses recognized in operations	(22,679		)	(19,536		)	(2,627		)
Loss on extinguishment of debt	—			—			(12,502		)
Total revenues	2,220,282			1,518,937			2,168,973
Benefits and expenses:
Insurance policy benefits and change in future policy benefits	52,483			45,458			41,815
Interest sensitive and index product benefits	725,472			968,053			1,473,700
Amortization of deferred sales inducements	251,166			209,390			131,419
Change in fair value of embedded derivatives	543,465			(464,698		)	32,321
Interest expense on notes and loan payable	28,248			28,849			36,370
Interest expense on subordinated debentures	12,958			12,239			12,122
Amortization of deferred policy acquisition costs	374,012			286,114			163,578
Other operating costs and expenses	102,231			96,218			81,584
Total benefits and expenses	2,090,035			1,181,623			1,972,909
Income before income taxes	130,247			337,314			196,064
Income tax expense	47,004			117,484			70,041
Net income	$	83,243		$	219,830		$	126,023
Earnings per common share	$	0.98		$	2.78		$	1.69
Earnings per common share - assuming dilution	$	0.97		$	2.72		$	1.58
Weighted average common shares outstanding (in thousands):
Earnings per common share	84,793			78,937			74,431
Earnings per common share - assuming dilution	85,605			80,961			79,894

See accompanying notes to consolidated financial statements.

F-4

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Dollars in thousands)

	Year Ended December 31,
	2016			2015			2014
Net income	$	83,243		$	219,830		$	126,023
Other comprehensive income (loss):
Change in net unrealized investment gains/losses (1)	207,994			(797,374		)	1,038,604
Noncredit component of OTTI losses (1)	556			(2,927		)	1,265
Reclassification of unrealized investment gains/losses to net income (1)	4,224			703			(1,092		)
Other comprehensive income (loss) before income tax	212,774			(799,598		)	1,038,777
Income tax effect related to other comprehensive income (loss)	(74,471		)	279,860			(363,572		)
Other comprehensive income (loss)	138,303			(519,738		)	675,205
Comprehensive income (loss)	$	221,546		$	(299,908	)	$	801,228

(1) Net of related adjustments to amortization of deferred sales inducements and deferred policy acquisition costs.

See accompanying notes to consolidated financial statements.

F-5

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

(Dollars in thousands, except per share data)

	Common Stock		Additional Paid-in Capital			Unallocated Common Stock Held by ESOP			Accumulated Other Comprehensive Income			Retained Earnings			Total Stockholders' Equity
Balance at December 31, 2013	$	70,535	$	550,400		$	(631	)	$	46,196		$	718,187		$	1,384,687
Net income for the year	—		—			—			—			126,023			126,023
Other comprehensive income	—		—			—			675,205			—			675,205
Allocation of 58,618 shares of common stock by ESOP, including excess income tax benefits	—		721			631			—			—			1,352
Share-based compensation, including excess income tax benefits	—		7,705			—			—			—			7,705
Issuance of 1,567,607 shares of common stock under compensation plans, including excess income tax benefits	1,568		13,137			—			—			—			14,705
Extinguishment of convertible senior notes, net of tax, including 3,959,396 shares of common stock issued upon conversion	3,959		(7,488		)	—			—			—			(3,529		)
Warrants reclassified to embedded derivative liability to be settled in cash	—		(51,257		)	—			—			—			(51,257		)
Dividends on common stock ($0.20 per share)	—		—			—			—			(15,015		)	(15,015		)
Balance at December 31, 2014	76,062		513,218			—			721,401			829,195			2,139,876
Net income for the year	—		—			—			—			219,830			219,830
Other comprehensive loss	—		—			—			(519,738		)	—			(519,738		)
Share-based compensation, including excess income tax benefits	—		9,976			—			—			—			9,976
Issuance of common stock via public offering	4,300		100,179			—			—			—			104,479
Issuance of 944,504 shares of common stock under compensation plans, including excess income tax benefits	944		7,042			—			—			—			7,986
Issuance of 47,868 shares of common stock to settle warrants that have reached their expiration	48		(48		)	—			—			—			—
Dividends on common stock ($0.22 per share)	—		—			—			—			(17,874		)	(17,874		)
Balance at December 31, 2015	81,354		630,367			—			201,663			1,031,151			1,944,535
Net income for the year	—		—			—			—			83,243			83,243
Other comprehensive income	—		—			—			138,303			—			138,303
Share-based compensation, including excess income tax benefits	—		7,218			—			—			—			7,218
Issuance of common stock via settlement of forward sale agreements	5,590		129,072			—			—			—			134,662
Issuance of 964,053 shares of common stock under compensation plans, including excess income tax benefits	964		3,781			—			—			—			4,745
Issuance of 92,998 shares of common stock to settle warrants that have reached their expiration	93		(94		)	—			—			—			(1		)
Dividends on common stock ($0.24 per share)	—		—			—			—			(21,110		)	(21,110		)
Balance at December 31, 2016	$	88,001	$	770,344		$	—		$	339,966		$	1,093,284		$	2,291,595

See accompanying notes to consolidated financial statements.

F-6

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

	Year Ended December 31,
	2016			2015			2014
Operating activities
Net income	$	83,243		$	219,830		$	126,023
Adjustments to reconcile net income to net cash provided by operating activities:
Interest sensitive and index product benefits	725,472			968,053			1,473,700
Amortization of deferred sales inducements	251,166			209,390			131,419
Annuity product charges	(173,579		)	(136,168		)	(118,990		)
Change in fair value of embedded derivatives	543,465			(464,698		)	32,321
Increase in traditional life and accident and health insurance reserves	12,724			5,097			2,385
Policy acquisition costs deferred	(543,325		)	(657,639		)	(426,882		)
Amortization of deferred policy acquisition costs	374,012			286,114			163,578
Provision for depreciation and other amortization	3,879			4,610			9,490
Amortization of discounts and premiums on investments	1,070			(8,464		)	(14,960		)
Loss on extinguishment of debt	—			—			12,502
Realized gains (losses) on investments and net OTTI losses recognized in operations	11,155			9,325			6,630
Change in fair value of derivatives	(165,727		)	334,300			(506,328		)
Deferred income taxes (benefits)	(10,408		)	41,916			(46,504		)
Share-based compensation	6,692			7,373			3,544
Change in accrued investment income	(35,669		)	(35,545		)	(24,918		)
Change in income taxes recoverable/payable	18,125			(20,027		)	(19,405		)
Change in other assets	1,812			71			(2,771		)
Change in other policy funds and contract claims	(34,411		)	(49,092		)	(60,931		)
Change in collateral held for derivatives	414,655			(269,474		)	27,839
Change in other liabilities	(55,940		)	75,794			(51,008		)
Other	(14,089		)	(15,962		)	(8,948		)
Net cash provided by operating activities	1,414,322			504,804			707,786
Investing activities
Sales, maturities, or repayments of investments:
Fixed maturity securities—available for sale	2,746,510			1,612,121			1,490,906
Mortgage loans on real estate	383,763			468,102			453,937
Derivative instruments	284,470			640,467			1,169,874
Other investments	14,045			16,792			23,165
Acquisitions of investments:
Fixed maturity securities—available for sale	(6,883,895		)	(7,256,137		)	(5,191,781		)
Mortgage loans on real estate	(428,833		)	(455,286		)	(327,654		)
Derivative instruments	(602,349		)	(588,859		)	(492,296		)
Other investments	(11,559		)	(13,092		)	(72,548		)
Purchases of property, furniture and equipment	(1,197		)	(1,313		)	(1,352		)
Net cash used in investing activities	(4,499,045		)	(5,577,205		)	(2,947,749		)

F-7

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)

(Dollars in thousands)

	Year Ended December 31,
	2016			2015			2014
Financing activities
Receipts credited to annuity and single premium universal life policyholder account balances	$	7,092,348		$	7,051,227		$	4,160,005
Coinsurance deposits	(1,317,555		)	(80,777		)	109,184
Return of annuity policyholder account balances	(2,535,669		)	(2,271,950		)	(2,025,203		)
Financing fees incurred and deferred	(1,456		)	—			(100		)
Repayment of notes payable	—			(48,152		)	(219,094		)
Proceeds from issuance of debt	100,000			—			—
Net proceeds from settlement of notes hedges and warrants	—			25,775			16,558
Acquisition of common stock	—			(16		)	—
Excess tax benefits realized from share-based compensation plans	527			3,649			5,184
Proceeds from issuance of common stock	139,654			112,481			13,681
Change in checks in excess of cash balance	21,501			(5,727		)	(1,252		)
Dividends paid	(21,110		)	(17,874		)	(15,015		)
Net cash provided by financing activities	3,478,240			4,768,636			2,043,948
Increase (decrease) in cash and cash equivalents	393,517			(303,765		)	(196,015		)
Cash and cash equivalents at beginning of year	397,749			701,514			897,529
Cash and cash equivalents at end of year	$	791,266		$	397,749		$	701,514
Supplemental disclosures of cash flow information
Cash paid during the year for:
Interest expense	$	39,647		$	39,118		$	42,989
Income taxes	39,066			91,887			132,754
Non-cash operating activity:
Deferral of sales inducements	353,966			486,924			330,079
Non-cash investing activity:
Real estate acquired in satisfaction of mortgage loans	—			—			14,555
Mortgage loan on real estate sold	—			4,879			—
Non-cash financing activity:
Common stock issued in extinguishment of debt	—			—			95,993
Common stock issued to settle warrants that have expired	93			48			—

See accompanying notes to consolidated financial statements.

F-8

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.     Significant Accounting Policies

Nature of Operations

American Equity Investment Life Holding Company ("we", "us", "our" or "parent company"), through its wholly-owned subsidiaries, American Equity Investment Life Insurance Company ("American Equity Life"), American Equity Investment Life Insurance Company of New York ("American Equity Life of New York") and Eagle Life Insurance Company ("Eagle Life"), is licensed to sell insurance products in 50 states and the District of Columbia at December 31, 2016. We operate solely in the insurance business.

We primarily market fixed index and fixed rate annuities and to a lesser extent, life insurance. Premiums and annuity deposits (net of coinsurance) collected in 2016, 2015 and 2014, by product type were as follows:

	Year Ended December 31,
Product Type	2016		2015		2014
	(Dollars in thousands)
Fixed index annuities	$	5,035,818	$	6,491,981	$	3,911,109
Annual reset fixed rate annuities	63,582		44,715		56,647
Multi-year fixed rate annuities	256,894		42,709		21,125
Single premium immediate annuities (SPIA)	35,851		32,752		24,580
Life insurance	9,946		10,917		10,810
	$	5,402,091	$	6,623,074	$	4,024,271

Agents contracted with us through two national marketing organizations accounted for more than 10% of the annuity deposits and insurance premium collections during 2016 by American Equity Life representing 19% and 10%, individually, of the annuity deposits and insurance premiums collected by American Equity Life. Agents contracted with us through one national marketing organization accounted for more than 10% of the annuity deposits and insurance premium collections during 2015 by American Equity Life, representing 24% of the annuity deposits and insurance premiums collected by American Equity Life. Agents contracted with us through two national marketing organizations accounted for more than 10% of the annuity deposits and insurance premium collections during 2014 by American Equity Life, each representing 10% individually, of the annuity deposits and insurance premiums collected by American Equity Life.

Consolidation and Basis of Presentation

The consolidated financial statements include our accounts and our wholly-owned subsidiaries: American Equity Life, American Equity Life of New York, Eagle Life, AERL, L.C., American Equity Capital, Inc., American Equity Investment Properties, L.C., American Equity Advisors, Inc. and American Equity Investment Service Company. All significant intercompany accounts and transactions have been eliminated.

Estimates and Assumptions

The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are utilized in the calculation of deferred policy acquisition costs, deferred sales inducements, policy benefit reserves, valuation of derivatives, including embedded derivatives on index annuity reserves, contingent convertible senior notes, valuation of investments, other than temporary impairment of investments, allowances for loan losses on mortgage loans and valuation allowances on deferred tax assets. A description of each critical estimate is incorporated within the discussion of the related accounting policies which follow. It is reasonably possible that actual experience could differ from the estimates and assumptions utilized.

Investments

Fixed maturity securities (bonds and redeemable preferred stocks maturing more than one year after issuance) that may be sold prior to maturity are classified as available for sale. Available for sale securities are reported at fair value and unrealized gains and losses, if any, on these securities are included directly in a separate component of stockholders' equity, net of income taxes and certain adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements. Fair values, as reported herein, of fixed maturity and equity securities are based on quoted market prices in active markets when available, or for those fixed maturity securities not actively traded, yield data and other factors relating to instruments or securities with similar characteristics are used. See Note 2 for more information on the determination of fair value. Premiums and discounts are amortized/accrued using methods which result in a constant yield over the securities' expected lives. Amortization/accrual of premiums and discounts on residential and commercial mortgage backed securities incorporate prepayment assumptions to estimate the securities' expected lives. Interest income is recognized as earned.

F-9

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Fixed maturity securities that we have the positive intent and ability to hold to maturity are classified as held for investment. Such securities may, at times, be called prior to maturity. Held for investment securities are reported at cost adjusted for amortization of premiums and discounts. Changes in the fair value of these securities, except for declines that are other than temporary, are not reflected in our consolidated financial statements.

The carrying amounts of our impaired investments in fixed maturity and equity securities are adjusted for declines in value that are other than temporary. Other than temporary impairment losses are reported as a component of revenues in the consolidated statements of operations, which presents the amount of noncredit impairment losses for certain fixed maturity securities that is reported in accumulated other comprehensive income (loss). See Note 3 for further discussion of other than temporary impairment losses.

Deterioration in credit quality of the companies or assets backing our investment securities, deterioration in the condition of the financial services industry, imbalances in liquidity recurring in the marketplace or declines in real estate values may further affect the fair value of these investment securities and increase the potential that certain unrealized losses will be recognized as other than temporary impairments in the future.

Mortgage loans on real estate are reported at cost, adjusted for amortization of premiums and accrual of discounts. Interest income is recorded when earned; however, interest ceases to accrue for loans on which interest is more than 90 days past due based upon contractual terms and/or when the collection of interest is not considered probable. We evaluate the mortgage loan portfolio for the establishment of a loan loss allowance by specific identification of impaired loans and the measurement of an estimated loss, if any, for each impaired loan identified and an analysis of the mortgage loan portfolio for the need of a general loan allowance for probable losses on all loans. If we determine that the value of any specific mortgage loan is impaired, the carrying amount of the mortgage loan will be reduced to its fair value, based upon the present value of expected future cash flows from the loan discounted at the loan's contractual interest rate, or the fair value of the underlying collateral, less costs to sell. The amount of the general loan allowance, if any, is based upon our evaluation of the probability of collection, historical loss experience, delinquencies, credit concentrations, underwriting standards and national and local economic conditions. The carrying value of impaired loans is reduced by the establishment of an allowance for loan losses, changes to which are recognized as realized gains or losses on investments. Interest income on impaired loans is recorded on a cash basis.

Other invested assets include company owned life insurance, equity securities, real estate, limited partnerships accounted for using the equity method and policy loans. Company owned life insurance is recorded at the amount that can be realized under the insurance contract at the end of the reporting period, which is the cash surrender value adjusted for other charges or other amounts due that are probable at settlement. Equity securities are classified as available for sale and are reported at fair value. Unrealized gains and losses are included directly in a separate component of stockholders' equity, net of income taxes and certain adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements. Dividends are recognized when declared. Policy loans are stated at current unpaid principal balances.

Real estate owned is reported at cost less accumulated depreciation. Cost is determined at the time ownership is acquired in satisfaction of mortgage loans and is the lower of the carrying value of the mortgage loan or fair value of the real estate less its estimated cost to sell. Buildings and improvements are depreciated using the straight-line method over their estimated useful lives. Impairment losses on real estate owned are recognized when there are indicators of impairment present and the expected future undiscounted cash flows are not sufficient to recover the real estate's carrying value. Any impairment losses are reported as realized losses and are part of net income.

Derivative Instruments

Our derivative instruments include call options used to fund fixed index annuity credits, interest rate swap and caps used to manage interest rate risk associated with the floating rate component on certain of our subordinated debentures, call options to hedge the conversion spread on our convertible senior notes (see Note 9) and certain other derivative instruments embedded in other contracts. All of our derivative instruments are recognized in the balance sheet at fair value and changes in fair value are recognized immediately in operations. See Note 5 for more information on derivative instruments.

Cash and Cash Equivalents

We consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

We also consider reverse repurchase agreements, which typically have an initial maturity of 6 weeks or less, to be cash equivalents. Amounts advanced under these agreements represent short-term loans that carry a fixed rate of interest. Borrowers under these agreements are required to post collateral that is investment grade debt securities with fair value in excess of the amount advanced.

Book Overdrafts

Under our cash management system, checks issued but not yet presented to banks frequently result in overdraft balances for accounting purposes and are classified as Other liabilities on our consolidated balance sheets. We report the changes in the amount of the overdraft balance as a financing activity in our consolidated statement of cash flows as Change in checks in excess of cash balance.

F-10

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Deferred Policy Acquisition Costs and Deferred Sales Inducements

To the extent recoverable from future policy revenues and gross profits, certain costs that are incremental or directly related to the successful production of new business are not expensed when incurred but instead are capitalized as deferred policy acquisition costs or deferred sales inducements. Deferred policy acquisition costs and deferred sales inducements are subject to loss recognition testing on a quarterly basis or when an event occurs that may warrant loss recognition. Deferred policy acquisition costs consist primarily of commissions and certain costs of policy issuance. Deferred sales inducements consist of premium and interest bonuses credited to policyholder account balances.

For annuity products, these capitalized costs are being amortized generally in proportion to expected gross profits from investment spreads, including the cost of hedging the fixed indexed annuity obligations, and, to a lesser extent, from product charges net of expected excess payments for lifetime income benefit riders, and mortality and expense margins. Current and future period gross profits/margins for fixed index annuities also include the impact of amounts recorded for the change in fair value of derivatives and the change in fair value of embedded derivatives. That amortization is adjusted retrospectively through an unlocking process when estimates of current or future gross profits/margins (including the impact of net realized gains on investments and net OTTI losses recognized in operations) to be realized from a group of products are revised. Deferred policy acquisition costs and deferred sales inducements are also adjusted for the change in amortization that would have occurred if available for sale fixed maturity securities and equity securities had been sold at their aggregate fair value at the end of the reporting period and the proceeds reinvested at current yields. The impact of this adjustment is included in accumulated other comprehensive income within consolidated stockholders' equity, net of applicable taxes. See Note 6 for more information on deferred policy acquisition costs and deferred sales inducements.

Policy Benefit Reserves

Policy benefit reserves for fixed index annuities with returns linked to the performance of a specified market index are equal to the sum of the fair value of the embedded derivatives and the host (or guaranteed) component of the contracts. The host value is established at inception of the contract and accreted over the policy's life at a constant rate of interest. Future policy benefit reserves for fixed index annuities earning a fixed rate of interest and other deferred annuity products are computed under a retrospective deposit method and represent policy account balances before applicable surrender charges. For the years ended December 31, 2016, 2015 and 2014, interest crediting rates for these products ranged from 1.00% to 3.30%.

The liability for lifetime income benefit riders is based on estimates of the value of benefit payments expected to be paid in excess of projected policy values recognizing the excess over the expected lives of the underlying policies based on actual and expected assessments including spreads and product charges and fees. The inputs used in the calculation of the liability for lifetime income benefit riders include actual policy values, actual income account values, actual payout factors, actual roll-up rates and our best estimate assumptions for future policy growth, future policy decrements, the ages at which policyholders are expected to elect to begin to receive lifetime income benefit payments, the percentage of policyholders who elect to receive lifetime income benefit payments and the type of income benefit payments selected upon election.

Policy benefit reserves are not reduced for amounts ceded under coinsurance agreements which are reported as coinsurance deposits on our consolidated balance sheets. See Note 7 for more information on reinsurance.

The liability for future policy benefits for traditional life insurance is based on net level premium reserves, including assumptions as to interest, mortality, and other assumptions underlying the guaranteed policy cash values. Reserve interest assumptions are level and range from 3.00% to 5.50%. Policy benefit claims are charged to expense in the period that the claims are incurred.

Deferred Income Taxes

Deferred income tax assets or liabilities are computed based on the temporary differences between the financial statement and income tax bases of assets and liabilities using the enacted marginal tax rate. Deferred income tax expenses or benefits are based on the changes in the asset or liability from period to period. Deferred income tax assets are subject to ongoing evaluation of whether such assets will more likely than not be realized. The realization of deferred income tax assets primarily depends on generating future taxable income during the periods in which temporary differences become deductible. Deferred income tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax asset will not be realized. In making such a determination, all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations, is considered. The realization of deferred income tax assets related to unrealized losses on available for sale fixed maturity securities is also based upon our intent and ability to hold those securities for a period of time sufficient to allow for a recovery in fair value and not realize the unrealized loss.

F-11

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Recognition of Premium Revenues and Costs

Revenues for annuity products include surrender and living income benefit rider charges assessed against policyholder account balances during the period. Interest sensitive and index product benefits related to annuity products include interest credited or index credits to policyholder account balances pursuant to accounting by insurance companies for certain long-duration contracts. The change in fair value of the embedded derivatives for fixed index annuities equals the change in the difference between policy benefit reserves for fixed index annuities computed under the derivative accounting standard and the long-duration contracts accounting standard at each balance sheet date.

Considerations from immediate annuities with life contingencies are recognized as revenue when the policy is issued.

Traditional life insurance premiums are recognized as revenues over the premium-paying period. Certain group policies include provisions for annual experience refunds of premiums equal to net premiums received less an administrative fee and less claims incurred. Such amounts (2016 - $1.5 million; 2015 - $1.5 million; and 2014 - $1.7 million) are reported as a reduction of traditional life insurance premiums in the consolidated statements of operations. Future policy benefits are recognized as expenses over the life of the policy by means of the provision for future policy benefits.

All insurance-related revenues, including the change in the fair value of derivatives for call options related to the business ceded under coinsurance agreements (see Note 7), benefits, losses and expenses are reported net of reinsurance ceded.

Other Comprehensive Income (Loss)

Other comprehensive income (loss) includes all changes in stockholders' equity during a period except those resulting from investments by and distributions to stockholders. Other comprehensive income (loss) excludes net realized investment gains (losses) included in net income which merely represent transfers from unrealized to realized gains and losses.

Adopted Accounting Pronouncements

In April 2015, the Financial Accounting Standards Board ("FASB") issued an accounting standards update ("ASU") which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. Subsequently, in August 2015, the FASB issued an ASU that states that the Securities and Exchange Commission staff would not object to an entity deferring and presenting debt issuance costs related to line-of-credit arrangements as an asset and expensing those costs ratably over the term of the line of credit arrangement. These ASU's became effective for us on January 1, 2016, and retroactive application was required. Adoption of these ASU's did not have a material impact on our consolidated financial statements.

New Accounting Pronouncements

In January 2016, the FASB issued an ASU that, among other aspects of recognition, measurement, presentation and disclosure of financial instruments, primarily requires equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Additionally, it changes the accounting for financial liabilities measured at fair value under the fair value option and eliminates some disclosures regarding fair value of financial assets and liabilities measured at amortized cost. This ASU will be effective for us on January 1, 2018, and we have not determined the effect it will have on our consolidated financial statements.

In February 2016, the FASB issued an ASU that will require recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This ASU affects accounting and disclosure more dramatically for lessees as accounting for lessors is mainly unchanged. This ASU will be effective for us on January 1, 2019, with early adoption permitted, and we have not determined the effect it will have on our consolidated financial statements.

In March 2016, the FASB issued an ASU related to the accounting for share-based payment transactions. The aspects of accounting guidance affected by this ASU are income taxes, classification of awards as either equity or liabilities, and classification on the statement of cash flows. This ASU will be effective for us on January 1, 2017, with early adoption permitted, and we have not determined the effect it will have on our consolidated financial statements.

In June 2016, the FASB issued an ASU that significantly changes the impairment model for most financial assets that are measured at amortized cost and certain other instruments from an incurred loss model to an expected loss model that requires these assets be presented at the net amount expected to be collected. In addition, credit losses on available for sale debt securities should be recorded through an allowance account.  This ASU will be effective for us on January 1, 2020, with early adoption permitted, and we have not yet determined the impact this updated guidance will have on our consolidated financial statements.

In August 2016, the FASB issued an ASU that clarifies how certain cash receipts and cash payments are to be presented and classified in the statement of cash flows. This ASU will be effective for us on January 1, 2018, with early adoption permitted, and we have not yet determined the impact this updated guidance will have on our consolidated financial statements.

F-12

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

2.     Fair Values of Financial Instruments

The following sets forth a comparison of the carrying amounts and fair values of our financial instruments:

	December 31,
	2016				2015
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
	(Dollars in thousands)
Assets
Fixed maturity securities:
Available for sale	$	41,060,494	$	41,060,494	$	36,421,839	$	36,421,839
Held for investment	76,825		68,766		76,622		65,377
Mortgage loans on real estate	2,480,956		2,522,035		2,435,257		2,471,864
Derivative instruments	830,519		830,519		337,256		337,256
Other investments	308,774		300,918		292,872		297,903
Cash and cash equivalents	791,266		791,266		397,749		397,749
Coinsurance deposits	4,639,492		4,150,792		3,187,470		2,860,882
Interest rate caps	1,082		1,082		1,410		1,410
Counterparty collateral	145,693		145,693		82,312		82,312
Liabilities
Policy benefit reserves	51,280,331		43,104,183		45,151,460		38,435,515
Single premium immediate annuity (SPIA) benefit reserves	297,724		308,028		324,264		336,066
Notes and loan payable	493,755		519,440		393,227		417,752
Subordinated debentures	241,853		225,106		241,452		216,933
Interest rate swap	2,113		2,113		3,139		3,139

Fair value is the price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The objective of a fair value measurement is to determine that price for each financial instrument at each measurement date. We meet this objective using various methods of valuation that include market, income and cost approaches.

We categorize our financial instruments into three levels of fair value hierarchy based on the priority of inputs used in determining fair value. The hierarchy defines the highest priority inputs (Level 1) as quoted prices in active markets for identical assets or liabilities. The lowest priority inputs (Level 3) are our own assumptions about what a market participant would use in determining fair value such as estimated future cash flows. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, a financial instrument's level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. We categorize financial assets and liabilities recorded at fair value in the consolidated balance sheets as follows:

Level 1— Quoted prices are available in active markets for identical financial instruments as of the reporting date. We do not adjust the quoted price for these financial instruments, even in situations where we hold a large position and a sale could reasonably impact the quoted price.

Level 2— Quoted prices in active markets for similar financial instruments, quoted prices for identical or similar financial instruments in markets that are not active; and models and other valuation methodologies using inputs other than quoted prices that are observable.

Level 3— Models and other valuation methodologies using significant inputs that are unobservable for financial instruments and include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in Level 3 are securities for which no market activity or data exists and for which we used discounted expected future cash flows with our own assumptions about what a market participant would use in determining fair value.

Transfers of securities among the levels occur at times and depend on the type of inputs used to determine fair value of each security. There were no transfers between levels during any period presented.

F-13

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Our assets and liabilities which are measured at fair value on a recurring basis as of December 31, 2016 and 2015 are presented below based on the fair value hierarchy levels:

	Total Fair Value		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(Dollars in thousands)
December 31, 2016
Assets
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	11,805	$	5,381	$	6,424	$	—
United States Government sponsored agencies	1,344,787		—		1,344,787		—
United States municipalities, states and territories	3,926,950		—		3,926,950		—
Foreign government obligations	232,233		—		232,233		—
Corporate securities	27,118,526		6		27,118,520		—
Residential mortgage backed securities	1,254,835		—		1,254,835		—
Commercial mortgage backed securities	5,365,235		—		5,365,235		—
Other asset backed securities	1,806,123		—		1,806,123		—
Other investments: equity securities, available for sale	8,000		—		8,000		—
Derivative instruments	830,519		—		830,519		—
Cash and cash equivalents	791,266		791,266		—		—
Interest rate caps	1,082		—		1,082		—
Counterparty collateral	145,693		—		145,693		—
	$	42,837,054	$	796,653	$	42,040,401	$	—
Liabilities
Interest rate swap	$	2,113	$	—	$	2,113	$	—
Fixed index annuities—embedded derivatives	6,563,288		—		—		6,563,288
	$	6,565,401	$	—	$	2,113	$	6,563,288
December 31, 2015
Assets
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	471,256	$	438,598	$	32,658	$	—
United States Government sponsored agencies	1,398,611		—		1,398,611		—
United States municipalities, states and territories	3,755,367		—		3,755,367		—
Foreign government obligations	212,565		—		212,565		—
Corporate securities	23,802,394		121		23,802,273		—
Residential mortgage backed securities	1,462,072		—		1,462,072		—
Commercial mortgage backed securities	4,174,396		—		4,174,396		—
Other asset backed securities	1,145,178		—		1,145,178		—
Other investments: equity securities, available for sale	7,828		—		7,828		—
Derivative instruments	337,256		—		337,256		—
Cash and cash equivalents	397,749		397,749		—		—
Interest rate caps	1,410		—		1,410		—
Counterparty collateral	82,312		—		82,312		—
	$	37,248,394	$	836,468	$	36,411,926	$	—
Liabilities
Interest rate swap	$	3,139	$	—	$	3,139	$	—
Fixed index annuities—embedded derivatives	5,983,622		—		—		5,983,622
	$	5,986,761	$	—	$	3,139	$	5,983,622

F-14

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following methods and assumptions were used in estimating the fair values of financial instruments during the periods presented in these consolidated financial statements.

Fixed maturity securities and equity securities

The fair values of fixed maturity securities and equity securities in an active and orderly market are determined by utilizing independent pricing services. The independent pricing services incorporate a variety of observable market data in their valuation techniques, including:

• reported trading prices,

• benchmark yields,

• broker-dealer quotes,

• benchmark securities,

• bids and offers,

• credit ratings,

• relative credit information, and

• other reference data.

The independent pricing services also take into account perceived market movements and sector news, as well as a security's terms and conditions, including any features specific to that issue that may influence risk and marketability. Depending on the security, the priority of the use of observable market inputs may change as some observable market inputs may not be relevant or additional inputs may be necessary.

The independent pricing services provide quoted market prices when available. Quoted prices are not always available due to market inactivity. When quoted market prices are not available, the third parties use yield data and other factors relating to instruments or securities with similar characteristics to determine fair value for securities that are not actively traded. We generally obtain one value from our primary external pricing service. In situations where a price is not available from this service, we may obtain further quotes or prices from additional parties as needed. In addition, for our callable United States Government sponsored agencies we obtain multiple broker quotes and take the average of the broker prices received. Market indices of similar rated asset class spreads are considered for valuations and broker indications of similar securities are compared. Inputs used by the broker include market information, such as yield data and other factors relating to instruments or securities with similar characteristics. Valuations and quotes obtained from third party commercial pricing services are non-binding and do not represent quotes on which one may execute the disposition of the assets.

We validate external valuations at least quarterly through a combination of procedures that include the evaluation of methodologies used by the pricing services, analytical reviews and performance analysis of the prices against trends, and maintenance of a securities watch list. Additionally, as needed we utilize discounted cash flow models or perform independent valuations on a case-by-case basis using inputs and assumptions similar to those used by the pricing services. Although we do identify differences from time to time as a result of these validation procedures, we did not make any significant adjustments as of December 31, 2016 and 2015.

Mortgage loans on real estate

Mortgage loans on real estate are not measured at fair value on a recurring basis. The fair values of mortgage loans on real estate are calculated using discounted expected cash flows using current competitive market interest rates currently being offered for similar loans. The fair values of impaired mortgage loans on real estate that we have considered to be collateral dependent are based on the fair value of the real estate collateral (based on appraised values) less estimated costs to sell. The inputs utilized to determine fair value of all mortgage loans are unobservable market data (competitive market interest rates); therefore, fair value of mortgage loans falls into Level 3 in the fair value hierarchy.

Derivative instruments

The fair values of derivative instruments, primarily call options, are based upon the amount of cash that we will receive to settle each derivative instrument on the reporting date. These amounts are determined by our investment team using industry accepted valuation models and are adjusted for the nonperformance risk of each counterparty net of any collateral held. Inputs include market volatility and risk free interest rates and are used in income valuation techniques in arriving at a fair value for each option contract. The nonperformance risk for each counterparty is based upon its credit default swap rate. We have no performance obligations related to the call options purchased to fund our fixed index annuity policy liabilities.

F-15

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Other investments

Available for sale equity securities are the only financial instruments included in other investments that are measured at fair value on a recurring basis (see determination of fair value above). Financial instruments included in other investments that are not measured at fair value on a recurring bases are policy loans, equity method investments and company owned life insurance (COLI). We have not attempted to determine the fair values associated with our policy loans, as we believe any differences between carrying value and the fair values afforded these instruments are immaterial to our consolidated financial position and, accordingly, the cost to provide such disclosure does not justify the benefit to be derived. The fair value of our equity method investments qualify as Level 3 fair values and were determined by calculating the present value of future cash flows discounted by a risk free rate, a risk spread and a liquidity discount. The risk spread and liquidity discount are rates determined by our investment professionals and are unobservable market inputs. The fair value of our COLI approximates the cash surrender value of the policies and whose fair values fall within Level 2 of the fair value hierarchy.

Cash and cash equivalents

Amounts reported in the consolidated balance sheets for these instruments are reported at their historical cost which approximates fair value due to the nature of the assets assigned to this category.

Interest rate swap and caps

The fair values of our pay fixed/receive variable interest rate swap and interest rate caps are obtained from third parties and are determined by discounting expected future cash flows using projected LIBOR rates for the term of the swap and caps.

Counterparty collateral

Amounts reported in other assets of the consolidated balance sheets for these instruments are reported at their historical cost which approximates fair value due to the nature of the assets assigned to this category.

Policy benefit reserves, coinsurance deposits and SPIA benefit reserves

The fair values of the liabilities under contracts not involving significant mortality or morbidity risks (principally deferred annuities), are stated at the cost we would incur to extinguish the liability (i.e., the cash surrender value) as these contracts are generally issued without an annuitization date. The coinsurance deposits related to the annuity benefit reserves have fair values determined in a similar fashion. For period-certain annuity benefit contracts, the fair value is determined by discounting the benefits at the interest rates currently in effect for newly issued immediate annuity contracts. We are not required to and have not estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value. Policy benefit reserves, coinsurance deposits and SPIA benefit reserves are not measured at fair value on a recurring basis. All of the fair values presented within these categories fall within Level 3 of the fair value hierarchy as most of the inputs are unobservable market data.

Notes and loan payable

The fair values of our senior unsecured notes are based upon pricing matrices developed by a third party pricing service when quoted market prices are not available and are categorized as Level 2 within the fair value hierarchy. The fair value of our term loan is estimated using discounted cash flow calculations based principally on observable inputs including our incremental borrowing rate, which reflects our credit rating, for a similar type of borrowing with a maturity consistent with that remaining for the term loan. Notes and loan payable are not remeasured at fair value on a recurring basis.

Subordinated debentures

Fair values for subordinated debentures are estimated using discounted cash flow calculations based principally on observable inputs including our incremental borrowing rates, which reflect our credit rating, for similar types of borrowings with maturities consistent with those remaining for the debt being valued. These fair values are categorized as Level 2 within the fair value hierarchy. Subordinated debentures are not measured at fair value on a recurring basis.

Fixed index annuities - embedded derivatives

We estimate the fair value of the embedded derivative component of our fixed index annuity policy benefit reserves at each valuation date by (i) projecting policy contract values and minimum guaranteed contract values over the expected lives of the contracts and (ii) discounting the excess of the projected contract value amounts at the applicable risk free interest rates adjusted for our nonperformance risk related to those liabilities. The projections of policy contract values are based on our best estimate assumptions for future policy growth and future policy decrements. Our best estimate assumptions for future policy growth include assumptions for the expected index credit on the next policy anniversary date which are derived from the fair values of the underlying call options purchased to fund such index credits and the expected costs of annual call options we will purchase in the future to fund index credits beyond the next policy anniversary. The projections of minimum guaranteed contract values include the same best estimate assumptions for policy decrements as were used to project policy contract values.

F-16

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Within this determination we have the following significant unobservable inputs: 1) the expected cost of annual call options we will purchase in the future to fund index credits beyond the next policy anniversary and 2) our best estimates for future policy decrements, primarily lapse, partial withdrawal and mortality rates. As of December 31, 2016 and 2015, we utilized an estimate of 3.10% for the expected cost of annual call options, which are based on estimated account value growth and a historical review of our actual option costs.

Our best estimate assumptions for lapse, partial withdrawal and mortality rates are based on our actual experience and our outlook as to future expectations for such assumptions. These assumptions, which are consistent with the assumptions used in calculating deferred policy acquisition costs and deferred sales inducements, are reviewed on a quarterly basis and are revised as our experience develops and/or as future expectations change. Our mortality rate assumptions are based on 65% of the 1983 Basic Annuity Mortality Tables. The following table presents average lapse rate and partial withdrawal rate assumptions, by contract duration, used in estimating the fair value of the embedded derivative component of our fixed index annuity policy benefit reserves at each reporting date:

	Average Lapse Rates		Average Partial Withdrawal Rates
Contract Duration (Years)	December 31, 2016	December 31, 2015	December 31, 2016	December 31, 2015
1 - 5	1.76%	1.58%	3.30%	3.08%
6 - 10	6.58%	8.55%	3.30%	3.55%
11 - 15	11.25%	12.01%	3.32%	3.59%
16 - 20	12.04%	12.99%	3.18%	3.22%
20+	11.68%	12.54%	3.18%	3.22%

Lapse rates are generally expected to increase as surrender charge percentages decrease. Lapse expectations reflect a significant increase in the year in which the surrender charge period on a contract ends.

The following table provides a reconciliation of the beginning and ending balances for our Level 3 liabilities, which are measured at fair value on a recurring basis using significant unobservable inputs for the years ended December 31, 2016 and 2015:

	Year Ended December 31,
	2016		2015
	(Dollars in thousands)
Fixed index annuities—embedded derivatives
Beginning balance	$	5,983,622	$	5,574,653
Premiums less benefits	434,621		1,234,637
Change in fair value, net	145,045		(825,668		)
Ending balance	$	6,563,288	$	5,983,622

Change in fair value, net for each period in our embedded derivatives are included in change in fair value of embedded derivatives in the consolidated statements of operations.

Certain derivatives embedded in our fixed index annuity contracts are our most significant financial instrument measured at fair value that are categorized as Level 3 in the fair value hierarchy. The contractual obligations for future annual index credits within our fixed index annuity contracts are treated as a "series of embedded derivatives" over the expected life of the applicable contracts. We estimate the fair value of these embedded derivatives at each valuation date by the method described above under fixed index annuities - embedded derivatives. The projections of minimum guaranteed contract values include the same best estimate assumptions for policy decrements as were used to project policy contract values.

The most sensitive assumption in determining policy liabilities for fixed index annuities is the rates used to discount the excess projected contract values. As indicated above, the discount rate reflects our nonperformance risk. If the discount rates used to discount the excess projected contract values at December 31, 2016, were to increase by 100 basis points, the fair value of the embedded derivatives would decrease by $451.4 million recorded through operations as a decrease in the change in fair value of embedded derivatives and there would be a corresponding decrease of $276.4 million to our combined balance for deferred policy acquisition costs and deferred sales inducements recorded through operations as an increase in amortization of deferred policy acquisition costs and deferred sales inducements. A decrease by 100 basis points in the discount rate used to discount the excess projected contract values would increase the fair value of the embedded derivatives by $504.5 million recorded through operations as an increase in the change in fair value of embedded derivatives and there would be a corresponding increase of $299.5 million to our combined balance for deferred policy acquisition costs and deferred sales inducements recorded through operations as a decrease in amortization of deferred policy acquisition costs and deferred sales inducements.

F-17

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

3.     Investments

At December 31, 2016 and 2015, the amortized cost and fair value of fixed maturity securities were as follows:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
	(Dollars in thousands)
December 31, 2016
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	11,864	$	229	$	(288	)	$	11,805
United States Government sponsored agencies	1,368,340		23,360		(46,913		)	1,344,787
United States municipalities, states and territories	3,626,395		322,948		(22,393		)	3,926,950
Foreign government obligations	224,588		12,725		(5,080		)	232,233
Corporate securities	26,338,214		1,149,085		(368,773		)	27,118,526
Residential mortgage backed securities	1,166,944		91,445		(3,554		)	1,254,835
Commercial mortgage backed securities	5,422,255		59,994		(117,014		)	5,365,235
Other asset backed securities	1,795,355		31,471		(20,703		)	1,806,123
	$	39,953,955	$	1,691,257	$	(584,718	)	$	41,060,494
Held for investment:
Corporate security	$	76,825	$	—	$	(8,059	)	$	68,766
Other investments - equity securities, available for sale:
Finance, insurance and real estate	$	7,521	$	479	$	—		$	8,000
December 31, 2015
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	470,567	$	988	$	(299	)	$	471,256
United States Government sponsored agencies	1,386,219		26,801		(14,409		)	1,398,611
United States municipalities, states and territories	3,422,667		341,328		(8,628		)	3,755,367
Foreign government obligations	210,953		12,547		(10,935		)	212,565
Corporate securities	23,597,530		887,288		(682,424		)	23,802,394
Residential mortgage backed securities	1,366,985		98,576		(3,489		)	1,462,072
Commercial mortgage backed securities	4,238,265		41,412		(105,281		)	4,174,396
Other asset backed securities	1,130,524		34,534		(19,880		)	1,145,178
	$	35,823,710	$	1,443,474	$	(845,345	)	$	36,421,839
Held for investment:
Corporate security	$	76,622	$	—	$	(11,245	)	$	65,377
Other investments - equity securities, available for sale:
Finance, insurance and real estate	$	7,515	$	313	$	—		$	7,828

At December 31, 2016, 35% of our fixed income securities have call features, of which 0.1% ($55.7 million) were subject to call redemption and another 3.1% ($1.3 billion) will become subject to call redemption during 2017. Approximately 70% of our fixed income securities that have call features are not callable until within six months of their stated maturities.

F-18

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The amortized cost and fair value of fixed maturity securities at December 31, 2016, by contractual maturity are shown below. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. All of our mortgage and other asset backed securities provide for periodic payments throughout their lives and are shown below as separate lines.

	Available for sale				Held for investment
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
	(Dollars in thousands)
Due in one year or less	$	236,707	$	241,934	$	—	$	—
Due after one year through five years	2,824,776		2,979,768		—		—
Due after five years through ten years	11,659,762		11,738,156		—		—
Due after ten years through twenty years	8,792,470		9,284,726		—		—
Due after twenty years	8,055,686		8,389,717		76,825		68,766
	31,569,401		32,634,301		76,825		68,766
Residential mortgage backed securities	1,166,944		1,254,835		—		—
Commercial mortgage backed securities	5,422,255		5,365,235		—		—
Other asset backed securities	1,795,355		1,806,123		—		—
	$	39,953,955	$	41,060,494	$	76,825	$	68,766

Net unrealized gains on available for sale fixed maturity securities and equity securities reported as a separate component of stockholders' equity were comprised of the following:

	December 31,
	2016			2015
	(Dollars in thousands)
Net unrealized gains on available for sale fixed maturity securities and equity securities	$	1,107,018		$	598,442
Adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements	(618,661		)	(322,859		)
Deferred income tax valuation allowance reversal	22,534			22,534
Deferred income tax expense	(170,925		)	(96,454		)
Net unrealized gains reported as accumulated other comprehensive income	$	339,966		$	201,663

The National Association of Insurance Commissioners ("NAIC") assigns designations to fixed maturity securities. These designations range from Class 1 (highest quality) to Class 6 (lowest quality). In general, securities are assigned a designation based upon the ratings they are given by the Nationally Recognized Statistical Rating Organizations ("NRSRO's"). The NAIC designations are utilized by insurers in preparing their annual statutory statements. NAIC Class 1 and 2 designations are considered "investment grade" while NAIC Class 3 through 6 designations are considered "non-investment grade." Based on the NAIC designations, we had 97% and 98% of our fixed maturity portfolio rated investment grade at December 31, 2016 and 2015, respectively.

The following table summarizes the credit quality, as determined by NAIC designation, of our fixed maturity portfolio as of the dates indicated:

	December 31,
	2016				2015
NAIC Designation	Amortized Cost		Fair Value		Amortized Cost		Fair Value
	(Dollars in thousands)
1	$	25,607,268	$	26,507,798	$	23,363,259	$	24,207,801
2	13,037,592		13,295,648		11,709,730		11,589,325
3	1,201,059		1,155,702		758,531		643,293
4	154,226		137,188		60,480		44,312
5	17,475		24,664		—		—
6	13,160		8,260		8,332		2,485
	$	40,030,780	$	41,129,260	$	35,900,332	$	36,487,216

F-19

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following table shows our investments' gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities (consisting of 1,514and 1,246 securities, respectively) have been in a continuous unrealized loss position, at December 31, 2016 and 2015:

	Less than 12 months					12 months or more					Total
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
	(Dollars in thousands)
December 31, 2016
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	7,405	$	(288	)	$	—	$	—		$	7,405	$	(288	)
United States Government sponsored agencies	995,548		(46,913		)	—		—			995,548		(46,913		)
United States municipalities, states and territories	463,409		(22,393		)	—		—			463,409		(22,393		)
Foreign government obligations	29,158		(913		)	20,388		(4,167		)	49,546		(5,080		)
Corporate securities:
Finance, insurance and real estate	2,302,103		(79,077		)	110,730		(9,834		)	2,412,833		(88,911		)
Manufacturing, construction and mining	2,556,147		(74,144		)	702,978		(74,382		)	3,259,125		(148,526		)
Utilities and related sectors	1,605,742		(53,055		)	196,085		(16,208		)	1,801,827		(69,263		)
Wholesale/retail trade	396,310		(9,433		)	57,708		(5,739		)	454,018		(15,172		)
Services, media and other	857,515		(35,107		)	132,170		(11,794		)	989,685		(46,901		)
Residential mortgage backed securities	81,762		(3,463		)	1,853		(91		)	83,615		(3,554		)
Commercial mortgage backed securities	3,148,395		(116,938		)	895		(76		)	3,149,290		(117,014		)
Other asset backed securities	751,533		(12,289		)	146,167		(8,414		)	897,700		(20,703		)
	$	13,195,027	$	(454,013	)	$	1,368,974	$	(130,705	)	$	14,564,001	$	(584,718	)
Held for investment:
Corporate security:
Insurance	$	—	$	—		$	68,766	$	(8,059	)	$	68,766	$	(8,059	)
December 31, 2015
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	37,730	$	(299	)	$	—	$	—		$	37,730	$	(299	)
United States Government sponsored agencies	957,053		(14,409		)	—		—			957,053		(14,409		)
United States municipalities, states and territories	261,823		(8,474		)	2,846		(154		)	264,669		(8,628		)
Foreign government obligations	42,966		(1,762		)	15,463		(9,173		)	58,429		(10,935		)
Corporate securities:
Finance, insurance and real estate	2,077,223		(59,607		)	49,912		(14,855		)	2,127,135		(74,462		)
Manufacturing, construction and mining	3,517,967		(246,456		)	376,229		(131,003		)	3,894,196		(377,459		)
Utilities and related sectors	2,240,652		(138,940		)	97,184		(22,565		)	2,337,836		(161,505		)
Wholesale/retail trade	473,050		(17,863		)	38,682		(8,125		)	511,732		(25,988		)
Services, media and other	1,037,011		(39,937		)	32,050		(3,073		)	1,069,061		(43,010		)
Residential mortgage backed securities	162,770		(2,958		)	6,438		(531		)	169,208		(3,489		)
Commercial mortgage backed securities	2,679,510		(105,002		)	11,495		(279		)	2,691,005		(105,281		)
Other asset backed securities	457,055		(10,581		)	46,657		(9,299		)	503,712		(19,880		)
	$	13,944,810	$	(646,288	)	$	676,956	$	(199,057	)	$	14,621,766	$	(845,345	)
Held for investment:
Corporate security:
Insurance	$	65,377	$	(11,245	)	$	—	$	—		$	65,377	$	(11,245	)

Based on the results of our process for evaluating available for sale securities in unrealized loss positions for other-than-temporary-impairments, which is discussed in detail later in this footnote, we have determined that the unrealized losses on the securities in the preceding table are temporary. The unrealized losses at December 31, 2016 are principally related to timing of the purchases of these securities, which carry less yield than those available at December 31, 2016.

F-20

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The commodity related sectors had most of the gross unrealized losses in our corporate fixed income securities portfolio as of December 31, 2016. Commodity prices, specifically oil, gas and base metals,declined significantly in late 2015, but prices have risen in 2016 to levels that appear sustainable and should support prices and NRSRO ratings longer term. The value of oil has been significantly depressed as the amount of supply from new production has exceeded demand. In addition, iron ore and other key industrial metals have depressed prices as investors perceive the economic slowdown in Asia Pacific will curb demand as supply remains high. The companies in the metal and mining sectors experienced the largest decline in values of their debt in late 2015. In the above table, oil and metals and mining exposure is reflected within the foreign government; manufacturing, construction and mining; and utilities and related sectors. Within these sectors, we continue to monitor the impact to our investment portfolio for those companies that may be adversely affected, both directly and indirectly. Even though the energy holdings and a majority of the metals and mining holdings have seen significant improvements in values as oil and iron ore prices have increased, they could continue to see price volatility and possible downgrades in credit ratings. If oil and commodity prices fall lower and remain at depressed levels for an extended period of time or decline further, certain issuers and investments may come under further stress. At this time, we believe the unrealized losses are temporary due to the fact that the price decline is driven by an over-supply of oil in the energy sector, which we feel is unsustainable long term. Our exposure is in companies that we believe have more financial flexibility and significant operational scale to manage through the downturn. In addition, price declines in the metal and mining sector have been heavily influenced by excess production and softer demand. Companies in the mining sector are more susceptible to rating downgrades and we believe companies will be under continued financial strain at the current commodity price structure. We believe company issuers in our portfolio will be able to meet their debt service obligations.

Approximately 86% and 84% of the unrealized losses on fixed maturity securities shown in the above table for December 31, 2016 and 2015, respectively, are on securities that are rated investment grade, defined as being the highest two NAIC designations. All of the fixed maturity securities with unrealized losses are current with respect to the payment of principal and interest.

Changes in net unrealized gains on investments for the years ended December 31, 2016, 2015 and 2014 are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Fixed maturity securities held for investment carried at amortized cost	$	3,186		$	(10,651	)	$	14,821
Investments carried at fair value:
Fixed maturity securities, available for sale	$	508,410		$	(1,642,027	)	$	2,157,439
Equity securities, available for sale	166			17			21
	508,576			(1,642,010		)	2,157,460
Adjustment for effect on other balance sheet accounts:
Deferred policy acquisition costs and deferred sales inducements	(295,802		)	842,412			(1,118,683		)
Deferred income tax asset/liability	(74,471		)	279,860			(363,572		)
	(370,273		)	1,122,272			(1,482,255		)
Change in net unrealized gains on investments carried at fair value	$	138,303		$	(519,738	)	$	675,205

Components of net investment income are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Fixed maturity securities	$	1,729,176		$	1,566,409		$	1,394,301
Equity securities	531			441			404
Mortgage loans on real estate	122,985			131,892			143,998
Cash and cash equivalents	3,201			601			286
Other	5,499			4,858			6,903
	1,861,392			1,704,201			1,545,892
Less investment expenses	(11,520		)	(12,009		)	(14,225		)
Net investment income	$	1,849,872		$	1,692,192		$	1,531,667

Proceeds from sales of available for sale securities for the years ended December 31, 2016, 2015 and 2014 were $1.0 billion, $0.4 billion and $0.2 billion, respectively. Scheduled principal repayments, calls and tenders for available for sale fixed maturity securities for the years ended December 31, 2016, 2015 and 2014 were $1.7 billion, $1.2 billion and $1.3 billion, respectively.

F-21

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Realized gains and losses on sales are determined on the basis of specific identification of investments based on the trade date. Net realized gains (losses) on investments, excluding net OTTI losses are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Available for sale fixed maturity securities:
Gross realized gains	$	14,132		$	7,230		$	3,273
Gross realized losses	(4,036		)	(5,787		)	(1,006		)
	10,096			1,443			2,267
Other investments:
Gain on sale of real estate	884			4,194			2,454
Loss on sale of real estate	(93		)	(575		)	(231		)
Impairment losses on real estate	—			(1,297		)	(2,441		)
	791			2,322			(218		)
Mortgage loans on real estate:
Decrease (increase) in allowance for credit losses	(4,846		)	1,018			(6,052		)
Recovery of specific allowance	5,483			5,428			—
	637			6,446			(6,052		)
	$	11,524		$	10,211		$	(4,003	)

Losses on available for sale fixed maturity securities in 2016, 2015 and 2014 were realized primarily due to strategies to reposition the fixed maturity security portfolio that result in improved net investment income, credit risk or duration profiles as they pertain to our asset liability management. Securities were sold at losses in 2016 and 2015 due to our long-term fundamental concern with the issuers' ability to meet their future financial obligations.

The following table summarizes the carrying value of our fixed maturity securities, mortgage loans on real estate and real estate owned that have been non-income producing for 12 consecutive months:

	December 31,
	2016		2015
	(Dollars in thousands)
Fixed maturity securities, available for sale	$	1,651	$	10
Real estate owned	—		1,800
	$	1,651	$	1,810

We review and analyze all investments on an ongoing basis for changes in market interest rates and credit deterioration. This review process includes analyzing our ability to recover the amortized cost basis of each investment that has a fair value that is materially lower than its amortized cost and requires a high degree of management judgment and involves uncertainty. The evaluation of securities for other than temporary impairments is a quantitative and qualitative process, which is subject to risks and uncertainties.

We have a policy and process to identify securities that could potentially have impairments that are other than temporary. This process involves monitoring market events and other items that could impact issuers. The evaluation includes but is not limited to such factors as:

• the length of time and the extent to which the fair value has been less than amortized cost or cost;

• whether the issuer is current on all payments and all contractual payments have been made as agreed;

• the remaining payment terms and the financial condition and near-term prospects of the issuer;

• the lack of ability to refinance due to liquidity problems in the credit market;

• the fair value of any underlying collateral;

• the existence of any credit protection available;

• our intent to sell and whether it is more likely than not we would be required to sell prior to recovery for debt securities;

• our assessment in the case of equity securities including perpetual preferred stocks with credit deterioration that the security cannot recover to cost in a reasonable period of time;

• our intent and ability to retain equity securities for a period of time sufficient to allow for recovery;

• consideration of rating agency actions; and

• changes in estimated cash flows of mortgage and asset backed securities.

F-22

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

We determine whether other than temporary impairment losses should be recognized for debt and equity securities by assessing all facts and circumstances surrounding each security. Where the decline in fair value of debt securities is attributable to changes in market interest rates or to factors such as market volatility, liquidity and spread widening, and we anticipate recovery of all contractual or expected cash flows, we do not consider these investments to be other than temporarily impaired because we do not intend to sell these investments and it is not more likely than not we will be required to sell these investments before a recovery of amortized cost, which may be maturity. For equity securities, we recognize an impairment charge in the period in which we do not have the intent and ability to hold the securities until recovery of cost or we determine that the security will not recover to book value within a reasonable period of time. We determine what constitutes a reasonable period of time on a security-by-security basis by considering all the evidence available to us, including the magnitude of any unrealized loss and its duration.

Other than temporary impairment losses on equity securities are recognized in operations. If we intend to sell a debt security or if it is more likely than not that we will be required to sell a debt security before recovery of its amortized cost basis, other than temporary impairment has occurred and the difference between amortized cost and fair value will be recognized as a loss in operations.

If we do not intend to sell and it is not more likely than not we will be required to sell the debt security but also do not expect to recover the entire amortized cost basis of the security, an impairment loss would be recognized in operations in the amount of the expected credit loss. We determine the amount of expected credit loss by calculating the present value of the cash flows expected to be collected discounted at each security's acquisition yield based on our consideration of whether the security was of high credit quality at the time of acquisition. The difference between the present value of expected future cash flows and the amortized cost basis of the security is the amount of credit loss recognized in operations. The remaining amount of the other than temporary impairment is recognized in other comprehensive income (loss).

The determination of the credit loss component of a mortgage backed security is based on a number of factors. The primary consideration in this evaluation process is the issuer's ability to meet current and future interest and principal payments as contractually stated at time of purchase. Our review of these securities includes an analysis of the cash flow modeling under various default scenarios considering independent third party benchmarks, the seniority of the specific tranche within the structure of the security, the composition of the collateral and the actual default, loss severity and prepayment experience exhibited. With the input of third party assumptions for default projections, loss severity and prepayment expectations, we evaluate the cash flow projections to determine whether the security is performing in accordance with its contractual obligation.

We utilize the models from a leading structured product software specialist serving institutional investors. These models incorporate each security's seniority and cash flow structure. In circumstances where the analysis implies a potential for principal loss at some point in the future, we use the "best estimate" cash flow projection discounted at the security's effective yield at acquisition to determine the amount of our potential credit loss associated with this security. The discounted expected future cash flows equates to our expected recovery value. Any shortfall of the expected recovery when compared to the amortized cost of the security will be recorded as the credit loss component of the other than temporary impairment.

The cash flow modeling is performed on a security-by-security basis and incorporates actual cash flows on the residential mortgage backed securities through the current period, as well as the projection of remaining cash flows using a number of assumptions including default rates, prepayment rates and loss severity rates. The default curves we use are tailored to the Prime or Alt-A residential mortgage backed securities that we own, which assume lower default rates and loss severity for Prime securities versus Alt-A securities. These default curves are scaled higher or lower depending on factors such as current underlying mortgage loan performance, rating agency loss projections, loan to value ratios, geographic diversity, as well as other appropriate considerations.

The following table presents the range of significant assumptions used to determine the credit loss component of other than temporary impairments we have recognized on residential mortgage backed securities for the years ended December 31, 2016 and 2015, which are all senior level tranches within the structure of the securities:

		Discount Rate				Default Rate				Loss Severity
Sector	Vintage	Min		Max		Min		Max		Min		Max
Year ended December 31, 2016
Prime	2005	7.7	%	7.7	%	8	%	14	%	50	%	50	%
	2006	6.5	%	7.3	%	12	%	13	%	40	%	50	%
	2007	6.2	%	6.4	%	18	%	31	%	50	%	55	%
Alt-A	2005	7.4	%	7.4	%	11	%	11	%	60	%	60	%
Year ended December 31, 2015
Prime	2006	6.5	%	7.4	%	12	%	14	%	40	%	50	%
	2007	5.8	%	7.0	%	15	%	25	%	45	%	55	%
Alt-A	2005	5.6	%	7.4	%	13	%	99	%	2	%	50	%

F-23

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The determination of the credit loss component of a corporate bond (including redeemable preferred stocks) is based on the underlying financial performance of the issuer and their ability to meet their contractual obligations. Considerations in our evaluation include, but are not limited to, credit rating changes, financial statement and ratio analysis, changes in management, significant changes in credit spreads, breaches of financial covenants and a review of the economic outlook for the industry and markets in which they trade. In circumstances where an issuer appears unlikely to meet its future obligation, or the security's price decline is deemed other than temporary, an estimate of credit loss is determined. Credit loss is calculated using default probabilities as derived from the credit default swaps markets in conjunction with recovery rates derived from independent third party analysis or a best estimate of credit loss. This credit loss rate is then incorporated into a present value calculation based on an expected principal loss in the future discounted at the yield at the date of purchase and compared to amortized cost to determine the amount of credit loss associated with the security.

In addition, for debt securities which we do not intend to sell and it is not more likely than not we will be required to sell, but our intent changes due to changes or events that could not have been reasonably anticipated, an other than temporary impairment charge is recognized. Once an impairment charge has been recorded, we then continue to review the other than temporarily impaired securities for appropriate valuation on an ongoing basis. Unrealized losses may be recognized in future periods through a charge to earnings should we later conclude that the decline in fair value below amortized cost is other than temporary pursuant to our accounting policy described above. The use of different methodologies and assumptions to determine the fair value of investments and the timing and amount of impairments may have a material effect on the amounts presented in our consolidated financial statements.

The following table summarizes other than temporary impairments by asset type:

	Number of Securities	Total OTTI Losses			Portion of OTTI Losses Recognized in (from) Other Comprehensive Income			Net OTTI Losses Recognized in Operations
		(Dollars in thousands)
Year ended December 31, 2016
Fixed maturity securities, available for sale:
Corporate securities:
Energy	2	$	(642	)	$	—		$	(642	)
Materials	1	(4,554		)	1,575			(2,979		)
Telecommunications	1	(4,462		)	562			(3,900		)
Utilities	2	(6,961		)	798			(6,163		)
Residential mortgage backed securities	9	—			(783		)	(783		)
Commercial mortgage backed securities	5	(1,540		)	—			(1,540		)
Other asset backed securities	2	(3,190		)	(3,482		)	(6,672		)
	22	$	(21,349	)	$	(1,330	)	$	(22,679	)
Year ended December 31, 2015
Fixed maturity securities, available for sale:
Corporate securities:
Industrial	2	$	(15,414	)	$	2,975		$	(12,439	)
Residential mortgage backed securities	11	(133		)	(2,089		)	(2,222		)
Other asset backed securities	1	(10,000		)	5,125			(4,875		)
	14	$	(25,547	)	$	6,011		$	(19,536	)
Year ended December 31, 2014
Fixed maturity securities, available for sale:
Residential mortgage backed securities	7	$	—		$	(2,627	)	$	(2,627	)

F-24

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The cumulative portion of other than temporary impairments determined to be credit losses which have been recognized in operations for debt securities are summarized as follows:

	Year Ended December 31,
	2016			2015
	(Dollars in thousands)
Cumulative credit loss at beginning of year	$	(145,824	)	$	(127,050	)
Credit losses on securities for which OTTI has not previously been recognized	(18,414		)	(17,447		)
Additional credit losses on securities for which OTTI has previously been recognized	(4,265		)	(2,089		)
Accumulated losses on securities that were disposed of during the period	2,128			762
Cumulative credit loss at end of year	$	(166,375	)	$	(145,824	)

The following table summarizes the cumulative noncredit portion of OTTI and the change in fair value since recognition of OTTI, both of which were recognized in other comprehensive income, by major type of security, for securities that are part of our investment portfolio at December 31, 2016 and 2015:

	Amortized Cost		OTTI Recognized in Other Comprehensive Income			Change in Fair Value Since OTTI was Recognized			Fair Value
	(Dollars in thousands)
December 31, 2016
Fixed maturity securities, available for sale:
Corporate securities	$	17,549	$	(5,910	)	$	13,566		$	25,205
Residential mortgage backed securities	368,862		(169,941		)	205,854			404,775
Commercial mortgage backed securities	6,596		—			(107		)	6,489
Other asset backed securities	6,683		(1,643		)	(1,566		)	3,474
	$	399,690	$	(177,494	)	$	217,747		$	439,943
December 31, 2015
Fixed maturity securities, available for sale:
Corporate securities	$	6,396	$	(2,975	)	$	9		$	3,430
Residential mortgage backed securities	466,871		(170,724		)	199,149			495,296
Other asset backed securities	8,154		(5,125		)	(553		)	2,476
	$	481,421	$	(178,824	)	$	198,605		$	501,202

At December 31, 2016 and 2015, fixed maturity securities and short-term investments with an amortized cost of $43.5 billion and $38.3 billion, respectively, were on deposit with state agencies to meet regulatory requirements. There are no restrictions on these assets.

At December 31, 2016 and 2015, we had no investment in any person or its affiliates (other than bonds issued by agencies of the United States Government) that exceeded 10% of stockholders' equity.

4.     Mortgage Loans on Real Estate

Our mortgage loan portfolio is summarized in the following table. There were commitments outstanding of $75.5 million at December 31, 2016.

	December 31,
	2016			2015
	(Dollars in thousands)
Principal outstanding	$	2,490,619		$	2,449,909
Loan loss allowance	(8,427		)	(14,142		)
Deferred prepayment fees	(1,236		)	(510		)
Carrying value	$	2,480,956		$	2,435,257

F-25

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The portfolio consists of commercial mortgage loans collateralized by the related properties and diversified as to property type, location and loan size. Our mortgage lending policies establish limits on the amount that can be loaned to one borrower and other criteria to attempt to reduce the risk of default. The mortgage loan portfolio is summarized by geographic region and property type as follows:

	December 31,
	2016				2015
	Principal		Percent		Principal		Percent
	(Dollars in thousands)
Geographic distribution
East	$	635,434	25.5	%	$	698,113	28.5	%
Middle Atlantic	151,640		6.1	%	160,261		6.6	%
Mountain	235,932		9.5	%	252,442		10.3	%
New England	12,724		0.5	%	13,161		0.5	%
Pacific	385,683		15.5	%	355,268		14.5	%
South Atlantic	519,065		20.8	%	456,227		18.6	%
West North Central	325,447		13.1	%	313,120		12.8	%
West South Central	224,694		9.0	%	201,317		8.2	%
	$	2,490,619	100.0	%	$	2,449,909	100.0	%
Property type distribution
Office	$	308,578	12.4	%	$	396,154	16.2	%
Medical Office	50,780		2.1	%	77,438		3.2	%
Retail	886,942		35.6	%	790,158		32.2	%
Industrial/Warehouse	700,644		28.1	%	686,400		28.0	%
Hotel	—		—	%	3,361		0.1	%
Apartment	375,837		15.1	%	352,971		14.4	%
Mixed use/other	167,838		6.7	%	143,427		5.9	%
	$	2,490,619	100.0	%	$	2,449,909	100.0	%

Our financing receivables currently consist of one portfolio segment which is our commercial mortgage loan portfolio. These are mortgage loans with collateral consisting of commercial real estate and borrowers consisting mostly of limited liability partnerships or limited liability corporations.

We evaluate our mortgage loan portfolio for the establishment of a loan loss allowance by specific identification of impaired loans and the measurement of an estimated loss for each individual loan identified. A mortgage loan is impaired when it is probable that we will be unable to collect all amounts due according to the contractual terms of the loan agreement. If we determine that the value of any specific mortgage loan is impaired, the carrying amount of the mortgage loan will be reduced to its fair value, based upon the present value of expected future cash flows from the loan discounted at the loan's effective interest rate, or the fair value of the underlying collateral less estimated costs to sell.

In addition, we analyze the mortgage loan portfolio for the need of a general loan allowance for probable losses on all other loans on a quantitative and qualitative basis. The amount of the general loan allowance is based upon management's evaluation of the collectability of the loan portfolio, historical loss experience, delinquencies, credit concentrations, underwriting standards and national and local economic conditions.

We rate each of the mortgage loans in our portfolio based on factors such as historical operating performance, loan to value ratio and economic outlook, among others. We calculate a loss factor to apply to each rating based on historical losses we have recognized in our mortgage loan portfolio. We apply the loss factors to the total principal outstanding within each rating category to determine an appropriate estimate of the general loan loss allowance. We also assess the portfolio qualitatively and apply a loss rate to all loans without a specific allowance based on management's assessment of economic conditions, and we apply an additional amount of loss allowance to a group of loans that we have identified as having higher risk of loss.

F-26

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following table presents a rollforward of our specific and general valuation allowances for mortgage loans on real estate:

	Year Ended December 31,
	2016						2015						2014
	Specific Allowance			General Allowance			Specific Allowance			General Allowance			Specific Allowance			General Allowance
	(Dollars in thousands)
Beginning allowance balance	$	(7,842	)	$	(6,300	)	$	(12,333	)	$	(10,300	)	$	(16,847	)	$	(9,200	)
Charge-offs	5,078			—			2,045			—			9,211			—
Recoveries	5,483			—			5,428			—			255			—
Change in provision for credit losses	(4,046		)	(800		)	(2,982		)	4,000			(4,952		)	(1,100		)
Ending allowance balance	$	(1,327	)	$	(7,100	)	$	(7,842	)	$	(6,300	)	$	(12,333	)	$	(10,300	)

The specific allowance represents the total credit loss allowances on loans which are individually evaluated for impairment. The general allowance is for the group of loans discussed above which are collectively evaluated for impairment. The following table presents the total outstanding principal of loans evaluated for impairment by basis of impairment method:

	December 31,
	2016		2015		2014
	(Dollars in thousands)
Individually evaluated for impairment	$	4,640	$	21,277	$	29,116
Collectively evaluated for impairment	2,485,979		2,428,632		2,428,605
Total loans evaluated for impairment	$	2,490,619	$	2,449,909	$	2,457,721

Charge-offs include allowances that have been established on loans that were satisfied either by taking ownership of the collateral or by some other means such as discounted pay-off or loan sale. When ownership of the property is taken it is recorded at the lower of the mortgage loan's carrying value or the property's fair value (based on appraised values) less estimated costs to sell. The real estate owned is recorded as a component of other investments and the mortgage loan is recorded as fully paid, with any allowance for credit loss that has been established charged off. Fair value of the real estate is determined by third party appraisal. Recoveries are situations where we have received a payment from the borrower in an amount greater than the carrying value of the loan (principal outstanding less specific allowance).

During the year ended December 31, 2014, seven mortgage loans were satisfied by taking ownership of any real estate serving as collateral. The following table summarizes the activity in the real estate owned, included in Other investments, which was obtained in satisfaction of mortgage loans on real estate:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Real estate owned at beginning of period	$	6,485		$	20,238		$	22,844
Real estate acquired in satisfaction of mortgage loans	—			—			14,555
Additions	—			121			—
Sales	(6,444		)	(12,322		)	(14,134		)
Impairments	—			(1,297		)	(2,441		)
Depreciation	(41		)	(255		)	(586		)
Real estate owned at end of period	$	—		$	6,485		$	20,238

F-27

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

We analyze credit risk of our mortgage loans by analyzing all available evidence on loans that are delinquent and loans that are in a workout period.

	December 31,
	2016		2015
	(Dollars in thousands)
Credit Exposure--By Payment Activity
Performing	$	2,489,028	$	2,438,341
In workout	1,591		11,568
Delinquent	—		—
Collateral dependent	—		—
	$	2,490,619	$	2,449,909

The loans that are categorized as "in workout" consist of loans that we have agreed to lower or no mortgage payments for a period of time while the borrowers address cash flow and/or operational issues. The key features of these workouts have been determined on a loan-by-loan basis. Most of these loans are in a period of low cash flow due to tenants vacating their space or tenants requesting rent relief during difficult economic periods. Generally, we have allowed the borrower a six month interest only period and in some cases a twelve month period of interest only. Interest only workout loans are expected to return to their regular debt service payments after the interest only period. Interest only loans that are not fully amortizing will have a larger balance at their balloon date than originally contracted. Fully amortizing loans that are in interest only periods will have larger debt service payments for their remaining term due to lost principal payments during the interest only period. In limited circumstances we have allowed borrowers to pay the principal portion of their loan payment into an escrow account that can be used for capital and tenant improvements for a period of not more than twelve months. In these situations new loan amortization schedules are calculated based on the principal not collected during this twelve month workout period and larger payments are collected for the remaining term of each loan. In all cases, the original interest rate and maturity date have not been modified, and we have not forgiven any principal amounts.

Mortgage loans are considered delinquent when they become 60 days or more past due. In general, when loans become 90 days past due, become collateral dependent or enter a period with no debt service payments required we place them on non-accrual status and discontinue recognizing interest income. If payments are received on a delinquent loan, interest income is recognized to the extent it would have been recognized if normal principal and interest would have been received timely. If the payments are received to bring a delinquent loan back to current we will resume accruing interest income on that loan. There were no loans in non-accrual status at December 31, 2016 or 2015.

We define collateral dependent loans as those mortgage loans for which we will depend on the value of the collateral real estate to satisfy the outstanding principal of the loan.

All of our commercial mortgage loans depend on the cash flow of the borrower to be at a sufficient level to service the principal and interest payments as they come due. In general, cash inflows of the borrowers are generated by collecting monthly rent from tenants occupying space within the borrowers' properties. Our borrowers face collateral risks such as tenants going out of business, tenants struggling to make rent payments as they become due, and tenants canceling leases and moving to other locations. We have a number of loans where the real estate is occupied by a single tenant. Our borrowers sometimes face both a reduction in cash flow on their mortgage property as well as a reduction in the fair value of the real estate collateral. If borrowers are unable to replace lost rent revenue and increases in the fair value of their property do not materialize we could potentially incur more losses than what we have allowed for in our specific and general loan loss allowances.

Aging of financing receivables is summarized in the following table, with loans in a "workout" period as of the reporting date considered current if payments are current in accordance with agreed upon terms:

	30 - 59 Days		60 - 89 Days		90 Days and Over		Total Past Due		Current		Collateral Dependent Receivables		Total Financing Receivables
	(Dollars in thousands)
Commercial Mortgage Loans
December 31, 2016	$	2,737	$	—	$	—	$	2,737	$	2,487,882	$	—	$	2,490,619
December 31, 2015	$	—	$	—	$	—	$	—	$	2,449,909	$	—	$	2,449,909

F-28

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Financing receivables summarized in the following two tables represent all loans that we are either not currently collecting, or those we feel it is probable we will not collect all amounts due according to the contractual terms of the loan agreements (all loans that we have worked with the borrower to alleviate short-term cash flow issues, loans delinquent for 60 days or more at the reporting date, loans we have determined to be collateral dependent and loans that we have recorded specific impairments on that we feel may continue to have performance issues).

	Recorded Investment		Unpaid Principal Balance		Related Allowance
	(Dollars in thousands)
December 31, 2016
Mortgage loans with an allowance	$	3,313	$	4,640	$	(1,327	)
Mortgage loans with no related allowance	1,591		1,591		—
	$	4,904	$	6,231	$	(1,327	)
December 31, 2015
Mortgage loans with an allowance	$	13,435	$	21,277	$	(7,842	)
Mortgage loans with no related allowance	8,859		8,859		—
	$	22,294	$	30,136	$	(7,842	)

	Average Recorded Investment		Interest Income Recognized
	(Dollars in thousands)
December 31, 2016
Mortgage loans with an allowance	$	3,398	$	301
Mortgage loans with no related allowance	1,665		73
	$	5,063	$	374
December 31, 2015
Mortgage loans with an allowance	$	13,893	$	1,117
Mortgage loans with no related allowance	8,930		584
	$	22,823	$	1,701
December 31, 2014
Mortgage loans with an allowance	$	18,465	$	1,797
Mortgage loans with no related allowance	2,656		43
	$	21,121	$	1,840

A Troubled Debt Restructuring ("TDR") is a situation where we have granted a concession to a borrower for economic or legal reasons related to the borrower's financial difficulties that we would not otherwise consider. A mortgage loan that has been granted new terms, including workout terms as described previously, would be considered a TDR if it meets conditions that would indicate a borrower is experiencing financial difficulty and the new terms constitute a concession on our part. We analyze all loans where we have agreed to workout terms and all loans that we have refinanced to determine if they meet the definition of a TDR. We consider the following factors in determining whether or not a borrower is experiencing financial difficulty:

• borrower is in default,

• borrower has declared bankruptcy,

• there is growing concern about the borrower's ability to continue as a going concern,

• borrower has insufficient cash flows to service debt,

• borrower's inability to obtain funds from other sources, and

• there is a breach of financial covenants by the borrower.

If the borrower is determined to be in financial difficulty, we consider the following conditions to determine if the borrower was granted a concession:

• assets used to satisfy debt are less than our recorded investment,

• interest rate is modified,

• maturity date extension at an interest rate less than market rate,

• capitalization of interest,

• delaying principal and/or interest for a period of three months or more, and

• partial forgiveness of the balance or charge-off.

F-29

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Mortgage loan workouts, refinances or restructures that are classified as TDRs are individually evaluated and measured for impairment. A summary of mortgage loans on commercial real estate with outstanding principal at December 31, 2016 and 2015 that we determined to be TDRs are as follows:

Geographic Region	Number of TDRs	Principal Balance Outstanding		Specific Loan Loss Allowance			Net Carrying Amount
		(Dollars in thousands)
Year ended December 31, 2016
South Atlantic	1	$	3,004	$	—		$	3,004
East North Central	1	2,020		(467		)	1,553
	2	$	5,024	$	(467	)	$	4,557
Year ended December 31, 2015
South Atlantic	6	$	11,155	$	(2,992	)	$	8,163
East North Central	2	3,306		(467		)	2,839
West North Central	1	5,913		—			5,913
	9	$	20,374	$	(3,459	)	$	16,915

5.     Derivative Instruments

None of our derivatives qualify for hedge accounting, thus, any change in the fair value of the derivatives is recognized immediately in the consolidated statements of operations. The fair value of our derivative instruments, including derivative instruments embedded in fixed index annuity contracts, presented in the consolidated balance sheets are as follows:

	December 31,
	2016		2015
	(Dollars in thousands)
Assets
Derivative instruments
Call options	$	830,519	$	337,256
Other assets
Interest rate caps	1,082		1,410
	$	831,601	$	338,666
Liabilities
Policy benefit reserves—annuity products
Fixed index annuities—embedded derivatives	$	6,563,288	$	5,983,622
Other liabilities
Interest rate swap	2,113		3,139
	$	6,565,401	$	5,986,761

The changes in fair value of derivatives included in the consolidated statements of operations are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Change in fair value of derivatives:
Call options	$	165,029		$	(327,921	)	$	521,947
2015 notes hedges	—			(4,516		)	(8,934		)
Interest rate swap	(482		)	(2,341		)	(4,863		)
Interest rate caps	(328		)	(1,368		)	(3,325		)
	$	164,219		$	(336,146	)	$	504,825
Change in fair value of embedded derivatives:
Fixed index annuities—embedded derivatives (see Note 2)	$	145,045		$	(825,668	)	$	(532,337	)
Other changes in difference between policy benefit reserves computed using derivative accounting vs. long-duration contracts accounting	398,420			365,486			579,885
2015 notes embedded conversion derivative (see Note 9)	—			(4,516		)	(19,036		)
2029 notes embedded conversion derivative (see Note 9)	—			—			3,809
	$	543,465		$	(464,698	)	$	32,321

The amounts presented as "Other changes in difference between policy benefit reserves computed using derivative accounting vs. long-duration contracts accounting" represents the total change in the difference between policy benefit reserves for fixed index annuities computed under the derivative accounting standard and the long-duration contracts accounting standard at each balance sheet date, less the change in fair value of our fixed index annuities embedded derivatives that is presented as Level 3 liabilities in Note 2.

We have fixed index annuity products that guarantee the return of principal to the policyholder and credit interest based on a percentage of the gain in a specified market index. When fixed index annuity deposits are received, a portion of the deposit is used to purchase derivatives consisting of call options on the applicable market indices to fund the index credits due to fixed index annuity policyholders. Substantially all such call options are one year options purchased to match the funding requirements of the underlying policies. The call options are marked to fair value with the change in fair value included as a component of revenues. The change in fair value of derivatives includes the gains or losses recognized at the expiration of the option term or upon early termination and the changes in fair value for open positions. On the respective anniversary dates of the index policies, the index used to compute the annual index credit is reset and we purchase new one-year call options to fund the next annual index credit. We manage the cost of these purchases through the terms of our fixed index annuities, which permit us to change caps, participation rates, and/or asset fees, subject to guaranteed minimums on each policy's anniversary date. By adjusting caps, participation rates, or asset fees, we can generally manage option costs except in cases where the contractual features would prevent further modifications.

Our strategy attempts to mitigate any potential risk of loss due to the nonperformance of the counterparties to these call options through a regular monitoring process which evaluates the program's effectiveness. We do not purchase call options that would require payment or collateral to another institution and our call options do not contain counterparty credit-risk-related contingent features. We are exposed to risk of loss in the event of nonperformance by the counterparties and, accordingly, we purchase our option contracts from multiple counterparties and evaluate the creditworthiness of all counterparties prior to purchase of the contracts. All of these options have been purchased from nationally recognized financial institutions with a Standard and Poor's credit rating of A- or higher at the time of purchase and the maximum credit exposure to any single counterparty is subject to concentration limits. We also have credit support agreements that allow us to request the counterparty to provide collateral to us when the fair value of our exposure to the counterparty exceeds specified amounts.

F-30

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The notional amount and fair value of our call options by counterparty and each counterparty's current credit rating are as follows:

			December 31,
			2016				2015
Counterparty	Credit Rating (S&P)	Credit Rating (Moody's)	Notional Amount		Fair Value		Notional Amount		Fair Value
			(Dollars in thousands)
Bank of America	A+	A1	$	5,958,884	$	178,477	$	6,257,861	$	67,662
Barclays	A-	A1	3,441,832		89,721		2,463,768		35,273
BNP Paribas	A	A1	1,199,265		19,598		1,520,710		16,944
Citibank, N.A.	A+	A1	4,038,528		97,094		3,786,498		23,587
Credit Suisse	A	A1	2,130,710		44,242		1,278,492		12,508
Deutsche Bank	BBB+	Baa2	25,935		892		1,349,002		10,704
J.P. Morgan	A+	Aa3	1,785,583		19,645		838,982		5,283
Morgan Stanley	A+	A1	2,543,421		64,425		3,465,457		33,171
Royal Bank of Canada	AA-	Aa3	3,384,310		103,510		2,820,410		48,654
SunTrust	A-	Baa1	2,375,418		72,990		1,308,434		20,028
Wells Fargo	AA-	Aa2	3,850,842		130,545		4,187,955		63,442
Exchange traded			313,354		9,380		—		—
			$	31,048,082	$	830,519	$	29,277,569	$	337,256

As of December 31, 2016 and 2015, we held $827.8 million and $349.8 million, respectively, of cash and cash equivalents and other securities from counterparties for derivative collateral, which is included in other liabilities on our consolidated balance sheets. This derivative collateral limits the maximum amount of economic loss due to credit risk that we would incur if parties to the call options failed completely to perform according to the terms of the contracts to $55.5 million and $36.9 million at December 31, 2016 and 2015, respectively.

The future annual index credits on our fixed index annuities are treated as a "series of embedded derivatives" over the expected life of the applicable contract. We do not purchase call options to fund the index liabilities which may arise after the next policy anniversary date. We must value both the call options and the related forward embedded options in the policies at fair value. During the year ended December 31, 2014, we revised future period assumptions for lapse rates and the expected costs of annual call options used in determining fixed index annuity embedded derivatives. These revisions decreased the change in fair value of embedded derivatives for the year ended December 31, 2014 by $62.6 million, which after related adjustments to deferred sales inducements and deferred policy acquisition costs and income taxes, increased net income by $14.8 million.

We entered into an interest rate swap and interest rate caps to manage interest rate risk associated with the floating rate component on certain of our subordinated debentures. See Note 10 for more information on our subordinated debentures. The terms of the interest rate swap provide that we pay a fixed rate of interest and receive a floating rate of interest. The terms of the interest rate caps limit the three month London Interbank Offered Rate ("LIBOR") to 2.50%. The interest rate swap and caps are not effective hedges under accounting guidance for derivative instruments and hedging activities. Therefore, we record the interest rate swap and caps at fair value and any net cash payments received or paid are included in the change in fair value of derivatives in the consolidated statements of operations.

Details regarding the interest rate swap are as follows:

						December 31,
						2016			2015
Maturity Date	Notional Amount		Receive Rate	Pay Rate	Counterparty	Fair Value			Fair Value
						(Dollars in thousands)
March 15, 2021	$	85,500	LIBOR	2.415%	SunTrust	$	(2,113	)	$	(3,139	)

F-31

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Details regarding the interest rate caps are as follows:

						December 31,
						2016		2015
Maturity Date	Notional Amount		Floating Rate	Cap Rate	Counterparty	Fair Value		Fair Value
						(Dollars in thousands)
July 7, 2021	$	40,000	LIBOR	2.50%	SunTrust	$	542	$	708
July 8, 2021	12,000		LIBOR	2.50%	SunTrust	163		212
July 29, 2021	27,000		LIBOR	2.50%	SunTrust	377		490
	$	79,000				$	1,082	$	1,410

The interest rate swap converts floating rates to fixed rates for seven years which began in March 2014. The interest rate caps cap our interest rates for seven years which began in July 2014. As of December 31, 2016, we deposited $0.7 million of collateral with the counterparty to the swap and caps.

In September 2010, concurrently with the issuance of $200.0 million principal amount of 3.50% Convertible Senior Notes due September 15, 2015 (the "2015 notes"), we entered into hedge transactions (the "2015 notes hedges") with two counterparties whereby we would receive the cash equivalent of the conversion spread on 16.0 million shares of our common stock based upon a strike price of $12.50 per share, subject to certain conversion rate adjustments in the 2015 notes. The number of shares and strike price of the 2015 notes hedges were subject to adjustment based on dividends we paid subsequent to their purchase. The 2015 notes hedges expired on September 15, 2015, and we received $25.8 million in cash. The 2015 notes hedges were accounted for as derivative assets and were included in other assets in our consolidated balance sheets. The 2015 notes embedded conversion derivative liability was settled with the extinguishment of the 2015 notes (see Note 9) whereby we paid holders of the notes a total of $25.8 million in cash to settle the conversion premium. The 2015 notes hedges and 2015 notes embedded conversion derivative were adjusted to fair value each reporting period and unrealized gains and losses are reflected in our consolidated statements of operations.

In separate transactions, we sold warrants (the "2015 warrants") to the 2015 notes hedges counterparties for the purchase of up to 16.0 million shares of our common stock at a price of $16.00 per share. We received $15.6 million in cash proceeds from the sale of the 2015 warrants, which was recorded as an increase in additional paid-in capital. The number of shares and strike price of the warrants were subject to adjustment based on dividends we paid subsequent to selling the warrants. The warrants expired on various dates from December 2015 through June 2016. Changes in the fair value of these warrants were not be recognized in our consolidated financial statements as the instruments remain classified as equity.

In December 2015, we began settling the 2015 warrants in net shares on a weekly basis, and completed the settlement of all warrants by June 30, 2016. 140,866 shares of our common stock were delivered to holders of the expiring warrants, of which 92,998 shares were issued during 2016. 2015 warrants remained outstanding on 1.6 million shares of our common stock at a strike price of $15.59 per share at December 31, 2015. As the average price of our common stock exceeded the strike price of the 2015 warrants while they were outstanding the dilutive effect of the 2015 warrants has been included in diluted earnings per share for the years ended December 31, 2016, 2015 and 2014.

In 2014, we entered into five separate partial unwind agreements with the counterparties to the 2015 notes hedges and the 2015 warrants to coincide with the extinguishment of a portion of our 2015 notes (see Note 9) whereby we agreed to settle the related 2015 notes hedges and the 2015 warrants and received net cash from the counterparties totaling $16.6 million. The agreements to settle the 2015 warrants in cash required us to reclassify $51.3 million from equity to a derivative liability which represented the fair value of the 2015 warrants committed to the unwind on the day that we entered into the unwind agreements. The fair value of these warrants did not change after reclassification as they were settled in cash at the time the agreements were executed.

F-32

6.     Deferred Policy Acquisition Costs and Deferred Sales Inducements

Policy acquisition costs deferred and amortized are as follows:

	December 31,
	2016			2015			2014
	(Dollars in thousands)
Balance at beginning of year	$	2,905,136		$	2,058,556		$	2,426,652
Costs deferred during the year:
Commissions	538,863			651,094			421,802
Policy issue costs	4,462			6,545			5,080
Amortization	(374,012		)	(286,114		)	(163,578		)
Effect of net unrealized gains/losses	(169,072		)	475,055			(631,400		)
Balance at end of year	$	2,905,377		$	2,905,136		$	2,058,556

Sales inducements deferred and amortized are as follows:

	December 31,
	2016			2015			2014
	(Dollars in thousands)
Balance at beginning of year	$	2,232,148		$	1,587,257		$	1,875,880
Costs deferred during the year	353,966			486,924			330,079
Amortization	(251,166		)	(209,390		)	(131,419		)
Effect of net unrealized gains/losses	(126,730		)	367,357			(487,283		)
Balance at end of year	$	2,208,218		$	2,232,148		$	1,587,257

We periodically revise the key assumptions used in the calculation of amortization of deferred policy acquisition costs and deferred sales inducements retrospectively through an unlocking process when estimates of current or future gross profits/margins (including the impact of realized investment gains and losses) to be realized from a group of products are revised. The unlocking adjustments in 2016 increased amortization of deferred policy acquisition costs by $48.2 million and amortization of deferred sales inducements by $35.8 million. We review these assumptions quarterly and as a result of this review we made adjustments in the first and third quarters of 2016. During the first quarter of 2016, we made adjustments to lower future spread assumptions after comparing investment spread assumptions to actual investment spreads earned in the three months ended December 31, 2015 and March 31, 2016 and determining that decreases in the average yield earned on invested assets resulting from the continued low interest rate environment was creating shortfalls in investment spread and gross profits. During the third quarter of 2016, we made adjustments to extend the period of time in which we assume investment spread will grade up to our long-term spread targets by an additional two years as yields obtained on investments purchased in the third quarter of 2016 were much lower than we had anticipated as a result of the overall decline in investment yields that followed the Brexit vote. In addition, during the third quarter of 2016, revisions to assumptions used in determining reserves held for living income benefit riders resulted in a decrease in estimated future gross profits.

The unlocking adjustment in 2015 decreased amortization of deferred policy acquisition costs by $11.0 million and amortization of deferred sales inducements by $5.6 million and included the impact of account balance true-ups as of September 30, 2015, which have been favorable to us due to stronger equity market performance than we assumed, favorable adjustments to lapse assumptions to reflect better persistency experienced than assumed and unfavorable adjustments to investment spread to reflect lower spreads being earned than assumed. In 2015, the favorable impact of the account balance true-up and lapse assumption change was largely offset by reductions in estimated future gross profits attributable to revisions to the assumptions for the lifetime income benefit rider liability. The unlocking adjustment in 2014 decreased amortization of deferred policy acquisition costs by $35.5 million and amortization for deferred sales inducements by $12.6 million and included the impact of account value true-ups as of September 30, 2014 and adjustments to future period assumptions for interest margins, surrenders and certain expenses.

7.     Reinsurance and Policy Provisions

Coinsurance

We have two coinsurance agreements with EquiTrust Life Insurance Company ("EquiTrust"), covering 70% of certain of American Equity Life's fixed index and fixed rate annuities issued from August 1, 2001 through December 31, 2001, 40% of those contracts issued during 2002 and 2003, and 20% of those contracts issued from January 1, 2004 to July 31, 2004. The business reinsured under these agreements may not be recaptured. Coinsurance deposits (aggregate policy benefit reserves transferred to EquiTrust under these agreements) were $0.7 billion and $0.8 billion at December 31, 2016 and 2015, respectively. We remain liable to policyholders with respect to the policy liabilities ceded to EquiTrust should EquiTrust fail to meet the obligations it has coinsured. None of the coinsurance deposits with EquiTrust are deemed by management to be uncollectible. The balance due under these agreements to EquiTrust was $9.7 million and $2.5 million at December 31, 2016 and 2015, respectively, and represents the fair value of call options held by us to fund index credits related to the ceded business net of cash due to or from EquiTrust related to monthly settlements of policy activity and other expenses.

F-33

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

We have three coinsurance agreements with Athene Life Re Ltd. ("Athene"), an unauthorized life reinsurer domiciled in Bermuda. One agreement ceded 20% of certain of American Equity Life's fixed index annuities issued from January 1, 2009 through March 31, 2010. The business reinsured under this agreement is not eligible for recapture until the end of the month following seven years after the date of issuance of the policy. The second agreement ceded 80% of American Equity Life's multi-year rate guaranteed annuities issued from July 1, 2009 through December 31, 2013 and 80% of Eagle Life's multi-year rate guaranteed annuities issued from November 20, 2013 through December 31, 2013. The business reinsured under this agreement may not be recaptured. The third agreement cedes 80% of American Equity Life's and Eagle Life's multi-year rate guaranteed annuities issued on or after January 1, 2014, 80% of Eagle Life's fixed index annuities issued on or after January 1, 2014 and 80% of certain of American Equity Life's fixed index annuities issued from August 1, 2016 through December 31, 2016. The reinsurance agreement specifies that the coinsurance percentage for Eagle Life's fixed index annuities decreases to 50% for policies issued between January 1, 2017 and December 31, 2018, and to 20% for policies issued on or after January 1, 2019. The business reinsured under this agreement may not be recaptured. Coinsurance deposits (aggregate policy benefit reserves transferred to Athene under these agreements) were $3.9 billion and $2.4 billion at December 31, 2016 and 2015, respectively. American Equity Life is an intermediary for reinsurance of Eagle Life's business ceded to Athene. American Equity Life and Eagle Life remain liable to policyholders with respect to the policy liabilities ceded to Athene should Athene fail to meet the obligations it has coinsured. The annuity deposits that have been ceded to Athene are held in trusts and American Equity Life is named as the sole beneficiary of the trusts. The assets in the trusts are required to remain at a value that is sufficient to support the current balance of policy benefit liabilities of the ceded business on a statutory basis. If the value of the trust accounts would ever be less than the amount of the ceded policy benefit liabilities on a statutory basis, Athene is required to either establish a letter of credit or deposit securities in the trusts for the amount of any shortfall. None of the coinsurance deposits with Athene are deemed by management to be uncollectible. The balance due under these agreements to Athene was $45.8 million and $12.7 million at December 31, 2016 and 2015, respectively, and represents the fair value of call options held by us to fund index credits related to the ceded business net of cash due from Athene related to monthly settlements of policy activity.

Amounts ceded to EquiTrust and Athene under these agreements are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Consolidated Statements of Operations
Annuity product charges	$	5,366		$	5,427		$	5,956
Change in fair value of derivatives	18,446			(14,360		)	31,076
	$	23,812		$	(8,933	)	$	37,032
Interest sensitive and index product benefits	$	93,487		$	88,923		$	122,666
Change in fair value of embedded derivatives	23,848			(22,616		)	35,820
Other operating costs and expenses	24,039			9,922			9,241
	$	141,374		$	76,229		$	167,727
Consolidated Statements of Cash Flows
Annuity deposits	$	(1,736,054	)	$	(471,822	)	$	(171,124	)
Cash payments to policyholders	418,499			391,045			280,308
	$	(1,317,555	)	$	(80,777	)	$	109,184

Financing Arrangements

We have a reinsurance transaction with Hannover Life Reassurance Company of America ("Hannover"), which is treated as reinsurance under statutory accounting practices and as a financing arrangement under GAAP. The statutory surplus benefit under this agreement is eliminated under GAAP and the associated charges are recorded as risk charges and included in other operating costs and expenses in the consolidated statements of operations. The transaction became effective July 1, 2013 (the "2013 Hannover Transaction").

The 2013 Hannover Transaction, which was amended effective October 1, 2016, is a yearly renewable term reinsurance agreement for statutory purposes covering 45.6% of waived surrender charges related to penalty free withdrawals, deaths and lifetime income benefit rider payments as well as lifetime income benefit rider payments in excess of policy fund values on certain business. We may recapture the risks reinsured under this agreement as of the end of any quarter after December 31, 2020 and the agreement, as amended, makes it punitive to us if we do not recapture the business ceded no later than the first quarter of 2021. The reserve credit recorded on a statutory basis by American Equity Life was $638.1 million and $480.7 million at December 31, 2016 and 2015, respectively. We pay quarterly reinsurance premiums under this agreement with an experience refund calculated on a quarterly basis and a risk charge based on the pretax statutory benefit as of the end of each calendar quarter. Risk charges attributable to the 2013 Hannover Transaction were $27.7 million and $21.0 million during 2016 and 2015.

F-34

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Prior to its recapture in 2015, we had a coinsurance and yearly renewable term reinsurance agreement for statutory purposes that provided $49.2 million in net pretax statutory surplus benefit at inception in 2011 (the "2011 Hannover Transaction"). Pursuant to the terms of this agreement, pretax statutory surplus was reduced by $10.3 million and $10.8 million in 2015 and 2014, respectively. These amounts include risk charges equal to 1.25% of the pretax statutory surplus benefit as of the end of each calendar quarter. Risk charges attributable to the 2011 Hannover Transaction were $0.3 million and $0.8 million during 2015 and 2014, respectively.

Indemnity Reinsurance

In the normal course of business, we seek to limit our exposure to loss on any single insured and to recover a portion of benefits paid under our annuity, life and accident and health insurance products by ceding reinsurance to other insurance enterprises or reinsurers. Reinsurance contracts do not relieve us of our obligations to our policyholders. To the extent that reinsuring companies are later unable to meet obligations under reinsurance agreements, our life insurance subsidiaries would be liable for these obligations, and payment of these obligations could result in losses to us. To limit the possibility of such losses, we evaluate the financial condition of our reinsurers, and monitor concentrations of credit risk. No allowance for uncollectible amounts has been established against our asset for amounts receivable from other insurance companies as none of the receivables are deemed by management to be uncollectible.

8.     Income Taxes

We file consolidated federal income tax returns that include all of our wholly-owned subsidiaries. Our income tax expense as presented in the consolidated financial statements is summarized as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Consolidated statements of operations:
Current income taxes	$	57,412		$	75,568		$	116,545
Deferred income taxes (benefits)	(10,408		)	41,916			(46,504		)
Total income tax expense included in consolidated statements of operations	47,004			117,484			70,041
Stockholders' equity:
Expense (benefit) relating to:
Change in net unrealized investment losses	74,471			(279,860		)	363,572
Share-based compensation	(527		)	(3,649		)	(5,716		)
Extinguishment of convertible debt	—			—			(9,284		)
Total income tax expense (benefit) included in consolidated financial statements	$	120,948		$	(166,025	)	$	418,613

Income tax expense in the consolidated statements of operations differed from the amount computed at the applicable statutory federal income tax rate of 35% as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Income before income taxes	$	130,247		$	337,314		$	196,064
Income tax expense on income before income taxes	$	45,586		$	118,060		$	68,622
Tax effect of:
State income taxes	2,559			2,924			1,145
Tax exempt net investment income	(2,167		)	(3,834		)	(3,669		)
Extinguishment of convertible debt	—			—			4,202
Other	1,026			334			(259		)
Income tax expense	$	47,004		$	117,484		$	70,041
Effective tax rate	36.1		%	34.8		%	35.7		%

F-35

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Deferred income tax assets or liabilities are established for temporary differences between the financial reporting amounts and tax bases of assets and liabilities that will result in deductible or taxable amounts, respectively, in future years. The tax effects of temporary differences that give rise to the deferred tax assets and liabilities at December 31, 2016 and 2015, are as follows:

	December 31,
	2016			2015
	(Dollars in thousands)
Deferred income tax assets:
Policy benefit reserves	$	2,354,786		$	2,092,731
Other than temporary impairments	15,681			7,801
Derivative instruments	—			91,638
Amounts due reinsurer	1,321			—
Other policyholder funds	6,474			6,861
Litigation settlement accrual	1,709			7,100
Deferred compensation	7,963			8,346
Share-based compensation	5,407			5,286
Net operating loss carryforwards	3,745			6,637
Other	9,658			8,031
Gross deferred tax assets	2,406,744			2,234,431
Deferred income tax liabilities:
Deferred policy acquisition costs and deferred sales inducements	(1,951,333		)	(1,860,722		)
Net unrealized gains on available for sale fixed maturity and equity securities	(170,925		)	(96,454		)
Derivative instruments	(75,405		)	—
Amounts due reinsurer	—			(9,677		)
Investment income items	(39,118		)	(32,466		)
Other	(1,385		)	(2,429		)
Gross deferred tax liabilities	(2,238,166		)	(2,001,748		)
Net deferred income tax asset	$	168,578		$	232,683

Included in the deferred income taxes is the expected income tax benefit attributable to unrealized losses on available for sale fixed maturity securities. There is no valuation allowance provided for the deferred income tax asset attributable to unrealized losses on available for sale fixed maturity securities. Management expects that the passage of time will result in the reversal of these unrealized losses due to the fair value increasing as these securities near maturity. We have the intent and ability to hold these securities to maturity, because we generate adequate cash flow from new business to fund all foreseeable cash flow needs and do not believe it would be necessary to liquidate these securities at a loss to meet cash flow needs.

Realization of our deferred income tax assets is more likely than not based on expectations as to our future taxable income and considering all other available evidence, both positive and negative. Therefore, no valuation allowance against deferred income tax assets has been established as of December 31, 2016 and 2015.

There were no material income tax contingencies requiring recognition in our consolidated financial statements as of December 31, 2016. We are no longer subject to income tax examinations by tax authorities for years prior to 2012.

At December 31, 2016, we have no non-life net operating loss carryforwards remaining for federal income tax purposes.

9.     Notes and Loan Payable and Amounts Due Under Repurchase Agreements

Notes and loan payable includes the following:

	December 31,
	2016			2015
	(Dollars in thousands)
Senior notes due 2021
Principal	$	400,000		$	400,000
Unamortized debt issue costs	(5,733		)	(6,773		)
Term loan due 2019
Principal	100,000			—
Unamortized debt issue costs	(512		)	—
	$	493,755		$	393,227

On July 17, 2013, we issued $400 million aggregate principal amount of senior unsecured notes due 2021 which bear interest at 6.625% per year and will mature on July 15, 2021. Contractual interest is payable semi-annually in arrears each January 15th and July 15th. The initial transaction fees and expenses totaling $9.0 million were capitalized as deferred financing costs and are being amortized over the term of the notes due 2021 using the effective interest method. We used $15 million of the net proceeds from the issuance to repay the entire amount outstanding under our revolving credit facility and the remainder of the net proceeds was used to pay the cash consideration portion of the convertible notes exchange offers and redemption discussed below.

In September 2010, we issued $200.0 million principal amount of 2015 notes. The 2015 notes had a coupon interest rate of 3.5% per year, matured on September 15, 2015, and were settled in cash on the maturity date. Contractual interest was payable semi-annually in arrears each March 15th and September 15th. The initial transaction fees and expenses totaling $6.8 million were capitalized as deferred financing costs and were amortized over the term of the 2015 notes using the effective interest method.

The conversion option of the 2015 notes (the "2015 notes embedded conversion derivative") was an embedded derivative that required bifurcation from the 2015 notes and was accounted for as a derivative liability, which was included in Other liabilities in our Consolidated Balance Sheets. The fair value of the 2015 notes embedded conversion derivative at the time of issuance of the 2015 notes was $37.0 million, and was recorded as the original debt discount for purposes of accounting for the debt component of the 2015 notes. This discount was amortized and recognized as interest expense using the effective interest method over the term of the 2015 notes.

In December 2009, we issued $115.8 million of contingent convertible senior notes due December 15, 2029 (the "2029 notes"), of which $15.6 million was assigned to the equity component (net of income tax of $11.0 million), and was recorded as the original debt discount for purposes of accounting for the debt component of the 2029 notes. The 2029 notes had a coupon interest rate of 5.25% per annum. Interest was payable semi-annually in arrears on June 6 and December 6 of each year.

We were required to include the dilutive effect of the 2029 notes in our diluted earnings per share calculation. Because these notes included a mandatory cash settlement feature for the principal amount, incremental dilutive shares only existed when the fair value of our common stock at the end of the reporting period exceeded the conversion price per share. The conversion premium of the 2029 notes was dilutive and the effect was included in diluted earnings per share for the year ended December 31, 2014. The 2015 notes were excluded from the dilutive effect in our diluted earnings per share calculation as they were intended to be settled only in cash.

The 2015 notes matured and were extinguished on September 15, 2015. Total consideration paid to holders of the 2015 notes at maturity was $48.2 million in cash, which included $22.4 million principal amount and $25.8 million conversion premium. See Note 5 for a discussion of the settlement of the 2015 notes embedded derivative liability.

In 2014, we extinguished $69.6 million principal amount of our 2015 notes and $36.2 million principal amount of our 2029 notes pursuant to private exchange offers with holders of our outstanding convertible debt instruments. Total consideration paid to holders of the 2015 notes consisted of $82.9 million in cash and $48.2 million in shares of our common stock (2,115,055 shares). Total consideration paid to holders of the 2029 notes consisted of $66.7 million in cash and $23.2 million in shares of our common stock (946,793 shares). Total consideration paid to the holders of the 2015 notes and 2029 notes excludes the accrued interest through the settlement date that was also paid. The carrying value of the convertible notes at extinguishment was $66.0 million and $34.6 million for the 2015 notes and the 2029 notes, respectively, and losses net of tax of $4.8 million for the 2015 notes and $2.5 million for the 2029 notes were recognized.

F-36

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Also in 2014, we issued a notice of mandatory redemption of all of the 2029 notes that were outstanding at the time the notice was issued and amended the terms of the indenture governing the 2029 notes to provide the holders with the option of receiving the conversion value of their notes entirely in cash rather than cash for the principal amount and net shares for the portion of the conversion value that exceeds the principal amount. As a result of this mandatory redemption and the change in terms, $32.1 million principal amount of the 2029 notes was converted into $69.4 million in cash and $24.6 million in shares of our common stock (897,548 shares). The amendment to the conversion terms resulted in a reclassification of the fair value of the conversion premium for the 2029 notes from equity to an embedded conversion derivative liability. The fair value of the conversion premium on the date of reclassification was $58.1 million. We applied fair value accounting to the embedded derivative liability from the date of reclassification to the dates of settlement of the conversions of the 2029 notes and recognized as expense the $3.8 million increase in the fair value of the embedded conversion derivative liability.

The debt discounts were amortized over the expected lives of the notes, which was December 15, 2014 for the 2029 notes and September 15, 2015 for the 2015 notes. The effective interest rates during the discount amortization periods were 8.9% and 11.9% on the 2015 notes and 2029 notes, respectively. The interest cost recognized in operations for the convertible notes, inclusive of the coupon and amortization of the discount and debt issue costs was $1.4 million, and $9.0 million for the years ended December 31, 2015 and 2014, respectively.

On September 30, 2016, we entered into a credit agreement with six banks that provided for a $150 million unsecured revolving line of credit (the "Revolving Facility") that terminates on September 30, 2021 and a $100 million term loan (the "Term Loan") that terminates on September 30, 2019 and can be prepaid prior to maturity without penalty. We utilized the proceeds from the Term Loan to make a contribution to the capital and surplus of our subsidiary, American Equity Life. Any proceeds from the Revolving Facility will be used to finance our general corporate purposes. Interest is paid quarterly on the Term Loan. The interest rate for all borrowings under the credit agreement is floating at a rate based on our election that will be equal to the alternate base rate (as defined in the credit agreement) plus the applicable margin or the adjusted LIBOR rate (as defined in the credit agreement) plus the applicable margin. We also pay a commitment fee based on the available unused portion of the Revolving Facility. The applicable margin and commitment fee rate are based on our credit rating and can change throughout the period of the borrowings. Based upon our current credit rating, the applicable margin is 0.75% for alternate base rate borrowings and 1.75% for adjusted LIBOR rate borrowings, and the commitment fee is 0.275%. The interest rate in effect on the Term Loan in 2016 was 2.625%. Under this agreement, we are required to maintain a minimum risk-based capital ratio at our subsidiary, American Equity Life, of 275%, a maximum ratio of adjusted debt to total adjusted capital of 0.35, and a minimum level of statutory surplus at American Equity Life equal to the sum of 1) 80% of statutory surplus at June 30, 2016, 2) 50% of the statutory net income for each fiscal quarter ending after June 30, 2016, and 3) 50% of all capital contributed to American Equity Life after June 30, 2016. The Revolving Facility contains an accordion feature that allows us, on up to three occasions and subject to credit availability, to increase the credit facility by an additional $50 million in the aggregate. We also have the ability to extend the maturity date of the Revolving Facility by an additional one year past the initial maturity date of September 30, 2021 with the consent of the extending banks. There are currently no guarantors of the Revolving Facility or the Term Loan, but certain of our subsidiaries must guarantee our obligations under the credit agreement if such subsidiaries guarantee other material amounts of our debt.  No amounts were outstanding under the Revolving Facility at December 31, 2016. As of December 31, 2016, $575.6 million is unrestricted and could be distributed to shareholders and still be in compliance with all covenants under this credit agreement.

The preceding replaced a $140 million unsecured revolving line of credit agreement with five banks dated November 22, 2013 that was scheduled to terminate on November 22, 2017.

As part of our investment strategy, we enter into securities repurchase agreements (short-term collateralized borrowings). The maximum amount borrowed during 2016, 2015 and 2014 was $113.0 million, $40.6 million and $138.7 million, respectively. When we do borrow cash on these repurchase agreements, we pledge collateral in the form of debt securities with fair values approximately equal to the amount due and we use the cash to purchase debt securities ahead of the time we collect the cash from selling annuity policies to avoid a lag between the investment of funds and the obligation to credit interest to policyholders. We earn investment income on the securities purchased with these borrowings at a rate in excess of the cost of these borrowings. Such borrowings averaged $4.5 million, $0.5 million and $9.2 million for the years ended December 31, 2016, 2015 and 2014, respectively. The weighted average interest rate on amounts due under repurchase agreements was 0.66%, 0.39% and 0.19% for the years ended December 31, 2016, 2015 and 2014, respectively.

10.   Subordinated Debentures

Our wholly-owned subsidiary trusts (which are not consolidated) have issued fixed rate and floating rate trust preferred securities and have used the proceeds from these offerings to purchase subordinated debentures from us. We also issued subordinated debentures to the trusts in exchange for all of the common securities of each trust. The sole assets of the trusts are the subordinated debentures and any interest accrued thereon. The interest payment dates on the subordinated debentures correspond to the distribution dates on the trust preferred securities issued by the trusts. The trust preferred securities mature simultaneously with the subordinated debentures. Our obligations under the subordinated debentures and related agreements provide a full and unconditional guarantee of payments due under the trust preferred securities. All subordinated debentures are callable by us at any time, except for the Trust II subordinated debt obligations.

F-37

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Following is a summary of subordinated debt obligations to the trusts at December 31, 2016 and 2015:

	December 31,
	2016			2015			Interest Rate		Due Date
	(Dollars in thousands)
American Equity Capital Trust II	$	77,061		$	76,840		5%		June 1, 2047
American Equity Capital Trust III	27,840			27,840			*LIBOR +	3.90%	April 29, 2034
American Equity Capital Trust IV	12,372			12,372			*LIBOR +	4.00%	January 8, 2034
American Equity Capital Trust VII	10,830			10,830			*LIBOR +	3.75%	December 14, 2034
American Equity Capital Trust VIII	20,620			20,620			*LIBOR +	3.75%	December 15, 2034
American Equity Capital Trust IX	15,470			15,470			*LIBOR +	3.65%	June 15, 2035
American Equity Capital Trust X	20,620			20,620			*LIBOR +	3.65%	September 15, 2035
American Equity Capital Trust XI	20,620			20,620			*LIBOR +	3.65%	December 15, 2035
American Equity Capital Trust XII	41,238			41,238			*LIBOR +	3.50%	April 7, 2036
	246,671			246,450
Unamortized debt issue costs	(4,818		)	(4,998		)
	$	241,853		$	241,452

*—three month London Interbank Offered Rate

The principal amount of the subordinated debentures issued by us to American Equity Capital Trust II ("Trust II") is $100.0 million. These debentures were assigned a fair value of $74.7 million at the date of issue (based upon an effective yield-to-maturity of 6.8%). The difference between the fair value at the date of issue and the principal amount is being accreted over the life of the debentures. The trust preferred securities issued by Trust II were issued to Iowa Farm Bureau Federation, which owns more than 50% of the voting capital stock of FBL Financial Group, Inc. ("FBL"). The consideration received by Trust II in connection with the issuance of its trust preferred securities consisted of fixed income securities of equal value which were issued by FBL.

11.   Retirement and Share-based Compensation Plans

We have adopted a contributory defined contribution plan which is qualified under Section 401(k) of the Internal Revenue Code. The plan covers substantially all of our full-time employees subject to minimum eligibility requirements. Employees can contribute a percentage of their annual salary (up to a maximum contribution of $18,000 in 2016, $18,000 in 2015 and $17,500 in 2014) to the plan. We contribute an additional amount, subject to limitations, based on the voluntary contribution of the employee. Further, the plan provides for additional employer contributions based on the discretion of the Board of Directors. Plan contributions charged to expense were $1.3 million, $0.4 million and $0.4 million for the years ended December 31, 2016, 2015 and 2014, respectively.

The following table summarizes compensation expense recognized for employees, directors and consultants as a result of share-based compensation:

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands)
ESOP	$	2,522	$	2,604	$	2,486
Employee Incentive Plans	1,207		1,911		1,306
Director Equity and Incentive Plan and Stock Option Plan	685		613		789
	$	4,414	$	5,128	$	4,581

The principal purpose of the American Equity Investment Employee Stock Ownership Plan ("ESOP") is to provide each eligible employee with an equity interest in us. Employees become eligible once they have completed a minimum of six months of service. Employees become 100% vested after two years of service. Our contribution to the ESOP is determined by the Board of Directors.

In 2016, we adopted the 2016 Employee Incentive Plan which authorized the issuance of up to 2,500,000 shares of our Common stock in the form of grants of options, stock appreciation rights, restricted stock awards and restricted stock units. At December 31, 2016, we had 2,226,256 shares of common stock available for future grant under the 2016 Employee Incentive Plan. The 2009 Employee Incentive Plan, which expired in June of 2014, authorized the issuance of up to 2,500,000 shares of our common stock in the form of grants of options, stock appreciation rights, restricted stock awards and restricted stock units. All options granted under this plan had six or ten year terms and a three year vesting period after which they become fully exercisable immediately.

F-38

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

We have a long-term performance incentive plan under which certain members of our senior management team are granted restricted stock units pursuant to the 2016 Employee Incentive Plan or the 2009 Employee Incentive Plan. During 2016, 2015 and 2014, we granted 208,565, 60,947 and 54,718 restricted stock units under these plans, respectively. Vesting is tied to threshold and target performance goals for the three year period ending December 31, 2018, December 31, 2017 and December 31, 2016, respectively. Fifty percent of the restricted stock units will vest if we meet threshold goals and 100% of the restricted stock units will vest if we meet target performance goals. Compensation expense is recognized over the three year vesting period based on the likelihood of meeting threshold and target goals. Restricted stock units that ultimately vest are payable in an equal number of shares of our common stock. Restricted stock units are accounted for as equity awards and the estimated fair value of restricted stock units is based upon the closing price of our common stock on the date of grant. During 2016, the 2015 restricted stock unit award agreements were amended and the restricted stock units granted during 2015 will be settled in cash if earned. This amendment was due to an administrative issue related to the grant, which was made under an expired equity plan.

During 2016, 2015 and 2014, we issued 43,373, 25,784 and 18,239 (43,373, 23,062 and 14,869 shares were restricted stock), respectively, shares of common stock under the 2016 Employee Incentive Plan or the 2009 Employee Incentive Plan to certain employees. These shares will vest on the date three years following the grant date provided the participant remains employed with us. Compensation expense is recognized over the three year vesting period. Shares vest immediately for participants over 65 years of age with 10 years of service with us, and compensation expense under this plan for these participants was recognized upon approval of the incentive award by the compensation committee. During 2016, the shares of restricted stock granted during 2015 were canceled due to an administrative issue related to the grant, which was made under an expired equity plan. During 2016, we issued 21,806 shares of common stock to the employees impacted by the cancellation taking into consideration the canceled 2015 grants.

The 2013 Director Equity and Incentive Plan authorizes the grant of options, stock appreciation rights, restricted stock awards and restricted stock units convertible into or based upon our common stock of up to 250,000 shares to our Directors. During 2016, 2015 and 2014, we issued 47,500, 22,000 and 24,000 shares of common stock, respectively, all of which are restricted stock, and which vest one year from the grant date provided the individual remains a Director during that time period. At 2016, we had 116,500 shares of common stock available for future grant under the 2013 Director and Equity Incentive Plan.

Our 1996 Stock Option Plan, 2000 Employee Stock Option Plan, 2000 Directors Stock Option Plan and 2011 Director Stock Option Plan authorized grants of options to officers, directors and employees for an aggregate of up to 3,475,000 shares of our common stock. All options granted under these plans have ten year terms and a six month or three year vesting period after which they become fully exercisable immediately. At December 31, 2016, we had 18,000 shares of common stock available for future grant under the 2011 Director Stock Option Plan.

During 2014, we established the 2014 Independent Insurance Agent Restricted Stock and Restricted Stock Unit Plan, which was amended during 2016. Under the amended plan, agents of American Equity Life may receive grants of restricted stock and restricted stock units based upon their individual sales. The plan authorizes grants of up to 1,800,000 shares of our common stock. We recognize commission expense and an increase to additional paid-in capital as share-based compensation equal to the fair value of the restricted stock and restricted stock units as they are earned.

In January 2017, American Equity Life's agents were granted 363,624 restricted stock units based on their production during 2016, and we recorded commission expense (capitalized as deferred policy acquisition costs) of $2.6 million in 2016. In January 2016, American Equity Life's agents were granted 650,683 restricted stock units based on their production during 2015, and we recorded commission expense (capitalized as deferred policy acquisition costs) of $3.5 million in 2015. In January 2017, agents vested in 246,532 restricted stock units granted in January 2016 based on their continued service as an independent agent and their 2016 individual sales of our products, and for which we recorded commission expense (capitalized as deferred policy acquisition costs) of $1.7 million in 2016. 20% of the restricted stock units will vest one year from the grant date if the agent is in good standing with American Equity Life at that date. The remaining 80% of the restricted stock units granted to retirement eligible individuals will vest over a four year period if the agent remains in good standing with American Equity Life. The remaining 80% of the restricted stock units granted to non-retirement eligible individuals will vest based on the agent's individual sales and continued service as an independent agent over a period of time not to exceed five years.

In January 2015, American Equity Life's agents were granted 27,985 shares of restricted stock and 221,489 restricted stock units based on their production during 2014, and we recorded commission expense (capitalized as deferred policy acquisition costs) of $1.9 million in 2014. In January 2016, agents vested in 85,104 restricted stock units granted in January of 2015 based on their continued service as an independent agent and their 2015 individual sales of our products, and for which we recorded commission expense (capitalized as deferred policy acquisition costs) of $1.3 million in 2015. In January 2017, agents vested in 36,609 restricted stock units granted in January 2015 based on their continued service as an independent agent and their 2016 individual sales of our products, and for which we recorded commission expense (capitalized as deferred policy acquisition costs) of $0.6 million in 2016. The restricted stock was granted to retirement eligible individuals and vested immediately upon grant. 20% of the restricted stock units vested one year from the grant date if the agent was in good standing with American Equity Life at that date. The remaining 80% of the restricted stock units granted will vest based on the agent's individual sales and continued service as an independent agent over a period of time not to exceed five years.

During 2007, 2010 and 2012 we established Independent Insurance Agent Stock Option plans. Under these plans, agents of American Equity Life received grants of options to acquire shares of our common stock based upon their individual sales. The plans authorize grants of options to agents for an aggregate of up to 8,000,000 shares of our common stock. We recognize commission expense and an increase to additional paid-in capital as share-based compensation equal to the fair value of the options as they are earned.

F-39

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Changes in the number of stock options outstanding during the years ended December 31, 2016, 2015 and 2014 are as follows:

	Number of Shares		Weighted-Average Exercise Price per Share		Total Exercise Price
	(Dollars in thousands, except per share data)
Outstanding at January 1, 2014	3,976,725		$	10.86	$	43,171
Granted	1,277,650		24.79		31,673
Canceled	(35,400	)	11.64		(412		)
Exercised	(1,174,800	)	11.64		(13,672		)
Outstanding at December 31, 2014	4,044,175		15.02		60,760
Granted	—		—		—
Canceled	(47,300	)	10.54		(499		)
Exercised	(552,884	)	14.51		(8,021		)
Outstanding at December 31, 2015	3,443,991		15.17		52,240
Granted	—		—		—
Canceled	(24,700	)	14.83		(366		)
Exercised	(500,345	)	9.97		(4,989		)
Outstanding at December 31, 2016	2,918,946		16.06		$	46,885

The following table summarizes information about stock options outstanding at December 31, 2016:

	Stock Options Outstanding				Stock Options Vested
Range of Exercise Prices	Number of Awards	Remaining Life (yrs)	Weighted-Average Exercise Price Per Share		Number of Awards	Remaining Life (yrs)	Weighted-Average Exercise Price Per Share
$5.07 - $8.02	248,225	1.74	$	7.16	248,225	1.74	$	7.16
$9.27 - $11.35	752,150	2.66	10.19		752,150	2.66	10.19
$12.04 - $24.79	1,918,571	3.24	19.52		1,918,571	3.24	19.52
$5.07 - $24.79	2,918,946	2.97	16.06		2,918,946	2.97	16.06

The aggregate intrinsic value for stock options outstanding and vested awards was $21.3 million and $21.3 million, respectively, at December 31, 2016. For the years ended December 31, 2016, 2015 and 2014, the total intrinsic value of options exercised by officers, directors and employees was $4.0 million, $1.4 million and $5.4 million, respectively. Intrinsic value for stock options is calculated as the difference between the exercise price of the underlying awards and the price of our common stock as of the reporting date. Cash received from stock options exercised for the years ended December 31, 2016, 2015 and 2014 was $5.0 million, $8.1 million and $13.7 million, respectively. The tax benefit realized for the tax deduction from the exercise of stock options by officers, directors, employees and agents for the years ended December 31, 2016, 2015 and 2014, was $0.0 million, $0.0 million and $1.0 million, respectively.

We have deferred compensation arrangements with certain officers, directors, and consultants, whereby these individuals agreed to take our common stock at a future date in lieu of cash payments at the time of service. The common stock is to be issued in conjunction with a "trigger event," as that term is defined in the individual agreements. At December 31, 2016 and 2015, these individuals have earned, and we have reserved for future issuance, 364,000 and 366,072 shares of common stock, respectively, pursuant to these arrangements. No deferred compensation arrangements were in effect during 2016. We incurred expense of $102,000 and $127,000 for the years ended December 31, 2015 and 2014, respectively, under these arrangements.

We have deferred compensation agreements with certain officers whereby these individuals may defer certain salary and bonus compensation which is deposited into the American Equity Officer Rabbi Trust (Officer Rabbi Trust). The amounts deferred for certain employees are invested in assets at the direction of the employee. The assets of the Officer Rabbi Trust are included in our assets and a corresponding deferred compensation liability is recorded. The deferred compensation liability is recorded at the fair market value of the assets in the Officer Rabbi Trust with the change in fair value included as a component of compensation expense. The deferred compensation liability related to these agreements was $3.5 million and $3.7 million at December 31, 2016 and 2015, respectively. The Officer Rabbi Trust held 102,932 shares and 103,251 shares of our common stock at December 31, 2016 and 2015, respectively, which are treated as treasury shares.

F-40

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

During 1997, we established the American Equity Investment NMO Deferred Compensation Plan ("NMO Deferred Compensation Plan") whereby agents could earn common stock in addition to their normal commissions. The NMO Deferred Compensation Plan was effective until December 31, 2006 at which time it was suspended. Awards were calculated using formulas determined annually by our Board of Directors. These shares are being distributed at the end of the vesting and deferral period of nine years. We recognize commission expense and an increase to additional paid-in capital as share-based compensation when the awards vest. All outstanding shares issued under this plan were fully vested at December 31, 2010. At December 31, 2016 and 2015, the total number of undistributed vested shares under the NMO Deferred Compensation Plan was 0 and 223,454, respectively. These shares are included in the computation of earnings per share and earnings per share—assuming dilution.

We have a Rabbi Trust, the NMO Deferred Compensation Trust (the "NMO Trust"), which has purchased shares of our common stock to fund the amount of vested shares under the NMO Deferred Compensation Plan. The common stock held in the NMO Trust is treated as treasury stock. The NMO Trust distributed 215,273, 313,108 and 349,568 shares during 2016, 2015 and 2014, respectively. The number of shares held by the NMO Trust at December 31, 2016 and 2015, was 15,058 and 230,012, respectively.

12.   Statutory Financial Information and Dividend Restrictions

Statutory accounting practices prescribed or permitted by regulatory authorities for our life insurance subsidiaries differ from GAAP. Net income for our primary life insurance subsidiary as determined in accordance with statutory accounting practices was as follows:

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands)
American Equity Life	$	75,035	$	131,452	$	340,000

Statutory capital and surplus for our primary life insurance subsidiary was as follows:

	December 31,
	2016		2015
	(Dollars in thousands)
American Equity Life	$	2,726,664	$	2,415,419

American Equity Life is domiciled in the state of Iowa and is regulated by the Iowa Insurance Division. Life insurance companies are subject to the National Association of Insurance Commissioners ("NAIC") risk-based capital (RBC) requirements which are intended to be used by insurance regulators as an early warning tool to identify deteriorating or weakly capitalized insurance companies for the purpose of initiating regulatory action. Calculations using the NAIC formula indicated that American Equity Life's ratio of total adjusted capital to the highest level of required capital at which regulatory action might be initiated (Company Action Level) is as follows:

	December 31,
	2016			2015
	(Dollars in thousands)
Total adjusted capital	$	2,933,193		$	2,593,472
Company Action Level RBC	857,321			771,293
Ratio of adjusted capital to Company Action Level RBC	342		%	336		%

Prior approval of regulatory authorities is required for the payment of dividends to the parent company by American Equity Life which exceed an annual limitation. American Equity Life may pay dividends without prior approval, unless such payments, together with all other such payments within the preceding twelve months, exceed the greater of (1) net gain from operations before net realized capital gains/losses for the preceding calendar year or, (2) 10% of the American Equity Life's surplus at the preceding year-end. The amount of dividends permitted to be paid by American Equity Life to its parent company without prior approval of regulatory authorities is $272.7 million as of December 31, 2016. No dividends were paid by any of our insurance subsidiaries for any of the years presented in these financial statements.

The Parent Company relies on its subsidiaries for cash flow, which has primarily been in the form of investment management fees and/or dividends. Retained earnings in our consolidated financial statements primarily represent undistributed earnings of American Equity Life. As such, our ability to pay dividends is limited by the regulatory restriction placed upon insurance companies as described above. In addition, American Equity Life retains funds to allow for sufficient capital for growth.

F-41

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

13.   Commitments and Contingencies

We lease our home office space and certain equipment under various operating leases. Rent expense for the years ended December 31, 2016, 2015 and 2014 totaled $2.8 million, $2.7 million and $2.7 million, respectively. At December 31, 2016, the aggregate future minimum lease payments are $16.9 million. The following represents payments due by period for operating lease obligations as of December 31, 2016 (dollars in thousands):

Year Ending December 31:
2017	$	1,890
2018	1,915
2019	1,898
2020	1,950
2021	1,754
2022 and thereafter	7,464

We are occasionally involved in litigation, both as a defendant and as a plaintiff. In addition, state regulatory bodies, such as state insurance departments, the SEC, FINRA, the Department of Labor, and other regulatory bodies regularly make inquiries and conduct examinations or investigations concerning our compliance with, among other things, insurance laws, securities laws, the Employee Retirement Income Security Act of 1974, as amended, and laws governing the activities of broker/dealers.

In accordance with applicable accounting guidelines, we establish an accrued liability for litigation and regulatory matters when those matters present loss contingencies that are both probable and estimable. As a litigation or regulatory matter is developing we, in conjunction with outside counsel, evaluate on an ongoing basis whether the matter presents a loss contingency that meets conditions indicating the need for accrual and/or disclosure, and if not the matter will continue to be monitored for further developments. If and when the loss contingency related to litigation or regulatory matters is deemed to be both probable and estimable, we will establish an accrued liability with respect to that matter and will continue to monitor the matter for further developments that may affect the amount of the accrued liability.

Companies in the life insurance and annuity business have faced litigation, including class action lawsuits, alleging improper product design, improper sales practices and similar claims. We were a defendant in a purported class action, McCormack, et al. v. American Equity Investment Life Insurance Company, et al., in the United States District Court for the Central District of California, Western Division and Anagnostis v. American Equity, et al., coordinated in the Central District, entitled, In Re: American Equity Annuity Practices and Sales Litigation (complaint filed September 7, 2005) (the "Los Angeles Case"), involving allegations of improper sales practices and similar claims.

The Los Angeles Case was a consolidated action involving several lawsuits filed by putative class members seeking class action status for a national class of purchasers of annuities issued by us. On July 30, 2013, the parties entered into a settlement agreement and stipulated to certification of the case as a class action for settlement purposes only. A class member filed an appeal with the United States Court of Appeals for the Ninth Circuit on February 28, 2014. On February 17, 2016, the United States Court of Appeals for the Ninth Circuit affirmed the terms of the settlement agreement and on April 6, 2016, the class member’s subsequent request for a rehearing en banc was denied. All remaining opportunities for appeal have passed.

During the third quarter of 2016, we reduced the litigation liability related to the Los Angeles Case by $6.4 million as we paid out $1.8 million in partial settlement, reclassified $1.8 million from the litigation liability to policy benefit reserves and other policy funds and contract claims and released $2.8 million of the litigation liability as additional information became available concerning the nature and magnitude of claims based on the terms of the settlement. During the fourth quarter of 2016, we paid out an additional $4.1 million and reduced the litigation liability by $4.1 million. After this activity, we estimate our litigation liability in this matter to be $0.6 million based on our best estimate of probable loss. There can be no assurance that any other pending or future litigation will not have a material adverse effect on our business, financial condition, or results of operations.

In addition to our commitments to fund mortgage loans, we have unfunded commitments at December 31, 2016 to limited partnerships of $48.4 million and to secured bank loans of $34.3 million.

F-42

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

14.   Earnings Per Share and Stockholders' Equity

Earnings Per Share

The following table sets forth the computation of earnings per common share and earnings per common share—assuming dilution:

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands, except per share data)
Numerator:
Net income—numerator for earnings per common share	$	83,243	$	219,830	$	126,023
Denominator:
Weighted average common shares outstanding (1)	84,793,151		78,936,828		74,431,087
Effect of dilutive securities:
Convertible senior notes	—		—		2,657,158
Equity forward sale agreements	—		67,575		—
2015 warrants	15,136		759,723		1,559,646
Stock options and deferred compensation agreements	456,236		1,040,922		1,178,783
Restricted stock and restricted stock units	340,646		155,520		66,926
Denominator for earnings per common share—assuming dilution	85,605,169		80,960,568		79,893,600
Earnings per common share	$	0.98	$	2.78	$	1.69
Earnings per common share—assuming dilution	$	0.97	$	2.72	$	1.58

(1) Weighted average common shares outstanding include shares vested under the NMO Deferred Compensation Plan and exclude unallocated shares held by the ESOP.

Options to purchase shares of our common stock that were outstanding during the respective periods indicated but were not included in the computation of diluted earnings per share because the options' exercise price was greater than the average market price of the common shares are as follows:

Period	Number of Shares	Range of Exercise Prices
		Minimum	Maximum
Year ended December 31, 2016	1,054,091	$24.79	$24.79
Year ended December 31, 2015	1,061,541	$24.79	$24.79
Year ended December 31, 2014	1,215,450	$24.79	$24.79

Stockholders' Equity

In August 2015, we completed an underwritten public offering of 8,600,000 shares of our common stock at a public offering price of $25.25 per share, of which 4,300,000 shares were subject to a forward sale agreement. The underwriters exercised in full their option to purchase 1,290,000 additional shares of common stock, which were subject to a separate forward sale agreement. We settled the forward sale agreements on August 1, 2016 and issued 5,590,000 shares of our common stock and received $134.7 million in net proceeds. We contributed the net proceeds from the settlement to the capital and surplus of American Equity Life.

The forward sale agreements had no initial fair value since they were entered into at the then market price of the common stock. The forward sale agreements were equity instruments and qualified for an exception from derivative and fair value accounting.

F-43

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

15.   Quarterly Financial Information (Unaudited)

Unaudited quarterly results of operations are summarized below.

	Quarter Ended
	March 31,			June 30,			September 30,			December 31,
	(Dollars in thousands, except per share data)
2016
Premiums and product charges	$	43,850		$	52,582		$	60,406		$	60,508
Net investment income	450,826			459,830			463,583			475,633
Change in fair value of derivatives	(74,065		)	39,099			103,794			95,391
Net realized gains (losses) on investments, excluding OTTI losses	2,687			2,737			5,256			844
Net OTTI losses recognized in operations	(5,694		)	(4,446		)	(2,979		)	(9,560		)
Total revenues	417,604			549,802			630,060			622,816
Net income (loss)	(44,841		)	14,708			(7,420		)	120,796
Earnings (loss) per common share	(0.55		)	0.18			(0.09		)	1.37
Earnings (loss) per common share—assuming dilution	(0.55		)	0.18			(0.09		)	1.35
2015
Premiums and product charges	$	35,679		$	42,446		$	46,310		$	47,781
Net investment income	399,669			418,176			436,085			438,262
Change in fair value of derivatives	(31,100		)	(23,024		)	(351,360		)	69,338
Net realized gains (losses) on investments, excluding OTTI losses	4,879			4,324			1,159			(151		)
Net OTTI losses recognized in operations	(132		)	(828		)	(5,229		)	(13,347		)
Total revenues	408,995			441,094			126,965			541,883
Net income	5,903			82,845			97,306			33,776
Earnings per common share	0.08			1.07			1.22			0.41
Earnings per common share—assuming dilution	0.07			1.05			1.19			0.40

Earnings (loss) per common share for each quarter is computed independently of earnings (loss) per common share for the year. As a result, the sum of the quarterly earnings (loss) per common share amounts may not equal the earnings (loss) per common share for the year.

The differences between the change in fair value of derivatives for each quarter primarily correspond to the performance of the indices upon which our call options are based. The comparability of net income (loss) is impacted by the application of fair value accounting to our fixed index annuity business is as follows:

	Quarter Ended
	March 31,		June 30,			September 30,			December 31,
	(Dollars in thousands)
2016	$	62,822	$	34,215		$	6,054		$	(66,618	)
2015	42,849		(28,596		)	(53,716		)	11,091

F-44

Schedule I—Summary of Investments—

Other Than Investments in Related Parties

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

December 31, 2016

Column A	Column B		Column C		Column D
Type of Investment	Amortized Cost (1)		Fair Value		Amount at which shown in the balance sheet
	(Dollars in thousands)
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	11,864	$	11,805	$	11,805
United States Government sponsored agencies	1,368,340		1,344,787		1,344,787
United States municipalities, states and territories	3,626,395		3,926,950		3,926,950
Foreign government obligations	224,588		232,233		232,233
Corporate securities	26,338,214		27,118,526		27,118,526
Residential mortgage backed securities	1,166,944		1,254,835		1,254,835
Commercial mortgage backed securities	5,422,255		5,365,235		5,365,235
Other asset backed securities	1,795,355		1,806,123		1,806,123
	39,953,955		41,060,494		41,060,494
Held for investment:
Corporate security	76,825		68,766		76,825
Total fixed maturity securities	40,030,780		41,129,260		41,137,319
Mortgage loans on real estate	2,480,956		2,522,035		2,480,956
Derivative instruments	313,729		830,519		830,519
Other investments	308,296				308,774
Total investments	$	43,133,761			$	44,757,568

(1) On the basis of cost adjusted for other than temporary impairments, repayments and amortization of premiums and accrual of discounts for fixed maturity securities and short-term investments, original cost for derivative instruments and unpaid principal balance less allowance for credit losses for mortgage loans.

See accompanying Report of Independent Registered Public Accounting Firm.

F-45

Schedule II—Condensed Financial Information of Registrant

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY (PARENT COMPANY)

Condensed Balance Sheets

(Dollars in thousands)

	December 31,
	2016		2015
Assets
Cash and cash equivalents	$	36,394	$	38,903
Equity securities of subsidiary trusts	7,422		7,415
Receivable from subsidiaries	182		207
Deferred income taxes	9,528		11,645
Federal income tax recoverable, including amount from subsidiaries	—		7,747
Other assets	2,540		2,270
	56,066		68,187
Investment in and advances to subsidiaries	2,992,217		2,526,972
Total assets	$	3,048,283	$	2,595,159
Liabilities and Stockholders' Equity
Liabilities:
Notes and loan payable	$	493,755	$	393,227
Subordinated debentures payable to subsidiary trusts	241,853		241,452
Federal income tax payable	3,614		—
Other liabilities	17,466		15,945
Total liabilities	756,688		650,624
Stockholders' equity:
Common stock	88,001		81,354
Additional paid-in capital	770,344		630,367
Accumulated other comprehensive income	339,966		201,663
Retained earnings	1,093,284		1,031,151
Total stockholders' equity	2,291,595		1,944,535
Total liabilities and stockholders' equity	$	3,048,283	$	2,595,159

See accompanying note to condensed financial statements.

See accompanying Report of Independent Registered Public Accounting Firm.

F-46

Schedule II—Condensed Financial Information of Registrant (Continued)

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY (PARENT COMPANY)

Condensed Statements of Operations

(Dollars in thousands)

	Year Ended December 31,
	2016			2015			2014
Revenues:
Net investment income	$	78		$	62		$	130
Dividends from subsidiary trusts	384			363			360
Investment advisory fees	75,706			65,957			58,044
Surplus note interest from subsidiary	4,080			4,080			4,080
Change in fair value of derivatives	(810		)	(8,225		)	(17,122		)
Loss on extinguishment of debt	—			—			(12,502		)
Total revenues	79,438			62,237			32,990
Expenses:
Change in fair value of embedded derivatives	—			(4,516		)	(15,227		)
Interest expense on notes and loan payable	28,248			28,849			36,370
Interest expense on subordinated debentures issued to subsidiary trusts	12,958			12,239			12,122
Other operating costs and expenses	8,551			8,195			7,928
Total expenses	49,757			44,767			41,193
Income (loss) before income taxes and equity in undistributed income of subsidiaries	29,681			17,470			(8,203		)
Income tax expense	12,073			7,338			664
Income (loss) before equity in undistributed income of subsidiaries	17,608			10,132			(8,867		)
Equity in undistributed income of subsidiaries	65,635			209,698			134,890
Net income	$	83,243		$	219,830		$	126,023

See accompanying note to condensed financial statements.

See accompanying Report of Independent Registered Public Accounting Firm.

F-47

Schedule II—Condensed Financial Information of Registrant (Continued)

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY (PARENT COMPANY)

Condensed Statements of Cash Flows

(Dollars in thousands)

	Year Ended December 31,
	2016			2015			2014
Operating activities
Net income	$	83,243		$	219,830		$	126,023
Adjustments to reconcile net income to net cash provided by operating activities:
Change in fair value of 2015 notes embedded conversion derivative	—			(4,516		)	(15,227		)
Provision for depreciation and amortization	1,946			1,613			2,081
Accrual of discount on equity security	(7		)	(6		)	(6		)
Equity in undistributed income of subsidiaries	(65,635		)	(209,698		)	(134,890		)
Accrual of discount on contingent convertible notes	—			698			4,417
Change in fair value of derivatives	(698		)	6,377			15,619
Loss on extinguishment of debt	—			—			12,502
Accrual of discount on debenture issued to subsidiary trust	221			207			193
Share-based compensation	818			1,026			1,141
ESOP compensation	—			—			82
Deferred income taxes	2,117			8,967			6,439
Other	—			—			(2,235		)
Changes in operating assets and liabilities:
Receivable from subsidiaries	(125		)	93			2,208
Federal income tax recoverable	11,361			2,683			1,121
Other assets	(326		)	(4		)	378
Other liabilities	2,546			(1,664		)	(7,256		)
Net cash provided by operating activities	35,461			25,606			12,590
Investing activities
Capital contributions to subsidiaries	$	(255,000	)	$	(120,000	)	$	—
Purchases of property, plant and equipment	(54		)	—			—
Net cash used in investing activities	(255,054		)	(120,000		)	—
Financing activities
Financing fees incurred and deferred	$	(1,456	)	$	—		$	(100	)
Repayments of notes payable	—			(48,152		)	(219,094		)
Net proceeds from settlement of notes hedges and warrants	—			25,775			16,558
Proceeds from issuance of debt	100,000			—			—
Excess tax benefits realized from share-based compensation plans	—			—			184
Proceeds from issuance of common stock	139,654			112,481			13,681
Dividends paid	(21,114		)	(17,946		)	(15,221		)
Net cash provided by (used in) financing activities	217,084			72,158			(203,992		)
Decrease in cash and cash equivalents	(2,509		)	(22,236		)	(191,402		)
Cash and cash equivalents at beginning of year	38,903			61,139			252,541
Cash and cash equivalents at end of year	$	36,394		$	38,903		$	61,139
Supplemental disclosures of cash flow information
Cash paid during the year for:
Interest on notes and loan payable	$	27,164		$	27,283		$	31,206
Interest on subordinated debentures	12,454			11,833			11,765
Non-cash financing activity:
Common stock issued in extinguishment of debt	—			—			95,993
Common stock issued to settle warrants that have expired	93			48			—

See accompanying note to condensed financial statements.

See accompanying Report of Independent Registered Public Accounting Firm.

F-48

Schedule II—Condensed Financial Information of Registrant (Continued)

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY (PARENT COMPANY)

Note to Condensed Financial Statements

December 31, 2016

1.     Basis of Presentation

The accompanying condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto of American Equity Investment Life Holding Company (Parent Company).

In the Parent Company financial statements, its investment in and advances to subsidiaries are stated at cost plus equity in undistributed income (losses) of subsidiaries since the date of acquisition and net unrealized gains/losses on the subsidiaries' fixed maturity securities classified as "available for sale" and equity securities.

See Notes 9 and 10 to the consolidated financial statements for a description of the Parent Company's notes payable and subordinated debentures payable to subsidiary trusts.

F-49

Schedule III—Supplementary Insurance Information

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

Column A	Column B		Column C		Column D		Column E
	Deferred policy acquisition costs		Future policy benefits, losses, claims and loss expenses		Unearned premiums		Other policy claims and benefits payable
	(Dollars in thousands)
As of December 31, 2016: Life insurance	$	2,905,377	$	51,637,026	$	—	$	298,347
As of December 31, 2015: Life insurance	$	2,905,136	$	45,495,431	$	—	$	324,850
As of December 31, 2014: Life insurance	$	2,058,556	$	39,802,861	$	—	$	365,819

Column A	Column F		Column G		Column H		Column I		Column J
	Premium revenue		Net investment income		Benefits, claims, losses and settlement expenses		Amortization of deferred policy acquisition costs		Other operating expenses
	(Dollars in thousands)
For the year ended December 31, 2016: Life insurance	$	217,346	$	1,849,872	$	1,572,586	$	374,012	$	143,437
For the year ended December 31, 2015: Life insurance	$	172,216	$	1,692,192	$	758,203	$	286,114	$	137,306
For the year ended December 31, 2014: Life insurance	$	151,613	$	1,531,667	$	1,679,255	$	163,578	$	130,076

See accompanying Report of Independent Registered Public Accounting Firm.

F-50

Schedule IV—Reinsurance

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

Column A	Column B		Column C		Column D		Column E		Column F
	Gross amount		Ceded to other companies		Assumed from other companies		Net amount		Percent of amount assumed to net
	(Dollars in thousands)
Year ended December 31, 2016
Life insurance in force, at end of year	$	1,996,446	$	10,045	$	57,849	$	2,044,250	2.83	%
Insurance premiums and other considerations:
Annuity product charges	$	178,945	$	5,366	$	—	$	173,579	—
Traditional life, accident and health insurance, and life contingent immediate annuity premiums	43,521		251		497		43,767		1.14	%
	$	222,466	$	5,617	$	497	$	217,346	0.23	%
Year ended December 31, 2015
Life insurance in force, at end of year	$	2,036,690	$	10,677	$	56,882	$	2,082,895	2.73	%
Insurance premiums and other considerations:
Annuity product charges	$	141,595	$	5,427	$	—	$	136,168	—
Traditional life, accident and health insurance, and life contingent immediate annuity premiums	35,715		256		589		36,048		1.63	%
	$	177,310	$	5,683	$	589	$	172,216	0.34	%
Year ended December 31, 2014
Life insurance in force, at end of year	$	2,171,426	$	11,548	$	56,509	$	2,216,387	2.55	%
Insurance premiums and other considerations:
Annuity product charges	$	124,946	$	5,956	$	—	$	118,990	—
Traditional life, accident and health insurance, and life contingent immediate annuity premiums	32,308		336		651		32,623		2.00	%
	$	157,254	$	6,292	$	651	$	151,613	0.43	%

See accompanying Report of Independent Registered Public Accounting Firm.

F-51

Schedule V—Valuation and Qualifying Accounts

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

	Balance January 1,			Charged to Costs and Expenses			Translation Adjustment		Write-offs/ Payments/Other		Balance December 31,
	(Dollars in thousands
Year ended December 31, 2016
Valuation allowance on mortgage loans	$	(14,142	)	$	(4,846	)	$	—	$	10,561	$	(8,427	)
Year ended December 31, 2015
Valuation allowance on mortgage loans	$	(22,633	)	$	1,018		$	—	$	7,473	$	(14,142	)
Year ended December 31, 2014
Valuation allowance on mortgage loans	$	(26,047	)	$	(6,052	)	$	—	$	9,466	$	(22,633	)

See accompanying Report of Independent Registered Public Accounting Firm.

F-52

Item 15.    Exhibits and Financial Statement Schedules.

(a)   Exhibits:

Exhibit No.	Description
3.1	Articles of Incorporation, including Articles of Amendment (Incorporated by reference to Exhibit 3.1 to Post-Effective Amendment No. 1 to the Registration Statement on Form 10, filed on July 22, 1999, File No. 000-25985)
3.2	Articles of Amendment to Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to Form 10-Q for the period ended June 30, 2000 filed on August 14, 2000, File No. 000-25985)
3.3	Articles of Amendment to Articles of Incorporation (Incorporated by reference to Exhibit 3.2 to Pre-Effective Amendment No. 1 to the Registration Statement on Form S-1 filed on October 20, 2003, File No. 333-108794)
3.4	Articles of Amendment to Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to the Registration Statement on Form S-3 filed on January 15, 2008, File No. 333-148681)
3.5	Articles of Amendment to Articles of Incorporation (Incorporated by reference to Exhibit 3.5 to Form 10-Q for the period ended June 30, 2011 filed on August 5, 2011, File No. 001-31911)
3.6	Third Amended and Restated Bylaws (Incorporated by reference to Exhibit 3.1 to Form 8-K filed on September 2, 2008, File No. 001-31911)
4.1	Indenture dated October 29, 1999 between American Equity Investment Life Holding Company and Wilmington Trust Company (as successor in interest to West Des Moines State Bank), as trustee (Incorporated by reference to Exhibit 10.19 to the Registration Statement on Form S-1, File No. 333-108794, including all pre-effective amendments thereto)
4.2	Trust Preferred Securities Guarantee Agreement dated October 29, 1999 between American Equity Investment Life Holding Company and Wilmington Trust Company (as successor in interest to West Des Moines State Bank), as trustee (Incorporated by reference to Exhibit 10.20 to the Registration Statement on Form S-1, File No. 333-108794, including all pre-effective amendments thereto)
4.3	Trust Common Securities Guarantee Agreement dated October 29, 1999 between American Equity Investment Life Holding Company and West Des Moines State Bank, as trustee (Incorporated by reference to Exhibit 10.21 to the Registration Statement on Form S-1, File No. 333-108794, including all pre-effective amendments thereto)
4.4	Instruments of Resignation, Appointment and Acceptance, effective September 12, 2006, among American Equity Investment Life Holding Company, Wilmington Trust Company, West Des Moines State Bank and Delaware Trust Company, National Association (formerly known as First Union Trust Company, National Association) (Incorporated by reference to Exhibit 4.10A to Form 10-K for the year ended December 31, 2008 filed on March 16, 2009)
4.5	Indenture dated December 16, 2003, between American Equity Investment Life Holding Company and Wilmington Trust Company, as trustee (Incorporated by reference to Exhibit 4.11 to Form 10-K for the year ended December 31, 2003 filed on March 4, 2004)
4.6	Guarantee Agreement dated December 16, 2003, between American Equity Investment Life Holding Company and Wilmington Trust Company, as trustee (Incorporated by reference to Exhibit 4.12 to Form 10-K for the year ended December 31, 2003 filed on March 4, 2004)
4.7	Indenture dated April 29, 2004, between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.13 to Form 10-Q for the period ended September 30, 2004 filed on November 9, 2004)
4.8	Guarantee Agreement dated April 29, 2004, between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.14 to Form 10-Q for the period ended September 30, 2004 filed on November 9, 2004)
4.9	Indenture dated September 14, 2004, between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.15 to Form 10-Q for the period ended September 30, 2004 filed on November 9, 2004)
4.10	Guarantee Agreement dated September 14, 2004, between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.16 to Form 10-Q for the period ended September 30, 2004 filed on November 9, 2004)
4.11	Indenture dated December 22, 2004, between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.17 to Form 10-K for the year ended December 31, 2004 filed on March 14, 2005)
4.12	Guarantee Agreement dated December 22, 2004, between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.18 to Form 10-K for the year ended December 31, 2004 filed on March 14, 2005)
4.13	Indenture dated June 15, 2005 between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.23 to Form 10-Q for the period ended June 30, 2005 filed on August 4, 2005)
4.14	Guarantee Agreement dated June 15, 2005 between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.24 to Form 10-Q for the period ended June 30, 2005 filed on August 4, 2005)
4.15	Indenture dated August 4, 2005 between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.25 to Form 10-Q for the period ended September 30, 2005 filed on November 4, 2005)
4.16	Guarantee Agreement dated August 4, 2005 between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.26 to Form 10-Q for the period ended September 30, 2005 filed on November 4, 2005)
4.17	Indenture dated December 15, 2005 between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.27 to Form 10-K for the year ended December 31, 2005 filed on March 14, 2006)
4.18	Guarantee Agreement dated December 15, 2005 between American Equity Investment Life Holding Company and JP Morgan Chase Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.28 to Form 10-K for the year ended December 31, 2005 filed on March 14, 2006)
4.19	Amended and Restated Indenture dated July 7, 2006 between American Equity Investment Life Holding Company and Wells Fargo Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.31 to Form 10-Q for the period ended September 30, 2006 filed on November 3, 2006)

F-53

Exhibit No.	Description
4.20	Amended and Restated Guarantee Agreement dated July 7, 2006 between American Equity Investment Life Holding Company and Wells Fargo Delaware Trust Company, as trustee (Incorporated by reference to Exhibit 4.32 to Form 10-Q for the period ended September 30, 2006 filed on November 3, 2006)
4.21	Senior Amended and Restated Indenture, dated as of April 22, 2004, between American Equity Investment Life Holding Company and U.S. Bank National Association, as trustee (Incorporated by reference to Exhibit 4.1 to Amendment No.1 to Form S-3 filed on April 22, 2004).
4.22	First Supplemental Indenture, dated July 17, 2013, among American Equity Investment Life Holding Company, U.S. Bank National Association, and Wells Fargo Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.2 to Form 8-K filed on July 17, 2013)
4.23	Second Supplemental Indenture, dated as of July 17, 2013, between American Equity Investment Life Holding Company and Wells Fargo Bank, National Association, as trustee (Incorporated by reference to Exhibit 4.3 to Form 8-K filed on July 17, 2013)
10.1 *	Deferred Compensation Agreement between American Equity Investment Life Holding Company and David S. Mulcahy dated December 31, 1997 (Incorporated by reference to Exhibit 10.5 to the Registration Statement on Form 10 filed on May 6, 1999)
10.2 *	2000 Employee Stock Option Plan (Incorporated by reference to Exhibit 10.7 to Form 10-Q for the period ended June 30, 2000 filed on August 14, 2000)
10.3 *	2000 Director Stock Option Plan (Incorporated by reference to Exhibit 10.8 to Form 10-Q for the period ended June 30, 2000 filed on August 14, 2000)
10.4 *	American Equity Investment Life Holding Company 2009 Employee Incentive Plan (Incorporated by reference to Exhibit 10.2 to Form 8-K filed on June 9, 2009)
10.5 *	Form of Change in Control Agreement between American Equity Investment Life Holding Company and each of John M. Matovina and Debra J. Richardson (Incorporated by reference to the Registration Statement on Form S-1, File No. 333-108794, including all pre-effective amendments thereto)
10.6 *	Form of Amendment to Change in Control Agreement between American Equity Investment Life Holding Company and each of John M. Matovina and Debra J. Richardson (Incorporated by reference to Exhibit 10.11-A to Form 10-K for the year ended December 31, 2012 filed on March 7, 2013)
10.7	American Equity Investment Life Holding Company Independent Insurance Agent Stock Option Plan (Incorporated by reference to Exhibit 10.26 to Form 10-Q for the period ended September 30, 2007 filed on November 2, 2007)
10.8	Coinsurance Agreement effective July 1, 2009, between American Equity Investment Life Insurance Company and Athene Life Re Ltd (Treaty #070109) (Incorporated by reference to Exhibit 10.29 to Form 10-Q for the period ended September 30, 2009 filed on November 9, 2009)
10.9	Coinsurance Agreement effective July 1, 2009, between American Equity Investment Life Insurance Company and Athene Life Re Ltd (Treaty #08042009) (Incorporated by reference to Exhibit 10.29 to Form 10-Q for the period ended September 30, 2009 filed on November 9, 2009)
10.10 *	Amended Retirement Benefit Agreement, dated as of March 29, 2010, between American Equity Investment Life Holding Company and David J. Noble (Incorporated by reference to Exhibit 10.1 to Form 8-K filed on April 2, 2010)
10.11 *	Amended and Restated Retirement Benefit Agreement by and between American Equity Investment Life Holding Company and David J. Noble (Incorporated by reference to Exhibit 10.3 to Form 10-Q filed on May 10, 2016)
10.12	2010 Independent Insurance Agent Stock Option Plan (Incorporated by reference to Exhibit 99.1 to the Registration Statement on Form S-3 filed on December 15, 2010)
10.13 *	American Equity Investment Life Holding Company 2011 Director Stock Option Plan (Incorporated by reference to Appendix A to Schedule 14A Definitive Proxy Statement for the 2011 annual meeting of stockholders filed on April 25, 2011)
10.14	2012 Independent Insurance Agent Stock Option Plan (Incorporated by reference to Exhibit 10.1 to the Registration Statement on Form S-3 filed on August 23, 2012)
10.15 *	Form of Change in Control Agreement between American Equity Investment Life Holding Company and each of Ted M. Johnson, Ronald J. Grensteiner, Jeffrey D. Lorenzen and Renee D. Montz (Incorporated by reference to Exhibit 10.1 to Form 8-K filed on December 13, 2012)
10.16 *	American Equity Investment Life Holding Company Short-Term Performance Incentive Plan adopted April 15, 2013, as amended and restated (Incorporated by reference to Exhibit 10.1 to Form 8-K filed on April 15, 2013)
10.17 *	Form of Restricted Stock Award Agreement with respect to Common Stock of American Equity Investment Life Holding Company-Nonperformance Based (Incorporated by reference to Exhibit 10.1 to Form 10-Q for the period ended March 31, 2013 filed on May 8, 2013)
10.18 *	Form of Performance Restricted Stock Unit Award Agreement (Incorporated by reference to Exhibit 10.2 to Form 10-Q for the period ended March 31, 2013 filed on May 8, 2013)
10.19 *	Form of First Amendment to the Performance Restricted Stock Unit Award Agreement (Incorporated by reference to Exhibit 10.1 to Form 10-Q filed on May 10, 2016)
10.20 *	Form of Restricted Stock Award Agreement with respect to Common Stock of American Equity Investment Life Holding Company-Performance Based (Incorporated by reference to Exhibit 10.3 to Form 10-Q for the period ended March 31, 2013 filed on May 8, 2013)
10.21 *	Form of Change in Control Agreement between American Equity Investment Life Holding Company and Scott A. Samuelson (Incorporated by reference to Exhibit 10.3 to Form 10-Q for the period ended June 30, 2013 filed on August 8, 2013)
10.22 *	2013 Director Equity and Incentive Plan (Incorporated by reference to Exhibit 10.4 to Form 10-Q for the period ended June 30, 2013 filed on August 8, 2013)
10.23	Credit Agreement dated September 30, 2016 among American Equity Life Investment Holding Company, JP Morgan Chase Bank, National Association, SunTrust Bank, and Citibank, National Association and Royal Bank of Canada (Incorporated by reference to Exhibit 10.1 to Form 8-K filed on October 3, 2016)
10.24	Amended and Restated American Equity Investment Life Holding Company 2014 Independent Insurance Agent Restricted Stock and Restricted Stock Unit Plan (Incorporated by reference to Exhibit 10.1 to the Registration Statement on Form S-3 filed on December 17, 2014)
10.25	Amended and Restated American Equity Investment Life Holding Company 2014 Independent Insurance Agent Restricted Stock and Restricted Stock Unit Plan, as amended (Incorporated by reference to the Appendix B to the Company's proxy statement on Form DEF 14A filed on April 18, 2016)
10.26	Confirmation, dated August 6, 2015, by and between American Equity Life Investment Holding Company and RBC Capital Markets, LLC, as agent for Royal Bank of Canada (Incorporated by reference to Exhibit 10.1 to Form 8-K filed on August 12, 2015)

F-54

Exhibit No.	Description
10.27	Confirmation, dated August 11, 2015, by and between American Equity Life Investment Holding Company and RBC Capital Markets, LLC, as agent for Royal Bank of Canada (Incorporated by reference to Exhibit 10.2 to Form 8-K filed on August 12, 2015)
10.28 *	Form of Restricted Stock Cancellation Agreement (Incorporated by reference to Exhibit 10.2 to Form 10-Q for the period ended March 31, 2016 filed on May 10, 2016)
10.29 *	American Equity Investment Life Holding Company 2016 Employee Incentive Plan (Incorporated by reference to the Appendix A to the Company's proxy statement on Form DEF 14A filed on April 18, 2016)
10.30 *	First Amendment to American Equity Investment Life Holding Company 2016 Employee Incentive Plan (Incorporated by reference to Exhibit 99.2 to Form S-8 filed on September 8, 2016)
10.31 *	Form of Restricted Stock Award Agreement with Respect to Common Stock of American Equity Investment Life Holding Company (Incorporated by reference to Exhibit 10.1 to Form 8-K filed on June 8, 2016)
10.32 *	Form of Performance Restricted Stock Unit Award Agreement (Incorporated by reference to Exhibit 10.2 to Form 8-K filed on June 8, 2016)
10.33 *	Form of First Amendment to Employee Stock Option Agreements between American Equity Investment Life Holding Company and each of David J. Noble and Debra J. Richardson (Incorporated by reference to Exhibit 10.2 to Form 10-Q filed on August 9, 2016)
10.34 *	Retirement and Transition Agreement by and between American Equity Investment Life Holding Company and Debra J. Richardson (Incorporated by reference to Exhibit 10.3 to Form 10-Q filed on August 9, 2016)
12.1	Ratio of Earnings to Fixed Charges
21.2	Subsidiaries of American Equity Investment Life Holding Company
23.1	Consent of Independent Registered Public Accounting Firm
31.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

* Denotes management contract or compensatory plan.

F-55

EX-12.1

Exhibit 12.1

Ratio of Earnings to Fixed Charges

	Year Ended December 31,
	2016		2015		2014		2013		2012
Consolidated income before income taxes	$	130,247	$	337,314	$	196,064	$	389,332	$	85,989
Interest sensitive and index product benefits and amortization of deferred sales inducements	976,638		1,177,443		1,605,119		1,525,980		895,636
Interest expense on notes and loan payable	28,248		28,849		36,370		38,870		28,479
Interest expense on subordinated debentures	12,958		12,239		12,122		12,088		13,458
Interest expense on amounts due under repurchase agreements and other interest expense	30		2		18		139		—
Interest portion of rental expense	920		902		896		843		741
Consolidated earnings	$	1,149,041	$	1,556,749	$	1,850,589	$	1,967,252	$	1,024,303
Interest sensitive and index product benefits and amortization of deferred sales inducements	$	976,638	$	1,177,443	$	1,605,119	$	1,525,980	$	895,636
Interest expense on notes and loan payable	28,248		28,849		36,370		38,870		28,479
Interest expense on subordinated debentures	12,958		12,239		12,122		12,088		13,458
Interest expense on amounts due under repurchase agreements and other interest expense	30		2		18		139		—
Interest portion of rental expense	920		902		896		843		741
Combined fixed charges	$	1,018,794	$	1,219,435	$	1,654,525	$	1,577,920	$	938,314
Ratio of consolidated earnings to fixed charges	1.1		1.3		1.1		1.2		1.1
Ratio of consolidated earnings to fixed charges, both excluding interest sensitive and index product benefits and amortization of deferred sales inducements	4.1		9.0		5.0		8.5		3.0

EX-21.2

Exhibit 21.2

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

Subsidiaries of American Equity Investment Life Holding Company

	State of Incorporation
Insurance Subsidiaries:
American Equity Investment Life Insurance Company	Iowa
American Equity Investment Life Insurance Company of New York	New York
Eagle Life Insurance Company	Iowa
Noninsurance Subsidiaries:
American Equity Investment Service Company	Iowa
American Equity Properties, L.C.	Iowa
American Equity Capital, Inc.	Iowa
American Equity Capital Trust II	Iowa
American Equity Capital Trust III	Iowa
American Equity Capital Trust IV	Iowa
American Equity Capital Trust V	Iowa
American Equity Capital Trust VI	Iowa
American Equity Capital Trust VII	Iowa
American Equity Capital Trust VIII	Iowa
American Equity Capital Trust IX	Iowa
American Equity Capital Trust X	Iowa
American Equity Capital Trust XI	Iowa
American Equity Capital Trust XII	Iowa
AERL, L.C.	Iowa
American Equity Advisors, Inc.	Iowa

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

American Equity Investment Life Holding Company:

We consent to the incorporation by reference in the registration statement (No. 333-213544, No. 333-207077, No. 333-201008, No. 333-184162, No. 333-183504, No. 333-171161, No. 333-149854, and No. 333-14868) on Form S-3 and the registration statements (No. 333-214885, No. 333-213545, No. 333-175355, No. 333-167755, and No. 333-127001) on Form S-8 of American Equity Investment Life Holding Company of our report dated February 27, 2017, with respect to the consolidated balance sheets of American Equity Investment Life Holding Company and subsidiaries as of December 31, 2016 and 2015, and the related consolidated statements of operations, comprehensive income (loss), changes in stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2016, and all related financial statement schedules, and the effectiveness of internal control over financial reporting as of December 31, 2016, which report appears in the December 31, 2016 annual report on Form 10‑K of American Equity Investment Life Holding Company.

/s/ KPMG LLP

Des Moines, Iowa

February 27, 2017

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, John M. Matovina, certify that:

1. I have reviewed this annual report on Form 10-K of American Equity Investment Life Holding Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	February 27, 2017	By:	/s/ JOHN M. MATOVINA
			John M. Matovina, Chief Executive Officer and President (Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Ted M. Johnson, certify that:

1. I have reviewed this annual report on Form 10-K of American Equity Investment Life Holding Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	February 27, 2017	By:	/s/ TED M. JOHNSON
			Ted M. Johnson, Chief Financial Officer and Treasurer (Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of American Equity Investment Life Holding Company (the "Company") on Form 10-K for the fiscal year ended December 31, 2016 as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), I, John M. Matovina, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934;

and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	February 27, 2017	By:	/s/ JOHN M. MATOVINA
			John M. Matovina, Chief Executive Officer and President (Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of American Equity Investment Life Holding Company (the "Company") on Form 10-K for the fiscal year ended December 31, 2016 as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), I, Ted M. Johnson, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934;

and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	February 27, 2017	By:	/s/ TED M. JOHNSON
			Ted M. Johnson, Chief Financial Officer and Treasurer (Principal Financial Officer)

XML

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2016	Feb. 22, 2017	Jun. 30, 2016
Document and Entitiy Information [Abstract]
Entity Registrant Name	AMERICAN EQUITY INVESTMENT LIFE HOLDING CO
Entity Central Index Key	0001039828
Document Type	10-K
Document Period End Date	Dec. 31, 2016
Amendment Flag	false
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 1,133,734,418
Entity Common Stock, Shares Outstanding		88,279,845

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Fixed maturity securities:
Available for sale, at fair value (amortized cost: 2016 - $39,953,955; 2015 - $35,823,710)	$ 41,060,494	$ 36,421,839
Held for investment, at amortized cost (fair value: 2016 - $68,766; 2015 - $65,377)	76,825	76,622
Mortgage loans on real estate	2,480,956	2,435,257
Derivative instruments	830,519	337,256
Other investments	308,774	299,358
Total investments	44,757,568	39,570,332
Cash and cash equivalents	791,266	397,749
Coinsurance deposits	4,639,492	3,187,470
Accrued investment income	397,773	362,104
Deferred policy acquisition costs	2,905,377	2,905,136
Deferred sales inducements	2,208,218	2,232,148
Deferred income taxes	168,578	232,683
Income taxes recoverable	11,474	29,599
Other assets	173,726	112,171
Total assets	56,053,472	49,029,392
Liabilities:
Policy benefit reserves	51,637,026	45,495,431
Other policy funds and contract claims	298,347	324,850
Notes and loan payable	493,755	393,227
Subordinated debentures	241,853	241,452
Other liabilities	1,090,896	629,897
Total liabilities	53,761,877	47,084,857
Stockholders' equity:
Preferred stock, par value $1 per share, 2,000,000 shares authorized, 2016 and 2015 - no shares issued and outstanding	0	0
Common stock, par value $1 per share, 200,000,000 shares authorized; issued and outstanding: 2016 - 88,001,130 shares (excluding 2,887,082 treasury shares); 2015 - 81,354,079 shares (excluding 3,448,750 treasury shares)	88,001	81,354
Additional paid-in capital	770,344	630,367
Accumulated other comprehensive income	339,966	201,663
Retained earnings	1,093,284	1,031,151
Total stockholders' equity	2,291,595	1,944,535
Total liabilities and stockholders' equity	$ 56,053,472	$ 49,029,392

XML

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Investments:
Available for sale, amortized cost	$ 39,953,955	$ 35,823,710
Held for investment, fair value	$ 68,766	$ 65,377
Stockholders' equity:
Preferred stock, par value (dollars per share)	$ 1	$ 1
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (dollars per share)	$ 1	$ 1
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	88,001,130	81,354,079
Common stock, shares outstanding	88,001,130	81,354,079
Common stock, shares held in treasury	2,887,082	3,448,750

XML

Consolidated Statements of Operations - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenues:
Premiums and other considerations		$ 43,767	$ 36,048	$ 32,623
Annuity product charges		173,579	136,168	118,990
Net investment income		1,849,872	1,692,192	1,531,667
Change in fair value of derivatives		164,219	(336,146)	504,825
Net realized gains (losses) on investments, excluding other than temporary impairment (OTTI) losses		11,524	10,211	(4,003)
OTTI losses on investments:
Total OTTI losses		(21,349)	(25,547)	0
Portion of OTTI losses recognized in (from) other comprehensive income		(1,330)	6,011	(2,627)
Net OTTI losses recognized in operations		(22,679)	(19,536)	(2,627)
Loss on extinguishment of debt		0	0	(12,502)
Total revenues		2,220,282	1,518,937	2,168,973
Benefits and expenses:
Insurance policy benefits and change in future policy benefits		52,483	45,458	41,815
Interest sensitive and index product benefits		725,472	968,053	1,473,700
Amortization of deferred sales inducements		251,166	209,390	131,419
Change in fair value of embedded derivatives		543,465	(464,698)	32,321
Interest expense on notes and loan payable		28,248	28,849	36,370
Interest expense on subordinated debentures		12,958	12,239	12,122
Amortization of deferred policy acquisition costs		374,012	286,114	163,578
Other operating costs and expenses		102,231	96,218	81,584
Total benefits and expenses		2,090,035	1,181,623	1,972,909
Income before income taxes		130,247	337,314	196,064
Income tax expense		47,004	117,484	70,041
Net income		$ 83,243	$ 219,830	$ 126,023
Earnings per common share		$ 0.98	$ 2.78	$ 1.69
Earnings per common share - assuming dilution		$ 0.97	$ 2.72	$ 1.58
Weighted average common shares outstanding: earnings per common share	[1]	84,793,151	78,936,828	74,431,087
Weighted average common shares outstanding: earnings per common share - assuming dilution		85,605,169	80,960,568	79,893,600

[1] Weighted average common shares outstanding include shares vested under the NMO Deferred Compensation Plan and exclude unallocated shares held by the ESOP.

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Net income		$ 83,243	$ 219,830	$ 126,023
Other comprehensive income (loss):
Change in net unrealized investment gains/losses (1)	[1]	207,994	(797,374)	1,038,604
Noncredit component of OTTI losses (1)	[1]	556	(2,927)	1,265
Reclassification of unrealized investment gains/losses to net income (1)	[1]	4,224	703	(1,092)
Other comprehensive income (loss) before income tax		212,774	(799,598)	1,038,777
Income tax effect related to other comprehensive income (loss)		(74,471)	279,860	(363,572)
Other comprehensive income (loss)		138,303	(519,738)	675,205
Comprehensive income (loss)		$ 221,546	$ (299,908)	$ 801,228

[1] Net of related adjustments to amortization of deferred sales inducements and deferred policy acquisition costs.

XML

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Unallocated Common Stock Held by ESOP [Member]	Accumulated Other Comprehensive Income [Member]	Retained Earnings [Member]
Stockholders' equity at beginning of period at Dec. 31, 2013	$ 1,384,687	$ 70,535	$ 550,400	$ (631)	$ 46,196	$ 718,187
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	126,023					126,023
Other comprehensive income (loss)	675,205				675,205
Allocation of common stock by ESOP, including excess income tax benefits	1,352		721	631
Share-based compensation, including excess income tax benefits	7,705		7,705
Issuance of common stock under compensation plans, including excess income tax benefits	14,705	1,568	13,137
Extinguishment of convertible senior notes, net of tax, including shares of common stock issued upon conversion	(3,529)	3,959	(7,488)
Warrants reclassified to embedded derivative liability to be settled in cash	(51,257)		(51,257)
Dividends on common stock	(15,015)					(15,015)
Stockholders' equity at end of period at Dec. 31, 2014	2,139,876	76,062	513,218	0	721,401	829,195
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	219,830					219,830
Other comprehensive income (loss)	(519,738)				(519,738)
Share-based compensation, including excess income tax benefits	9,976		9,976
Issuance of common stock	104,479	4,300	100,179
Issuance of common stock under compensation plans, including excess income tax benefits	7,986	944	7,042
Issuance of common stock to settle warrants that have reached their expiration	0	48	(48)
Dividends on common stock	(17,874)					(17,874)
Stockholders' equity at end of period at Dec. 31, 2015	1,944,535	81,354	630,367	0	201,663	1,031,151
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	83,243					83,243
Other comprehensive income (loss)	138,303				138,303
Share-based compensation, including excess income tax benefits	7,218		7,218
Issuance of common stock	134,662	5,590	129,072
Issuance of common stock under compensation plans, including excess income tax benefits	4,745	964	3,781
Issuance of common stock to settle warrants that have reached their expiration	(1)	93	(94)
Dividends on common stock	(21,110)					(21,110)
Stockholders' equity at end of period at Dec. 31, 2016	$ 2,291,595	$ 88,001	$ 770,344	$ 0	$ 339,966	$ 1,093,284

XML

Consolidated Statements of Changes in Stockholders' Equity (Parentheticals) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Statement of Stockholders' Equity [Abstract]
Shares of common stock allocated by ESOP, including excess income tax benefits			58,618
Shares of common stock issued under compensation plans, including excess income tax benefits	964,053	944,504	1,567,607
Shares of common stock issued upon extinguishment of convertible senior notes			3,959,396
Shares of common stock issued to settle warrants that have reached their expiration	92,998	47,868
Dividends on common stock, per share amount	$ 0.24	$ 0.22	$ 0.20

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Operating activities
Net income	$ 83,243	$ 219,830	$ 126,023
Adjustments to reconcile net income to net cash provided by operating activities:
Interest sensitive and index product benefits	725,472	968,053	1,473,700
Amortization of deferred sales inducements	251,166	209,390	131,419
Annuity product charges	(173,579)	(136,168)	(118,990)
Change in fair value of embedded derivatives	543,465	(464,698)	32,321
Increase in traditional life and accident and health insurance reserves	12,724	5,097	2,385
Policy acquisition costs deferred	(543,325)	(657,639)	(426,882)
Amortization of deferred policy acquisition costs	374,012	286,114	163,578
Provision for depreciation and other amortization	3,879	4,610	9,490
Amortization of discounts and premiums on investments	1,070	(8,464)	(14,960)
Loss on extinguishment of debt	0	0	12,502
Realized gains (losses) on investments and net OTTI losses recognized in operations	11,155	9,325	6,630
Change in fair value of derivatives	(165,727)	334,300	(506,328)
Deferred income taxes (benefits)	(10,408)	41,916	(46,504)
Share-based compensation	6,692	7,373	3,544
Change in accrued investment income	(35,669)	(35,545)	(24,918)
Change in income taxes recoverable/payable	18,125	(20,027)	(19,405)
Change in other assets	1,812	71	(2,771)
Change in other policy funds and contract claims	(34,411)	(49,092)	(60,931)
Change in collateral held for derivatives	414,655	(269,474)	27,839
Change in other liabilities	(55,940)	75,794	(51,008)
Other	(14,089)	(15,962)	(8,948)
Net cash provided by operating activities	1,414,322	504,804	707,786
Sales, maturities, or repayments of investments:
Fixed maturity securities—available for sale	2,746,510	1,612,121	1,490,906
Mortgage loans on real estate	383,763	468,102	453,937
Derivative instruments	284,470	640,467	1,169,874
Other investments	14,045	16,792	23,165
Acquisitions of investments:
Fixed maturity securities—available for sale	(6,883,895)	(7,256,137)	(5,191,781)
Mortgage loans on real estate	(428,833)	(455,286)	(327,654)
Derivative instruments	(602,349)	(588,859)	(492,296)
Other investments	(11,559)	(13,092)	(72,548)
Purchases of property, furniture and equipment	(1,197)	(1,313)	(1,352)
Net cash used in investing activities	(4,499,045)	(5,577,205)	(2,947,749)
Financing activities
Receipts credited to annuity and single premium universal life policyholder account balances	7,092,348	7,051,227	4,160,005
Coinsurance deposits	(1,317,555)	(80,777)	109,184
Return of annuity policyholder account balances	(2,535,669)	(2,271,950)	(2,025,203)
Financing fees incurred and deferred	(1,456)	0	(100)
Repayment of notes payable	0	(48,152)	(219,094)
Proceeds from issuance of debt	100,000	0	0
Net proceeds from settlement of notes hedges and warrants	0	25,775	16,558
Acquisition of common stock	0	(16)	0
Excess tax benefits realized from share-based compensation plans	527	3,649	5,184
Proceeds from issuance of common stock	139,654	112,481	13,681
Change in checks in excess of cash balance	21,501	(5,727)	(1,252)
Dividends paid	(21,110)	(17,874)	(15,015)
Net cash provided by (used in) financing activities	3,478,240	4,768,636	2,043,948
Increase (decrease) in cash and cash equivalents	393,517	(303,765)	(196,015)
Cash and cash equivalents at beginning of year	397,749	701,514	897,529
Cash and cash equivalents at end of year	791,266	397,749	701,514
Cash paid during the year for interest:
Interest expense	39,647	39,118	42,989
Cash paid during the year for income taxes:
Income taxes	39,066	91,887	132,754
Non-cash operating activity:
Deferral of sales inducements	353,966	486,924	330,079
Non-cash investing and financing activities:
Real estate acquired in satisfaction of mortgage loans	0	0	14,555
Mortgage loan on real estate sold	0	4,879	0
Common Stock Issued in Extinguishment of Debt [Member]
Non-cash investing and financing activities:
Common stock issued	0	0	95,993
Common Stock Issued to Settle Warrants That Have Expired [Member]
Non-cash investing and financing activities:
Common stock issued	$ 93	$ 48	$ 0

XML

Significant Accounting Policies

12 Months Ended

Dec. 31, 2016

Accounting Policies [Abstract]

Significant Accounting Policies

Significant Accounting Policies

Nature of Operations

American Equity Investment Life Holding Company ("we", "us", "our" or "parent company"), through its wholly-owned subsidiaries, American Equity Investment Life Insurance Company ("American Equity Life"), American Equity Investment Life Insurance Company of New York ("American Equity Life of New York") and Eagle Life Insurance Company ("Eagle Life"), is licensed to sell insurance products in 50 states and the District of Columbia at December 31, 2016. We operate solely in the insurance business.

We primarily market fixed index and fixed rate annuities and to a lesser extent, life insurance. Premiums and annuity deposits (net of coinsurance) collected in 2016, 2015 and 2014, by product type were as follows:

	Year Ended December 31,
Product Type	2016		2015		2014
	(Dollars in thousands)
Fixed index annuities	$	5,035,818	$	6,491,981	$	3,911,109
Annual reset fixed rate annuities	63,582		44,715		56,647
Multi-year fixed rate annuities	256,894		42,709		21,125
Single premium immediate annuities (SPIA)	35,851		32,752		24,580
Life insurance	9,946		10,917		10,810
	$	5,402,091	$	6,623,074	$	4,024,271

Agents contracted with us through two national marketing organizations accounted for more than 10% of the annuity deposits and insurance premium collections during 2016 by American Equity Life representing 19% and 10%, individually, of the annuity deposits and insurance premiums collected by American Equity Life. Agents contracted with us through one national marketing organization accounted for more than 10% of the annuity deposits and insurance premium collections during 2015 by American Equity Life, representing 24% of the annuity deposits and insurance premiums collected by American Equity Life. Agents contracted with us through two national marketing organizations accounted for more than 10% of the annuity deposits and insurance premium collections during 2014 by American Equity Life, each representing 10% individually, of the annuity deposits and insurance premiums collected by American Equity Life.

Consolidation and Basis of Presentation

The consolidated financial statements include our accounts and our wholly-owned subsidiaries: American Equity Life, American Equity Life of New York, Eagle Life, AERL, L.C., American Equity Capital, Inc., American Equity Investment Properties, L.C., American Equity Advisors, Inc. and American Equity Investment Service Company. All significant intercompany accounts and transactions have been eliminated.

Estimates and Assumptions

The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are utilized in the calculation of deferred policy acquisition costs, deferred sales inducements, policy benefit reserves, valuation of derivatives, including embedded derivatives on index annuity reserves, contingent convertible senior notes, valuation of investments, other than temporary impairment of investments, allowances for loan losses on mortgage loans and valuation allowances on deferred tax assets. A description of each critical estimate is incorporated within the discussion of the related accounting policies which follow. It is reasonably possible that actual experience could differ from the estimates and assumptions utilized.

Investments

Fixed maturity securities (bonds and redeemable preferred stocks maturing more than one year after issuance) that may be sold prior to maturity are classified as available for sale. Available for sale securities are reported at fair value and unrealized gains and losses, if any, on these securities are included directly in a separate component of stockholders' equity, net of income taxes and certain adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements. Fair values, as reported herein, of fixed maturity and equity securities are based on quoted market prices in active markets when available, or for those fixed maturity securities not actively traded, yield data and other factors relating to instruments or securities with similar characteristics are used. See Note 2 for more information on the determination of fair value. Premiums and discounts are amortized/accrued using methods which result in a constant yield over the securities' expected lives. Amortization/accrual of premiums and discounts on residential and commercial mortgage backed securities incorporate prepayment assumptions to estimate the securities' expected lives. Interest income is recognized as earned.

Fixed maturity securities that we have the positive intent and ability to hold to maturity are classified as held for investment. Such securities may, at times, be called prior to maturity. Held for investment securities are reported at cost adjusted for amortization of premiums and discounts. Changes in the fair value of these securities, except for declines that are other than temporary, are not reflected in our consolidated financial statements.

The carrying amounts of our impaired investments in fixed maturity and equity securities are adjusted for declines in value that are other than temporary. Other than temporary impairment losses are reported as a component of revenues in the consolidated statements of operations, which presents the amount of noncredit impairment losses for certain fixed maturity securities that is reported in accumulated other comprehensive income (loss). See Note 3 for further discussion of other than temporary impairment losses.

Deterioration in credit quality of the companies or assets backing our investment securities, deterioration in the condition of the financial services industry, imbalances in liquidity recurring in the marketplace or declines in real estate values may further affect the fair value of these investment securities and increase the potential that certain unrealized losses will be recognized as other than temporary impairments in the future.

Mortgage loans on real estate are reported at cost, adjusted for amortization of premiums and accrual of discounts. Interest income is recorded when earned; however, interest ceases to accrue for loans on which interest is more than 90 days past due based upon contractual terms and/or when the collection of interest is not considered probable. We evaluate the mortgage loan portfolio for the establishment of a loan loss allowance by specific identification of impaired loans and the measurement of an estimated loss, if any, for each impaired loan identified and an analysis of the mortgage loan portfolio for the need of a general loan allowance for probable losses on all loans. If we determine that the value of any specific mortgage loan is impaired, the carrying amount of the mortgage loan will be reduced to its fair value, based upon the present value of expected future cash flows from the loan discounted at the loan's contractual interest rate, or the fair value of the underlying collateral, less costs to sell. The amount of the general loan allowance, if any, is based upon our evaluation of the probability of collection, historical loss experience, delinquencies, credit concentrations, underwriting standards and national and local economic conditions. The carrying value of impaired loans is reduced by the establishment of an allowance for loan losses, changes to which are recognized as realized gains or losses on investments. Interest income on impaired loans is recorded on a cash basis.

Other invested assets include company owned life insurance, equity securities, real estate, limited partnerships accounted for using the equity method and policy loans. Company owned life insurance is recorded at the amount that can be realized under the insurance contract at the end of the reporting period, which is the cash surrender value adjusted for other charges or other amounts due that are probable at settlement. Equity securities are classified as available for sale and are reported at fair value. Unrealized gains and losses are included directly in a separate component of stockholders' equity, net of income taxes and certain adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements. Dividends are recognized when declared. Policy loans are stated at current unpaid principal balances.

Real estate owned is reported at cost less accumulated depreciation. Cost is determined at the time ownership is acquired in satisfaction of mortgage loans and is the lower of the carrying value of the mortgage loan or fair value of the real estate less its estimated cost to sell. Buildings and improvements are depreciated using the straight-line method over their estimated useful lives. Impairment losses on real estate owned are recognized when there are indicators of impairment present and the expected future undiscounted cash flows are not sufficient to recover the real estate's carrying value. Any impairment losses are reported as realized losses and are part of net income.

Derivative Instruments

Our derivative instruments include call options used to fund fixed index annuity credits, interest rate swap and caps used to manage interest rate risk associated with the floating rate component on certain of our subordinated debentures, call options to hedge the conversion spread on our convertible senior notes (see Note 9) and certain other derivative instruments embedded in other contracts. All of our derivative instruments are recognized in the balance sheet at fair value and changes in fair value are recognized immediately in operations. See Note 5 for more information on derivative instruments.

Cash and Cash Equivalents

We consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

We also consider reverse repurchase agreements, which typically have an initial maturity of 6 weeks or less, to be cash equivalents. Amounts advanced under these agreements represent short-term loans that carry a fixed rate of interest. Borrowers under these agreements are required to post collateral that is investment grade debt securities with fair value in excess of the amount advanced.

Book Overdrafts

Under our cash management system, checks issued but not yet presented to banks frequently result in overdraft balances for accounting purposes and are classified as Other liabilities on our consolidated balance sheets. We report the changes in the amount of the overdraft balance as a financing activity in our consolidated statement of cash flows as Change in checks in excess of cash balance.

Deferred Policy Acquisition Costs and Deferred Sales Inducements

To the extent recoverable from future policy revenues and gross profits, certain costs that are incremental or directly related to the successful production of new business are not expensed when incurred but instead are capitalized as deferred policy acquisition costs or deferred sales inducements. Deferred policy acquisition costs and deferred sales inducements are subject to loss recognition testing on a quarterly basis or when an event occurs that may warrant loss recognition. Deferred policy acquisition costs consist primarily of commissions and certain costs of policy issuance. Deferred sales inducements consist of premium and interest bonuses credited to policyholder account balances.

For annuity products, these capitalized costs are being amortized generally in proportion to expected gross profits from investment spreads, including the cost of hedging the fixed indexed annuity obligations, and, to a lesser extent, from product charges net of expected excess payments for lifetime income benefit riders, and mortality and expense margins. Current and future period gross profits/margins for fixed index annuities also include the impact of amounts recorded for the change in fair value of derivatives and the change in fair value of embedded derivatives. That amortization is adjusted retrospectively through an unlocking process when estimates of current or future gross profits/margins (including the impact of net realized gains on investments and net OTTI losses recognized in operations) to be realized from a group of products are revised. Deferred policy acquisition costs and deferred sales inducements are also adjusted for the change in amortization that would have occurred if available for sale fixed maturity securities and equity securities had been sold at their aggregate fair value at the end of the reporting period and the proceeds reinvested at current yields. The impact of this adjustment is included in accumulated other comprehensive income within consolidated stockholders' equity, net of applicable taxes. See Note 6 for more information on deferred policy acquisition costs and deferred sales inducements.

Policy Benefit Reserves

Policy benefit reserves for fixed index annuities with returns linked to the performance of a specified market index are equal to the sum of the fair value of the embedded derivatives and the host (or guaranteed) component of the contracts. The host value is established at inception of the contract and accreted over the policy's life at a constant rate of interest. Future policy benefit reserves for fixed index annuities earning a fixed rate of interest and other deferred annuity products are computed under a retrospective deposit method and represent policy account balances before applicable surrender charges. For the years ended December 31, 2016, 2015 and 2014, interest crediting rates for these products ranged from 1.00% to 3.30%.

The liability for lifetime income benefit riders is based on estimates of the value of benefit payments expected to be paid in excess of projected policy values recognizing the excess over the expected lives of the underlying policies based on actual and expected assessments including spreads and product charges and fees. The inputs used in the calculation of the liability for lifetime income benefit riders include actual policy values, actual income account values, actual payout factors, actual roll-up rates and our best estimate assumptions for future policy growth, future policy decrements, the ages at which policyholders are expected to elect to begin to receive lifetime income benefit payments, the percentage of policyholders who elect to receive lifetime income benefit payments and the type of income benefit payments selected upon election.

Policy benefit reserves are not reduced for amounts ceded under coinsurance agreements which are reported as coinsurance deposits on our consolidated balance sheets. See Note 7 for more information on reinsurance.

The liability for future policy benefits for traditional life insurance is based on net level premium reserves, including assumptions as to interest, mortality, and other assumptions underlying the guaranteed policy cash values. Reserve interest assumptions are level and range from 3.00% to 5.50%. Policy benefit claims are charged to expense in the period that the claims are incurred.

Deferred Income Taxes

Deferred income tax assets or liabilities are computed based on the temporary differences between the financial statement and income tax bases of assets and liabilities using the enacted marginal tax rate. Deferred income tax expenses or benefits are based on the changes in the asset or liability from period to period. Deferred income tax assets are subject to ongoing evaluation of whether such assets will more likely than not be realized. The realization of deferred income tax assets primarily depends on generating future taxable income during the periods in which temporary differences become deductible. Deferred income tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax asset will not be realized. In making such a determination, all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations, is considered. The realization of deferred income tax assets related to unrealized losses on available for sale fixed maturity securities is also based upon our intent and ability to hold those securities for a period of time sufficient to allow for a recovery in fair value and not realize the unrealized loss.

Recognition of Premium Revenues and Costs

Revenues for annuity products include surrender and living income benefit rider charges assessed against policyholder account balances during the period. Interest sensitive and index product benefits related to annuity products include interest credited or index credits to policyholder account balances pursuant to accounting by insurance companies for certain long-duration contracts. The change in fair value of the embedded derivatives for fixed index annuities equals the change in the difference between policy benefit reserves for fixed index annuities computed under the derivative accounting standard and the long-duration contracts accounting standard at each balance sheet date.

Considerations from immediate annuities with life contingencies are recognized as revenue when the policy is issued.

Traditional life insurance premiums are recognized as revenues over the premium-paying period. Certain group policies include provisions for annual experience refunds of premiums equal to net premiums received less an administrative fee and less claims incurred. Such amounts (2016 - $1.5 million; 2015 - $1.5 million; and 2014 - $1.7 million) are reported as a reduction of traditional life insurance premiums in the consolidated statements of operations. Future policy benefits are recognized as expenses over the life of the policy by means of the provision for future policy benefits.

All insurance-related revenues, including the change in the fair value of derivatives for call options related to the business ceded under coinsurance agreements (see Note 7), benefits, losses and expenses are reported net of reinsurance ceded.

Other Comprehensive Income (Loss)

Other comprehensive income (loss) includes all changes in stockholders' equity during a period except those resulting from investments by and distributions to stockholders. Other comprehensive income (loss) excludes net realized investment gains (losses) included in net income which merely represent transfers from unrealized to realized gains and losses.

Adopted Accounting Pronouncements

In April 2015, the Financial Accounting Standards Board ("FASB") issued an accounting standards update ("ASU") which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. Subsequently, in August 2015, the FASB issued an ASU that states that the Securities and Exchange Commission staff would not object to an entity deferring and presenting debt issuance costs related to line-of-credit arrangements as an asset and expensing those costs ratably over the term of the line of credit arrangement. These ASU's became effective for us on January 1, 2016, and retroactive application was required. Adoption of these ASU's did not have a material impact on our consolidated financial statements.

New Accounting Pronouncements

In January 2016, the FASB issued an ASU that, among other aspects of recognition, measurement, presentation and disclosure of financial instruments, primarily requires equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Additionally, it changes the accounting for financial liabilities measured at fair value under the fair value option and eliminates some disclosures regarding fair value of financial assets and liabilities measured at amortized cost. This ASU will be effective for us on January 1, 2018, and we have not determined the effect it will have on our consolidated financial statements.

In February 2016, the FASB issued an ASU that will require recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This ASU affects accounting and disclosure more dramatically for lessees as accounting for lessors is mainly unchanged. This ASU will be effective for us on January 1, 2019, with early adoption permitted, and we have not determined the effect it will have on our consolidated financial statements.

In March 2016, the FASB issued an ASU related to the accounting for share-based payment transactions. The aspects of accounting guidance affected by this ASU are income taxes, classification of awards as either equity or liabilities, and classification on the statement of cash flows. This ASU will be effective for us on January 1, 2017, with early adoption permitted, and we have not determined the effect it will have on our consolidated financial statements.

In June 2016, the FASB issued an ASU that significantly changes the impairment model for most financial assets that are measured at amortized cost and certain other instruments from an incurred loss model to an expected loss model that requires these assets be presented at the net amount expected to be collected. In addition, credit losses on available for sale debt securities should be recorded through an allowance account.  This ASU will be effective for us on January 1, 2020, with early adoption permitted, and we have not yet determined the impact this updated guidance will have on our consolidated financial statements.

In August 2016, the FASB issued an ASU that clarifies how certain cash receipts and cash payments are to be presented and classified in the statement of cash flows. This ASU will be effective for us on January 1, 2018, with early adoption permitted, and we have not yet determined the impact this updated guidance will have on our consolidated financial statements.

XML

Fair Values of Financial Instruments

12 Months Ended

Dec. 31, 2016

Fair Value Disclosures [Abstract]

Fair Values of Financial Instruments

Fair Values of Financial Instruments

The following sets forth a comparison of the carrying amounts and fair values of our financial instruments:

	December 31,
	2016				2015
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
	(Dollars in thousands)
Assets
Fixed maturity securities:
Available for sale	$	41,060,494	$	41,060,494	$	36,421,839	$	36,421,839
Held for investment	76,825		68,766		76,622		65,377
Mortgage loans on real estate	2,480,956		2,522,035		2,435,257		2,471,864
Derivative instruments	830,519		830,519		337,256		337,256
Other investments	308,774		300,918		292,872		297,903
Cash and cash equivalents	791,266		791,266		397,749		397,749
Coinsurance deposits	4,639,492		4,150,792		3,187,470		2,860,882
Interest rate caps	1,082		1,082		1,410		1,410
Counterparty collateral	145,693		145,693		82,312		82,312
Liabilities
Policy benefit reserves	51,280,331		43,104,183		45,151,460		38,435,515
Single premium immediate annuity (SPIA) benefit reserves	297,724		308,028		324,264		336,066
Notes and loan payable	493,755		519,440		393,227		417,752
Subordinated debentures	241,853		225,106		241,452		216,933
Interest rate swap	2,113		2,113		3,139		3,139

Fair value is the price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The objective of a fair value measurement is to determine that price for each financial instrument at each measurement date. We meet this objective using various methods of valuation that include market, income and cost approaches.

We categorize our financial instruments into three levels of fair value hierarchy based on the priority of inputs used in determining fair value. The hierarchy defines the highest priority inputs (Level 1) as quoted prices in active markets for identical assets or liabilities. The lowest priority inputs (Level 3) are our own assumptions about what a market participant would use in determining fair value such as estimated future cash flows. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, a financial instrument's level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. We categorize financial assets and liabilities recorded at fair value in the consolidated balance sheets as follows:

Level 1— Quoted prices are available in active markets for identical financial instruments as of the reporting date. We do not adjust the quoted price for these financial instruments, even in situations where we hold a large position and a sale could reasonably impact the quoted price.

Level 2— Quoted prices in active markets for similar financial instruments, quoted prices for identical or similar financial instruments in markets that are not active; and models and other valuation methodologies using inputs other than quoted prices that are observable.

Level 3— Models and other valuation methodologies using significant inputs that are unobservable for financial instruments and include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in Level 3 are securities for which no market activity or data exists and for which we used discounted expected future cash flows with our own assumptions about what a market participant would use in determining fair value.

Transfers of securities among the levels occur at times and depend on the type of inputs used to determine fair value of each security. There were no transfers between levels during any period presented.

Our assets and liabilities which are measured at fair value on a recurring basis as of December 31, 2016 and 2015 are presented below based on the fair value hierarchy levels:

	Total Fair Value		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(Dollars in thousands)
December 31, 2016
Assets
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	11,805	$	5,381	$	6,424	$	—
United States Government sponsored agencies	1,344,787		—		1,344,787		—
United States municipalities, states and territories	3,926,950		—		3,926,950		—
Foreign government obligations	232,233		—		232,233		—
Corporate securities	27,118,526		6		27,118,520		—
Residential mortgage backed securities	1,254,835		—		1,254,835		—
Commercial mortgage backed securities	5,365,235		—		5,365,235		—
Other asset backed securities	1,806,123		—		1,806,123		—
Other investments: equity securities, available for sale	8,000		—		8,000		—
Derivative instruments	830,519		—		830,519		—
Cash and cash equivalents	791,266		791,266		—		—
Interest rate caps	1,082		—		1,082		—
Counterparty collateral	145,693		—		145,693		—
	$	42,837,054	$	796,653	$	42,040,401	$	—
Liabilities
Interest rate swap	$	2,113	$	—	$	2,113	$	—
Fixed index annuities—embedded derivatives	6,563,288		—		—		6,563,288
	$	6,565,401	$	—	$	2,113	$	6,563,288
December 31, 2015
Assets
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	471,256	$	438,598	$	32,658	$	—
United States Government sponsored agencies	1,398,611		—		1,398,611		—
United States municipalities, states and territories	3,755,367		—		3,755,367		—
Foreign government obligations	212,565		—		212,565		—
Corporate securities	23,802,394		121		23,802,273		—
Residential mortgage backed securities	1,462,072		—		1,462,072		—
Commercial mortgage backed securities	4,174,396		—		4,174,396		—
Other asset backed securities	1,145,178		—		1,145,178		—
Other investments: equity securities, available for sale	7,828		—		7,828		—
Derivative instruments	337,256		—		337,256		—
Cash and cash equivalents	397,749		397,749		—		—
Interest rate caps	1,410		—		1,410		—
Counterparty collateral	82,312		—		82,312		—
	$	37,248,394	$	836,468	$	36,411,926	$	—
Liabilities
Interest rate swap	$	3,139	$	—	$	3,139	$	—
Fixed index annuities—embedded derivatives	5,983,622		—		—		5,983,622
	$	5,986,761	$	—	$	3,139	$	5,983,622

The following methods and assumptions were used in estimating the fair values of financial instruments during the periods presented in these consolidated financial statements.

Fixed maturity securities and equity securities

The fair values of fixed maturity securities and equity securities in an active and orderly market are determined by utilizing independent pricing services. The independent pricing services incorporate a variety of observable market data in their valuation techniques, including:

• reported trading prices,

• benchmark yields,

• broker-dealer quotes,

• benchmark securities,

• bids and offers,

• credit ratings,

• relative credit information, and

• other reference data.

The independent pricing services also take into account perceived market movements and sector news, as well as a security's terms and conditions, including any features specific to that issue that may influence risk and marketability. Depending on the security, the priority of the use of observable market inputs may change as some observable market inputs may not be relevant or additional inputs may be necessary.

The independent pricing services provide quoted market prices when available. Quoted prices are not always available due to market inactivity. When quoted market prices are not available, the third parties use yield data and other factors relating to instruments or securities with similar characteristics to determine fair value for securities that are not actively traded. We generally obtain one value from our primary external pricing service. In situations where a price is not available from this service, we may obtain further quotes or prices from additional parties as needed. In addition, for our callable United States Government sponsored agencies we obtain multiple broker quotes and take the average of the broker prices received. Market indices of similar rated asset class spreads are considered for valuations and broker indications of similar securities are compared. Inputs used by the broker include market information, such as yield data and other factors relating to instruments or securities with similar characteristics. Valuations and quotes obtained from third party commercial pricing services are non-binding and do not represent quotes on which one may execute the disposition of the assets.

We validate external valuations at least quarterly through a combination of procedures that include the evaluation of methodologies used by the pricing services, analytical reviews and performance analysis of the prices against trends, and maintenance of a securities watch list. Additionally, as needed we utilize discounted cash flow models or perform independent valuations on a case-by-case basis using inputs and assumptions similar to those used by the pricing services. Although we do identify differences from time to time as a result of these validation procedures, we did not make any significant adjustments as of December 31, 2016 and 2015.

Mortgage loans on real estate

Mortgage loans on real estate are not measured at fair value on a recurring basis. The fair values of mortgage loans on real estate are calculated using discounted expected cash flows using current competitive market interest rates currently being offered for similar loans. The fair values of impaired mortgage loans on real estate that we have considered to be collateral dependent are based on the fair value of the real estate collateral (based on appraised values) less estimated costs to sell. The inputs utilized to determine fair value of all mortgage loans are unobservable market data (competitive market interest rates); therefore, fair value of mortgage loans falls into Level 3 in the fair value hierarchy.

Derivative instruments

The fair values of derivative instruments, primarily call options, are based upon the amount of cash that we will receive to settle each derivative instrument on the reporting date. These amounts are determined by our investment team using industry accepted valuation models and are adjusted for the nonperformance risk of each counterparty net of any collateral held. Inputs include market volatility and risk free interest rates and are used in income valuation techniques in arriving at a fair value for each option contract. The nonperformance risk for each counterparty is based upon its credit default swap rate. We have no performance obligations related to the call options purchased to fund our fixed index annuity policy liabilities.

Other investments

Available for sale equity securities are the only financial instruments included in other investments that are measured at fair value on a recurring basis (see determination of fair value above). Financial instruments included in other investments that are not measured at fair value on a recurring bases are policy loans, equity method investments and company owned life insurance (COLI). We have not attempted to determine the fair values associated with our policy loans, as we believe any differences between carrying value and the fair values afforded these instruments are immaterial to our consolidated financial position and, accordingly, the cost to provide such disclosure does not justify the benefit to be derived. The fair value of our equity method investments qualify as Level 3 fair values and were determined by calculating the present value of future cash flows discounted by a risk free rate, a risk spread and a liquidity discount. The risk spread and liquidity discount are rates determined by our investment professionals and are unobservable market inputs. The fair value of our COLI approximates the cash surrender value of the policies and whose fair values fall within Level 2 of the fair value hierarchy.

Cash and cash equivalents

Amounts reported in the consolidated balance sheets for these instruments are reported at their historical cost which approximates fair value due to the nature of the assets assigned to this category.

Interest rate swap and caps

The fair values of our pay fixed/receive variable interest rate swap and interest rate caps are obtained from third parties and are determined by discounting expected future cash flows using projected LIBOR rates for the term of the swap and caps.

Counterparty collateral

Amounts reported in other assets of the consolidated balance sheets for these instruments are reported at their historical cost which approximates fair value due to the nature of the assets assigned to this category.

Policy benefit reserves, coinsurance deposits and SPIA benefit reserves

The fair values of the liabilities under contracts not involving significant mortality or morbidity risks (principally deferred annuities), are stated at the cost we would incur to extinguish the liability (i.e., the cash surrender value) as these contracts are generally issued without an annuitization date. The coinsurance deposits related to the annuity benefit reserves have fair values determined in a similar fashion. For period-certain annuity benefit contracts, the fair value is determined by discounting the benefits at the interest rates currently in effect for newly issued immediate annuity contracts. We are not required to and have not estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value. Policy benefit reserves, coinsurance deposits and SPIA benefit reserves are not measured at fair value on a recurring basis. All of the fair values presented within these categories fall within Level 3 of the fair value hierarchy as most of the inputs are unobservable market data.

Notes and loan payable

The fair values of our senior unsecured notes are based upon pricing matrices developed by a third party pricing service when quoted market prices are not available and are categorized as Level 2 within the fair value hierarchy. The fair value of our term loan is estimated using discounted cash flow calculations based principally on observable inputs including our incremental borrowing rate, which reflects our credit rating, for a similar type of borrowing with a maturity consistent with that remaining for the term loan. Notes and loan payable are not remeasured at fair value on a recurring basis.

Subordinated debentures

Fair values for subordinated debentures are estimated using discounted cash flow calculations based principally on observable inputs including our incremental borrowing rates, which reflect our credit rating, for similar types of borrowings with maturities consistent with those remaining for the debt being valued. These fair values are categorized as Level 2 within the fair value hierarchy. Subordinated debentures are not measured at fair value on a recurring basis.

Fixed index annuities - embedded derivatives

We estimate the fair value of the embedded derivative component of our fixed index annuity policy benefit reserves at each valuation date by (i) projecting policy contract values and minimum guaranteed contract values over the expected lives of the contracts and (ii) discounting the excess of the projected contract value amounts at the applicable risk free interest rates adjusted for our nonperformance risk related to those liabilities. The projections of policy contract values are based on our best estimate assumptions for future policy growth and future policy decrements. Our best estimate assumptions for future policy growth include assumptions for the expected index credit on the next policy anniversary date which are derived from the fair values of the underlying call options purchased to fund such index credits and the expected costs of annual call options we will purchase in the future to fund index credits beyond the next policy anniversary. The projections of minimum guaranteed contract values include the same best estimate assumptions for policy decrements as were used to project policy contract values.

Within this determination we have the following significant unobservable inputs: 1) the expected cost of annual call options we will purchase in the future to fund index credits beyond the next policy anniversary and 2) our best estimates for future policy decrements, primarily lapse, partial withdrawal and mortality rates. As of December 31, 2016 and 2015, we utilized an estimate of 3.10% for the expected cost of annual call options, which are based on estimated account value growth and a historical review of our actual option costs.

Our best estimate assumptions for lapse, partial withdrawal and mortality rates are based on our actual experience and our outlook as to future expectations for such assumptions. These assumptions, which are consistent with the assumptions used in calculating deferred policy acquisition costs and deferred sales inducements, are reviewed on a quarterly basis and are revised as our experience develops and/or as future expectations change. Our mortality rate assumptions are based on 65% of the 1983 Basic Annuity Mortality Tables. The following table presents average lapse rate and partial withdrawal rate assumptions, by contract duration, used in estimating the fair value of the embedded derivative component of our fixed index annuity policy benefit reserves at each reporting date:

	Average Lapse Rates		Average Partial Withdrawal Rates
Contract Duration (Years)	December 31, 2016	December 31, 2015	December 31, 2016	December 31, 2015
1 - 5	1.76%	1.58%	3.30%	3.08%
6 - 10	6.58%	8.55%	3.30%	3.55%
11 - 15	11.25%	12.01%	3.32%	3.59%
16 - 20	12.04%	12.99%	3.18%	3.22%
20+	11.68%	12.54%	3.18%	3.22%

Lapse rates are generally expected to increase as surrender charge percentages decrease. Lapse expectations reflect a significant increase in the year in which the surrender charge period on a contract ends.

The following table provides a reconciliation of the beginning and ending balances for our Level 3 liabilities, which are measured at fair value on a recurring basis using significant unobservable inputs for the years ended December 31, 2016 and 2015:

	Year Ended December 31,
	2016		2015
	(Dollars in thousands)
Fixed index annuities—embedded derivatives
Beginning balance	$	5,983,622	$	5,574,653
Premiums less benefits	434,621		1,234,637
Change in fair value, net	145,045		(825,668		)
Ending balance	$	6,563,288	$	5,983,622

Change in fair value, net for each period in our embedded derivatives are included in change in fair value of embedded derivatives in the consolidated statements of operations.

Certain derivatives embedded in our fixed index annuity contracts are our most significant financial instrument measured at fair value that are categorized as Level 3 in the fair value hierarchy. The contractual obligations for future annual index credits within our fixed index annuity contracts are treated as a "series of embedded derivatives" over the expected life of the applicable contracts. We estimate the fair value of these embedded derivatives at each valuation date by the method described above under fixed index annuities - embedded derivatives. The projections of minimum guaranteed contract values include the same best estimate assumptions for policy decrements as were used to project policy contract values.

The most sensitive assumption in determining policy liabilities for fixed index annuities is the rates used to discount the excess projected contract values. As indicated above, the discount rate reflects our nonperformance risk. If the discount rates used to discount the excess projected contract values at December 31, 2016, were to increase by 100 basis points, the fair value of the embedded derivatives would decrease by $451.4 million recorded through operations as a decrease in the change in fair value of embedded derivatives and there would be a corresponding decrease of $276.4 million to our combined balance for deferred policy acquisition costs and deferred sales inducements recorded through operations as an increase in amortization of deferred policy acquisition costs and deferred sales inducements. A decrease by 100 basis points in the discount rate used to discount the excess projected contract values would increase the fair value of the embedded derivatives by $504.5 million recorded through operations as an increase in the change in fair value of embedded derivatives and there would be a corresponding increase of $299.5 million to our combined balance for deferred policy acquisition costs and deferred sales inducements recorded through operations as a decrease in amortization of deferred policy acquisition costs and deferred sales inducements.

XML

Investments

12 Months Ended

Dec. 31, 2016

Investments [Abstract]

Investments

Investments

At December 31, 2016 and 2015, the amortized cost and fair value of fixed maturity securities were as follows:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
	(Dollars in thousands)
December 31, 2016
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	11,864	$	229	$	(288	)	$	11,805
United States Government sponsored agencies	1,368,340		23,360		(46,913		)	1,344,787
United States municipalities, states and territories	3,626,395		322,948		(22,393		)	3,926,950
Foreign government obligations	224,588		12,725		(5,080		)	232,233
Corporate securities	26,338,214		1,149,085		(368,773		)	27,118,526
Residential mortgage backed securities	1,166,944		91,445		(3,554		)	1,254,835
Commercial mortgage backed securities	5,422,255		59,994		(117,014		)	5,365,235
Other asset backed securities	1,795,355		31,471		(20,703		)	1,806,123
	$	39,953,955	$	1,691,257	$	(584,718	)	$	41,060,494
Held for investment:
Corporate security	$	76,825	$	—	$	(8,059	)	$	68,766
Other investments - equity securities, available for sale:
Finance, insurance and real estate	$	7,521	$	479	$	—		$	8,000
December 31, 2015
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	470,567	$	988	$	(299	)	$	471,256
United States Government sponsored agencies	1,386,219		26,801		(14,409		)	1,398,611
United States municipalities, states and territories	3,422,667		341,328		(8,628		)	3,755,367
Foreign government obligations	210,953		12,547		(10,935		)	212,565
Corporate securities	23,597,530		887,288		(682,424		)	23,802,394
Residential mortgage backed securities	1,366,985		98,576		(3,489		)	1,462,072
Commercial mortgage backed securities	4,238,265		41,412		(105,281		)	4,174,396
Other asset backed securities	1,130,524		34,534		(19,880		)	1,145,178
	$	35,823,710	$	1,443,474	$	(845,345	)	$	36,421,839
Held for investment:
Corporate security	$	76,622	$	—	$	(11,245	)	$	65,377
Other investments - equity securities, available for sale:
Finance, insurance and real estate	$	7,515	$	313	$	—		$	7,828

At December 31, 2016, 35% of our fixed income securities have call features, of which 0.1% ($55.7 million) were subject to call redemption and another 3.1% ($1.3 billion) will become subject to call redemption during 2017. Approximately 70% of our fixed income securities that have call features are not callable until within six months of their stated maturities.

The amortized cost and fair value of fixed maturity securities at December 31, 2016, by contractual maturity are shown below. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. All of our mortgage and other asset backed securities provide for periodic payments throughout their lives and are shown below as separate lines.

	Available for sale				Held for investment
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
	(Dollars in thousands)
Due in one year or less	$	236,707	$	241,934	$	—	$	—
Due after one year through five years	2,824,776		2,979,768		—		—
Due after five years through ten years	11,659,762		11,738,156		—		—
Due after ten years through twenty years	8,792,470		9,284,726		—		—
Due after twenty years	8,055,686		8,389,717		76,825		68,766
	31,569,401		32,634,301		76,825		68,766
Residential mortgage backed securities	1,166,944		1,254,835		—		—
Commercial mortgage backed securities	5,422,255		5,365,235		—		—
Other asset backed securities	1,795,355		1,806,123		—		—
	$	39,953,955	$	41,060,494	$	76,825	$	68,766

Net unrealized gains on available for sale fixed maturity securities and equity securities reported as a separate component of stockholders' equity were comprised of the following:

	December 31,
	2016			2015
	(Dollars in thousands)
Net unrealized gains on available for sale fixed maturity securities and equity securities	$	1,107,018		$	598,442
Adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements	(618,661		)	(322,859		)
Deferred income tax valuation allowance reversal	22,534			22,534
Deferred income tax expense	(170,925		)	(96,454		)
Net unrealized gains reported as accumulated other comprehensive income	$	339,966		$	201,663

The National Association of Insurance Commissioners ("NAIC") assigns designations to fixed maturity securities. These designations range from Class 1 (highest quality) to Class 6 (lowest quality). In general, securities are assigned a designation based upon the ratings they are given by the Nationally Recognized Statistical Rating Organizations ("NRSRO's"). The NAIC designations are utilized by insurers in preparing their annual statutory statements. NAIC Class 1 and 2 designations are considered "investment grade" while NAIC Class 3 through 6 designations are considered "non-investment grade." Based on the NAIC designations, we had 97% and 98% of our fixed maturity portfolio rated investment grade at December 31, 2016 and 2015, respectively.

The following table summarizes the credit quality, as determined by NAIC designation, of our fixed maturity portfolio as of the dates indicated:

	December 31,
	2016				2015
NAIC Designation	Amortized Cost		Fair Value		Amortized Cost		Fair Value
	(Dollars in thousands)
1	$	25,607,268	$	26,507,798	$	23,363,259	$	24,207,801
2	13,037,592		13,295,648		11,709,730		11,589,325
3	1,201,059		1,155,702		758,531		643,293
4	154,226		137,188		60,480		44,312
5	17,475		24,664		—		—
6	13,160		8,260		8,332		2,485
	$	40,030,780	$	41,129,260	$	35,900,332	$	36,487,216

The following table shows our investments' gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities (consisting of 1,514and 1,246 securities, respectively) have been in a continuous unrealized loss position, at December 31, 2016 and 2015:

	Less than 12 months					12 months or more					Total
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
	(Dollars in thousands)
December 31, 2016
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	7,405	$	(288	)	$	—	$	—		$	7,405	$	(288	)
United States Government sponsored agencies	995,548		(46,913		)	—		—			995,548		(46,913		)
United States municipalities, states and territories	463,409		(22,393		)	—		—			463,409		(22,393		)
Foreign government obligations	29,158		(913		)	20,388		(4,167		)	49,546		(5,080		)
Corporate securities:
Finance, insurance and real estate	2,302,103		(79,077		)	110,730		(9,834		)	2,412,833		(88,911		)
Manufacturing, construction and mining	2,556,147		(74,144		)	702,978		(74,382		)	3,259,125		(148,526		)
Utilities and related sectors	1,605,742		(53,055		)	196,085		(16,208		)	1,801,827		(69,263		)
Wholesale/retail trade	396,310		(9,433		)	57,708		(5,739		)	454,018		(15,172		)
Services, media and other	857,515		(35,107		)	132,170		(11,794		)	989,685		(46,901		)
Residential mortgage backed securities	81,762		(3,463		)	1,853		(91		)	83,615		(3,554		)
Commercial mortgage backed securities	3,148,395		(116,938		)	895		(76		)	3,149,290		(117,014		)
Other asset backed securities	751,533		(12,289		)	146,167		(8,414		)	897,700		(20,703		)
	$	13,195,027	$	(454,013	)	$	1,368,974	$	(130,705	)	$	14,564,001	$	(584,718	)
Held for investment:
Corporate security:
Insurance	$	—	$	—		$	68,766	$	(8,059	)	$	68,766	$	(8,059	)
December 31, 2015
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	37,730	$	(299	)	$	—	$	—		$	37,730	$	(299	)
United States Government sponsored agencies	957,053		(14,409		)	—		—			957,053		(14,409		)
United States municipalities, states and territories	261,823		(8,474		)	2,846		(154		)	264,669		(8,628		)
Foreign government obligations	42,966		(1,762		)	15,463		(9,173		)	58,429		(10,935		)
Corporate securities:
Finance, insurance and real estate	2,077,223		(59,607		)	49,912		(14,855		)	2,127,135		(74,462		)
Manufacturing, construction and mining	3,517,967		(246,456		)	376,229		(131,003		)	3,894,196		(377,459		)
Utilities and related sectors	2,240,652		(138,940		)	97,184		(22,565		)	2,337,836		(161,505		)
Wholesale/retail trade	473,050		(17,863		)	38,682		(8,125		)	511,732		(25,988		)
Services, media and other	1,037,011		(39,937		)	32,050		(3,073		)	1,069,061		(43,010		)
Residential mortgage backed securities	162,770		(2,958		)	6,438		(531		)	169,208		(3,489		)
Commercial mortgage backed securities	2,679,510		(105,002		)	11,495		(279		)	2,691,005		(105,281		)
Other asset backed securities	457,055		(10,581		)	46,657		(9,299		)	503,712		(19,880		)
	$	13,944,810	$	(646,288	)	$	676,956	$	(199,057	)	$	14,621,766	$	(845,345	)
Held for investment:
Corporate security:
Insurance	$	65,377	$	(11,245	)	$	—	$	—		$	65,377	$	(11,245	)

Based on the results of our process for evaluating available for sale securities in unrealized loss positions for other-than-temporary-impairments, which is discussed in detail later in this footnote, we have determined that the unrealized losses on the securities in the preceding table are temporary. The unrealized losses at December 31, 2016 are principally related to timing of the purchases of these securities, which carry less yield than those available at December 31, 2016.

The commodity related sectors had most of the gross unrealized losses in our corporate fixed income securities portfolio as of December 31, 2016. Commodity prices, specifically oil, gas and base metals,declined significantly in late 2015, but prices have risen in 2016 to levels that appear sustainable and should support prices and NRSRO ratings longer term. The value of oil has been significantly depressed as the amount of supply from new production has exceeded demand. In addition, iron ore and other key industrial metals have depressed prices as investors perceive the economic slowdown in Asia Pacific will curb demand as supply remains high. The companies in the metal and mining sectors experienced the largest decline in values of their debt in late 2015. In the above table, oil and metals and mining exposure is reflected within the foreign government; manufacturing, construction and mining; and utilities and related sectors. Within these sectors, we continue to monitor the impact to our investment portfolio for those companies that may be adversely affected, both directly and indirectly. Even though the energy holdings and a majority of the metals and mining holdings have seen significant improvements in values as oil and iron ore prices have increased, they could continue to see price volatility and possible downgrades in credit ratings. If oil and commodity prices fall lower and remain at depressed levels for an extended period of time or decline further, certain issuers and investments may come under further stress. At this time, we believe the unrealized losses are temporary due to the fact that the price decline is driven by an over-supply of oil in the energy sector, which we feel is unsustainable long term. Our exposure is in companies that we believe have more financial flexibility and significant operational scale to manage through the downturn. In addition, price declines in the metal and mining sector have been heavily influenced by excess production and softer demand. Companies in the mining sector are more susceptible to rating downgrades and we believe companies will be under continued financial strain at the current commodity price structure. We believe company issuers in our portfolio will be able to meet their debt service obligations.

Approximately 86% and 84% of the unrealized losses on fixed maturity securities shown in the above table for December 31, 2016 and 2015, respectively, are on securities that are rated investment grade, defined as being the highest two NAIC designations. All of the fixed maturity securities with unrealized losses are current with respect to the payment of principal and interest.

Changes in net unrealized gains on investments for the years ended December 31, 2016, 2015 and 2014 are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Fixed maturity securities held for investment carried at amortized cost	$	3,186		$	(10,651	)	$	14,821
Investments carried at fair value:
Fixed maturity securities, available for sale	$	508,410		$	(1,642,027	)	$	2,157,439
Equity securities, available for sale	166			17			21
	508,576			(1,642,010		)	2,157,460
Adjustment for effect on other balance sheet accounts:
Deferred policy acquisition costs and deferred sales inducements	(295,802		)	842,412			(1,118,683		)
Deferred income tax asset/liability	(74,471		)	279,860			(363,572		)
	(370,273		)	1,122,272			(1,482,255		)
Change in net unrealized gains on investments carried at fair value	$	138,303		$	(519,738	)	$	675,205

Components of net investment income are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Fixed maturity securities	$	1,729,176		$	1,566,409		$	1,394,301
Equity securities	531			441			404
Mortgage loans on real estate	122,985			131,892			143,998
Cash and cash equivalents	3,201			601			286
Other	5,499			4,858			6,903
	1,861,392			1,704,201			1,545,892
Less investment expenses	(11,520		)	(12,009		)	(14,225		)
Net investment income	$	1,849,872		$	1,692,192		$	1,531,667

Proceeds from sales of available for sale securities for the years ended December 31, 2016, 2015 and 2014 were $1.0 billion, $0.4 billion and $0.2 billion, respectively. Scheduled principal repayments, calls and tenders for available for sale fixed maturity securities for the years ended December 31, 2016, 2015 and 2014 were $1.7 billion, $1.2 billion and $1.3 billion, respectively.

Realized gains and losses on sales are determined on the basis of specific identification of investments based on the trade date. Net realized gains (losses) on investments, excluding net OTTI losses are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Available for sale fixed maturity securities:
Gross realized gains	$	14,132		$	7,230		$	3,273
Gross realized losses	(4,036		)	(5,787		)	(1,006		)
	10,096			1,443			2,267
Other investments:
Gain on sale of real estate	884			4,194			2,454
Loss on sale of real estate	(93		)	(575		)	(231		)
Impairment losses on real estate	—			(1,297		)	(2,441		)
	791			2,322			(218		)
Mortgage loans on real estate:
Decrease (increase) in allowance for credit losses	(4,846		)	1,018			(6,052		)
Recovery of specific allowance	5,483			5,428			—
	637			6,446			(6,052		)
	$	11,524		$	10,211		$	(4,003	)

Losses on available for sale fixed maturity securities in 2016, 2015 and 2014 were realized primarily due to strategies to reposition the fixed maturity security portfolio that result in improved net investment income, credit risk or duration profiles as they pertain to our asset liability management. Securities were sold at losses in 2016 and 2015 due to our long-term fundamental concern with the issuers' ability to meet their future financial obligations.

The following table summarizes the carrying value of our fixed maturity securities, mortgage loans on real estate and real estate owned that have been non-income producing for 12 consecutive months:

	December 31,
	2016		2015
	(Dollars in thousands)
Fixed maturity securities, available for sale	$	1,651	$	10
Real estate owned	—		1,800
	$	1,651	$	1,810

We review and analyze all investments on an ongoing basis for changes in market interest rates and credit deterioration. This review process includes analyzing our ability to recover the amortized cost basis of each investment that has a fair value that is materially lower than its amortized cost and requires a high degree of management judgment and involves uncertainty. The evaluation of securities for other than temporary impairments is a quantitative and qualitative process, which is subject to risks and uncertainties.

We have a policy and process to identify securities that could potentially have impairments that are other than temporary. This process involves monitoring market events and other items that could impact issuers. The evaluation includes but is not limited to such factors as:

• the length of time and the extent to which the fair value has been less than amortized cost or cost;

• whether the issuer is current on all payments and all contractual payments have been made as agreed;

• the remaining payment terms and the financial condition and near-term prospects of the issuer;

• the lack of ability to refinance due to liquidity problems in the credit market;

• the fair value of any underlying collateral;

• the existence of any credit protection available;

• our intent to sell and whether it is more likely than not we would be required to sell prior to recovery for debt securities;

• our assessment in the case of equity securities including perpetual preferred stocks with credit deterioration that the security cannot recover to cost in a reasonable period of time;

• our intent and ability to retain equity securities for a period of time sufficient to allow for recovery;

• consideration of rating agency actions; and

• changes in estimated cash flows of mortgage and asset backed securities.

We determine whether other than temporary impairment losses should be recognized for debt and equity securities by assessing all facts and circumstances surrounding each security. Where the decline in fair value of debt securities is attributable to changes in market interest rates or to factors such as market volatility, liquidity and spread widening, and we anticipate recovery of all contractual or expected cash flows, we do not consider these investments to be other than temporarily impaired because we do not intend to sell these investments and it is not more likely than not we will be required to sell these investments before a recovery of amortized cost, which may be maturity. For equity securities, we recognize an impairment charge in the period in which we do not have the intent and ability to hold the securities until recovery of cost or we determine that the security will not recover to book value within a reasonable period of time. We determine what constitutes a reasonable period of time on a security-by-security basis by considering all the evidence available to us, including the magnitude of any unrealized loss and its duration.

Other than temporary impairment losses on equity securities are recognized in operations. If we intend to sell a debt security or if it is more likely than not that we will be required to sell a debt security before recovery of its amortized cost basis, other than temporary impairment has occurred and the difference between amortized cost and fair value will be recognized as a loss in operations.

If we do not intend to sell and it is not more likely than not we will be required to sell the debt security but also do not expect to recover the entire amortized cost basis of the security, an impairment loss would be recognized in operations in the amount of the expected credit loss. We determine the amount of expected credit loss by calculating the present value of the cash flows expected to be collected discounted at each security's acquisition yield based on our consideration of whether the security was of high credit quality at the time of acquisition. The difference between the present value of expected future cash flows and the amortized cost basis of the security is the amount of credit loss recognized in operations. The remaining amount of the other than temporary impairment is recognized in other comprehensive income (loss).

The determination of the credit loss component of a mortgage backed security is based on a number of factors. The primary consideration in this evaluation process is the issuer's ability to meet current and future interest and principal payments as contractually stated at time of purchase. Our review of these securities includes an analysis of the cash flow modeling under various default scenarios considering independent third party benchmarks, the seniority of the specific tranche within the structure of the security, the composition of the collateral and the actual default, loss severity and prepayment experience exhibited. With the input of third party assumptions for default projections, loss severity and prepayment expectations, we evaluate the cash flow projections to determine whether the security is performing in accordance with its contractual obligation.

We utilize the models from a leading structured product software specialist serving institutional investors. These models incorporate each security's seniority and cash flow structure. In circumstances where the analysis implies a potential for principal loss at some point in the future, we use the "best estimate" cash flow projection discounted at the security's effective yield at acquisition to determine the amount of our potential credit loss associated with this security. The discounted expected future cash flows equates to our expected recovery value. Any shortfall of the expected recovery when compared to the amortized cost of the security will be recorded as the credit loss component of the other than temporary impairment.

The cash flow modeling is performed on a security-by-security basis and incorporates actual cash flows on the residential mortgage backed securities through the current period, as well as the projection of remaining cash flows using a number of assumptions including default rates, prepayment rates and loss severity rates. The default curves we use are tailored to the Prime or Alt-A residential mortgage backed securities that we own, which assume lower default rates and loss severity for Prime securities versus Alt-A securities. These default curves are scaled higher or lower depending on factors such as current underlying mortgage loan performance, rating agency loss projections, loan to value ratios, geographic diversity, as well as other appropriate considerations.

The following table presents the range of significant assumptions used to determine the credit loss component of other than temporary impairments we have recognized on residential mortgage backed securities for the years ended December 31, 2016 and 2015, which are all senior level tranches within the structure of the securities:

		Discount Rate				Default Rate				Loss Severity
Sector	Vintage	Min		Max		Min		Max		Min		Max
Year ended December 31, 2016
Prime	2005	7.7	%	7.7	%	8	%	14	%	50	%	50	%
	2006	6.5	%	7.3	%	12	%	13	%	40	%	50	%
	2007	6.2	%	6.4	%	18	%	31	%	50	%	55	%
Alt-A	2005	7.4	%	7.4	%	11	%	11	%	60	%	60	%
Year ended December 31, 2015
Prime	2006	6.5	%	7.4	%	12	%	14	%	40	%	50	%
	2007	5.8	%	7.0	%	15	%	25	%	45	%	55	%
Alt-A	2005	5.6	%	7.4	%	13	%	99	%	2	%	50	%

The determination of the credit loss component of a corporate bond (including redeemable preferred stocks) is based on the underlying financial performance of the issuer and their ability to meet their contractual obligations. Considerations in our evaluation include, but are not limited to, credit rating changes, financial statement and ratio analysis, changes in management, significant changes in credit spreads, breaches of financial covenants and a review of the economic outlook for the industry and markets in which they trade. In circumstances where an issuer appears unlikely to meet its future obligation, or the security's price decline is deemed other than temporary, an estimate of credit loss is determined. Credit loss is calculated using default probabilities as derived from the credit default swaps markets in conjunction with recovery rates derived from independent third party analysis or a best estimate of credit loss. This credit loss rate is then incorporated into a present value calculation based on an expected principal loss in the future discounted at the yield at the date of purchase and compared to amortized cost to determine the amount of credit loss associated with the security.

In addition, for debt securities which we do not intend to sell and it is not more likely than not we will be required to sell, but our intent changes due to changes or events that could not have been reasonably anticipated, an other than temporary impairment charge is recognized. Once an impairment charge has been recorded, we then continue to review the other than temporarily impaired securities for appropriate valuation on an ongoing basis. Unrealized losses may be recognized in future periods through a charge to earnings should we later conclude that the decline in fair value below amortized cost is other than temporary pursuant to our accounting policy described above. The use of different methodologies and assumptions to determine the fair value of investments and the timing and amount of impairments may have a material effect on the amounts presented in our consolidated financial statements.

The following table summarizes other than temporary impairments by asset type:

	Number of Securities	Total OTTI Losses			Portion of OTTI Losses Recognized in (from) Other Comprehensive Income			Net OTTI Losses Recognized in Operations
		(Dollars in thousands)
Year ended December 31, 2016
Fixed maturity securities, available for sale:
Corporate securities:
Energy	2	$	(642	)	$	—		$	(642	)
Materials	1	(4,554		)	1,575			(2,979		)
Telecommunications	1	(4,462		)	562			(3,900		)
Utilities	2	(6,961		)	798			(6,163		)
Residential mortgage backed securities	9	—			(783		)	(783		)
Commercial mortgage backed securities	5	(1,540		)	—			(1,540		)
Other asset backed securities	2	(3,190		)	(3,482		)	(6,672		)
	22	$	(21,349	)	$	(1,330	)	$	(22,679	)
Year ended December 31, 2015
Fixed maturity securities, available for sale:
Corporate securities:
Industrial	2	$	(15,414	)	$	2,975		$	(12,439	)
Residential mortgage backed securities	11	(133		)	(2,089		)	(2,222		)
Other asset backed securities	1	(10,000		)	5,125			(4,875		)
	14	$	(25,547	)	$	6,011		$	(19,536	)
Year ended December 31, 2014
Fixed maturity securities, available for sale:
Residential mortgage backed securities	7	$	—		$	(2,627	)	$	(2,627	)

The cumulative portion of other than temporary impairments determined to be credit losses which have been recognized in operations for debt securities are summarized as follows:

	Year Ended December 31,
	2016			2015
	(Dollars in thousands)
Cumulative credit loss at beginning of year	$	(145,824	)	$	(127,050	)
Credit losses on securities for which OTTI has not previously been recognized	(18,414		)	(17,447		)
Additional credit losses on securities for which OTTI has previously been recognized	(4,265		)	(2,089		)
Accumulated losses on securities that were disposed of during the period	2,128			762
Cumulative credit loss at end of year	$	(166,375	)	$	(145,824	)

The following table summarizes the cumulative noncredit portion of OTTI and the change in fair value since recognition of OTTI, both of which were recognized in other comprehensive income, by major type of security, for securities that are part of our investment portfolio at December 31, 2016 and 2015:

	Amortized Cost		OTTI Recognized in Other Comprehensive Income			Change in Fair Value Since OTTI was Recognized			Fair Value
	(Dollars in thousands)
December 31, 2016
Fixed maturity securities, available for sale:
Corporate securities	$	17,549	$	(5,910	)	$	13,566		$	25,205
Residential mortgage backed securities	368,862		(169,941		)	205,854			404,775
Commercial mortgage backed securities	6,596		—			(107		)	6,489
Other asset backed securities	6,683		(1,643		)	(1,566		)	3,474
	$	399,690	$	(177,494	)	$	217,747		$	439,943
December 31, 2015
Fixed maturity securities, available for sale:
Corporate securities	$	6,396	$	(2,975	)	$	9		$	3,430
Residential mortgage backed securities	466,871		(170,724		)	199,149			495,296
Other asset backed securities	8,154		(5,125		)	(553		)	2,476
	$	481,421	$	(178,824	)	$	198,605		$	501,202

At December 31, 2016 and 2015, fixed maturity securities and short-term investments with an amortized cost of $43.5 billion and $38.3 billion, respectively, were on deposit with state agencies to meet regulatory requirements. There are no restrictions on these assets.

At December 31, 2016 and 2015, we had no investment in any person or its affiliates (other than bonds issued by agencies of the United States Government) that exceeded 10% of stockholders' equity.

XML

Mortgage Loans on Real Estate

12 Months Ended

Dec. 31, 2016

Mortgage Loans on Real Estate [Abstract]

Mortgage Loans on Real Estate

Mortgage Loans on Real Estate

Our mortgage loan portfolio is summarized in the following table. There were commitments outstanding of $75.5 million at December 31, 2016.

	December 31,
	2016			2015
	(Dollars in thousands)
Principal outstanding	$	2,490,619		$	2,449,909
Loan loss allowance	(8,427		)	(14,142		)
Deferred prepayment fees	(1,236		)	(510		)
Carrying value	$	2,480,956		$	2,435,257

The portfolio consists of commercial mortgage loans collateralized by the related properties and diversified as to property type, location and loan size. Our mortgage lending policies establish limits on the amount that can be loaned to one borrower and other criteria to attempt to reduce the risk of default. The mortgage loan portfolio is summarized by geographic region and property type as follows:

	December 31,
	2016				2015
	Principal		Percent		Principal		Percent
	(Dollars in thousands)
Geographic distribution
East	$	635,434	25.5	%	$	698,113	28.5	%
Middle Atlantic	151,640		6.1	%	160,261		6.6	%
Mountain	235,932		9.5	%	252,442		10.3	%
New England	12,724		0.5	%	13,161		0.5	%
Pacific	385,683		15.5	%	355,268		14.5	%
South Atlantic	519,065		20.8	%	456,227		18.6	%
West North Central	325,447		13.1	%	313,120		12.8	%
West South Central	224,694		9.0	%	201,317		8.2	%
	$	2,490,619	100.0	%	$	2,449,909	100.0	%
Property type distribution
Office	$	308,578	12.4	%	$	396,154	16.2	%
Medical Office	50,780		2.1	%	77,438		3.2	%
Retail	886,942		35.6	%	790,158		32.2	%
Industrial/Warehouse	700,644		28.1	%	686,400		28.0	%
Hotel	—		—	%	3,361		0.1	%
Apartment	375,837		15.1	%	352,971		14.4	%
Mixed use/other	167,838		6.7	%	143,427		5.9	%
	$	2,490,619	100.0	%	$	2,449,909	100.0	%

Our financing receivables currently consist of one portfolio segment which is our commercial mortgage loan portfolio. These are mortgage loans with collateral consisting of commercial real estate and borrowers consisting mostly of limited liability partnerships or limited liability corporations.

We evaluate our mortgage loan portfolio for the establishment of a loan loss allowance by specific identification of impaired loans and the measurement of an estimated loss for each individual loan identified. A mortgage loan is impaired when it is probable that we will be unable to collect all amounts due according to the contractual terms of the loan agreement. If we determine that the value of any specific mortgage loan is impaired, the carrying amount of the mortgage loan will be reduced to its fair value, based upon the present value of expected future cash flows from the loan discounted at the loan's effective interest rate, or the fair value of the underlying collateral less estimated costs to sell.

In addition, we analyze the mortgage loan portfolio for the need of a general loan allowance for probable losses on all other loans on a quantitative and qualitative basis. The amount of the general loan allowance is based upon management's evaluation of the collectability of the loan portfolio, historical loss experience, delinquencies, credit concentrations, underwriting standards and national and local economic conditions.

We rate each of the mortgage loans in our portfolio based on factors such as historical operating performance, loan to value ratio and economic outlook, among others. We calculate a loss factor to apply to each rating based on historical losses we have recognized in our mortgage loan portfolio. We apply the loss factors to the total principal outstanding within each rating category to determine an appropriate estimate of the general loan loss allowance. We also assess the portfolio qualitatively and apply a loss rate to all loans without a specific allowance based on management's assessment of economic conditions, and we apply an additional amount of loss allowance to a group of loans that we have identified as having higher risk of loss.

The following table presents a rollforward of our specific and general valuation allowances for mortgage loans on real estate:

	Year Ended December 31,
	2016						2015						2014
	Specific Allowance			General Allowance			Specific Allowance			General Allowance			Specific Allowance			General Allowance
	(Dollars in thousands)
Beginning allowance balance	$	(7,842	)	$	(6,300	)	$	(12,333	)	$	(10,300	)	$	(16,847	)	$	(9,200	)
Charge-offs	5,078			—			2,045			—			9,211			—
Recoveries	5,483			—			5,428			—			255			—
Change in provision for credit losses	(4,046		)	(800		)	(2,982		)	4,000			(4,952		)	(1,100		)
Ending allowance balance	$	(1,327	)	$	(7,100	)	$	(7,842	)	$	(6,300	)	$	(12,333	)	$	(10,300	)

The specific allowance represents the total credit loss allowances on loans which are individually evaluated for impairment. The general allowance is for the group of loans discussed above which are collectively evaluated for impairment. The following table presents the total outstanding principal of loans evaluated for impairment by basis of impairment method:

	December 31,
	2016		2015		2014
	(Dollars in thousands)
Individually evaluated for impairment	$	4,640	$	21,277	$	29,116
Collectively evaluated for impairment	2,485,979		2,428,632		2,428,605
Total loans evaluated for impairment	$	2,490,619	$	2,449,909	$	2,457,721

Charge-offs include allowances that have been established on loans that were satisfied either by taking ownership of the collateral or by some other means such as discounted pay-off or loan sale. When ownership of the property is taken it is recorded at the lower of the mortgage loan's carrying value or the property's fair value (based on appraised values) less estimated costs to sell. The real estate owned is recorded as a component of other investments and the mortgage loan is recorded as fully paid, with any allowance for credit loss that has been established charged off. Fair value of the real estate is determined by third party appraisal. Recoveries are situations where we have received a payment from the borrower in an amount greater than the carrying value of the loan (principal outstanding less specific allowance).

During the year ended December 31, 2014, seven mortgage loans were satisfied by taking ownership of any real estate serving as collateral. The following table summarizes the activity in the real estate owned, included in Other investments, which was obtained in satisfaction of mortgage loans on real estate:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Real estate owned at beginning of period	$	6,485		$	20,238		$	22,844
Real estate acquired in satisfaction of mortgage loans	—			—			14,555
Additions	—			121			—
Sales	(6,444		)	(12,322		)	(14,134		)
Impairments	—			(1,297		)	(2,441		)
Depreciation	(41		)	(255		)	(586		)
Real estate owned at end of period	$	—		$	6,485		$	20,238

We analyze credit risk of our mortgage loans by analyzing all available evidence on loans that are delinquent and loans that are in a workout period.

	December 31,
	2016		2015
	(Dollars in thousands)
Credit Exposure--By Payment Activity
Performing	$	2,489,028	$	2,438,341
In workout	1,591		11,568
Delinquent	—		—
Collateral dependent	—		—
	$	2,490,619	$	2,449,909

The loans that are categorized as "in workout" consist of loans that we have agreed to lower or no mortgage payments for a period of time while the borrowers address cash flow and/or operational issues. The key features of these workouts have been determined on a loan-by-loan basis. Most of these loans are in a period of low cash flow due to tenants vacating their space or tenants requesting rent relief during difficult economic periods. Generally, we have allowed the borrower a six month interest only period and in some cases a twelve month period of interest only. Interest only workout loans are expected to return to their regular debt service payments after the interest only period. Interest only loans that are not fully amortizing will have a larger balance at their balloon date than originally contracted. Fully amortizing loans that are in interest only periods will have larger debt service payments for their remaining term due to lost principal payments during the interest only period. In limited circumstances we have allowed borrowers to pay the principal portion of their loan payment into an escrow account that can be used for capital and tenant improvements for a period of not more than twelve months. In these situations new loan amortization schedules are calculated based on the principal not collected during this twelve month workout period and larger payments are collected for the remaining term of each loan. In all cases, the original interest rate and maturity date have not been modified, and we have not forgiven any principal amounts.

Mortgage loans are considered delinquent when they become 60 days or more past due. In general, when loans become 90 days past due, become collateral dependent or enter a period with no debt service payments required we place them on non-accrual status and discontinue recognizing interest income. If payments are received on a delinquent loan, interest income is recognized to the extent it would have been recognized if normal principal and interest would have been received timely. If the payments are received to bring a delinquent loan back to current we will resume accruing interest income on that loan. There were no loans in non-accrual status at December 31, 2016 or 2015.

We define collateral dependent loans as those mortgage loans for which we will depend on the value of the collateral real estate to satisfy the outstanding principal of the loan.

All of our commercial mortgage loans depend on the cash flow of the borrower to be at a sufficient level to service the principal and interest payments as they come due. In general, cash inflows of the borrowers are generated by collecting monthly rent from tenants occupying space within the borrowers' properties. Our borrowers face collateral risks such as tenants going out of business, tenants struggling to make rent payments as they become due, and tenants canceling leases and moving to other locations. We have a number of loans where the real estate is occupied by a single tenant. Our borrowers sometimes face both a reduction in cash flow on their mortgage property as well as a reduction in the fair value of the real estate collateral. If borrowers are unable to replace lost rent revenue and increases in the fair value of their property do not materialize we could potentially incur more losses than what we have allowed for in our specific and general loan loss allowances.

Aging of financing receivables is summarized in the following table, with loans in a "workout" period as of the reporting date considered current if payments are current in accordance with agreed upon terms:

	30 - 59 Days		60 - 89 Days		90 Days and Over		Total Past Due		Current		Collateral Dependent Receivables		Total Financing Receivables
	(Dollars in thousands)
Commercial Mortgage Loans
December 31, 2016	$	2,737	$	—	$	—	$	2,737	$	2,487,882	$	—	$	2,490,619
December 31, 2015	$	—	$	—	$	—	$	—	$	2,449,909	$	—	$	2,449,909

Financing receivables summarized in the following two tables represent all loans that we are either not currently collecting, or those we feel it is probable we will not collect all amounts due according to the contractual terms of the loan agreements (all loans that we have worked with the borrower to alleviate short-term cash flow issues, loans delinquent for 60 days or more at the reporting date, loans we have determined to be collateral dependent and loans that we have recorded specific impairments on that we feel may continue to have performance issues).

	Recorded Investment		Unpaid Principal Balance		Related Allowance
	(Dollars in thousands)
December 31, 2016
Mortgage loans with an allowance	$	3,313	$	4,640	$	(1,327	)
Mortgage loans with no related allowance	1,591		1,591		—
	$	4,904	$	6,231	$	(1,327	)
December 31, 2015
Mortgage loans with an allowance	$	13,435	$	21,277	$	(7,842	)
Mortgage loans with no related allowance	8,859		8,859		—
	$	22,294	$	30,136	$	(7,842	)

	Average Recorded Investment		Interest Income Recognized
	(Dollars in thousands)
December 31, 2016
Mortgage loans with an allowance	$	3,398	$	301
Mortgage loans with no related allowance	1,665		73
	$	5,063	$	374
December 31, 2015
Mortgage loans with an allowance	$	13,893	$	1,117
Mortgage loans with no related allowance	8,930		584
	$	22,823	$	1,701
December 31, 2014
Mortgage loans with an allowance	$	18,465	$	1,797
Mortgage loans with no related allowance	2,656		43
	$	21,121	$	1,840

A Troubled Debt Restructuring ("TDR") is a situation where we have granted a concession to a borrower for economic or legal reasons related to the borrower's financial difficulties that we would not otherwise consider. A mortgage loan that has been granted new terms, including workout terms as described previously, would be considered a TDR if it meets conditions that would indicate a borrower is experiencing financial difficulty and the new terms constitute a concession on our part. We analyze all loans where we have agreed to workout terms and all loans that we have refinanced to determine if they meet the definition of a TDR. We consider the following factors in determining whether or not a borrower is experiencing financial difficulty:

• borrower is in default,

• borrower has declared bankruptcy,

• there is growing concern about the borrower's ability to continue as a going concern,

• borrower has insufficient cash flows to service debt,

• borrower's inability to obtain funds from other sources, and

• there is a breach of financial covenants by the borrower.

If the borrower is determined to be in financial difficulty, we consider the following conditions to determine if the borrower was granted a concession:

• assets used to satisfy debt are less than our recorded investment,

• interest rate is modified,

• maturity date extension at an interest rate less than market rate,

• capitalization of interest,

• delaying principal and/or interest for a period of three months or more, and

• partial forgiveness of the balance or charge-off.

Mortgage loan workouts, refinances or restructures that are classified as TDRs are individually evaluated and measured for impairment. A summary of mortgage loans on commercial real estate with outstanding principal at December 31, 2016 and 2015 that we determined to be TDRs are as follows:

Geographic Region	Number of TDRs	Principal Balance Outstanding		Specific Loan Loss Allowance			Net Carrying Amount
		(Dollars in thousands)
Year ended December 31, 2016
South Atlantic	1	$	3,004	$	—		$	3,004
East North Central	1	2,020		(467		)	1,553
	2	$	5,024	$	(467	)	$	4,557
Year ended December 31, 2015
South Atlantic	6	$	11,155	$	(2,992	)	$	8,163
East North Central	2	3,306		(467		)	2,839
West North Central	1	5,913		—			5,913
	9	$	20,374	$	(3,459	)	$	16,915

XML

Derivative Instruments

12 Months Ended

Dec. 31, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

Derivative Instruments

None of our derivatives qualify for hedge accounting, thus, any change in the fair value of the derivatives is recognized immediately in the consolidated statements of operations. The fair value of our derivative instruments, including derivative instruments embedded in fixed index annuity contracts, presented in the consolidated balance sheets are as follows:

	December 31,
	2016		2015
	(Dollars in thousands)
Assets
Derivative instruments
Call options	$	830,519	$	337,256
Other assets
Interest rate caps	1,082		1,410
	$	831,601	$	338,666
Liabilities
Policy benefit reserves—annuity products
Fixed index annuities—embedded derivatives	$	6,563,288	$	5,983,622
Other liabilities
Interest rate swap	2,113		3,139
	$	6,565,401	$	5,986,761

The changes in fair value of derivatives included in the consolidated statements of operations are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Change in fair value of derivatives:
Call options	$	165,029		$	(327,921	)	$	521,947
2015 notes hedges	—			(4,516		)	(8,934		)
Interest rate swap	(482		)	(2,341		)	(4,863		)
Interest rate caps	(328		)	(1,368		)	(3,325		)
	$	164,219		$	(336,146	)	$	504,825
Change in fair value of embedded derivatives:
Fixed index annuities—embedded derivatives (see Note 2)	$	145,045		$	(825,668	)	$	(532,337	)
Other changes in difference between policy benefit reserves computed using derivative accounting vs. long-duration contracts accounting	398,420			365,486			579,885
2015 notes embedded conversion derivative (see Note 9)	—			(4,516		)	(19,036		)
2029 notes embedded conversion derivative (see Note 9)	—			—			3,809
	$	543,465		$	(464,698	)	$	32,321

The amounts presented as "Other changes in difference between policy benefit reserves computed using derivative accounting vs. long-duration contracts accounting" represents the total change in the difference between policy benefit reserves for fixed index annuities computed under the derivative accounting standard and the long-duration contracts accounting standard at each balance sheet date, less the change in fair value of our fixed index annuities embedded derivatives that is presented as Level 3 liabilities in Note 2.

We have fixed index annuity products that guarantee the return of principal to the policyholder and credit interest based on a percentage of the gain in a specified market index. When fixed index annuity deposits are received, a portion of the deposit is used to purchase derivatives consisting of call options on the applicable market indices to fund the index credits due to fixed index annuity policyholders. Substantially all such call options are one year options purchased to match the funding requirements of the underlying policies. The call options are marked to fair value with the change in fair value included as a component of revenues. The change in fair value of derivatives includes the gains or losses recognized at the expiration of the option term or upon early termination and the changes in fair value for open positions. On the respective anniversary dates of the index policies, the index used to compute the annual index credit is reset and we purchase new one-year call options to fund the next annual index credit. We manage the cost of these purchases through the terms of our fixed index annuities, which permit us to change caps, participation rates, and/or asset fees, subject to guaranteed minimums on each policy's anniversary date. By adjusting caps, participation rates, or asset fees, we can generally manage option costs except in cases where the contractual features would prevent further modifications.

Our strategy attempts to mitigate any potential risk of loss due to the nonperformance of the counterparties to these call options through a regular monitoring process which evaluates the program's effectiveness. We do not purchase call options that would require payment or collateral to another institution and our call options do not contain counterparty credit-risk-related contingent features. We are exposed to risk of loss in the event of nonperformance by the counterparties and, accordingly, we purchase our option contracts from multiple counterparties and evaluate the creditworthiness of all counterparties prior to purchase of the contracts. All of these options have been purchased from nationally recognized financial institutions with a Standard and Poor's credit rating of A- or higher at the time of purchase and the maximum credit exposure to any single counterparty is subject to concentration limits. We also have credit support agreements that allow us to request the counterparty to provide collateral to us when the fair value of our exposure to the counterparty exceeds specified amounts.

The notional amount and fair value of our call options by counterparty and each counterparty's current credit rating are as follows:

			December 31,
			2016				2015
Counterparty	Credit Rating (S&P)	Credit Rating (Moody's)	Notional Amount		Fair Value		Notional Amount		Fair Value
			(Dollars in thousands)
Bank of America	A+	A1	$	5,958,884	$	178,477	$	6,257,861	$	67,662
Barclays	A-	A1	3,441,832		89,721		2,463,768		35,273
BNP Paribas	A	A1	1,199,265		19,598		1,520,710		16,944
Citibank, N.A.	A+	A1	4,038,528		97,094		3,786,498		23,587
Credit Suisse	A	A1	2,130,710		44,242		1,278,492		12,508
Deutsche Bank	BBB+	Baa2	25,935		892		1,349,002		10,704
J.P. Morgan	A+	Aa3	1,785,583		19,645		838,982		5,283
Morgan Stanley	A+	A1	2,543,421		64,425		3,465,457		33,171
Royal Bank of Canada	AA-	Aa3	3,384,310		103,510		2,820,410		48,654
SunTrust	A-	Baa1	2,375,418		72,990		1,308,434		20,028
Wells Fargo	AA-	Aa2	3,850,842		130,545		4,187,955		63,442
Exchange traded			313,354		9,380		—		—
			$	31,048,082	$	830,519	$	29,277,569	$	337,256

As of December 31, 2016 and 2015, we held $827.8 million and $349.8 million, respectively, of cash and cash equivalents and other securities from counterparties for derivative collateral, which is included in other liabilities on our consolidated balance sheets. This derivative collateral limits the maximum amount of economic loss due to credit risk that we would incur if parties to the call options failed completely to perform according to the terms of the contracts to $55.5 million and $36.9 million at December 31, 2016 and 2015, respectively.

The future annual index credits on our fixed index annuities are treated as a "series of embedded derivatives" over the expected life of the applicable contract. We do not purchase call options to fund the index liabilities which may arise after the next policy anniversary date. We must value both the call options and the related forward embedded options in the policies at fair value. During the year ended December 31, 2014, we revised future period assumptions for lapse rates and the expected costs of annual call options used in determining fixed index annuity embedded derivatives. These revisions decreased the change in fair value of embedded derivatives for the year ended December 31, 2014 by $62.6 million, which after related adjustments to deferred sales inducements and deferred policy acquisition costs and income taxes, increased net income by $14.8 million.

We entered into an interest rate swap and interest rate caps to manage interest rate risk associated with the floating rate component on certain of our subordinated debentures. See Note 10 for more information on our subordinated debentures. The terms of the interest rate swap provide that we pay a fixed rate of interest and receive a floating rate of interest. The terms of the interest rate caps limit the three month London Interbank Offered Rate ("LIBOR") to 2.50%. The interest rate swap and caps are not effective hedges under accounting guidance for derivative instruments and hedging activities. Therefore, we record the interest rate swap and caps at fair value and any net cash payments received or paid are included in the change in fair value of derivatives in the consolidated statements of operations.

Details regarding the interest rate swap are as follows:

						December 31,
						2016			2015
Maturity Date	Notional Amount		Receive Rate	Pay Rate	Counterparty	Fair Value			Fair Value
						(Dollars in thousands)
March 15, 2021	$	85,500	LIBOR	2.415%	SunTrust	$	(2,113	)	$	(3,139	)

Details regarding the interest rate caps are as follows:

						December 31,
						2016		2015
Maturity Date	Notional Amount		Floating Rate	Cap Rate	Counterparty	Fair Value		Fair Value
						(Dollars in thousands)
July 7, 2021	$	40,000	LIBOR	2.50%	SunTrust	$	542	$	708
July 8, 2021	12,000		LIBOR	2.50%	SunTrust	163		212
July 29, 2021	27,000		LIBOR	2.50%	SunTrust	377		490
	$	79,000				$	1,082	$	1,410

The interest rate swap converts floating rates to fixed rates for seven years which began in March 2014. The interest rate caps cap our interest rates for seven years which began in July 2014. As of December 31, 2016, we deposited $0.7 million of collateral with the counterparty to the swap and caps.

In September 2010, concurrently with the issuance of $200.0 million principal amount of 3.50% Convertible Senior Notes due September 15, 2015 (the "2015 notes"), we entered into hedge transactions (the "2015 notes hedges") with two counterparties whereby we would receive the cash equivalent of the conversion spread on 16.0 million shares of our common stock based upon a strike price of $12.50 per share, subject to certain conversion rate adjustments in the 2015 notes. The number of shares and strike price of the 2015 notes hedges were subject to adjustment based on dividends we paid subsequent to their purchase. The 2015 notes hedges expired on September 15, 2015, and we received $25.8 million in cash. The 2015 notes hedges were accounted for as derivative assets and were included in other assets in our consolidated balance sheets. The 2015 notes embedded conversion derivative liability was settled with the extinguishment of the 2015 notes (see Note 9) whereby we paid holders of the notes a total of $25.8 million in cash to settle the conversion premium. The 2015 notes hedges and 2015 notes embedded conversion derivative were adjusted to fair value each reporting period and unrealized gains and losses are reflected in our consolidated statements of operations.

In separate transactions, we sold warrants (the "2015 warrants") to the 2015 notes hedges counterparties for the purchase of up to 16.0 million shares of our common stock at a price of $16.00 per share. We received $15.6 million in cash proceeds from the sale of the 2015 warrants, which was recorded as an increase in additional paid-in capital. The number of shares and strike price of the warrants were subject to adjustment based on dividends we paid subsequent to selling the warrants. The warrants expired on various dates from December 2015 through June 2016. Changes in the fair value of these warrants were not be recognized in our consolidated financial statements as the instruments remain classified as equity.

In December 2015, we began settling the 2015 warrants in net shares on a weekly basis, and completed the settlement of all warrants by June 30, 2016. 140,866 shares of our common stock were delivered to holders of the expiring warrants, of which 92,998 shares were issued during 2016. 2015 warrants remained outstanding on 1.6 million shares of our common stock at a strike price of $15.59 per share at December 31, 2015. As the average price of our common stock exceeded the strike price of the 2015 warrants while they were outstanding the dilutive effect of the 2015 warrants has been included in diluted earnings per share for the years ended December 31, 2016, 2015 and 2014.

In 2014, we entered into five separate partial unwind agreements with the counterparties to the 2015 notes hedges and the 2015 warrants to coincide with the extinguishment of a portion of our 2015 notes (see Note 9) whereby we agreed to settle the related 2015 notes hedges and the 2015 warrants and received net cash from the counterparties totaling $16.6 million. The agreements to settle the 2015 warrants in cash required us to reclassify $51.3 million from equity to a derivative liability which represented the fair value of the 2015 warrants committed to the unwind on the day that we entered into the unwind agreements. The fair value of these warrants did not change after reclassification as they were settled in cash at the time the agreements were executed.

XML

Deferred Policy Acquisition Costs and Deferred Sales Inducements

12 Months Ended

Dec. 31, 2016

Insurance [Abstract]

Deferred Policy Acquisition Costs and Deferred Sales Inducements

Deferred Policy Acquisition Costs and Deferred Sales Inducements

Policy acquisition costs deferred and amortized are as follows:

	December 31,
	2016			2015			2014
	(Dollars in thousands)
Balance at beginning of year	$	2,905,136		$	2,058,556		$	2,426,652
Costs deferred during the year:
Commissions	538,863			651,094			421,802
Policy issue costs	4,462			6,545			5,080
Amortization	(374,012		)	(286,114		)	(163,578		)
Effect of net unrealized gains/losses	(169,072		)	475,055			(631,400		)
Balance at end of year	$	2,905,377		$	2,905,136		$	2,058,556

Sales inducements deferred and amortized are as follows:

	December 31,
	2016			2015			2014
	(Dollars in thousands)
Balance at beginning of year	$	2,232,148		$	1,587,257		$	1,875,880
Costs deferred during the year	353,966			486,924			330,079
Amortization	(251,166		)	(209,390		)	(131,419		)
Effect of net unrealized gains/losses	(126,730		)	367,357			(487,283		)
Balance at end of year	$	2,208,218		$	2,232,148		$	1,587,257

We periodically revise the key assumptions used in the calculation of amortization of deferred policy acquisition costs and deferred sales inducements retrospectively through an unlocking process when estimates of current or future gross profits/margins (including the impact of realized investment gains and losses) to be realized from a group of products are revised. The unlocking adjustments in 2016 increased amortization of deferred policy acquisition costs by $48.2 million and amortization of deferred sales inducements by $35.8 million. We review these assumptions quarterly and as a result of this review we made adjustments in the first and third quarters of 2016. During the first quarter of 2016, we made adjustments to lower future spread assumptions after comparing investment spread assumptions to actual investment spreads earned in the three months ended December 31, 2015 and March 31, 2016 and determining that decreases in the average yield earned on invested assets resulting from the continued low interest rate environment was creating shortfalls in investment spread and gross profits. During the third quarter of 2016, we made adjustments to extend the period of time in which we assume investment spread will grade up to our long-term spread targets by an additional two years as yields obtained on investments purchased in the third quarter of 2016 were much lower than we had anticipated as a result of the overall decline in investment yields that followed the Brexit vote. In addition, during the third quarter of 2016, revisions to assumptions used in determining reserves held for living income benefit riders resulted in a decrease in estimated future gross profits.

The unlocking adjustment in 2015 decreased amortization of deferred policy acquisition costs by $11.0 million and amortization of deferred sales inducements by $5.6 million and included the impact of account balance true-ups as of September 30, 2015, which have been favorable to us due to stronger equity market performance than we assumed, favorable adjustments to lapse assumptions to reflect better persistency experienced than assumed and unfavorable adjustments to investment spread to reflect lower spreads being earned than assumed. In 2015, the favorable impact of the account balance true-up and lapse assumption change was largely offset by reductions in estimated future gross profits attributable to revisions to the assumptions for the lifetime income benefit rider liability. The unlocking adjustment in 2014 decreased amortization of deferred policy acquisition costs by $35.5 million and amortization for deferred sales inducements by $12.6 million and included the impact of account value true-ups as of September 30, 2014 and adjustments to future period assumptions for interest margins, surrenders and certain expenses.

XML

Reinsurance and Policy Provisions

12 Months Ended

Dec. 31, 2016

Reinsurance Disclosures [Abstract]

Reinsurance and Policy Provisions

Reinsurance and Policy Provisions

Coinsurance

We have two coinsurance agreements with EquiTrust Life Insurance Company ("EquiTrust"), covering 70% of certain of American Equity Life's fixed index and fixed rate annuities issued from August 1, 2001 through December 31, 2001, 40% of those contracts issued during 2002 and 2003, and 20% of those contracts issued from January 1, 2004 to July 31, 2004. The business reinsured under these agreements may not be recaptured. Coinsurance deposits (aggregate policy benefit reserves transferred to EquiTrust under these agreements) were $0.7 billion and $0.8 billion at December 31, 2016 and 2015, respectively. We remain liable to policyholders with respect to the policy liabilities ceded to EquiTrust should EquiTrust fail to meet the obligations it has coinsured. None of the coinsurance deposits with EquiTrust are deemed by management to be uncollectible. The balance due under these agreements to EquiTrust was $9.7 million and $2.5 million at December 31, 2016 and 2015, respectively, and represents the fair value of call options held by us to fund index credits related to the ceded business net of cash due to or from EquiTrust related to monthly settlements of policy activity and other expenses.

We have three coinsurance agreements with Athene Life Re Ltd. ("Athene"), an unauthorized life reinsurer domiciled in Bermuda. One agreement ceded 20% of certain of American Equity Life's fixed index annuities issued from January 1, 2009 through March 31, 2010. The business reinsured under this agreement is not eligible for recapture until the end of the month following seven years after the date of issuance of the policy. The second agreement ceded 80% of American Equity Life's multi-year rate guaranteed annuities issued from July 1, 2009 through December 31, 2013 and 80% of Eagle Life's multi-year rate guaranteed annuities issued from November 20, 2013 through December 31, 2013. The business reinsured under this agreement may not be recaptured. The third agreement cedes 80% of American Equity Life's and Eagle Life's multi-year rate guaranteed annuities issued on or after January 1, 2014, 80% of Eagle Life's fixed index annuities issued on or after January 1, 2014 and 80% of certain of American Equity Life's fixed index annuities issued from August 1, 2016 through December 31, 2016. The reinsurance agreement specifies that the coinsurance percentage for Eagle Life's fixed index annuities decreases to 50% for policies issued between January 1, 2017 and December 31, 2018, and to 20% for policies issued on or after January 1, 2019. The business reinsured under this agreement may not be recaptured. Coinsurance deposits (aggregate policy benefit reserves transferred to Athene under these agreements) were $3.9 billion and $2.4 billion at December 31, 2016 and 2015, respectively. American Equity Life is an intermediary for reinsurance of Eagle Life's business ceded to Athene. American Equity Life and Eagle Life remain liable to policyholders with respect to the policy liabilities ceded to Athene should Athene fail to meet the obligations it has coinsured. The annuity deposits that have been ceded to Athene are held in trusts and American Equity Life is named as the sole beneficiary of the trusts. The assets in the trusts are required to remain at a value that is sufficient to support the current balance of policy benefit liabilities of the ceded business on a statutory basis. If the value of the trust accounts would ever be less than the amount of the ceded policy benefit liabilities on a statutory basis, Athene is required to either establish a letter of credit or deposit securities in the trusts for the amount of any shortfall. None of the coinsurance deposits with Athene are deemed by management to be uncollectible. The balance due under these agreements to Athene was $45.8 million and $12.7 million at December 31, 2016 and 2015, respectively, and represents the fair value of call options held by us to fund index credits related to the ceded business net of cash due from Athene related to monthly settlements of policy activity.

Amounts ceded to EquiTrust and Athene under these agreements are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Consolidated Statements of Operations
Annuity product charges	$	5,366		$	5,427		$	5,956
Change in fair value of derivatives	18,446			(14,360		)	31,076
	$	23,812		$	(8,933	)	$	37,032
Interest sensitive and index product benefits	$	93,487		$	88,923		$	122,666
Change in fair value of embedded derivatives	23,848			(22,616		)	35,820
Other operating costs and expenses	24,039			9,922			9,241
	$	141,374		$	76,229		$	167,727
Consolidated Statements of Cash Flows
Annuity deposits	$	(1,736,054	)	$	(471,822	)	$	(171,124	)
Cash payments to policyholders	418,499			391,045			280,308
	$	(1,317,555	)	$	(80,777	)	$	109,184

Financing Arrangements

We have a reinsurance transaction with Hannover Life Reassurance Company of America ("Hannover"), which is treated as reinsurance under statutory accounting practices and as a financing arrangement under GAAP. The statutory surplus benefit under this agreement is eliminated under GAAP and the associated charges are recorded as risk charges and included in other operating costs and expenses in the consolidated statements of operations. The transaction became effective July 1, 2013 (the "2013 Hannover Transaction").

The 2013 Hannover Transaction, which was amended effective October 1, 2016, is a yearly renewable term reinsurance agreement for statutory purposes covering 45.6% of waived surrender charges related to penalty free withdrawals, deaths and lifetime income benefit rider payments as well as lifetime income benefit rider payments in excess of policy fund values on certain business. We may recapture the risks reinsured under this agreement as of the end of any quarter after December 31, 2020 and the agreement, as amended, makes it punitive to us if we do not recapture the business ceded no later than the first quarter of 2021. The reserve credit recorded on a statutory basis by American Equity Life was $638.1 million and $480.7 million at December 31, 2016 and 2015, respectively. We pay quarterly reinsurance premiums under this agreement with an experience refund calculated on a quarterly basis and a risk charge based on the pretax statutory benefit as of the end of each calendar quarter. Risk charges attributable to the 2013 Hannover Transaction were $27.7 million and $21.0 million during 2016 and 2015.

Prior to its recapture in 2015, we had a coinsurance and yearly renewable term reinsurance agreement for statutory purposes that provided $49.2 million in net pretax statutory surplus benefit at inception in 2011 (the "2011 Hannover Transaction"). Pursuant to the terms of this agreement, pretax statutory surplus was reduced by $10.3 million and $10.8 million in 2015 and 2014, respectively. These amounts include risk charges equal to 1.25% of the pretax statutory surplus benefit as of the end of each calendar quarter. Risk charges attributable to the 2011 Hannover Transaction were $0.3 million and $0.8 million during 2015 and 2014, respectively.

Indemnity Reinsurance

In the normal course of business, we seek to limit our exposure to loss on any single insured and to recover a portion of benefits paid under our annuity, life and accident and health insurance products by ceding reinsurance to other insurance enterprises or reinsurers. Reinsurance contracts do not relieve us of our obligations to our policyholders. To the extent that reinsuring companies are later unable to meet obligations under reinsurance agreements, our life insurance subsidiaries would be liable for these obligations, and payment of these obligations could result in losses to us. To limit the possibility of such losses, we evaluate the financial condition of our reinsurers, and monitor concentrations of credit risk. No allowance for uncollectible amounts has been established against our asset for amounts receivable from other insurance companies as none of the receivables are deemed by management to be uncollectible.

XML

Income Taxes

12 Months Ended

Dec. 31, 2016

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

We file consolidated federal income tax returns that include all of our wholly-owned subsidiaries. Our income tax expense as presented in the consolidated financial statements is summarized as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Consolidated statements of operations:
Current income taxes	$	57,412		$	75,568		$	116,545
Deferred income taxes (benefits)	(10,408		)	41,916			(46,504		)
Total income tax expense included in consolidated statements of operations	47,004			117,484			70,041
Stockholders' equity:
Expense (benefit) relating to:
Change in net unrealized investment losses	74,471			(279,860		)	363,572
Share-based compensation	(527		)	(3,649		)	(5,716		)
Extinguishment of convertible debt	—			—			(9,284		)
Total income tax expense (benefit) included in consolidated financial statements	$	120,948		$	(166,025	)	$	418,613

Income tax expense in the consolidated statements of operations differed from the amount computed at the applicable statutory federal income tax rate of 35% as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Income before income taxes	$	130,247		$	337,314		$	196,064
Income tax expense on income before income taxes	$	45,586		$	118,060		$	68,622
Tax effect of:
State income taxes	2,559			2,924			1,145
Tax exempt net investment income	(2,167		)	(3,834		)	(3,669		)
Extinguishment of convertible debt	—			—			4,202
Other	1,026			334			(259		)
Income tax expense	$	47,004		$	117,484		$	70,041
Effective tax rate	36.1		%	34.8		%	35.7		%

Deferred income tax assets or liabilities are established for temporary differences between the financial reporting amounts and tax bases of assets and liabilities that will result in deductible or taxable amounts, respectively, in future years. The tax effects of temporary differences that give rise to the deferred tax assets and liabilities at December 31, 2016 and 2015, are as follows:

	December 31,
	2016			2015
	(Dollars in thousands)
Deferred income tax assets:
Policy benefit reserves	$	2,354,786		$	2,092,731
Other than temporary impairments	15,681			7,801
Derivative instruments	—			91,638
Amounts due reinsurer	1,321			—
Other policyholder funds	6,474			6,861
Litigation settlement accrual	1,709			7,100
Deferred compensation	7,963			8,346
Share-based compensation	5,407			5,286
Net operating loss carryforwards	3,745			6,637
Other	9,658			8,031
Gross deferred tax assets	2,406,744			2,234,431
Deferred income tax liabilities:
Deferred policy acquisition costs and deferred sales inducements	(1,951,333		)	(1,860,722		)
Net unrealized gains on available for sale fixed maturity and equity securities	(170,925		)	(96,454		)
Derivative instruments	(75,405		)	—
Amounts due reinsurer	—			(9,677		)
Investment income items	(39,118		)	(32,466		)
Other	(1,385		)	(2,429		)
Gross deferred tax liabilities	(2,238,166		)	(2,001,748		)
Net deferred income tax asset	$	168,578		$	232,683

Included in the deferred income taxes is the expected income tax benefit attributable to unrealized losses on available for sale fixed maturity securities. There is no valuation allowance provided for the deferred income tax asset attributable to unrealized losses on available for sale fixed maturity securities. Management expects that the passage of time will result in the reversal of these unrealized losses due to the fair value increasing as these securities near maturity. We have the intent and ability to hold these securities to maturity, because we generate adequate cash flow from new business to fund all foreseeable cash flow needs and do not believe it would be necessary to liquidate these securities at a loss to meet cash flow needs.

Realization of our deferred income tax assets is more likely than not based on expectations as to our future taxable income and considering all other available evidence, both positive and negative. Therefore, no valuation allowance against deferred income tax assets has been established as of December 31, 2016 and 2015.

There were no material income tax contingencies requiring recognition in our consolidated financial statements as of December 31, 2016. We are no longer subject to income tax examinations by tax authorities for years prior to 2012.

At December 31, 2016, we have no non-life net operating loss carryforwards remaining for federal income tax purposes.

XML

Notes and Loan Payable and Amounts Due Under Repurchase Agreements

12 Months Ended

Dec. 31, 2016

Debt Disclosure [Abstract]

Notes and Loan Payable and Amounts Due Under Repurchase Agreements

Notes and Loan Payable and Amounts Due Under Repurchase Agreements

Notes and loan payable includes the following:

	December 31,
	2016			2015
	(Dollars in thousands)
Senior notes due 2021
Principal	$	400,000		$	400,000
Unamortized debt issue costs	(5,733		)	(6,773		)
Term loan due 2019
Principal	100,000			—
Unamortized debt issue costs	(512		)	—
	$	493,755		$	393,227

On July 17, 2013, we issued $400 million aggregate principal amount of senior unsecured notes due 2021 which bear interest at 6.625% per year and will mature on July 15, 2021. Contractual interest is payable semi-annually in arrears each January 15th and July 15th. The initial transaction fees and expenses totaling $9.0 million were capitalized as deferred financing costs and are being amortized over the term of the notes due 2021 using the effective interest method. We used $15 million of the net proceeds from the issuance to repay the entire amount outstanding under our revolving credit facility and the remainder of the net proceeds was used to pay the cash consideration portion of the convertible notes exchange offers and redemption discussed below.

In September 2010, we issued $200.0 million principal amount of 2015 notes. The 2015 notes had a coupon interest rate of 3.5% per year, matured on September 15, 2015, and were settled in cash on the maturity date. Contractual interest was payable semi-annually in arrears each March 15th and September 15th. The initial transaction fees and expenses totaling $6.8 million were capitalized as deferred financing costs and were amortized over the term of the 2015 notes using the effective interest method.

The conversion option of the 2015 notes (the "2015 notes embedded conversion derivative") was an embedded derivative that required bifurcation from the 2015 notes and was accounted for as a derivative liability, which was included in Other liabilities in our Consolidated Balance Sheets. The fair value of the 2015 notes embedded conversion derivative at the time of issuance of the 2015 notes was $37.0 million, and was recorded as the original debt discount for purposes of accounting for the debt component of the 2015 notes. This discount was amortized and recognized as interest expense using the effective interest method over the term of the 2015 notes.

In December 2009, we issued $115.8 million of contingent convertible senior notes due December 15, 2029 (the "2029 notes"), of which $15.6 million was assigned to the equity component (net of income tax of $11.0 million), and was recorded as the original debt discount for purposes of accounting for the debt component of the 2029 notes. The 2029 notes had a coupon interest rate of 5.25% per annum. Interest was payable semi-annually in arrears on June 6 and December 6 of each year.

We were required to include the dilutive effect of the 2029 notes in our diluted earnings per share calculation. Because these notes included a mandatory cash settlement feature for the principal amount, incremental dilutive shares only existed when the fair value of our common stock at the end of the reporting period exceeded the conversion price per share. The conversion premium of the 2029 notes was dilutive and the effect was included in diluted earnings per share for the year ended December 31, 2014. The 2015 notes were excluded from the dilutive effect in our diluted earnings per share calculation as they were intended to be settled only in cash.

The 2015 notes matured and were extinguished on September 15, 2015. Total consideration paid to holders of the 2015 notes at maturity was $48.2 million in cash, which included $22.4 million principal amount and $25.8 million conversion premium. See Note 5 for a discussion of the settlement of the 2015 notes embedded derivative liability.

In 2014, we extinguished $69.6 million principal amount of our 2015 notes and $36.2 million principal amount of our 2029 notes pursuant to private exchange offers with holders of our outstanding convertible debt instruments. Total consideration paid to holders of the 2015 notes consisted of $82.9 million in cash and $48.2 million in shares of our common stock (2,115,055 shares). Total consideration paid to holders of the 2029 notes consisted of $66.7 million in cash and $23.2 million in shares of our common stock (946,793 shares). Total consideration paid to the holders of the 2015 notes and 2029 notes excludes the accrued interest through the settlement date that was also paid. The carrying value of the convertible notes at extinguishment was $66.0 million and $34.6 million for the 2015 notes and the 2029 notes, respectively, and losses net of tax of $4.8 million for the 2015 notes and $2.5 million for the 2029 notes were recognized.

Also in 2014, we issued a notice of mandatory redemption of all of the 2029 notes that were outstanding at the time the notice was issued and amended the terms of the indenture governing the 2029 notes to provide the holders with the option of receiving the conversion value of their notes entirely in cash rather than cash for the principal amount and net shares for the portion of the conversion value that exceeds the principal amount. As a result of this mandatory redemption and the change in terms, $32.1 million principal amount of the 2029 notes was converted into $69.4 million in cash and $24.6 million in shares of our common stock (897,548 shares). The amendment to the conversion terms resulted in a reclassification of the fair value of the conversion premium for the 2029 notes from equity to an embedded conversion derivative liability. The fair value of the conversion premium on the date of reclassification was $58.1 million. We applied fair value accounting to the embedded derivative liability from the date of reclassification to the dates of settlement of the conversions of the 2029 notes and recognized as expense the $3.8 million increase in the fair value of the embedded conversion derivative liability.

The debt discounts were amortized over the expected lives of the notes, which was December 15, 2014 for the 2029 notes and September 15, 2015 for the 2015 notes. The effective interest rates during the discount amortization periods were 8.9% and 11.9% on the 2015 notes and 2029 notes, respectively. The interest cost recognized in operations for the convertible notes, inclusive of the coupon and amortization of the discount and debt issue costs was $1.4 million, and $9.0 million for the years ended December 31, 2015 and 2014, respectively.

On September 30, 2016, we entered into a credit agreement with six banks that provided for a $150 million unsecured revolving line of credit (the "Revolving Facility") that terminates on September 30, 2021 and a $100 million term loan (the "Term Loan") that terminates on September 30, 2019 and can be prepaid prior to maturity without penalty. We utilized the proceeds from the Term Loan to make a contribution to the capital and surplus of our subsidiary, American Equity Life. Any proceeds from the Revolving Facility will be used to finance our general corporate purposes. Interest is paid quarterly on the Term Loan. The interest rate for all borrowings under the credit agreement is floating at a rate based on our election that will be equal to the alternate base rate (as defined in the credit agreement) plus the applicable margin or the adjusted LIBOR rate (as defined in the credit agreement) plus the applicable margin. We also pay a commitment fee based on the available unused portion of the Revolving Facility. The applicable margin and commitment fee rate are based on our credit rating and can change throughout the period of the borrowings. Based upon our current credit rating, the applicable margin is 0.75% for alternate base rate borrowings and 1.75% for adjusted LIBOR rate borrowings, and the commitment fee is 0.275%. The interest rate in effect on the Term Loan in 2016 was 2.625%. Under this agreement, we are required to maintain a minimum risk-based capital ratio at our subsidiary, American Equity Life, of 275%, a maximum ratio of adjusted debt to total adjusted capital of 0.35, and a minimum level of statutory surplus at American Equity Life equal to the sum of 1) 80% of statutory surplus at June 30, 2016, 2) 50% of the statutory net income for each fiscal quarter ending after June 30, 2016, and 3) 50% of all capital contributed to American Equity Life after June 30, 2016. The Revolving Facility contains an accordion feature that allows us, on up to three occasions and subject to credit availability, to increase the credit facility by an additional $50 million in the aggregate. We also have the ability to extend the maturity date of the Revolving Facility by an additional one year past the initial maturity date of September 30, 2021 with the consent of the extending banks. There are currently no guarantors of the Revolving Facility or the Term Loan, but certain of our subsidiaries must guarantee our obligations under the credit agreement if such subsidiaries guarantee other material amounts of our debt.  No amounts were outstanding under the Revolving Facility at December 31, 2016. As of December 31, 2016, $575.6 million is unrestricted and could be distributed to shareholders and still be in compliance with all covenants under this credit agreement.

The preceding replaced a $140 million unsecured revolving line of credit agreement with five banks dated November 22, 2013 that was scheduled to terminate on November 22, 2017.

As part of our investment strategy, we enter into securities repurchase agreements (short-term collateralized borrowings). The maximum amount borrowed during 2016, 2015 and 2014 was $113.0 million, $40.6 million and $138.7 million, respectively. When we do borrow cash on these repurchase agreements, we pledge collateral in the form of debt securities with fair values approximately equal to the amount due and we use the cash to purchase debt securities ahead of the time we collect the cash from selling annuity policies to avoid a lag between the investment of funds and the obligation to credit interest to policyholders. We earn investment income on the securities purchased with these borrowings at a rate in excess of the cost of these borrowings. Such borrowings averaged $4.5 million, $0.5 million and $9.2 million for the years ended December 31, 2016, 2015 and 2014, respectively. The weighted average interest rate on amounts due under repurchase agreements was 0.66%, 0.39% and 0.19% for the years ended December 31, 2016, 2015 and 2014, respectively.

XML

Subordinated Debentures

12 Months Ended

Dec. 31, 2016

Subordinated Borrowings [Abstract]

Subordinated Debentures

Subordinated Debentures

Our wholly-owned subsidiary trusts (which are not consolidated) have issued fixed rate and floating rate trust preferred securities and have used the proceeds from these offerings to purchase subordinated debentures from us. We also issued subordinated debentures to the trusts in exchange for all of the common securities of each trust. The sole assets of the trusts are the subordinated debentures and any interest accrued thereon. The interest payment dates on the subordinated debentures correspond to the distribution dates on the trust preferred securities issued by the trusts. The trust preferred securities mature simultaneously with the subordinated debentures. Our obligations under the subordinated debentures and related agreements provide a full and unconditional guarantee of payments due under the trust preferred securities. All subordinated debentures are callable by us at any time, except for the Trust II subordinated debt obligations.

Following is a summary of subordinated debt obligations to the trusts at December 31, 2016 and 2015:

	December 31,
	2016			2015			Interest Rate		Due Date
	(Dollars in thousands)
American Equity Capital Trust II	$	77,061		$	76,840		5%		June 1, 2047
American Equity Capital Trust III	27,840			27,840			*LIBOR +	3.90%	April 29, 2034
American Equity Capital Trust IV	12,372			12,372			*LIBOR +	4.00%	January 8, 2034
American Equity Capital Trust VII	10,830			10,830			*LIBOR +	3.75%	December 14, 2034
American Equity Capital Trust VIII	20,620			20,620			*LIBOR +	3.75%	December 15, 2034
American Equity Capital Trust IX	15,470			15,470			*LIBOR +	3.65%	June 15, 2035
American Equity Capital Trust X	20,620			20,620			*LIBOR +	3.65%	September 15, 2035
American Equity Capital Trust XI	20,620			20,620			*LIBOR +	3.65%	December 15, 2035
American Equity Capital Trust XII	41,238			41,238			*LIBOR +	3.50%	April 7, 2036
	246,671			246,450
Unamortized debt issue costs	(4,818		)	(4,998		)
	$	241,853		$	241,452

*—three month London Interbank Offered Rate

The principal amount of the subordinated debentures issued by us to American Equity Capital Trust II ("Trust II") is $100.0 million. These debentures were assigned a fair value of $74.7 million at the date of issue (based upon an effective yield-to-maturity of 6.8%). The difference between the fair value at the date of issue and the principal amount is being accreted over the life of the debentures. The trust preferred securities issued by Trust II were issued to Iowa Farm Bureau Federation, which owns more than 50% of the voting capital stock of FBL Financial Group, Inc. ("FBL"). The consideration received by Trust II in connection with the issuance of its trust preferred securities consisted of fixed income securities of equal value which were issued by FBL.

XML

Retirement and Share-based Compensation Plans

12 Months Ended

Dec. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Retirement and Share-based Compensation Plans

Retirement and Share-based Compensation Plans

We have adopted a contributory defined contribution plan which is qualified under Section 401(k) of the Internal Revenue Code. The plan covers substantially all of our full-time employees subject to minimum eligibility requirements. Employees can contribute a percentage of their annual salary (up to a maximum contribution of $18,000 in 2016, $18,000 in 2015 and $17,500 in 2014) to the plan. We contribute an additional amount, subject to limitations, based on the voluntary contribution of the employee. Further, the plan provides for additional employer contributions based on the discretion of the Board of Directors. Plan contributions charged to expense were $1.3 million, $0.4 million and $0.4 million for the years ended December 31, 2016, 2015 and 2014, respectively.

The following table summarizes compensation expense recognized for employees, directors and consultants as a result of share-based compensation:

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands)
ESOP	$	2,522	$	2,604	$	2,486
Employee Incentive Plans	1,207		1,911		1,306
Director Equity and Incentive Plan and Stock Option Plan	685		613		789
	$	4,414	$	5,128	$	4,581

The principal purpose of the American Equity Investment Employee Stock Ownership Plan ("ESOP") is to provide each eligible employee with an equity interest in us. Employees become eligible once they have completed a minimum of six months of service. Employees become 100% vested after two years of service. Our contribution to the ESOP is determined by the Board of Directors.

In 2016, we adopted the 2016 Employee Incentive Plan which authorized the issuance of up to 2,500,000 shares of our Common stock in the form of grants of options, stock appreciation rights, restricted stock awards and restricted stock units. At December 31, 2016, we had 2,226,256 shares of common stock available for future grant under the 2016 Employee Incentive Plan. The 2009 Employee Incentive Plan, which expired in June of 2014, authorized the issuance of up to 2,500,000 shares of our common stock in the form of grants of options, stock appreciation rights, restricted stock awards and restricted stock units. All options granted under this plan had six or ten year terms and a three year vesting period after which they become fully exercisable immediately.

We have a long-term performance incentive plan under which certain members of our senior management team are granted restricted stock units pursuant to the 2016 Employee Incentive Plan or the 2009 Employee Incentive Plan. During 2016, 2015 and 2014, we granted 208,565, 60,947 and 54,718 restricted stock units under these plans, respectively. Vesting is tied to threshold and target performance goals for the three year period ending December 31, 2018, December 31, 2017 and December 31, 2016, respectively. Fifty percent of the restricted stock units will vest if we meet threshold goals and 100% of the restricted stock units will vest if we meet target performance goals. Compensation expense is recognized over the three year vesting period based on the likelihood of meeting threshold and target goals. Restricted stock units that ultimately vest are payable in an equal number of shares of our common stock. Restricted stock units are accounted for as equity awards and the estimated fair value of restricted stock units is based upon the closing price of our common stock on the date of grant. During 2016, the 2015 restricted stock unit award agreements were amended and the restricted stock units granted during 2015 will be settled in cash if earned. This amendment was due to an administrative issue related to the grant, which was made under an expired equity plan.

During 2016, 2015 and 2014, we issued 43,373, 25,784 and 18,239 (43,373, 23,062 and 14,869 shares were restricted stock), respectively, shares of common stock under the 2016 Employee Incentive Plan or the 2009 Employee Incentive Plan to certain employees. These shares will vest on the date three years following the grant date provided the participant remains employed with us. Compensation expense is recognized over the three year vesting period. Shares vest immediately for participants over 65 years of age with 10 years of service with us, and compensation expense under this plan for these participants was recognized upon approval of the incentive award by the compensation committee. During 2016, the shares of restricted stock granted during 2015 were canceled due to an administrative issue related to the grant, which was made under an expired equity plan. During 2016, we issued 21,806 shares of common stock to the employees impacted by the cancellation taking into consideration the canceled 2015 grants.

The 2013 Director Equity and Incentive Plan authorizes the grant of options, stock appreciation rights, restricted stock awards and restricted stock units convertible into or based upon our common stock of up to 250,000 shares to our Directors. During 2016, 2015 and 2014, we issued 47,500, 22,000 and 24,000 shares of common stock, respectively, all of which are restricted stock, and which vest one year from the grant date provided the individual remains a Director during that time period. At 2016, we had 116,500 shares of common stock available for future grant under the 2013 Director and Equity Incentive Plan.

Our 1996 Stock Option Plan, 2000 Employee Stock Option Plan, 2000 Directors Stock Option Plan and 2011 Director Stock Option Plan authorized grants of options to officers, directors and employees for an aggregate of up to 3,475,000 shares of our common stock. All options granted under these plans have ten year terms and a six month or three year vesting period after which they become fully exercisable immediately. At December 31, 2016, we had 18,000 shares of common stock available for future grant under the 2011 Director Stock Option Plan.

During 2014, we established the 2014 Independent Insurance Agent Restricted Stock and Restricted Stock Unit Plan, which was amended during 2016. Under the amended plan, agents of American Equity Life may receive grants of restricted stock and restricted stock units based upon their individual sales. The plan authorizes grants of up to 1,800,000 shares of our common stock. We recognize commission expense and an increase to additional paid-in capital as share-based compensation equal to the fair value of the restricted stock and restricted stock units as they are earned.

In January 2017, American Equity Life's agents were granted 363,624 restricted stock units based on their production during 2016, and we recorded commission expense (capitalized as deferred policy acquisition costs) of $2.6 million in 2016. In January 2016, American Equity Life's agents were granted 650,683 restricted stock units based on their production during 2015, and we recorded commission expense (capitalized as deferred policy acquisition costs) of $3.5 million in 2015. In January 2017, agents vested in 246,532 restricted stock units granted in January 2016 based on their continued service as an independent agent and their 2016 individual sales of our products, and for which we recorded commission expense (capitalized as deferred policy acquisition costs) of $1.7 million in 2016. 20% of the restricted stock units will vest one year from the grant date if the agent is in good standing with American Equity Life at that date. The remaining 80% of the restricted stock units granted to retirement eligible individuals will vest over a four year period if the agent remains in good standing with American Equity Life. The remaining 80% of the restricted stock units granted to non-retirement eligible individuals will vest based on the agent's individual sales and continued service as an independent agent over a period of time not to exceed five years.

In January 2015, American Equity Life's agents were granted 27,985 shares of restricted stock and 221,489 restricted stock units based on their production during 2014, and we recorded commission expense (capitalized as deferred policy acquisition costs) of $1.9 million in 2014. In January 2016, agents vested in 85,104 restricted stock units granted in January of 2015 based on their continued service as an independent agent and their 2015 individual sales of our products, and for which we recorded commission expense (capitalized as deferred policy acquisition costs) of $1.3 million in 2015. In January 2017, agents vested in 36,609 restricted stock units granted in January 2015 based on their continued service as an independent agent and their 2016 individual sales of our products, and for which we recorded commission expense (capitalized as deferred policy acquisition costs) of $0.6 million in 2016. The restricted stock was granted to retirement eligible individuals and vested immediately upon grant. 20% of the restricted stock units vested one year from the grant date if the agent was in good standing with American Equity Life at that date. The remaining 80% of the restricted stock units granted will vest based on the agent's individual sales and continued service as an independent agent over a period of time not to exceed five years.

During 2007, 2010 and 2012 we established Independent Insurance Agent Stock Option plans. Under these plans, agents of American Equity Life received grants of options to acquire shares of our common stock based upon their individual sales. The plans authorize grants of options to agents for an aggregate of up to 8,000,000 shares of our common stock. We recognize commission expense and an increase to additional paid-in capital as share-based compensation equal to the fair value of the options as they are earned.

Changes in the number of stock options outstanding during the years ended December 31, 2016, 2015 and 2014 are as follows:

	Number of Shares		Weighted-Average Exercise Price per Share		Total Exercise Price
	(Dollars in thousands, except per share data)
Outstanding at January 1, 2014	3,976,725		$	10.86	$	43,171
Granted	1,277,650		24.79		31,673
Canceled	(35,400	)	11.64		(412		)
Exercised	(1,174,800	)	11.64		(13,672		)
Outstanding at December 31, 2014	4,044,175		15.02		60,760
Granted	—		—		—
Canceled	(47,300	)	10.54		(499		)
Exercised	(552,884	)	14.51		(8,021		)
Outstanding at December 31, 2015	3,443,991		15.17		52,240
Granted	—		—		—
Canceled	(24,700	)	14.83		(366		)
Exercised	(500,345	)	9.97		(4,989		)
Outstanding at December 31, 2016	2,918,946		16.06		$	46,885

The following table summarizes information about stock options outstanding at December 31, 2016:

	Stock Options Outstanding				Stock Options Vested
Range of Exercise Prices	Number of Awards	Remaining Life (yrs)	Weighted-Average Exercise Price Per Share		Number of Awards	Remaining Life (yrs)	Weighted-Average Exercise Price Per Share
$5.07 - $8.02	248,225	1.74	$	7.16	248,225	1.74	$	7.16
$9.27 - $11.35	752,150	2.66	10.19		752,150	2.66	10.19
$12.04 - $24.79	1,918,571	3.24	19.52		1,918,571	3.24	19.52
$5.07 - $24.79	2,918,946	2.97	16.06		2,918,946	2.97	16.06

The aggregate intrinsic value for stock options outstanding and vested awards was $21.3 million and $21.3 million, respectively, at December 31, 2016. For the years ended December 31, 2016, 2015 and 2014, the total intrinsic value of options exercised by officers, directors and employees was $4.0 million, $1.4 million and $5.4 million, respectively. Intrinsic value for stock options is calculated as the difference between the exercise price of the underlying awards and the price of our common stock as of the reporting date. Cash received from stock options exercised for the years ended December 31, 2016, 2015 and 2014 was $5.0 million, $8.1 million and $13.7 million, respectively. The tax benefit realized for the tax deduction from the exercise of stock options by officers, directors, employees and agents for the years ended December 31, 2016, 2015 and 2014, was $0.0 million, $0.0 million and $1.0 million, respectively.

We have deferred compensation arrangements with certain officers, directors, and consultants, whereby these individuals agreed to take our common stock at a future date in lieu of cash payments at the time of service. The common stock is to be issued in conjunction with a "trigger event," as that term is defined in the individual agreements. At December 31, 2016 and 2015, these individuals have earned, and we have reserved for future issuance, 364,000 and 366,072 shares of common stock, respectively, pursuant to these arrangements. No deferred compensation arrangements were in effect during 2016. We incurred expense of $102,000 and $127,000 for the years ended December 31, 2015 and 2014, respectively, under these arrangements.

We have deferred compensation agreements with certain officers whereby these individuals may defer certain salary and bonus compensation which is deposited into the American Equity Officer Rabbi Trust (Officer Rabbi Trust). The amounts deferred for certain employees are invested in assets at the direction of the employee. The assets of the Officer Rabbi Trust are included in our assets and a corresponding deferred compensation liability is recorded. The deferred compensation liability is recorded at the fair market value of the assets in the Officer Rabbi Trust with the change in fair value included as a component of compensation expense. The deferred compensation liability related to these agreements was $3.5 million and $3.7 million at December 31, 2016 and 2015, respectively. The Officer Rabbi Trust held 102,932 shares and 103,251 shares of our common stock at December 31, 2016 and 2015, respectively, which are treated as treasury shares.

During 1997, we established the American Equity Investment NMO Deferred Compensation Plan ("NMO Deferred Compensation Plan") whereby agents could earn common stock in addition to their normal commissions. The NMO Deferred Compensation Plan was effective until December 31, 2006 at which time it was suspended. Awards were calculated using formulas determined annually by our Board of Directors. These shares are being distributed at the end of the vesting and deferral period of nine years. We recognize commission expense and an increase to additional paid-in capital as share-based compensation when the awards vest. All outstanding shares issued under this plan were fully vested at December 31, 2010. At December 31, 2016 and 2015, the total number of undistributed vested shares under the NMO Deferred Compensation Plan was 0 and 223,454, respectively. These shares are included in the computation of earnings per share and earnings per share—assuming dilution.

We have a Rabbi Trust, the NMO Deferred Compensation Trust (the "NMO Trust"), which has purchased shares of our common stock to fund the amount of vested shares under the NMO Deferred Compensation Plan. The common stock held in the NMO Trust is treated as treasury stock. The NMO Trust distributed 215,273, 313,108 and 349,568 shares during 2016, 2015 and 2014, respectively. The number of shares held by the NMO Trust at December 31, 2016 and 2015, was 15,058 and 230,012, respectively.

XML

Statutory Financial Information and Dividend Restrictions

12 Months Ended

Dec. 31, 2016

Insurance [Abstract]

Statutory Financial Information and Dividend Restrictions

Statutory Financial Information and Dividend Restrictions

Statutory accounting practices prescribed or permitted by regulatory authorities for our life insurance subsidiaries differ from GAAP. Net income for our primary life insurance subsidiary as determined in accordance with statutory accounting practices was as follows:

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands)
American Equity Life	$	75,035	$	131,452	$	340,000

Statutory capital and surplus for our primary life insurance subsidiary was as follows:

	December 31,
	2016		2015
	(Dollars in thousands)
American Equity Life	$	2,726,664	$	2,415,419

American Equity Life is domiciled in the state of Iowa and is regulated by the Iowa Insurance Division. Life insurance companies are subject to the National Association of Insurance Commissioners ("NAIC") risk-based capital (RBC) requirements which are intended to be used by insurance regulators as an early warning tool to identify deteriorating or weakly capitalized insurance companies for the purpose of initiating regulatory action. Calculations using the NAIC formula indicated that American Equity Life's ratio of total adjusted capital to the highest level of required capital at which regulatory action might be initiated (Company Action Level) is as follows:

	December 31,
	2016			2015
	(Dollars in thousands)
Total adjusted capital	$	2,933,193		$	2,593,472
Company Action Level RBC	857,321			771,293
Ratio of adjusted capital to Company Action Level RBC	342		%	336		%

Prior approval of regulatory authorities is required for the payment of dividends to the parent company by American Equity Life which exceed an annual limitation. American Equity Life may pay dividends without prior approval, unless such payments, together with all other such payments within the preceding twelve months, exceed the greater of (1) net gain from operations before net realized capital gains/losses for the preceding calendar year or, (2) 10% of the American Equity Life's surplus at the preceding year-end. The amount of dividends permitted to be paid by American Equity Life to its parent company without prior approval of regulatory authorities is $272.7 million as of December 31, 2016. No dividends were paid by any of our insurance subsidiaries for any of the years presented in these financial statements.

The Parent Company relies on its subsidiaries for cash flow, which has primarily been in the form of investment management fees and/or dividends. Retained earnings in our consolidated financial statements primarily represent undistributed earnings of American Equity Life. As such, our ability to pay dividends is limited by the regulatory restriction placed upon insurance companies as described above. In addition, American Equity Life retains funds to allow for sufficient capital for growth.

XML

Commitments and Contingencies

12 Months Ended

Dec. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

We lease our home office space and certain equipment under various operating leases. Rent expense for the years ended December 31, 2016, 2015 and 2014 totaled $2.8 million, $2.7 million and $2.7 million, respectively. At December 31, 2016, the aggregate future minimum lease payments are $16.9 million. The following represents payments due by period for operating lease obligations as of December 31, 2016 (dollars in thousands):

Year Ending December 31:
2017	$	1,890
2018	1,915
2019	1,898
2020	1,950
2021	1,754
2022 and thereafter	7,464

We are occasionally involved in litigation, both as a defendant and as a plaintiff. In addition, state regulatory bodies, such as state insurance departments, the SEC, FINRA, the Department of Labor, and other regulatory bodies regularly make inquiries and conduct examinations or investigations concerning our compliance with, among other things, insurance laws, securities laws, the Employee Retirement Income Security Act of 1974, as amended, and laws governing the activities of broker/dealers.

In accordance with applicable accounting guidelines, we establish an accrued liability for litigation and regulatory matters when those matters present loss contingencies that are both probable and estimable. As a litigation or regulatory matter is developing we, in conjunction with outside counsel, evaluate on an ongoing basis whether the matter presents a loss contingency that meets conditions indicating the need for accrual and/or disclosure, and if not the matter will continue to be monitored for further developments. If and when the loss contingency related to litigation or regulatory matters is deemed to be both probable and estimable, we will establish an accrued liability with respect to that matter and will continue to monitor the matter for further developments that may affect the amount of the accrued liability.

Companies in the life insurance and annuity business have faced litigation, including class action lawsuits, alleging improper product design, improper sales practices and similar claims. We were a defendant in a purported class action, McCormack, et al. v. American Equity Investment Life Insurance Company, et al., in the United States District Court for the Central District of California, Western Division and Anagnostis v. American Equity, et al., coordinated in the Central District, entitled, In Re: American Equity Annuity Practices and Sales Litigation (complaint filed September 7, 2005) (the "Los Angeles Case"), involving allegations of improper sales practices and similar claims.

The Los Angeles Case was a consolidated action involving several lawsuits filed by putative class members seeking class action status for a national class of purchasers of annuities issued by us. On July 30, 2013, the parties entered into a settlement agreement and stipulated to certification of the case as a class action for settlement purposes only. A class member filed an appeal with the United States Court of Appeals for the Ninth Circuit on February 28, 2014. On February 17, 2016, the United States Court of Appeals for the Ninth Circuit affirmed the terms of the settlement agreement and on April 6, 2016, the class member’s subsequent request for a rehearing en banc was denied. All remaining opportunities for appeal have passed.

During the third quarter of 2016, we reduced the litigation liability related to the Los Angeles Case by $6.4 million as we paid out $1.8 million in partial settlement, reclassified $1.8 million from the litigation liability to policy benefit reserves and other policy funds and contract claims and released $2.8 million of the litigation liability as additional information became available concerning the nature and magnitude of claims based on the terms of the settlement. During the fourth quarter of 2016, we paid out an additional $4.1 million and reduced the litigation liability by $4.1 million. After this activity, we estimate our litigation liability in this matter to be $0.6 million based on our best estimate of probable loss. There can be no assurance that any other pending or future litigation will not have a material adverse effect on our business, financial condition, or results of operations.

In addition to our commitments to fund mortgage loans, we have unfunded commitments at December 31, 2016 to limited partnerships of $48.4 million and to secured bank loans of $34.3 million.

XML

Earnings Per Share and Stockholders' Equity

12 Months Ended

Dec. 31, 2016

Earnings Per Share [Abstract]

Earnings Per Share and Stockholders' Equity

Earnings Per Share and Stockholders' Equity

Earnings Per Share

The following table sets forth the computation of earnings per common share and earnings per common share—assuming dilution:

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands, except per share data)
Numerator:
Net income—numerator for earnings per common share	$	83,243	$	219,830	$	126,023
Denominator:
Weighted average common shares outstanding (1)	84,793,151		78,936,828		74,431,087
Effect of dilutive securities:
Convertible senior notes	—		—		2,657,158
Equity forward sale agreements	—		67,575		—
2015 warrants	15,136		759,723		1,559,646
Stock options and deferred compensation agreements	456,236		1,040,922		1,178,783
Restricted stock and restricted stock units	340,646		155,520		66,926
Denominator for earnings per common share—assuming dilution	85,605,169		80,960,568		79,893,600
Earnings per common share	$	0.98	$	2.78	$	1.69
Earnings per common share—assuming dilution	$	0.97	$	2.72	$	1.58

(1) Weighted average common shares outstanding include shares vested under the NMO Deferred Compensation Plan and exclude unallocated shares held by the ESOP.

Options to purchase shares of our common stock that were outstanding during the respective periods indicated but were not included in the computation of diluted earnings per share because the options' exercise price was greater than the average market price of the common shares are as follows:

Period	Number of Shares	Range of Exercise Prices
		Minimum	Maximum
Year ended December 31, 2016	1,054,091	$24.79	$24.79
Year ended December 31, 2015	1,061,541	$24.79	$24.79
Year ended December 31, 2014	1,215,450	$24.79	$24.79

Stockholders' Equity

In August 2015, we completed an underwritten public offering of 8,600,000 shares of our common stock at a public offering price of $25.25 per share, of which 4,300,000 shares were subject to a forward sale agreement. The underwriters exercised in full their option to purchase 1,290,000 additional shares of common stock, which were subject to a separate forward sale agreement. We settled the forward sale agreements on August 1, 2016 and issued 5,590,000 shares of our common stock and received $134.7 million in net proceeds. We contributed the net proceeds from the settlement to the capital and surplus of American Equity Life.

The forward sale agreements had no initial fair value since they were entered into at the then market price of the common stock. The forward sale agreements were equity instruments and qualified for an exception from derivative and fair value accounting.

XML

Quarterly Financial Information (Unaudited)

12 Months Ended

Dec. 31, 2016

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information (Unaudited)

Quarterly Financial Information (Unaudited)

Unaudited quarterly results of operations are summarized below.

	Quarter Ended
	March 31,			June 30,			September 30,			December 31,
	(Dollars in thousands, except per share data)
2016
Premiums and product charges	$	43,850		$	52,582		$	60,406		$	60,508
Net investment income	450,826			459,830			463,583			475,633
Change in fair value of derivatives	(74,065		)	39,099			103,794			95,391
Net realized gains (losses) on investments, excluding OTTI losses	2,687			2,737			5,256			844
Net OTTI losses recognized in operations	(5,694		)	(4,446		)	(2,979		)	(9,560		)
Total revenues	417,604			549,802			630,060			622,816
Net income (loss)	(44,841		)	14,708			(7,420		)	120,796
Earnings (loss) per common share	(0.55		)	0.18			(0.09		)	1.37
Earnings (loss) per common share—assuming dilution	(0.55		)	0.18			(0.09		)	1.35
2015
Premiums and product charges	$	35,679		$	42,446		$	46,310		$	47,781
Net investment income	399,669			418,176			436,085			438,262
Change in fair value of derivatives	(31,100		)	(23,024		)	(351,360		)	69,338
Net realized gains (losses) on investments, excluding OTTI losses	4,879			4,324			1,159			(151		)
Net OTTI losses recognized in operations	(132		)	(828		)	(5,229		)	(13,347		)
Total revenues	408,995			441,094			126,965			541,883
Net income	5,903			82,845			97,306			33,776
Earnings per common share	0.08			1.07			1.22			0.41
Earnings per common share—assuming dilution	0.07			1.05			1.19			0.40

Earnings (loss) per common share for each quarter is computed independently of earnings (loss) per common share for the year. As a result, the sum of the quarterly earnings (loss) per common share amounts may not equal the earnings (loss) per common share for the year.

The differences between the change in fair value of derivatives for each quarter primarily correspond to the performance of the indices upon which our call options are based. The comparability of net income (loss) is impacted by the application of fair value accounting to our fixed index annuity business is as follows:

	Quarter Ended
	March 31,		June 30,			September 30,			December 31,
	(Dollars in thousands)
2016	$	62,822	$	34,215		$	6,054		$	(66,618	)
2015	42,849		(28,596		)	(53,716		)	11,091

XML

Schedule I - Summary of Investments - Other Than Investments in Related Parties

12 Months Ended

Dec. 31, 2016

Summary of Investments, Other than Investments in Related Parties [Abstract]

Schedule I - Summary of Investments - Other Than Investments in Related Parties

Schedule I—Summary of Investments—

Other Than Investments in Related Parties

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

December 31, 2016

Column A	Column B		Column C		Column D
Type of Investment	Amortized Cost (1)		Fair Value		Amount at which shown in the balance sheet
	(Dollars in thousands)
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	11,864	$	11,805	$	11,805
United States Government sponsored agencies	1,368,340		1,344,787		1,344,787
United States municipalities, states and territories	3,626,395		3,926,950		3,926,950
Foreign government obligations	224,588		232,233		232,233
Corporate securities	26,338,214		27,118,526		27,118,526
Residential mortgage backed securities	1,166,944		1,254,835		1,254,835
Commercial mortgage backed securities	5,422,255		5,365,235		5,365,235
Other asset backed securities	1,795,355		1,806,123		1,806,123
	39,953,955		41,060,494		41,060,494
Held for investment:
Corporate security	76,825		68,766		76,825
Total fixed maturity securities	40,030,780		41,129,260		41,137,319
Mortgage loans on real estate	2,480,956		2,522,035		2,480,956
Derivative instruments	313,729		830,519		830,519
Other investments	308,296				308,774
Total investments	$	43,133,761			$	44,757,568

(1) On the basis of cost adjusted for other than temporary impairments, repayments and amortization of premiums and accrual of discounts for fixed maturity securities and short-term investments, original cost for derivative instruments and unpaid principal balance less allowance for credit losses for mortgage loans.

See accompanying Report of Independent Registered Public Accounting Firm.

XML

Schedule II - Condensed Financial Information of Registrant

12 Months Ended

Dec. 31, 2016

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Schedule II - Condensed Financial Information of Registrant

	December 31,
	2016		2015
Assets
Cash and cash equivalents	$	36,394	$	38,903
Equity securities of subsidiary trusts	7,422		7,415
Receivable from subsidiaries	182		207
Deferred income taxes	9,528		11,645
Federal income tax recoverable, including amount from subsidiaries	—		7,747
Other assets	2,540		2,270
	56,066		68,187
Investment in and advances to subsidiaries	2,992,217		2,526,972
Total assets	$	3,048,283	$	2,595,159
Liabilities and Stockholders' Equity
Liabilities:
Notes and loan payable	$	493,755	$	393,227
Subordinated debentures payable to subsidiary trusts	241,853		241,452
Federal income tax payable	3,614		—
Other liabilities	17,466		15,945
Total liabilities	756,688		650,624
Stockholders' equity:
Common stock	88,001		81,354
Additional paid-in capital	770,344		630,367
Accumulated other comprehensive income	339,966		201,663
Retained earnings	1,093,284		1,031,151
Total stockholders' equity	2,291,595		1,944,535
Total liabilities and stockholders' equity	$	3,048,283	$	2,595,159

See accompanying note to condensed financial statements.

See accompanying Report of Independent Registered Public Accounting Firm.

	Year Ended December 31,
	2016			2015			2014
Revenues:
Net investment income	$	78		$	62		$	130
Dividends from subsidiary trusts	384			363			360
Investment advisory fees	75,706			65,957			58,044
Surplus note interest from subsidiary	4,080			4,080			4,080
Change in fair value of derivatives	(810		)	(8,225		)	(17,122		)
Loss on extinguishment of debt	—			—			(12,502		)
Total revenues	79,438			62,237			32,990
Expenses:
Change in fair value of embedded derivatives	—			(4,516		)	(15,227		)
Interest expense on notes and loan payable	28,248			28,849			36,370
Interest expense on subordinated debentures issued to subsidiary trusts	12,958			12,239			12,122
Other operating costs and expenses	8,551			8,195			7,928
Total expenses	49,757			44,767			41,193
Income (loss) before income taxes and equity in undistributed income of subsidiaries	29,681			17,470			(8,203		)
Income tax expense	12,073			7,338			664
Income (loss) before equity in undistributed income of subsidiaries	17,608			10,132			(8,867		)
Equity in undistributed income of subsidiaries	65,635			209,698			134,890
Net income	$	83,243		$	219,830		$	126,023

See accompanying note to condensed financial statements.

See accompanying Report of Independent Registered Public Accounting Firm.

	Year Ended December 31,
	2016			2015			2014
Operating activities
Net income	$	83,243		$	219,830		$	126,023
Adjustments to reconcile net income to net cash provided by operating activities:
Change in fair value of 2015 notes embedded conversion derivative	—			(4,516		)	(15,227		)
Provision for depreciation and amortization	1,946			1,613			2,081
Accrual of discount on equity security	(7		)	(6		)	(6		)
Equity in undistributed income of subsidiaries	(65,635		)	(209,698		)	(134,890		)
Accrual of discount on contingent convertible notes	—			698			4,417
Change in fair value of derivatives	(698		)	6,377			15,619
Loss on extinguishment of debt	—			—			12,502
Accrual of discount on debenture issued to subsidiary trust	221			207			193
Share-based compensation	818			1,026			1,141
ESOP compensation	—			—			82
Deferred income taxes	2,117			8,967			6,439
Other	—			—			(2,235		)
Changes in operating assets and liabilities:
Receivable from subsidiaries	(125		)	93			2,208
Federal income tax recoverable	11,361			2,683			1,121
Other assets	(326		)	(4		)	378
Other liabilities	2,546			(1,664		)	(7,256		)
Net cash provided by operating activities	35,461			25,606			12,590
Investing activities
Capital contributions to subsidiaries	$	(255,000	)	$	(120,000	)	$	—
Purchases of property, plant and equipment	(54		)	—			—
Net cash used in investing activities	(255,054		)	(120,000		)	—
Financing activities
Financing fees incurred and deferred	$	(1,456	)	$	—		$	(100	)
Repayments of notes payable	—			(48,152		)	(219,094		)
Net proceeds from settlement of notes hedges and warrants	—			25,775			16,558
Proceeds from issuance of debt	100,000			—			—
Excess tax benefits realized from share-based compensation plans	—			—			184
Proceeds from issuance of common stock	139,654			112,481			13,681
Dividends paid	(21,114		)	(17,946		)	(15,221		)
Net cash provided by (used in) financing activities	217,084			72,158			(203,992		)
Decrease in cash and cash equivalents	(2,509		)	(22,236		)	(191,402		)
Cash and cash equivalents at beginning of year	38,903			61,139			252,541
Cash and cash equivalents at end of year	$	36,394		$	38,903		$	61,139
Supplemental disclosures of cash flow information
Cash paid during the year for:
Interest on notes and loan payable	$	27,164		$	27,283		$	31,206
Interest on subordinated debentures	12,454			11,833			11,765
Non-cash financing activity:
Common stock issued in extinguishment of debt	—			—			95,993
Common stock issued to settle warrants that have expired	93			48			—

See accompanying note to condensed financial statements.

See accompanying Report of Independent Registered Public Accounting Firm.

1.     Basis of Presentation

The accompanying condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto of American Equity Investment Life Holding Company (Parent Company).

In the Parent Company financial statements, its investment in and advances to subsidiaries are stated at cost plus equity in undistributed income (losses) of subsidiaries since the date of acquisition and net unrealized gains/losses on the subsidiaries' fixed maturity securities classified as "available for sale" and equity securities.

See Notes 9 and 10 to the consolidated financial statements for a description of the Parent Company's notes payable and subordinated debentures payable to subsidiary trusts.

XML

Schedule III - Supplementary Insurance Information

12 Months Ended

Dec. 31, 2016

Supplementary Insurance Information [Abstract]

Schedule III - Supplementary Insurance Information

Schedule III—Supplementary Insurance Information

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

Column A	Column B		Column C		Column D		Column E
	Deferred policy acquisition costs		Future policy benefits, losses, claims and loss expenses		Unearned premiums		Other policy claims and benefits payable
	(Dollars in thousands)
As of December 31, 2016: Life insurance	$	2,905,377	$	51,637,026	$	—	$	298,347
As of December 31, 2015: Life insurance	$	2,905,136	$	45,495,431	$	—	$	324,850
As of December 31, 2014: Life insurance	$	2,058,556	$	39,802,861	$	—	$	365,819

Column A	Column F		Column G		Column H		Column I		Column J
	Premium revenue		Net investment income		Benefits, claims, losses and settlement expenses		Amortization of deferred policy acquisition costs		Other operating expenses
	(Dollars in thousands)
For the year ended December 31, 2016: Life insurance	$	217,346	$	1,849,872	$	1,572,586	$	374,012	$	143,437
For the year ended December 31, 2015: Life insurance	$	172,216	$	1,692,192	$	758,203	$	286,114	$	137,306
For the year ended December 31, 2014: Life insurance	$	151,613	$	1,531,667	$	1,679,255	$	163,578	$	130,076

See accompanying Report of Independent Registered Public Accounting Firm.

XML

Schedule IV - Reinsurance

12 Months Ended

Dec. 31, 2016

Supplemental Schedule of Reinsurance Premiums for Insurance Companies [Abstract]

Schedule IV - Reinsurance

Schedule IV—Reinsurance

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

Column A	Column B		Column C		Column D		Column E		Column F
	Gross amount		Ceded to other companies		Assumed from other companies		Net amount		Percent of amount assumed to net
	(Dollars in thousands)
Year ended December 31, 2016
Life insurance in force, at end of year	$	1,996,446	$	10,045	$	57,849	$	2,044,250	2.83	%
Insurance premiums and other considerations:
Annuity product charges	$	178,945	$	5,366	$	—	$	173,579	—
Traditional life, accident and health insurance, and life contingent immediate annuity premiums	43,521		251		497		43,767		1.14	%
	$	222,466	$	5,617	$	497	$	217,346	0.23	%
Year ended December 31, 2015
Life insurance in force, at end of year	$	2,036,690	$	10,677	$	56,882	$	2,082,895	2.73	%
Insurance premiums and other considerations:
Annuity product charges	$	141,595	$	5,427	$	—	$	136,168	—
Traditional life, accident and health insurance, and life contingent immediate annuity premiums	35,715		256		589		36,048		1.63	%
	$	177,310	$	5,683	$	589	$	172,216	0.34	%
Year ended December 31, 2014
Life insurance in force, at end of year	$	2,171,426	$	11,548	$	56,509	$	2,216,387	2.55	%
Insurance premiums and other considerations:
Annuity product charges	$	124,946	$	5,956	$	—	$	118,990	—
Traditional life, accident and health insurance, and life contingent immediate annuity premiums	32,308		336		651		32,623		2.00	%
	$	157,254	$	6,292	$	651	$	151,613	0.43	%

See accompanying Report of Independent Registered Public Accounting Firm.

XML

Schedule V - Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2016

Valuation and Qualifying Accounts [Abstract]

Schedule V - Valuation and Qualifying Accounts

Schedule V—Valuation and Qualifying Accounts

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

	Balance January 1,			Charged to Costs and Expenses			Translation Adjustment		Write-offs/ Payments/Other		Balance December 31,
	(Dollars in thousands
Year ended December 31, 2016
Valuation allowance on mortgage loans	$	(14,142	)	$	(4,846	)	$	—	$	10,561	$	(8,427	)
Year ended December 31, 2015
Valuation allowance on mortgage loans	$	(22,633	)	$	1,018		$	—	$	7,473	$	(14,142	)
Year ended December 31, 2014
Valuation allowance on mortgage loans	$	(26,047	)	$	(6,052	)	$	—	$	9,466	$	(22,633	)

See accompanying Report of Independent Registered Public Accounting Firm.

XML

Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2016

Accounting Policies [Abstract]

Consolidation and Basis of Presentation, Policy

Consolidation and Basis of Presentation

The consolidated financial statements include our accounts and our wholly-owned subsidiaries: American Equity Life, American Equity Life of New York, Eagle Life, AERL, L.C., American Equity Capital, Inc., American Equity Investment Properties, L.C., American Equity Advisors, Inc. and American Equity Investment Service Company. All significant intercompany accounts and transactions have been eliminated.

Estimates and Assumptions, Policy

Estimates and Assumptions

The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are utilized in the calculation of deferred policy acquisition costs, deferred sales inducements, policy benefit reserves, valuation of derivatives, including embedded derivatives on index annuity reserves, contingent convertible senior notes, valuation of investments, other than temporary impairment of investments, allowances for loan losses on mortgage loans and valuation allowances on deferred tax assets. A description of each critical estimate is incorporated within the discussion of the related accounting policies which follow. It is reasonably possible that actual experience could differ from the estimates and assumptions utilized.

Investments, Policy

Investments

Fixed maturity securities (bonds and redeemable preferred stocks maturing more than one year after issuance) that may be sold prior to maturity are classified as available for sale. Available for sale securities are reported at fair value and unrealized gains and losses, if any, on these securities are included directly in a separate component of stockholders' equity, net of income taxes and certain adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements. Fair values, as reported herein, of fixed maturity and equity securities are based on quoted market prices in active markets when available, or for those fixed maturity securities not actively traded, yield data and other factors relating to instruments or securities with similar characteristics are used. See Note 2 for more information on the determination of fair value. Premiums and discounts are amortized/accrued using methods which result in a constant yield over the securities' expected lives. Amortization/accrual of premiums and discounts on residential and commercial mortgage backed securities incorporate prepayment assumptions to estimate the securities' expected lives. Interest income is recognized as earned.

Fixed maturity securities that we have the positive intent and ability to hold to maturity are classified as held for investment. Such securities may, at times, be called prior to maturity. Held for investment securities are reported at cost adjusted for amortization of premiums and discounts. Changes in the fair value of these securities, except for declines that are other than temporary, are not reflected in our consolidated financial statements.

The carrying amounts of our impaired investments in fixed maturity and equity securities are adjusted for declines in value that are other than temporary. Other than temporary impairment losses are reported as a component of revenues in the consolidated statements of operations, which presents the amount of noncredit impairment losses for certain fixed maturity securities that is reported in accumulated other comprehensive income (loss). See Note 3 for further discussion of other than temporary impairment losses.

Deterioration in credit quality of the companies or assets backing our investment securities, deterioration in the condition of the financial services industry, imbalances in liquidity recurring in the marketplace or declines in real estate values may further affect the fair value of these investment securities and increase the potential that certain unrealized losses will be recognized as other than temporary impairments in the future.

Mortgage loans on real estate are reported at cost, adjusted for amortization of premiums and accrual of discounts. Interest income is recorded when earned; however, interest ceases to accrue for loans on which interest is more than 90 days past due based upon contractual terms and/or when the collection of interest is not considered probable. We evaluate the mortgage loan portfolio for the establishment of a loan loss allowance by specific identification of impaired loans and the measurement of an estimated loss, if any, for each impaired loan identified and an analysis of the mortgage loan portfolio for the need of a general loan allowance for probable losses on all loans. If we determine that the value of any specific mortgage loan is impaired, the carrying amount of the mortgage loan will be reduced to its fair value, based upon the present value of expected future cash flows from the loan discounted at the loan's contractual interest rate, or the fair value of the underlying collateral, less costs to sell. The amount of the general loan allowance, if any, is based upon our evaluation of the probability of collection, historical loss experience, delinquencies, credit concentrations, underwriting standards and national and local economic conditions. The carrying value of impaired loans is reduced by the establishment of an allowance for loan losses, changes to which are recognized as realized gains or losses on investments. Interest income on impaired loans is recorded on a cash basis.

Other invested assets include company owned life insurance, equity securities, real estate, limited partnerships accounted for using the equity method and policy loans. Company owned life insurance is recorded at the amount that can be realized under the insurance contract at the end of the reporting period, which is the cash surrender value adjusted for other charges or other amounts due that are probable at settlement. Equity securities are classified as available for sale and are reported at fair value. Unrealized gains and losses are included directly in a separate component of stockholders' equity, net of income taxes and certain adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements. Dividends are recognized when declared. Policy loans are stated at current unpaid principal balances.

Real estate owned is reported at cost less accumulated depreciation. Cost is determined at the time ownership is acquired in satisfaction of mortgage loans and is the lower of the carrying value of the mortgage loan or fair value of the real estate less its estimated cost to sell. Buildings and improvements are depreciated using the straight-line method over their estimated useful lives. Impairment losses on real estate owned are recognized when there are indicators of impairment present and the expected future undiscounted cash flows are not sufficient to recover the real estate's carrying value. Any impairment losses are reported as realized losses and are part of net income.

The determination of the credit loss component of a corporate bond (including redeemable preferred stocks) is based on the underlying financial performance of the issuer and their ability to meet their contractual obligations. Considerations in our evaluation include, but are not limited to, credit rating changes, financial statement and ratio analysis, changes in management, significant changes in credit spreads, breaches of financial covenants and a review of the economic outlook for the industry and markets in which they trade. In circumstances where an issuer appears unlikely to meet its future obligation, or the security's price decline is deemed other than temporary, an estimate of credit loss is determined. Credit loss is calculated using default probabilities as derived from the credit default swaps markets in conjunction with recovery rates derived from independent third party analysis or a best estimate of credit loss. This credit loss rate is then incorporated into a present value calculation based on an expected principal loss in the future discounted at the yield at the date of purchase and compared to amortized cost to determine the amount of credit loss associated with the security.

In addition, for debt securities which we do not intend to sell and it is not more likely than not we will be required to sell, but our intent changes due to changes or events that could not have been reasonably anticipated, an other than temporary impairment charge is recognized. Once an impairment charge has been recorded, we then continue to review the other than temporarily impaired securities for appropriate valuation on an ongoing basis. Unrealized losses may be recognized in future periods through a charge to earnings should we later conclude that the decline in fair value below amortized cost is other than temporary pursuant to our accounting policy described above. The use of different methodologies and assumptions to determine the fair value of investments and the timing and amount of impairments may have a material effect on the amounts presented in our consolidated financial statements.

We review and analyze all investments on an ongoing basis for changes in market interest rates and credit deterioration. This review process includes analyzing our ability to recover the amortized cost basis of each investment that has a fair value that is materially lower than its amortized cost and requires a high degree of management judgment and involves uncertainty. The evaluation of securities for other than temporary impairments is a quantitative and qualitative process, which is subject to risks and uncertainties.

We have a policy and process to identify securities that could potentially have impairments that are other than temporary. This process involves monitoring market events and other items that could impact issuers. The evaluation includes but is not limited to such factors as:

• the length of time and the extent to which the fair value has been less than amortized cost or cost;

• whether the issuer is current on all payments and all contractual payments have been made as agreed;

• the remaining payment terms and the financial condition and near-term prospects of the issuer;

• the lack of ability to refinance due to liquidity problems in the credit market;

• the fair value of any underlying collateral;

• the existence of any credit protection available;

• our intent to sell and whether it is more likely than not we would be required to sell prior to recovery for debt securities;

• our assessment in the case of equity securities including perpetual preferred stocks with credit deterioration that the security cannot recover to cost in a reasonable period of time;

• our intent and ability to retain equity securities for a period of time sufficient to allow for recovery;

• consideration of rating agency actions; and

• changes in estimated cash flows of mortgage and asset backed securities.

We determine whether other than temporary impairment losses should be recognized for debt and equity securities by assessing all facts and circumstances surrounding each security. Where the decline in fair value of debt securities is attributable to changes in market interest rates or to factors such as market volatility, liquidity and spread widening, and we anticipate recovery of all contractual or expected cash flows, we do not consider these investments to be other than temporarily impaired because we do not intend to sell these investments and it is not more likely than not we will be required to sell these investments before a recovery of amortized cost, which may be maturity. For equity securities, we recognize an impairment charge in the period in which we do not have the intent and ability to hold the securities until recovery of cost or we determine that the security will not recover to book value within a reasonable period of time. We determine what constitutes a reasonable period of time on a security-by-security basis by considering all the evidence available to us, including the magnitude of any unrealized loss and its duration.

Other than temporary impairment losses on equity securities are recognized in operations. If we intend to sell a debt security or if it is more likely than not that we will be required to sell a debt security before recovery of its amortized cost basis, other than temporary impairment has occurred and the difference between amortized cost and fair value will be recognized as a loss in operations.

If we do not intend to sell and it is not more likely than not we will be required to sell the debt security but also do not expect to recover the entire amortized cost basis of the security, an impairment loss would be recognized in operations in the amount of the expected credit loss. We determine the amount of expected credit loss by calculating the present value of the cash flows expected to be collected discounted at each security's acquisition yield based on our consideration of whether the security was of high credit quality at the time of acquisition. The difference between the present value of expected future cash flows and the amortized cost basis of the security is the amount of credit loss recognized in operations. The remaining amount of the other than temporary impairment is recognized in other comprehensive income (loss).

The determination of the credit loss component of a mortgage backed security is based on a number of factors. The primary consideration in this evaluation process is the issuer's ability to meet current and future interest and principal payments as contractually stated at time of purchase. Our review of these securities includes an analysis of the cash flow modeling under various default scenarios considering independent third party benchmarks, the seniority of the specific tranche within the structure of the security, the composition of the collateral and the actual default, loss severity and prepayment experience exhibited. With the input of third party assumptions for default projections, loss severity and prepayment expectations, we evaluate the cash flow projections to determine whether the security is performing in accordance with its contractual obligation.

We utilize the models from a leading structured product software specialist serving institutional investors. These models incorporate each security's seniority and cash flow structure. In circumstances where the analysis implies a potential for principal loss at some point in the future, we use the "best estimate" cash flow projection discounted at the security's effective yield at acquisition to determine the amount of our potential credit loss associated with this security. The discounted expected future cash flows equates to our expected recovery value. Any shortfall of the expected recovery when compared to the amortized cost of the security will be recorded as the credit loss component of the other than temporary impairment.

The cash flow modeling is performed on a security-by-security basis and incorporates actual cash flows on the residential mortgage backed securities through the current period, as well as the projection of remaining cash flows using a number of assumptions including default rates, prepayment rates and loss severity rates. The default curves we use are tailored to the Prime or Alt-A residential mortgage backed securities that we own, which assume lower default rates and loss severity for Prime securities versus Alt-A securities. These default curves are scaled higher or lower depending on factors such as current underlying mortgage loan performance, rating agency loss projections, loan to value ratios, geographic diversity, as well as other appropriate considerations.

Derivative Instruments, Policy

Derivative Instruments

Our derivative instruments include call options used to fund fixed index annuity credits, interest rate swap and caps used to manage interest rate risk associated with the floating rate component on certain of our subordinated debentures, call options to hedge the conversion spread on our convertible senior notes (see Note 9) and certain other derivative instruments embedded in other contracts. All of our derivative instruments are recognized in the balance sheet at fair value and changes in fair value are recognized immediately in operations. See Note 5 for more information on derivative instruments.

Cash and Cash Equivalents, Policy

Cash and Cash Equivalents

We consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

We also consider reverse repurchase agreements, which typically have an initial maturity of 6 weeks or less, to be cash equivalents. Amounts advanced under these agreements represent short-term loans that carry a fixed rate of interest. Borrowers under these agreements are required to post collateral that is investment grade debt securities with fair value in excess of the amount advanced.

Book Overdrafts

Under our cash management system, checks issued but not yet presented to banks frequently result in overdraft balances for accounting purposes and are classified as Other liabilities on our consolidated balance sheets. We report the changes in the amount of the overdraft balance as a financing activity in our consolidated statement of cash flows as Change in checks in excess of cash balance.

Deferred Policy Acquisition Costs, Policy

Deferred Policy Acquisition Costs and Deferred Sales Inducements

To the extent recoverable from future policy revenues and gross profits, certain costs that are incremental or directly related to the successful production of new business are not expensed when incurred but instead are capitalized as deferred policy acquisition costs or deferred sales inducements. Deferred policy acquisition costs and deferred sales inducements are subject to loss recognition testing on a quarterly basis or when an event occurs that may warrant loss recognition. Deferred policy acquisition costs consist primarily of commissions and certain costs of policy issuance. Deferred sales inducements consist of premium and interest bonuses credited to policyholder account balances.

For annuity products, these capitalized costs are being amortized generally in proportion to expected gross profits from investment spreads, including the cost of hedging the fixed indexed annuity obligations, and, to a lesser extent, from product charges net of expected excess payments for lifetime income benefit riders, and mortality and expense margins. Current and future period gross profits/margins for fixed index annuities also include the impact of amounts recorded for the change in fair value of derivatives and the change in fair value of embedded derivatives. That amortization is adjusted retrospectively through an unlocking process when estimates of current or future gross profits/margins (including the impact of net realized gains on investments and net OTTI losses recognized in operations) to be realized from a group of products are revised. Deferred policy acquisition costs and deferred sales inducements are also adjusted for the change in amortization that would have occurred if available for sale fixed maturity securities and equity securities had been sold at their aggregate fair value at the end of the reporting period and the proceeds reinvested at current yields. The impact of this adjustment is included in accumulated other comprehensive income within consolidated stockholders' equity, net of applicable taxes. See Note 6 for more information on deferred policy acquisition costs and deferred sales inducements.

Deferred Sales Inducements, Policy

Deferred Policy Acquisition Costs and Deferred Sales Inducements

To the extent recoverable from future policy revenues and gross profits, certain costs that are incremental or directly related to the successful production of new business are not expensed when incurred but instead are capitalized as deferred policy acquisition costs or deferred sales inducements. Deferred policy acquisition costs and deferred sales inducements are subject to loss recognition testing on a quarterly basis or when an event occurs that may warrant loss recognition. Deferred policy acquisition costs consist primarily of commissions and certain costs of policy issuance. Deferred sales inducements consist of premium and interest bonuses credited to policyholder account balances.

For annuity products, these capitalized costs are being amortized generally in proportion to expected gross profits from investment spreads, including the cost of hedging the fixed indexed annuity obligations, and, to a lesser extent, from product charges net of expected excess payments for lifetime income benefit riders, and mortality and expense margins. Current and future period gross profits/margins for fixed index annuities also include the impact of amounts recorded for the change in fair value of derivatives and the change in fair value of embedded derivatives. That amortization is adjusted retrospectively through an unlocking process when estimates of current or future gross profits/margins (including the impact of net realized gains on investments and net OTTI losses recognized in operations) to be realized from a group of products are revised. Deferred policy acquisition costs and deferred sales inducements are also adjusted for the change in amortization that would have occurred if available for sale fixed maturity securities and equity securities had been sold at their aggregate fair value at the end of the reporting period and the proceeds reinvested at current yields. The impact of this adjustment is included in accumulated other comprehensive income within consolidated stockholders' equity, net of applicable taxes. See Note 6 for more information on deferred policy acquisition costs and deferred sales inducements.

Policy Benefit Reserves, Policy

Policy Benefit Reserves

Policy benefit reserves for fixed index annuities with returns linked to the performance of a specified market index are equal to the sum of the fair value of the embedded derivatives and the host (or guaranteed) component of the contracts. The host value is established at inception of the contract and accreted over the policy's life at a constant rate of interest. Future policy benefit reserves for fixed index annuities earning a fixed rate of interest and other deferred annuity products are computed under a retrospective deposit method and represent policy account balances before applicable surrender charges. For the years ended December 31, 2016, 2015 and 2014, interest crediting rates for these products ranged from 1.00% to 3.30%.

The liability for lifetime income benefit riders is based on estimates of the value of benefit payments expected to be paid in excess of projected policy values recognizing the excess over the expected lives of the underlying policies based on actual and expected assessments including spreads and product charges and fees. The inputs used in the calculation of the liability for lifetime income benefit riders include actual policy values, actual income account values, actual payout factors, actual roll-up rates and our best estimate assumptions for future policy growth, future policy decrements, the ages at which policyholders are expected to elect to begin to receive lifetime income benefit payments, the percentage of policyholders who elect to receive lifetime income benefit payments and the type of income benefit payments selected upon election.

Policy benefit reserves are not reduced for amounts ceded under coinsurance agreements which are reported as coinsurance deposits on our consolidated balance sheets. See Note 7 for more information on reinsurance.

The liability for future policy benefits for traditional life insurance is based on net level premium reserves, including assumptions as to interest, mortality, and other assumptions underlying the guaranteed policy cash values. Reserve interest assumptions are level and range from 3.00% to 5.50%. Policy benefit claims are charged to expense in the period that the claims are incurred.

Deferred Income Taxes, Policy

Deferred Income Taxes

Deferred income tax assets or liabilities are computed based on the temporary differences between the financial statement and income tax bases of assets and liabilities using the enacted marginal tax rate. Deferred income tax expenses or benefits are based on the changes in the asset or liability from period to period. Deferred income tax assets are subject to ongoing evaluation of whether such assets will more likely than not be realized. The realization of deferred income tax assets primarily depends on generating future taxable income during the periods in which temporary differences become deductible. Deferred income tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax asset will not be realized. In making such a determination, all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations, is considered. The realization of deferred income tax assets related to unrealized losses on available for sale fixed maturity securities is also based upon our intent and ability to hold those securities for a period of time sufficient to allow for a recovery in fair value and not realize the unrealized loss.

Recognition of Premium Revenues and Costs, Policy

Recognition of Premium Revenues and Costs

Revenues for annuity products include surrender and living income benefit rider charges assessed against policyholder account balances during the period. Interest sensitive and index product benefits related to annuity products include interest credited or index credits to policyholder account balances pursuant to accounting by insurance companies for certain long-duration contracts. The change in fair value of the embedded derivatives for fixed index annuities equals the change in the difference between policy benefit reserves for fixed index annuities computed under the derivative accounting standard and the long-duration contracts accounting standard at each balance sheet date.

Considerations from immediate annuities with life contingencies are recognized as revenue when the policy is issued.

Traditional life insurance premiums are recognized as revenues over the premium-paying period. Certain group policies include provisions for annual experience refunds of premiums equal to net premiums received less an administrative fee and less claims incurred. Such amounts (2016 - $1.5 million; 2015 - $1.5 million; and 2014 - $1.7 million) are reported as a reduction of traditional life insurance premiums in the consolidated statements of operations. Future policy benefits are recognized as expenses over the life of the policy by means of the provision for future policy benefits.

All insurance-related revenues, including the change in the fair value of derivatives for call options related to the business ceded under coinsurance agreements (see Note 7), benefits, losses and expenses are reported net of reinsurance ceded.

Other Comprehensive Income (Loss), Policy

Other Comprehensive Income (Loss)

Other comprehensive income (loss) includes all changes in stockholders' equity during a period except those resulting from investments by and distributions to stockholders. Other comprehensive income (loss) excludes net realized investment gains (losses) included in net income which merely represent transfers from unrealized to realized gains and losses.

New Accounting Pronouncements, Policy

New Accounting Pronouncements

In January 2016, the FASB issued an ASU that, among other aspects of recognition, measurement, presentation and disclosure of financial instruments, primarily requires equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Additionally, it changes the accounting for financial liabilities measured at fair value under the fair value option and eliminates some disclosures regarding fair value of financial assets and liabilities measured at amortized cost. This ASU will be effective for us on January 1, 2018, and we have not determined the effect it will have on our consolidated financial statements.

In February 2016, the FASB issued an ASU that will require recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This ASU affects accounting and disclosure more dramatically for lessees as accounting for lessors is mainly unchanged. This ASU will be effective for us on January 1, 2019, with early adoption permitted, and we have not determined the effect it will have on our consolidated financial statements.

In March 2016, the FASB issued an ASU related to the accounting for share-based payment transactions. The aspects of accounting guidance affected by this ASU are income taxes, classification of awards as either equity or liabilities, and classification on the statement of cash flows. This ASU will be effective for us on January 1, 2017, with early adoption permitted, and we have not determined the effect it will have on our consolidated financial statements.

In June 2016, the FASB issued an ASU that significantly changes the impairment model for most financial assets that are measured at amortized cost and certain other instruments from an incurred loss model to an expected loss model that requires these assets be presented at the net amount expected to be collected. In addition, credit losses on available for sale debt securities should be recorded through an allowance account.  This ASU will be effective for us on January 1, 2020, with early adoption permitted, and we have not yet determined the impact this updated guidance will have on our consolidated financial statements.

In August 2016, the FASB issued an ASU that clarifies how certain cash receipts and cash payments are to be presented and classified in the statement of cash flows. This ASU will be effective for us on January 1, 2018, with early adoption permitted, and we have not yet determined the impact this updated guidance will have on our consolidated financial statements.

Fair Value of Financial Instruments, Policy

Fair value is the price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The objective of a fair value measurement is to determine that price for each financial instrument at each measurement date. We meet this objective using various methods of valuation that include market, income and cost approaches.

We categorize our financial instruments into three levels of fair value hierarchy based on the priority of inputs used in determining fair value. The hierarchy defines the highest priority inputs (Level 1) as quoted prices in active markets for identical assets or liabilities. The lowest priority inputs (Level 3) are our own assumptions about what a market participant would use in determining fair value such as estimated future cash flows. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, a financial instrument's level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. We categorize financial assets and liabilities recorded at fair value in the consolidated balance sheets as follows:

Level 1— Quoted prices are available in active markets for identical financial instruments as of the reporting date. We do not adjust the quoted price for these financial instruments, even in situations where we hold a large position and a sale could reasonably impact the quoted price.

Level 2— Quoted prices in active markets for similar financial instruments, quoted prices for identical or similar financial instruments in markets that are not active; and models and other valuation methodologies using inputs other than quoted prices that are observable.

Level 3— Models and other valuation methodologies using significant inputs that are unobservable for financial instruments and include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in Level 3 are securities for which no market activity or data exists and for which we used discounted expected future cash flows with our own assumptions about what a market participant would use in determining fair value.

Transfers of securities among the levels occur at times and depend on the type of inputs used to determine fair value of each security.

Mortgage Loans on Real Estate, Allowance for Loan Losses, Policy

We evaluate our mortgage loan portfolio for the establishment of a loan loss allowance by specific identification of impaired loans and the measurement of an estimated loss for each individual loan identified. A mortgage loan is impaired when it is probable that we will be unable to collect all amounts due according to the contractual terms of the loan agreement. If we determine that the value of any specific mortgage loan is impaired, the carrying amount of the mortgage loan will be reduced to its fair value, based upon the present value of expected future cash flows from the loan discounted at the loan's effective interest rate, or the fair value of the underlying collateral less estimated costs to sell.

In addition, we analyze the mortgage loan portfolio for the need of a general loan allowance for probable losses on all other loans on a quantitative and qualitative basis. The amount of the general loan allowance is based upon management's evaluation of the collectability of the loan portfolio, historical loss experience, delinquencies, credit concentrations, underwriting standards and national and local economic conditions.

We rate each of the mortgage loans in our portfolio based on factors such as historical operating performance, loan to value ratio and economic outlook, among others. We calculate a loss factor to apply to each rating based on historical losses we have recognized in our mortgage loan portfolio. We apply the loss factors to the total principal outstanding within each rating category to determine an appropriate estimate of the general loan loss allowance. We also assess the portfolio qualitatively and apply a loss rate to all loans without a specific allowance based on management's assessment of economic conditions, and we apply an additional amount of loss allowance to a group of loans that we have identified as having higher risk of loss.

Mortgage Loans on Real Estate, Real Estate Acquired Through Foreclosure, Policy

Charge-offs include allowances that have been established on loans that were satisfied either by taking ownership of the collateral or by some other means such as discounted pay-off or loan sale. When ownership of the property is taken it is recorded at the lower of the mortgage loan's carrying value or the property's fair value (based on appraised values) less estimated costs to sell. The real estate owned is recorded as a component of other investments and the mortgage loan is recorded as fully paid, with any allowance for credit loss that has been established charged off. Fair value of the real estate is determined by third party appraisal. Recoveries are situations where we have received a payment from the borrower in an amount greater than the carrying value of the loan (principal outstanding less specific allowance).

Mortgage Loans on Real Estate, Non-Accrual Loan Status, Policy

The loans that are categorized as "in workout" consist of loans that we have agreed to lower or no mortgage payments for a period of time while the borrowers address cash flow and/or operational issues. The key features of these workouts have been determined on a loan-by-loan basis. Most of these loans are in a period of low cash flow due to tenants vacating their space or tenants requesting rent relief during difficult economic periods. Generally, we have allowed the borrower a six month interest only period and in some cases a twelve month period of interest only. Interest only workout loans are expected to return to their regular debt service payments after the interest only period. Interest only loans that are not fully amortizing will have a larger balance at their balloon date than originally contracted. Fully amortizing loans that are in interest only periods will have larger debt service payments for their remaining term due to lost principal payments during the interest only period. In limited circumstances we have allowed borrowers to pay the principal portion of their loan payment into an escrow account that can be used for capital and tenant improvements for a period of not more than twelve months. In these situations new loan amortization schedules are calculated based on the principal not collected during this twelve month workout period and larger payments are collected for the remaining term of each loan. In all cases, the original interest rate and maturity date have not been modified, and we have not forgiven any principal amounts.

Mortgage loans are considered delinquent when they become 60 days or more past due. In general, when loans become 90 days past due, become collateral dependent or enter a period with no debt service payments required we place them on non-accrual status and discontinue recognizing interest income. If payments are received on a delinquent loan, interest income is recognized to the extent it would have been recognized if normal principal and interest would have been received timely. If the payments are received to bring a delinquent loan back to current we will resume accruing interest income on that loan.

Mortgage Loans on Real Estate, Troubled Debt Restructuring, Policy

A Troubled Debt Restructuring ("TDR") is a situation where we have granted a concession to a borrower for economic or legal reasons related to the borrower's financial difficulties that we would not otherwise consider. A mortgage loan that has been granted new terms, including workout terms as described previously, would be considered a TDR if it meets conditions that would indicate a borrower is experiencing financial difficulty and the new terms constitute a concession on our part. We analyze all loans where we have agreed to workout terms and all loans that we have refinanced to determine if they meet the definition of a TDR. We consider the following factors in determining whether or not a borrower is experiencing financial difficulty:

• borrower is in default,

• borrower has declared bankruptcy,

• there is growing concern about the borrower's ability to continue as a going concern,

• borrower has insufficient cash flows to service debt,

• borrower's inability to obtain funds from other sources, and

• there is a breach of financial covenants by the borrower.

If the borrower is determined to be in financial difficulty, we consider the following conditions to determine if the borrower was granted a concession:

• assets used to satisfy debt are less than our recorded investment,

• interest rate is modified,

• maturity date extension at an interest rate less than market rate,

• capitalization of interest,

• delaying principal and/or interest for a period of three months or more, and

• partial forgiveness of the balance or charge-off.

Mortgage loan workouts, refinances or restructures that are classified as TDRs are individually evaluated and measured for impairment.

Commitments and Contingencies, Policy

In accordance with applicable accounting guidelines, we establish an accrued liability for litigation and regulatory matters when those matters present loss contingencies that are both probable and estimable. As a litigation or regulatory matter is developing we, in conjunction with outside counsel, evaluate on an ongoing basis whether the matter presents a loss contingency that meets conditions indicating the need for accrual and/or disclosure, and if not the matter will continue to be monitored for further developments. If and when the loss contingency related to litigation or regulatory matters is deemed to be both probable and estimable, we will establish an accrued liability with respect to that matter and will continue to monitor the matter for further developments that may affect the amount of the accrued liability.

XML

Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2016

Accounting Policies [Abstract]

Premiums and Annuity Deposits, Net of Coinsurance, By Product Type

Premiums and annuity deposits (net of coinsurance) collected in 2016, 2015 and 2014, by product type were as follows:

	Year Ended December 31,
Product Type	2016		2015		2014
	(Dollars in thousands)
Fixed index annuities	$	5,035,818	$	6,491,981	$	3,911,109
Annual reset fixed rate annuities	63,582		44,715		56,647
Multi-year fixed rate annuities	256,894		42,709		21,125
Single premium immediate annuities (SPIA)	35,851		32,752		24,580
Life insurance	9,946		10,917		10,810
	$	5,402,091	$	6,623,074	$	4,024,271

XML

Fair Values of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2016

Fair Value Disclosures [Abstract]

Carrying Amounts and Fair Values of Financial Instruments

The following sets forth a comparison of the carrying amounts and fair values of our financial instruments:

	December 31,
	2016				2015
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
	(Dollars in thousands)
Assets
Fixed maturity securities:
Available for sale	$	41,060,494	$	41,060,494	$	36,421,839	$	36,421,839
Held for investment	76,825		68,766		76,622		65,377
Mortgage loans on real estate	2,480,956		2,522,035		2,435,257		2,471,864
Derivative instruments	830,519		830,519		337,256		337,256
Other investments	308,774		300,918		292,872		297,903
Cash and cash equivalents	791,266		791,266		397,749		397,749
Coinsurance deposits	4,639,492		4,150,792		3,187,470		2,860,882
Interest rate caps	1,082		1,082		1,410		1,410
Counterparty collateral	145,693		145,693		82,312		82,312
Liabilities
Policy benefit reserves	51,280,331		43,104,183		45,151,460		38,435,515
Single premium immediate annuity (SPIA) benefit reserves	297,724		308,028		324,264		336,066
Notes and loan payable	493,755		519,440		393,227		417,752
Subordinated debentures	241,853		225,106		241,452		216,933
Interest rate swap	2,113		2,113		3,139		3,139

Assets and Liabilities Measured on a Recurring Basis by Fair Value Hierarchy

Our assets and liabilities which are measured at fair value on a recurring basis as of December 31, 2016 and 2015 are presented below based on the fair value hierarchy levels:

	Total Fair Value		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(Dollars in thousands)
December 31, 2016
Assets
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	11,805	$	5,381	$	6,424	$	—
United States Government sponsored agencies	1,344,787		—		1,344,787		—
United States municipalities, states and territories	3,926,950		—		3,926,950		—
Foreign government obligations	232,233		—		232,233		—
Corporate securities	27,118,526		6		27,118,520		—
Residential mortgage backed securities	1,254,835		—		1,254,835		—
Commercial mortgage backed securities	5,365,235		—		5,365,235		—
Other asset backed securities	1,806,123		—		1,806,123		—
Other investments: equity securities, available for sale	8,000		—		8,000		—
Derivative instruments	830,519		—		830,519		—
Cash and cash equivalents	791,266		791,266		—		—
Interest rate caps	1,082		—		1,082		—
Counterparty collateral	145,693		—		145,693		—
	$	42,837,054	$	796,653	$	42,040,401	$	—
Liabilities
Interest rate swap	$	2,113	$	—	$	2,113	$	—
Fixed index annuities—embedded derivatives	6,563,288		—		—		6,563,288
	$	6,565,401	$	—	$	2,113	$	6,563,288
December 31, 2015
Assets
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	471,256	$	438,598	$	32,658	$	—
United States Government sponsored agencies	1,398,611		—		1,398,611		—
United States municipalities, states and territories	3,755,367		—		3,755,367		—
Foreign government obligations	212,565		—		212,565		—
Corporate securities	23,802,394		121		23,802,273		—
Residential mortgage backed securities	1,462,072		—		1,462,072		—
Commercial mortgage backed securities	4,174,396		—		4,174,396		—
Other asset backed securities	1,145,178		—		1,145,178		—
Other investments: equity securities, available for sale	7,828		—		7,828		—
Derivative instruments	337,256		—		337,256		—
Cash and cash equivalents	397,749		397,749		—		—
Interest rate caps	1,410		—		1,410		—
Counterparty collateral	82,312		—		82,312		—
	$	37,248,394	$	836,468	$	36,411,926	$	—
Liabilities
Interest rate swap	$	3,139	$	—	$	3,139	$	—
Fixed index annuities—embedded derivatives	5,983,622		—		—		5,983,622
	$	5,986,761	$	—	$	3,139	$	5,983,622

Schedule of Assumptions Used in Estimating Fair Value

The following table presents average lapse rate and partial withdrawal rate assumptions, by contract duration, used in estimating the fair value of the embedded derivative component of our fixed index annuity policy benefit reserves at each reporting date:

	Average Lapse Rates		Average Partial Withdrawal Rates
Contract Duration (Years)	December 31, 2016	December 31, 2015	December 31, 2016	December 31, 2015
1 - 5	1.76%	1.58%	3.30%	3.08%
6 - 10	6.58%	8.55%	3.30%	3.55%
11 - 15	11.25%	12.01%	3.32%	3.59%
16 - 20	12.04%	12.99%	3.18%	3.22%
20+	11.68%	12.54%	3.18%	3.22%

Liabilities Measured at Fair Value on Recurring Basis, Level 3 Reconciliation

The following table provides a reconciliation of the beginning and ending balances for our Level 3 liabilities, which are measured at fair value on a recurring basis using significant unobservable inputs for the years ended December 31, 2016 and 2015:

	Year Ended December 31,
	2016		2015
	(Dollars in thousands)
Fixed index annuities—embedded derivatives
Beginning balance	$	5,983,622	$	5,574,653
Premiums less benefits	434,621		1,234,637
Change in fair value, net	145,045		(825,668		)
Ending balance	$	6,563,288	$	5,983,622

XML

Investments (Tables)

12 Months Ended

Dec. 31, 2016

Investments [Abstract]

Schedule of Fixed Maturity Securities

At December 31, 2016 and 2015, the amortized cost and fair value of fixed maturity securities were as follows:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
	(Dollars in thousands)
December 31, 2016
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	11,864	$	229	$	(288	)	$	11,805
United States Government sponsored agencies	1,368,340		23,360		(46,913		)	1,344,787
United States municipalities, states and territories	3,626,395		322,948		(22,393		)	3,926,950
Foreign government obligations	224,588		12,725		(5,080		)	232,233
Corporate securities	26,338,214		1,149,085		(368,773		)	27,118,526
Residential mortgage backed securities	1,166,944		91,445		(3,554		)	1,254,835
Commercial mortgage backed securities	5,422,255		59,994		(117,014		)	5,365,235
Other asset backed securities	1,795,355		31,471		(20,703		)	1,806,123
	$	39,953,955	$	1,691,257	$	(584,718	)	$	41,060,494
Held for investment:
Corporate security	$	76,825	$	—	$	(8,059	)	$	68,766
Other investments - equity securities, available for sale:
Finance, insurance and real estate	$	7,521	$	479	$	—		$	8,000
December 31, 2015
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	470,567	$	988	$	(299	)	$	471,256
United States Government sponsored agencies	1,386,219		26,801		(14,409		)	1,398,611
United States municipalities, states and territories	3,422,667		341,328		(8,628		)	3,755,367
Foreign government obligations	210,953		12,547		(10,935		)	212,565
Corporate securities	23,597,530		887,288		(682,424		)	23,802,394
Residential mortgage backed securities	1,366,985		98,576		(3,489		)	1,462,072
Commercial mortgage backed securities	4,238,265		41,412		(105,281		)	4,174,396
Other asset backed securities	1,130,524		34,534		(19,880		)	1,145,178
	$	35,823,710	$	1,443,474	$	(845,345	)	$	36,421,839
Held for investment:
Corporate security	$	76,622	$	—	$	(11,245	)	$	65,377
Other investments - equity securities, available for sale:
Finance, insurance and real estate	$	7,515	$	313	$	—		$	7,828

Schedule of Fixed Maturity Securities by Contractual Maturity Date

The amortized cost and fair value of fixed maturity securities at December 31, 2016, by contractual maturity are shown below. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. All of our mortgage and other asset backed securities provide for periodic payments throughout their lives and are shown below as separate lines.

	Available for sale				Held for investment
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
	(Dollars in thousands)
Due in one year or less	$	236,707	$	241,934	$	—	$	—
Due after one year through five years	2,824,776		2,979,768		—		—
Due after five years through ten years	11,659,762		11,738,156		—		—
Due after ten years through twenty years	8,792,470		9,284,726		—		—
Due after twenty years	8,055,686		8,389,717		76,825		68,766
	31,569,401		32,634,301		76,825		68,766
Residential mortgage backed securities	1,166,944		1,254,835		—		—
Commercial mortgage backed securities	5,422,255		5,365,235		—		—
Other asset backed securities	1,795,355		1,806,123		—		—
	$	39,953,955	$	41,060,494	$	76,825	$	68,766

Schedule of Components of Net Unrealized Gains on Availabe For Sale Fixed Maturity and Equity Securities Reported as Separate Component of Stockholders' Equity

Net unrealized gains on available for sale fixed maturity securities and equity securities reported as a separate component of stockholders' equity were comprised of the following:

	December 31,
	2016			2015
	(Dollars in thousands)
Net unrealized gains on available for sale fixed maturity securities and equity securities	$	1,107,018		$	598,442
Adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements	(618,661		)	(322,859		)
Deferred income tax valuation allowance reversal	22,534			22,534
Deferred income tax expense	(170,925		)	(96,454		)
Net unrealized gains reported as accumulated other comprehensive income	$	339,966		$	201,663

Schedule of Credit Quality of Fixed Maturity Security Portfolio by NAIC Designation

The following table summarizes the credit quality, as determined by NAIC designation, of our fixed maturity portfolio as of the dates indicated:

	December 31,
	2016				2015
NAIC Designation	Amortized Cost		Fair Value		Amortized Cost		Fair Value
	(Dollars in thousands)
1	$	25,607,268	$	26,507,798	$	23,363,259	$	24,207,801
2	13,037,592		13,295,648		11,709,730		11,589,325
3	1,201,059		1,155,702		758,531		643,293
4	154,226		137,188		60,480		44,312
5	17,475		24,664		—		—
6	13,160		8,260		8,332		2,485
	$	40,030,780	$	41,129,260	$	35,900,332	$	36,487,216

Schedule of Gross Unrealized Losses on Investments, By Category and Length of Time

The following table shows our investments' gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities (consisting of 1,514and 1,246 securities, respectively) have been in a continuous unrealized loss position, at December 31, 2016 and 2015:

	Less than 12 months					12 months or more					Total
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
	(Dollars in thousands)
December 31, 2016
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	7,405	$	(288	)	$	—	$	—		$	7,405	$	(288	)
United States Government sponsored agencies	995,548		(46,913		)	—		—			995,548		(46,913		)
United States municipalities, states and territories	463,409		(22,393		)	—		—			463,409		(22,393		)
Foreign government obligations	29,158		(913		)	20,388		(4,167		)	49,546		(5,080		)
Corporate securities:
Finance, insurance and real estate	2,302,103		(79,077		)	110,730		(9,834		)	2,412,833		(88,911		)
Manufacturing, construction and mining	2,556,147		(74,144		)	702,978		(74,382		)	3,259,125		(148,526		)
Utilities and related sectors	1,605,742		(53,055		)	196,085		(16,208		)	1,801,827		(69,263		)
Wholesale/retail trade	396,310		(9,433		)	57,708		(5,739		)	454,018		(15,172		)
Services, media and other	857,515		(35,107		)	132,170		(11,794		)	989,685		(46,901		)
Residential mortgage backed securities	81,762		(3,463		)	1,853		(91		)	83,615		(3,554		)
Commercial mortgage backed securities	3,148,395		(116,938		)	895		(76		)	3,149,290		(117,014		)
Other asset backed securities	751,533		(12,289		)	146,167		(8,414		)	897,700		(20,703		)
	$	13,195,027	$	(454,013	)	$	1,368,974	$	(130,705	)	$	14,564,001	$	(584,718	)
Held for investment:
Corporate security:
Insurance	$	—	$	—		$	68,766	$	(8,059	)	$	68,766	$	(8,059	)
December 31, 2015
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	37,730	$	(299	)	$	—	$	—		$	37,730	$	(299	)
United States Government sponsored agencies	957,053		(14,409		)	—		—			957,053		(14,409		)
United States municipalities, states and territories	261,823		(8,474		)	2,846		(154		)	264,669		(8,628		)
Foreign government obligations	42,966		(1,762		)	15,463		(9,173		)	58,429		(10,935		)
Corporate securities:
Finance, insurance and real estate	2,077,223		(59,607		)	49,912		(14,855		)	2,127,135		(74,462		)
Manufacturing, construction and mining	3,517,967		(246,456		)	376,229		(131,003		)	3,894,196		(377,459		)
Utilities and related sectors	2,240,652		(138,940		)	97,184		(22,565		)	2,337,836		(161,505		)
Wholesale/retail trade	473,050		(17,863		)	38,682		(8,125		)	511,732		(25,988		)
Services, media and other	1,037,011		(39,937		)	32,050		(3,073		)	1,069,061		(43,010		)
Residential mortgage backed securities	162,770		(2,958		)	6,438		(531		)	169,208		(3,489		)
Commercial mortgage backed securities	2,679,510		(105,002		)	11,495		(279		)	2,691,005		(105,281		)
Other asset backed securities	457,055		(10,581		)	46,657		(9,299		)	503,712		(19,880		)
	$	13,944,810	$	(646,288	)	$	676,956	$	(199,057	)	$	14,621,766	$	(845,345	)
Held for investment:
Corporate security:
Insurance	$	65,377	$	(11,245	)	$	—	$	—		$	65,377	$	(11,245	)

Schedule of Changes in Net Unrealized Gains/Losses on Investments

Changes in net unrealized gains on investments for the years ended December 31, 2016, 2015 and 2014 are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Fixed maturity securities held for investment carried at amortized cost	$	3,186		$	(10,651	)	$	14,821
Investments carried at fair value:
Fixed maturity securities, available for sale	$	508,410		$	(1,642,027	)	$	2,157,439
Equity securities, available for sale	166			17			21
	508,576			(1,642,010		)	2,157,460
Adjustment for effect on other balance sheet accounts:
Deferred policy acquisition costs and deferred sales inducements	(295,802		)	842,412			(1,118,683		)
Deferred income tax asset/liability	(74,471		)	279,860			(363,572		)
	(370,273		)	1,122,272			(1,482,255		)
Change in net unrealized gains on investments carried at fair value	$	138,303		$	(519,738	)	$	675,205

Components of Net Investment Income

Components of net investment income are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Fixed maturity securities	$	1,729,176		$	1,566,409		$	1,394,301
Equity securities	531			441			404
Mortgage loans on real estate	122,985			131,892			143,998
Cash and cash equivalents	3,201			601			286
Other	5,499			4,858			6,903
	1,861,392			1,704,201			1,545,892
Less investment expenses	(11,520		)	(12,009		)	(14,225		)
Net investment income	$	1,849,872		$	1,692,192		$	1,531,667

Net Realized Gains (Losses) on Investments

Net realized gains (losses) on investments, excluding net OTTI losses are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Available for sale fixed maturity securities:
Gross realized gains	$	14,132		$	7,230		$	3,273
Gross realized losses	(4,036		)	(5,787		)	(1,006		)
	10,096			1,443			2,267
Other investments:
Gain on sale of real estate	884			4,194			2,454
Loss on sale of real estate	(93		)	(575		)	(231		)
Impairment losses on real estate	—			(1,297		)	(2,441		)
	791			2,322			(218		)
Mortgage loans on real estate:
Decrease (increase) in allowance for credit losses	(4,846		)	1,018			(6,052		)
Recovery of specific allowance	5,483			5,428			—
	637			6,446			(6,052		)
	$	11,524		$	10,211		$	(4,003	)

Non-Income Producing Investments

The following table summarizes the carrying value of our fixed maturity securities, mortgage loans on real estate and real estate owned that have been non-income producing for 12 consecutive months:

	December 31,
	2016		2015
	(Dollars in thousands)
Fixed maturity securities, available for sale	$	1,651	$	10
Real estate owned	—		1,800
	$	1,651	$	1,810

Significant Assumptions Used to Determine the Credit Loss Component of Other Than Temporary Impairment on Residential Mortgage Backed Securities

The following table presents the range of significant assumptions used to determine the credit loss component of other than temporary impairments we have recognized on residential mortgage backed securities for the years ended December 31, 2016 and 2015, which are all senior level tranches within the structure of the securities:

		Discount Rate				Default Rate				Loss Severity
Sector	Vintage	Min		Max		Min		Max		Min		Max
Year ended December 31, 2016
Prime	2005	7.7	%	7.7	%	8	%	14	%	50	%	50	%
	2006	6.5	%	7.3	%	12	%	13	%	40	%	50	%
	2007	6.2	%	6.4	%	18	%	31	%	50	%	55	%
Alt-A	2005	7.4	%	7.4	%	11	%	11	%	60	%	60	%
Year ended December 31, 2015
Prime	2006	6.5	%	7.4	%	12	%	14	%	40	%	50	%
	2007	5.8	%	7.0	%	15	%	25	%	45	%	55	%
Alt-A	2005	5.6	%	7.4	%	13	%	99	%	2	%	50	%

Other Than Temporary Impairment by Asset Type

The following table summarizes other than temporary impairments by asset type:

	Number of Securities	Total OTTI Losses			Portion of OTTI Losses Recognized in (from) Other Comprehensive Income			Net OTTI Losses Recognized in Operations
		(Dollars in thousands)
Year ended December 31, 2016
Fixed maturity securities, available for sale:
Corporate securities:
Energy	2	$	(642	)	$	—		$	(642	)
Materials	1	(4,554		)	1,575			(2,979		)
Telecommunications	1	(4,462		)	562			(3,900		)
Utilities	2	(6,961		)	798			(6,163		)
Residential mortgage backed securities	9	—			(783		)	(783		)
Commercial mortgage backed securities	5	(1,540		)	—			(1,540		)
Other asset backed securities	2	(3,190		)	(3,482		)	(6,672		)
	22	$	(21,349	)	$	(1,330	)	$	(22,679	)
Year ended December 31, 2015
Fixed maturity securities, available for sale:
Corporate securities:
Industrial	2	$	(15,414	)	$	2,975		$	(12,439	)
Residential mortgage backed securities	11	(133		)	(2,089		)	(2,222		)
Other asset backed securities	1	(10,000		)	5,125			(4,875		)
	14	$	(25,547	)	$	6,011		$	(19,536	)
Year ended December 31, 2014
Fixed maturity securities, available for sale:
Residential mortgage backed securities	7	$	—		$	(2,627	)	$	(2,627	)

Other Than Temporary Impairment, Credit Losses Recognized in Earnings

The cumulative portion of other than temporary impairments determined to be credit losses which have been recognized in operations for debt securities are summarized as follows:

	Year Ended December 31,
	2016			2015
	(Dollars in thousands)
Cumulative credit loss at beginning of year	$	(145,824	)	$	(127,050	)
Credit losses on securities for which OTTI has not previously been recognized	(18,414		)	(17,447		)
Additional credit losses on securities for which OTTI has previously been recognized	(4,265		)	(2,089		)
Accumulated losses on securities that were disposed of during the period	2,128			762
Cumulative credit loss at end of year	$	(166,375	)	$	(145,824	)

Schedule of Other Than Temporary Impairment Losses, Investments

The following table summarizes the cumulative noncredit portion of OTTI and the change in fair value since recognition of OTTI, both of which were recognized in other comprehensive income, by major type of security, for securities that are part of our investment portfolio at December 31, 2016 and 2015:

	Amortized Cost		OTTI Recognized in Other Comprehensive Income			Change in Fair Value Since OTTI was Recognized			Fair Value
	(Dollars in thousands)
December 31, 2016
Fixed maturity securities, available for sale:
Corporate securities	$	17,549	$	(5,910	)	$	13,566		$	25,205
Residential mortgage backed securities	368,862		(169,941		)	205,854			404,775
Commercial mortgage backed securities	6,596		—			(107		)	6,489
Other asset backed securities	6,683		(1,643		)	(1,566		)	3,474
	$	399,690	$	(177,494	)	$	217,747		$	439,943
December 31, 2015
Fixed maturity securities, available for sale:
Corporate securities	$	6,396	$	(2,975	)	$	9		$	3,430
Residential mortgage backed securities	466,871		(170,724		)	199,149			495,296
Other asset backed securities	8,154		(5,125		)	(553		)	2,476
	$	481,421	$	(178,824	)	$	198,605		$	501,202

XML

Mortgage Loans on Real Estate (Tables)

12 Months Ended

Dec. 31, 2016

Mortgage Loans on Real Estate [Abstract]

Summary of Mortgage Loan Portfolio

Our mortgage loan portfolio is summarized in the following table. There were commitments outstanding of $75.5 million at December 31, 2016.

	December 31,
	2016			2015
	(Dollars in thousands)
Principal outstanding	$	2,490,619		$	2,449,909
Loan loss allowance	(8,427		)	(14,142		)
Deferred prepayment fees	(1,236		)	(510		)
Carrying value	$	2,480,956		$	2,435,257

Mortgage Loan Portfolio Summarized by Geographic Region and Property Type

The portfolio consists of commercial mortgage loans collateralized by the related properties and diversified as to property type, location and loan size. Our mortgage lending policies establish limits on the amount that can be loaned to one borrower and other criteria to attempt to reduce the risk of default. The mortgage loan portfolio is summarized by geographic region and property type as follows:

	December 31,
	2016				2015
	Principal		Percent		Principal		Percent
	(Dollars in thousands)
Geographic distribution
East	$	635,434	25.5	%	$	698,113	28.5	%
Middle Atlantic	151,640		6.1	%	160,261		6.6	%
Mountain	235,932		9.5	%	252,442		10.3	%
New England	12,724		0.5	%	13,161		0.5	%
Pacific	385,683		15.5	%	355,268		14.5	%
South Atlantic	519,065		20.8	%	456,227		18.6	%
West North Central	325,447		13.1	%	313,120		12.8	%
West South Central	224,694		9.0	%	201,317		8.2	%
	$	2,490,619	100.0	%	$	2,449,909	100.0	%
Property type distribution
Office	$	308,578	12.4	%	$	396,154	16.2	%
Medical Office	50,780		2.1	%	77,438		3.2	%
Retail	886,942		35.6	%	790,158		32.2	%
Industrial/Warehouse	700,644		28.1	%	686,400		28.0	%
Hotel	—		—	%	3,361		0.1	%
Apartment	375,837		15.1	%	352,971		14.4	%
Mixed use/other	167,838		6.7	%	143,427		5.9	%
	$	2,490,619	100.0	%	$	2,449,909	100.0	%

Rollforward of Allowance For Credit Losses

The following table presents a rollforward of our specific and general valuation allowances for mortgage loans on real estate:

	Year Ended December 31,
	2016						2015						2014
	Specific Allowance			General Allowance			Specific Allowance			General Allowance			Specific Allowance			General Allowance
	(Dollars in thousands)
Beginning allowance balance	$	(7,842	)	$	(6,300	)	$	(12,333	)	$	(10,300	)	$	(16,847	)	$	(9,200	)
Charge-offs	5,078			—			2,045			—			9,211			—
Recoveries	5,483			—			5,428			—			255			—
Change in provision for credit losses	(4,046		)	(800		)	(2,982		)	4,000			(4,952		)	(1,100		)
Ending allowance balance	$	(1,327	)	$	(7,100	)	$	(7,842	)	$	(6,300	)	$	(12,333	)	$	(10,300	)

Impaired Mortgage Loans on Real Estate by Basis of Impairment

The following table presents the total outstanding principal of loans evaluated for impairment by basis of impairment method:

	December 31,
	2016		2015		2014
	(Dollars in thousands)
Individually evaluated for impairment	$	4,640	$	21,277	$	29,116
Collectively evaluated for impairment	2,485,979		2,428,632		2,428,605
Total loans evaluated for impairment	$	2,490,619	$	2,449,909	$	2,457,721

Real Estate Acquired Via Foreclosure or Deed In Lieu

e following table summarizes the activity in the real estate owned, included in Other investments, which was obtained in satisfaction of mortgage loans on real estate:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Real estate owned at beginning of period	$	6,485		$	20,238		$	22,844
Real estate acquired in satisfaction of mortgage loans	—			—			14,555
Additions	—			121			—
Sales	(6,444		)	(12,322		)	(14,134		)
Impairments	—			(1,297		)	(2,441		)
Depreciation	(41		)	(255		)	(586		)
Real estate owned at end of period	$	—		$	6,485		$	20,238

Mortgage Loans By Credit Quality Indicator

We analyze credit risk of our mortgage loans by analyzing all available evidence on loans that are delinquent and loans that are in a workout period.

	December 31,
	2016		2015
	(Dollars in thousands)
Credit Exposure--By Payment Activity
Performing	$	2,489,028	$	2,438,341
In workout	1,591		11,568
Delinquent	—		—
Collateral dependent	—		—
	$	2,490,619	$	2,449,909

Aging of Financing Receivables

Aging of financing receivables is summarized in the following table, with loans in a "workout" period as of the reporting date considered current if payments are current in accordance with agreed upon terms:

	30 - 59 Days		60 - 89 Days		90 Days and Over		Total Past Due		Current		Collateral Dependent Receivables		Total Financing Receivables
	(Dollars in thousands)
Commercial Mortgage Loans
December 31, 2016	$	2,737	$	—	$	—	$	2,737	$	2,487,882	$	—	$	2,490,619
December 31, 2015	$	—	$	—	$	—	$	—	$	2,449,909	$	—	$	2,449,909

Impaired Financing Receivables

Financing receivables summarized in the following two tables represent all loans that we are either not currently collecting, or those we feel it is probable we will not collect all amounts due according to the contractual terms of the loan agreements (all loans that we have worked with the borrower to alleviate short-term cash flow issues, loans delinquent for 60 days or more at the reporting date, loans we have determined to be collateral dependent and loans that we have recorded specific impairments on that we feel may continue to have performance issues).

	Recorded Investment		Unpaid Principal Balance		Related Allowance
	(Dollars in thousands)
December 31, 2016
Mortgage loans with an allowance	$	3,313	$	4,640	$	(1,327	)
Mortgage loans with no related allowance	1,591		1,591		—
	$	4,904	$	6,231	$	(1,327	)
December 31, 2015
Mortgage loans with an allowance	$	13,435	$	21,277	$	(7,842	)
Mortgage loans with no related allowance	8,859		8,859		—
	$	22,294	$	30,136	$	(7,842	)

	Average Recorded Investment		Interest Income Recognized
	(Dollars in thousands)
December 31, 2016
Mortgage loans with an allowance	$	3,398	$	301
Mortgage loans with no related allowance	1,665		73
	$	5,063	$	374
December 31, 2015
Mortgage loans with an allowance	$	13,893	$	1,117
Mortgage loans with no related allowance	8,930		584
	$	22,823	$	1,701
December 31, 2014
Mortgage loans with an allowance	$	18,465	$	1,797
Mortgage loans with no related allowance	2,656		43
	$	21,121	$	1,840

Troubled Debt Restructurings on Financing Receivables

A summary of mortgage loans on commercial real estate with outstanding principal at December 31, 2016 and 2015 that we determined to be TDRs are as follows:

Geographic Region	Number of TDRs	Principal Balance Outstanding		Specific Loan Loss Allowance			Net Carrying Amount
		(Dollars in thousands)
Year ended December 31, 2016
South Atlantic	1	$	3,004	$	—		$	3,004
East North Central	1	2,020		(467		)	1,553
	2	$	5,024	$	(467	)	$	4,557
Year ended December 31, 2015
South Atlantic	6	$	11,155	$	(2,992	)	$	8,163
East North Central	2	3,306		(467		)	2,839
West North Central	1	5,913		—			5,913
	9	$	20,374	$	(3,459	)	$	16,915

XML

Derivative Instruments (Tables)

12 Months Ended

Dec. 31, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair Value of Derivative Instruments as Presented in the Consolidated Balance Sheets

The fair value of our derivative instruments, including derivative instruments embedded in fixed index annuity contracts, presented in the consolidated balance sheets are as follows:

	December 31,
	2016		2015
	(Dollars in thousands)
Assets
Derivative instruments
Call options	$	830,519	$	337,256
Other assets
Interest rate caps	1,082		1,410
	$	831,601	$	338,666
Liabilities
Policy benefit reserves—annuity products
Fixed index annuities—embedded derivatives	$	6,563,288	$	5,983,622
Other liabilities
Interest rate swap	2,113		3,139
	$	6,565,401	$	5,986,761

Schedule of Changes in Fair Value of Derivative Instruments

The changes in fair value of derivatives included in the consolidated statements of operations are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Change in fair value of derivatives:
Call options	$	165,029		$	(327,921	)	$	521,947
2015 notes hedges	—			(4,516		)	(8,934		)
Interest rate swap	(482		)	(2,341		)	(4,863		)
Interest rate caps	(328		)	(1,368		)	(3,325		)
	$	164,219		$	(336,146	)	$	504,825
Change in fair value of embedded derivatives:
Fixed index annuities—embedded derivatives (see Note 2)	$	145,045		$	(825,668	)	$	(532,337	)
Other changes in difference between policy benefit reserves computed using derivative accounting vs. long-duration contracts accounting	398,420			365,486			579,885
2015 notes embedded conversion derivative (see Note 9)	—			(4,516		)	(19,036		)
2029 notes embedded conversion derivative (see Note 9)	—			—			3,809
	$	543,465		$	(464,698	)	$	32,321

Schedule of Call Options by Counterparty

The notional amount and fair value of our call options by counterparty and each counterparty's current credit rating are as follows:

			December 31,
			2016				2015
Counterparty	Credit Rating (S&P)	Credit Rating (Moody's)	Notional Amount		Fair Value		Notional Amount		Fair Value
			(Dollars in thousands)
Bank of America	A+	A1	$	5,958,884	$	178,477	$	6,257,861	$	67,662
Barclays	A-	A1	3,441,832		89,721		2,463,768		35,273
BNP Paribas	A	A1	1,199,265		19,598		1,520,710		16,944
Citibank, N.A.	A+	A1	4,038,528		97,094		3,786,498		23,587
Credit Suisse	A	A1	2,130,710		44,242		1,278,492		12,508
Deutsche Bank	BBB+	Baa2	25,935		892		1,349,002		10,704
J.P. Morgan	A+	Aa3	1,785,583		19,645		838,982		5,283
Morgan Stanley	A+	A1	2,543,421		64,425		3,465,457		33,171
Royal Bank of Canada	AA-	Aa3	3,384,310		103,510		2,820,410		48,654
SunTrust	A-	Baa1	2,375,418		72,990		1,308,434		20,028
Wells Fargo	AA-	Aa2	3,850,842		130,545		4,187,955		63,442
Exchange traded			313,354		9,380		—		—
			$	31,048,082	$	830,519	$	29,277,569	$	337,256

Schedule of Interest Rate Derivatives

Details regarding the interest rate swap are as follows:

						December 31,
						2016			2015
Maturity Date	Notional Amount		Receive Rate	Pay Rate	Counterparty	Fair Value			Fair Value
						(Dollars in thousands)
March 15, 2021	$	85,500	LIBOR	2.415%	SunTrust	$	(2,113	)	$	(3,139	)

Details regarding the interest rate caps are as follows:

						December 31,
						2016		2015
Maturity Date	Notional Amount		Floating Rate	Cap Rate	Counterparty	Fair Value		Fair Value
						(Dollars in thousands)
July 7, 2021	$	40,000	LIBOR	2.50%	SunTrust	$	542	$	708
July 8, 2021	12,000		LIBOR	2.50%	SunTrust	163		212
July 29, 2021	27,000		LIBOR	2.50%	SunTrust	377		490
	$	79,000				$	1,082	$	1,410

XML

Deferred Policy Acquisition Costs and Deferred Sales Inducements (Tables)

12 Months Ended

Dec. 31, 2016

Insurance [Abstract]

Deferred Policy Acquisition Costs

Policy acquisition costs deferred and amortized are as follows:

	December 31,
	2016			2015			2014
	(Dollars in thousands)
Balance at beginning of year	$	2,905,136		$	2,058,556		$	2,426,652
Costs deferred during the year:
Commissions	538,863			651,094			421,802
Policy issue costs	4,462			6,545			5,080
Amortization	(374,012		)	(286,114		)	(163,578		)
Effect of net unrealized gains/losses	(169,072		)	475,055			(631,400		)
Balance at end of year	$	2,905,377		$	2,905,136		$	2,058,556

Deferred Sales Inducements

Sales inducements deferred and amortized are as follows:

	December 31,
	2016			2015			2014
	(Dollars in thousands)
Balance at beginning of year	$	2,232,148		$	1,587,257		$	1,875,880
Costs deferred during the year	353,966			486,924			330,079
Amortization	(251,166		)	(209,390		)	(131,419		)
Effect of net unrealized gains/losses	(126,730		)	367,357			(487,283		)
Balance at end of year	$	2,208,218		$	2,232,148		$	1,587,257

XML

Reinsurance and Policy Provisions (Tables)

12 Months Ended

Dec. 31, 2016

Reinsurance Disclosures [Abstract]

Amounts Ceded to EquiTrust and Athene, Impact on Consolidated Statements of Operations and Cash Flows

Amounts ceded to EquiTrust and Athene under these agreements are as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Consolidated Statements of Operations
Annuity product charges	$	5,366		$	5,427		$	5,956
Change in fair value of derivatives	18,446			(14,360		)	31,076
	$	23,812		$	(8,933	)	$	37,032
Interest sensitive and index product benefits	$	93,487		$	88,923		$	122,666
Change in fair value of embedded derivatives	23,848			(22,616		)	35,820
Other operating costs and expenses	24,039			9,922			9,241
	$	141,374		$	76,229		$	167,727
Consolidated Statements of Cash Flows
Annuity deposits	$	(1,736,054	)	$	(471,822	)	$	(171,124	)
Cash payments to policyholders	418,499			391,045			280,308
	$	(1,317,555	)	$	(80,777	)	$	109,184

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2016

Income Tax Disclosure [Abstract]

Components of Income Tax Expense

Our income tax expense as presented in the consolidated financial statements is summarized as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Consolidated statements of operations:
Current income taxes	$	57,412		$	75,568		$	116,545
Deferred income taxes (benefits)	(10,408		)	41,916			(46,504		)
Total income tax expense included in consolidated statements of operations	47,004			117,484			70,041
Stockholders' equity:
Expense (benefit) relating to:
Change in net unrealized investment losses	74,471			(279,860		)	363,572
Share-based compensation	(527		)	(3,649		)	(5,716		)
Extinguishment of convertible debt	—			—			(9,284		)
Total income tax expense (benefit) included in consolidated financial statements	$	120,948		$	(166,025	)	$	418,613

Effective Income Tax Rate Reconciliation

Income tax expense in the consolidated statements of operations differed from the amount computed at the applicable statutory federal income tax rate of 35% as follows:

	Year Ended December 31,
	2016			2015			2014
	(Dollars in thousands)
Income before income taxes	$	130,247		$	337,314		$	196,064
Income tax expense on income before income taxes	$	45,586		$	118,060		$	68,622
Tax effect of:
State income taxes	2,559			2,924			1,145
Tax exempt net investment income	(2,167		)	(3,834		)	(3,669		)
Extinguishment of convertible debt	—			—			4,202
Other	1,026			334			(259		)
Income tax expense	$	47,004		$	117,484		$	70,041
Effective tax rate	36.1		%	34.8		%	35.7		%

Deferred Tax Assets and Liabilities

The tax effects of temporary differences that give rise to the deferred tax assets and liabilities at December 31, 2016 and 2015, are as follows:

	December 31,
	2016			2015
	(Dollars in thousands)
Deferred income tax assets:
Policy benefit reserves	$	2,354,786		$	2,092,731
Other than temporary impairments	15,681			7,801
Derivative instruments	—			91,638
Amounts due reinsurer	1,321			—
Other policyholder funds	6,474			6,861
Litigation settlement accrual	1,709			7,100
Deferred compensation	7,963			8,346
Share-based compensation	5,407			5,286
Net operating loss carryforwards	3,745			6,637
Other	9,658			8,031
Gross deferred tax assets	2,406,744			2,234,431
Deferred income tax liabilities:
Deferred policy acquisition costs and deferred sales inducements	(1,951,333		)	(1,860,722		)
Net unrealized gains on available for sale fixed maturity and equity securities	(170,925		)	(96,454		)
Derivative instruments	(75,405		)	—
Amounts due reinsurer	—			(9,677		)
Investment income items	(39,118		)	(32,466		)
Other	(1,385		)	(2,429		)
Gross deferred tax liabilities	(2,238,166		)	(2,001,748		)
Net deferred income tax asset	$	168,578		$	232,683

XML

Notes and Loan Payable and Amounts Due Under Repurchase Agreements (Tables)

12 Months Ended

Dec. 31, 2016

Debt Disclosure [Abstract]

Schedule of Notes and Loan Payable

Notes and loan payable includes the following:

	December 31,
	2016			2015
	(Dollars in thousands)
Senior notes due 2021
Principal	$	400,000		$	400,000
Unamortized debt issue costs	(5,733		)	(6,773		)
Term loan due 2019
Principal	100,000			—
Unamortized debt issue costs	(512		)	—
	$	493,755		$	393,227

XML

Subordinated Debentures (Tables)

12 Months Ended

Dec. 31, 2016

Subordinated Borrowings [Abstract]

Summary of Subordinated Debt Obligations to the Trusts

Following is a summary of subordinated debt obligations to the trusts at December 31, 2016 and 2015:

	December 31,
	2016			2015			Interest Rate		Due Date
	(Dollars in thousands)
American Equity Capital Trust II	$	77,061		$	76,840		5%		June 1, 2047
American Equity Capital Trust III	27,840			27,840			*LIBOR +	3.90%	April 29, 2034
American Equity Capital Trust IV	12,372			12,372			*LIBOR +	4.00%	January 8, 2034
American Equity Capital Trust VII	10,830			10,830			*LIBOR +	3.75%	December 14, 2034
American Equity Capital Trust VIII	20,620			20,620			*LIBOR +	3.75%	December 15, 2034
American Equity Capital Trust IX	15,470			15,470			*LIBOR +	3.65%	June 15, 2035
American Equity Capital Trust X	20,620			20,620			*LIBOR +	3.65%	September 15, 2035
American Equity Capital Trust XI	20,620			20,620			*LIBOR +	3.65%	December 15, 2035
American Equity Capital Trust XII	41,238			41,238			*LIBOR +	3.50%	April 7, 2036
	246,671			246,450
Unamortized debt issue costs	(4,818		)	(4,998		)
	$	241,853		$	241,452

*—three month London Interbank Offered Rate

XML

Retirement and Share-based Compensation Plans (Tables)

12 Months Ended

Dec. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-based Compensation Expense By Plan

The following table summarizes compensation expense recognized for employees, directors and consultants as a result of share-based compensation:

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands)
ESOP	$	2,522	$	2,604	$	2,486
Employee Incentive Plans	1,207		1,911		1,306
Director Equity and Incentive Plan and Stock Option Plan	685		613		789
	$	4,414	$	5,128	$	4,581

Schedule of Stock Options Outstanding

Changes in the number of stock options outstanding during the years ended December 31, 2016, 2015 and 2014 are as follows:

	Number of Shares		Weighted-Average Exercise Price per Share		Total Exercise Price
	(Dollars in thousands, except per share data)
Outstanding at January 1, 2014	3,976,725		$	10.86	$	43,171
Granted	1,277,650		24.79		31,673
Canceled	(35,400	)	11.64		(412		)
Exercised	(1,174,800	)	11.64		(13,672		)
Outstanding at December 31, 2014	4,044,175		15.02		60,760
Granted	—		—		—
Canceled	(47,300	)	10.54		(499		)
Exercised	(552,884	)	14.51		(8,021		)
Outstanding at December 31, 2015	3,443,991		15.17		52,240
Granted	—		—		—
Canceled	(24,700	)	14.83		(366		)
Exercised	(500,345	)	9.97		(4,989		)
Outstanding at December 31, 2016	2,918,946		16.06		$	46,885

Schedule of Stock Options Outstanding, By Exercise Price Range

The following table summarizes information about stock options outstanding at December 31, 2016:

	Stock Options Outstanding				Stock Options Vested
Range of Exercise Prices	Number of Awards	Remaining Life (yrs)	Weighted-Average Exercise Price Per Share		Number of Awards	Remaining Life (yrs)	Weighted-Average Exercise Price Per Share
$5.07 - $8.02	248,225	1.74	$	7.16	248,225	1.74	$	7.16
$9.27 - $11.35	752,150	2.66	10.19		752,150	2.66	10.19
$12.04 - $24.79	1,918,571	3.24	19.52		1,918,571	3.24	19.52
$5.07 - $24.79	2,918,946	2.97	16.06		2,918,946	2.97	16.06

XML

Statutory Financial Information and Dividend Restrictions (Tables)

12 Months Ended

Dec. 31, 2016

Insurance [Abstract]

Statutory Accounting Practices Disclosure

Calculations using the NAIC formula indicated that American Equity Life's ratio of total adjusted capital to the highest level of required capital at which regulatory action might be initiated (Company Action Level) is as follows:

	December 31,
	2016			2015
	(Dollars in thousands)
Total adjusted capital	$	2,933,193		$	2,593,472
Company Action Level RBC	857,321			771,293
Ratio of adjusted capital to Company Action Level RBC	342		%	336		%

Net income for our primary life insurance subsidiary as determined in accordance with statutory accounting practices was as follows:

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands)
American Equity Life	$	75,035	$	131,452	$	340,000

Statutory capital and surplus for our primary life insurance subsidiary was as follows:

	December 31,
	2016		2015
	(Dollars in thousands)
American Equity Life	$	2,726,664	$	2,415,419

XML

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases

The following represents payments due by period for operating lease obligations as of December 31, 2016 (dollars in thousands):

Year Ending December 31:
2017	$	1,890
2018	1,915
2019	1,898
2020	1,950
2021	1,754
2022 and thereafter	7,464

XML

Earnings Per Share and Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2016

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of earnings per common share and earnings per common share—assuming dilution:

	Year Ended December 31,
	2016		2015		2014
	(Dollars in thousands, except per share data)
Numerator:
Net income—numerator for earnings per common share	$	83,243	$	219,830	$	126,023
Denominator:
Weighted average common shares outstanding (1)	84,793,151		78,936,828		74,431,087
Effect of dilutive securities:
Convertible senior notes	—		—		2,657,158
Equity forward sale agreements	—		67,575		—
2015 warrants	15,136		759,723		1,559,646
Stock options and deferred compensation agreements	456,236		1,040,922		1,178,783
Restricted stock and restricted stock units	340,646		155,520		66,926
Denominator for earnings per common share—assuming dilution	85,605,169		80,960,568		79,893,600
Earnings per common share	$	0.98	$	2.78	$	1.69
Earnings per common share—assuming dilution	$	0.97	$	2.72	$	1.58

(1) Weighted average common shares outstanding include shares vested under the NMO Deferred Compensation Plan and exclude unallocated shares held by the ESOP.

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Options to purchase shares of our common stock that were outstanding during the respective periods indicated but were not included in the computation of diluted earnings per share because the options' exercise price was greater than the average market price of the common shares are as follows:

Period	Number of Shares	Range of Exercise Prices
		Minimum	Maximum
Year ended December 31, 2016	1,054,091	$24.79	$24.79
Year ended December 31, 2015	1,061,541	$24.79	$24.79
Year ended December 31, 2014	1,215,450	$24.79	$24.79

XML

Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2016

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information

Unaudited quarterly results of operations are summarized below.

	Quarter Ended
	March 31,			June 30,			September 30,			December 31,
	(Dollars in thousands, except per share data)
2016
Premiums and product charges	$	43,850		$	52,582		$	60,406		$	60,508
Net investment income	450,826			459,830			463,583			475,633
Change in fair value of derivatives	(74,065		)	39,099			103,794			95,391
Net realized gains (losses) on investments, excluding OTTI losses	2,687			2,737			5,256			844
Net OTTI losses recognized in operations	(5,694		)	(4,446		)	(2,979		)	(9,560		)
Total revenues	417,604			549,802			630,060			622,816
Net income (loss)	(44,841		)	14,708			(7,420		)	120,796
Earnings (loss) per common share	(0.55		)	0.18			(0.09		)	1.37
Earnings (loss) per common share—assuming dilution	(0.55		)	0.18			(0.09		)	1.35
2015
Premiums and product charges	$	35,679		$	42,446		$	46,310		$	47,781
Net investment income	399,669			418,176			436,085			438,262
Change in fair value of derivatives	(31,100		)	(23,024		)	(351,360		)	69,338
Net realized gains (losses) on investments, excluding OTTI losses	4,879			4,324			1,159			(151		)
Net OTTI losses recognized in operations	(132		)	(828		)	(5,229		)	(13,347		)
Total revenues	408,995			441,094			126,965			541,883
Net income	5,903			82,845			97,306			33,776
Earnings per common share	0.08			1.07			1.22			0.41
Earnings per common share—assuming dilution	0.07			1.05			1.19			0.40

Comparability of Net Income (Loss), Impact of Fair Value Accounting to Fixed Index Annuity Business

The differences between the change in fair value of derivatives for each quarter primarily correspond to the performance of the indices upon which our call options are based. The comparability of net income (loss) is impacted by the application of fair value accounting to our fixed index annuity business is as follows:

	Quarter Ended
	March 31,		June 30,			September 30,			December 31,
	(Dollars in thousands)
2016	$	62,822	$	34,215		$	6,054		$	(66,618	)
2015	42,849		(28,596		)	(53,716		)	11,091

XML

Schedule I - Summary of Investments - Other Than Investments in Related Parties (Tables)

12 Months Ended

Dec. 31, 2016

Summary of Investments, Other than Investments in Related Parties [Abstract]

Summary of Investments - Other Than Investments in Related Parties

Schedule I—Summary of Investments—

Other Than Investments in Related Parties

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

December 31, 2016

Column A	Column B		Column C		Column D
Type of Investment	Amortized Cost (1)		Fair Value		Amount at which shown in the balance sheet
	(Dollars in thousands)
Fixed maturity securities:
Available for sale:
United States Government full faith and credit	$	11,864	$	11,805	$	11,805
United States Government sponsored agencies	1,368,340		1,344,787		1,344,787
United States municipalities, states and territories	3,626,395		3,926,950		3,926,950
Foreign government obligations	224,588		232,233		232,233
Corporate securities	26,338,214		27,118,526		27,118,526
Residential mortgage backed securities	1,166,944		1,254,835		1,254,835
Commercial mortgage backed securities	5,422,255		5,365,235		5,365,235
Other asset backed securities	1,795,355		1,806,123		1,806,123
	39,953,955		41,060,494		41,060,494
Held for investment:
Corporate security	76,825		68,766		76,825
Total fixed maturity securities	40,030,780		41,129,260		41,137,319
Mortgage loans on real estate	2,480,956		2,522,035		2,480,956
Derivative instruments	313,729		830,519		830,519
Other investments	308,296				308,774
Total investments	$	43,133,761			$	44,757,568

(1) On the basis of cost adjusted for other than temporary impairments, repayments and amortization of premiums and accrual of discounts for fixed maturity securities and short-term investments, original cost for derivative instruments and unpaid principal balance less allowance for credit losses for mortgage loans.

See accompanying Report of Independent Registered Public Accounting Firm.

XML

Schedule II - Condensed Financial Information of Registrant (Tables)

12 Months Ended

Dec. 31, 2016

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Condensed Balance Sheets

	December 31,
	2016		2015
Assets
Cash and cash equivalents	$	36,394	$	38,903
Equity securities of subsidiary trusts	7,422		7,415
Receivable from subsidiaries	182		207
Deferred income taxes	9,528		11,645
Federal income tax recoverable, including amount from subsidiaries	—		7,747
Other assets	2,540		2,270
	56,066		68,187
Investment in and advances to subsidiaries	2,992,217		2,526,972
Total assets	$	3,048,283	$	2,595,159
Liabilities and Stockholders' Equity
Liabilities:
Notes and loan payable	$	493,755	$	393,227
Subordinated debentures payable to subsidiary trusts	241,853		241,452
Federal income tax payable	3,614		—
Other liabilities	17,466		15,945
Total liabilities	756,688		650,624
Stockholders' equity:
Common stock	88,001		81,354
Additional paid-in capital	770,344		630,367
Accumulated other comprehensive income	339,966		201,663
Retained earnings	1,093,284		1,031,151
Total stockholders' equity	2,291,595		1,944,535
Total liabilities and stockholders' equity	$	3,048,283	$	2,595,159

See accompanying note to condensed financial statements.

See accompanying Report of Independent Registered Public Accounting Firm.

Condensed Statements of Operations

	Year Ended December 31,
	2016			2015			2014
Revenues:
Net investment income	$	78		$	62		$	130
Dividends from subsidiary trusts	384			363			360
Investment advisory fees	75,706			65,957			58,044
Surplus note interest from subsidiary	4,080			4,080			4,080
Change in fair value of derivatives	(810		)	(8,225		)	(17,122		)
Loss on extinguishment of debt	—			—			(12,502		)
Total revenues	79,438			62,237			32,990
Expenses:
Change in fair value of embedded derivatives	—			(4,516		)	(15,227		)
Interest expense on notes and loan payable	28,248			28,849			36,370
Interest expense on subordinated debentures issued to subsidiary trusts	12,958			12,239			12,122
Other operating costs and expenses	8,551			8,195			7,928
Total expenses	49,757			44,767			41,193
Income (loss) before income taxes and equity in undistributed income of subsidiaries	29,681			17,470			(8,203		)
Income tax expense	12,073			7,338			664
Income (loss) before equity in undistributed income of subsidiaries	17,608			10,132			(8,867		)
Equity in undistributed income of subsidiaries	65,635			209,698			134,890
Net income	$	83,243		$	219,830		$	126,023

See accompanying note to condensed financial statements.

See accompanying Report of Independent Registered Public Accounting Firm.

Condensed Statements of Cash Flows

	Year Ended December 31,
	2016			2015			2014
Operating activities
Net income	$	83,243		$	219,830		$	126,023
Adjustments to reconcile net income to net cash provided by operating activities:
Change in fair value of 2015 notes embedded conversion derivative	—			(4,516		)	(15,227		)
Provision for depreciation and amortization	1,946			1,613			2,081
Accrual of discount on equity security	(7		)	(6		)	(6		)
Equity in undistributed income of subsidiaries	(65,635		)	(209,698		)	(134,890		)
Accrual of discount on contingent convertible notes	—			698			4,417
Change in fair value of derivatives	(698		)	6,377			15,619
Loss on extinguishment of debt	—			—			12,502
Accrual of discount on debenture issued to subsidiary trust	221			207			193
Share-based compensation	818			1,026			1,141
ESOP compensation	—			—			82
Deferred income taxes	2,117			8,967			6,439
Other	—			—			(2,235		)
Changes in operating assets and liabilities:
Receivable from subsidiaries	(125		)	93			2,208
Federal income tax recoverable	11,361			2,683			1,121
Other assets	(326		)	(4		)	378
Other liabilities	2,546			(1,664		)	(7,256		)
Net cash provided by operating activities	35,461			25,606			12,590
Investing activities
Capital contributions to subsidiaries	$	(255,000	)	$	(120,000	)	$	—
Purchases of property, plant and equipment	(54		)	—			—
Net cash used in investing activities	(255,054		)	(120,000		)	—
Financing activities
Financing fees incurred and deferred	$	(1,456	)	$	—		$	(100	)
Repayments of notes payable	—			(48,152		)	(219,094		)
Net proceeds from settlement of notes hedges and warrants	—			25,775			16,558
Proceeds from issuance of debt	100,000			—			—
Excess tax benefits realized from share-based compensation plans	—			—			184
Proceeds from issuance of common stock	139,654			112,481			13,681
Dividends paid	(21,114		)	(17,946		)	(15,221		)
Net cash provided by (used in) financing activities	217,084			72,158			(203,992		)
Decrease in cash and cash equivalents	(2,509		)	(22,236		)	(191,402		)
Cash and cash equivalents at beginning of year	38,903			61,139			252,541
Cash and cash equivalents at end of year	$	36,394		$	38,903		$	61,139
Supplemental disclosures of cash flow information
Cash paid during the year for:
Interest on notes and loan payable	$	27,164		$	27,283		$	31,206
Interest on subordinated debentures	12,454			11,833			11,765
Non-cash financing activity:
Common stock issued in extinguishment of debt	—			—			95,993
Common stock issued to settle warrants that have expired	93			48			—

See accompanying note to condensed financial statements.

See accompanying Report of Independent Registered Public Accounting Firm.

XML

Schedule III - Supplementary Insurance Information (Tables)

12 Months Ended

Dec. 31, 2016

Supplementary Insurance Information [Abstract]

Supplemental Insurance Information

Schedule III—Supplementary Insurance Information

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

Column A	Column B		Column C		Column D		Column E
	Deferred policy acquisition costs		Future policy benefits, losses, claims and loss expenses		Unearned premiums		Other policy claims and benefits payable
	(Dollars in thousands)
As of December 31, 2016: Life insurance	$	2,905,377	$	51,637,026	$	—	$	298,347
As of December 31, 2015: Life insurance	$	2,905,136	$	45,495,431	$	—	$	324,850
As of December 31, 2014: Life insurance	$	2,058,556	$	39,802,861	$	—	$	365,819

Column A	Column F		Column G		Column H		Column I		Column J
	Premium revenue		Net investment income		Benefits, claims, losses and settlement expenses		Amortization of deferred policy acquisition costs		Other operating expenses
	(Dollars in thousands)
For the year ended December 31, 2016: Life insurance	$	217,346	$	1,849,872	$	1,572,586	$	374,012	$	143,437
For the year ended December 31, 2015: Life insurance	$	172,216	$	1,692,192	$	758,203	$	286,114	$	137,306
For the year ended December 31, 2014: Life insurance	$	151,613	$	1,531,667	$	1,679,255	$	163,578	$	130,076

See accompanying Report of Independent Registered Public Accounting Firm.

XML

Schedule IV - Reinsurance (Tables)

12 Months Ended

Dec. 31, 2016

Supplemental Schedule of Reinsurance Premiums for Insurance Companies [Abstract]

Supplemental Schedule of Reinsurance

Schedule IV—Reinsurance

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

Column A	Column B		Column C		Column D		Column E		Column F
	Gross amount		Ceded to other companies		Assumed from other companies		Net amount		Percent of amount assumed to net
	(Dollars in thousands)
Year ended December 31, 2016
Life insurance in force, at end of year	$	1,996,446	$	10,045	$	57,849	$	2,044,250	2.83	%
Insurance premiums and other considerations:
Annuity product charges	$	178,945	$	5,366	$	—	$	173,579	—
Traditional life, accident and health insurance, and life contingent immediate annuity premiums	43,521		251		497		43,767		1.14	%
	$	222,466	$	5,617	$	497	$	217,346	0.23	%
Year ended December 31, 2015
Life insurance in force, at end of year	$	2,036,690	$	10,677	$	56,882	$	2,082,895	2.73	%
Insurance premiums and other considerations:
Annuity product charges	$	141,595	$	5,427	$	—	$	136,168	—
Traditional life, accident and health insurance, and life contingent immediate annuity premiums	35,715		256		589		36,048		1.63	%
	$	177,310	$	5,683	$	589	$	172,216	0.34	%
Year ended December 31, 2014
Life insurance in force, at end of year	$	2,171,426	$	11,548	$	56,509	$	2,216,387	2.55	%
Insurance premiums and other considerations:
Annuity product charges	$	124,946	$	5,956	$	—	$	118,990	—
Traditional life, accident and health insurance, and life contingent immediate annuity premiums	32,308		336		651		32,623		2.00	%
	$	157,254	$	6,292	$	651	$	151,613	0.43	%

See accompanying Report of Independent Registered Public Accounting Firm.

XML

Schedule V - Valuation and Qualifying Accounts (Tables)

12 Months Ended

Dec. 31, 2016

Valuation and Qualifying Accounts [Abstract]

Valuation and Qualifying Accounts

Schedule V—Valuation and Qualifying Accounts

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

	Balance January 1,			Charged to Costs and Expenses			Translation Adjustment		Write-offs/ Payments/Other		Balance December 31,
	(Dollars in thousands
Year ended December 31, 2016
Valuation allowance on mortgage loans	$	(14,142	)	$	(4,846	)	$	—	$	10,561	$	(8,427	)
Year ended December 31, 2015
Valuation allowance on mortgage loans	$	(22,633	)	$	1,018		$	—	$	7,473	$	(14,142	)
Year ended December 31, 2014
Valuation allowance on mortgage loans	$	(26,047	)	$	(6,052	)	$	—	$	9,466	$	(22,633	)

See accompanying Report of Independent Registered Public Accounting Firm.

XML

Significant Accounting Policies (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2016 USD ($) states NMOs	Dec. 31, 2015 USD ($) NMOs	Dec. 31, 2014 USD ($) NMOs
Accounting Policies [Abstract]
Number of states in which entity is licensed to sell insurance products | states	50
Number of days past due, non-accrual status	90 days
Provision for annual experience refunds of premiums | $	$ 1.5	$ 1.5	$ 1.7
National marketing organizations, number of organizations accounting for more than 10% of annuity deposits and insurance premium collections | NMOs	2	1	2
Minimum [Member]
Interest crediting rate, range for fixed index annuities and other deferred annuity products	1.00%	1.00%	1.00%
Reserve interest assumptions, range	3.00%
Maximum [Member]
Interest crediting rate, range for fixed index annuities and other deferred annuity products	3.30%	3.30%	3.30%
Reserve interest assumptions, range	5.50%
Cash and Cash Equivalents [Member]
Investment maturity period (less than)	3 months
Repurchase Agreements [Member]
Investment maturity period (less than)	42 days
National Marketing Organization, Greater than 10%, NMO 1 [Member]
National marketing organizations, percent of annuity deposits and insurance premiums collected individually	19.00%	24.00%	10.00%
National Marketing Organization, Greater than 10%, NMO 2 [Member]
National marketing organizations, percent of annuity deposits and insurance premiums collected individually	10.00%		10.00%

XML

Significant Accounting Policies (Premiums and Annuity Deposits, By Product Type) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Product Information [Line Items]
Fixed index annuities	$ 5,035,818	$ 6,491,981	$ 3,911,109
Annual reset fixed rate annuities	63,582	44,715	56,647
Multi-year fixed rate annuities	256,894	42,709	21,125
Single premium immediate annuities (SPIA)	35,851	32,752	24,580
Life insurance	9,946	10,917	10,810
Premiums and annuity deposits, net of coinsurance	$ 5,402,091	$ 6,623,074	$ 4,024,271

XML

Fair Values of Financial Instruments (Narrative) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2016 USD ($) Basis_Points	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Level 1 to Level 2 transfers, amount	$ 0	$ 0
Liabilities, Level 1 to Level 2 transfers, amount	0	0
Assets, Level 2 to Level 1 transfers, amount	0	0
Liabilities, Level 2 to Level 1 transfers, amount	0	0
Assets, transfers into Level 3, amount	0	0	$ 0
Liabilities, transfers into Level 3, amount	0	0	0
Assets, transfers out of Level 3, amount	0	0	0
Liabilities, transfers out of Level 3, amount	$ 0	$ 0	$ 0
Fair Value, Sensitivity, Increase in Discount Rate by 10 Percent [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, sensitivity, discount rate adjustment (basis points) | Basis_Points	100
Fixed index annuities embedded derivative, adjustment due to change in discount rate	$ (451,400)
Deferred policy acquisition costs and deferred sales inducements, combined balance, adjustment due to change in discount rate	$ (276,400)
Fair Value, Sensitivity, Decrease in Discount Rate by 10 Percent [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, sensitivity, discount rate adjustment (basis points) | Basis_Points	100
Fixed index annuities embedded derivative, adjustment due to change in discount rate	$ 504,500
Deferred policy acquisition costs and deferred sales inducements, combined balance, adjustment due to change in discount rate	$ 299,500

XML

Fair Values of Financial Instruments (Carrying Amounts and Fair Values of Financial Instruments) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Assets
Held for investment	$ 68,766	$ 65,377
Other investments	308,774	299,358
Coinsurance deposits	4,639,492	3,187,470
Liabilities
Policy benefit reserves	51,637,026	45,495,431
Carrying Amount [Member]
Assets
Mortgage loans on real estate	2,480,956	2,435,257
Derivative assets	830,519	337,256
Other investments	308,774	292,872
Cash and cash equivalents	791,266	397,749
Coinsurance deposits	4,639,492	3,187,470
Counterparty collateral	145,693	82,312
Liabilities
Policy benefit reserves	51,280,331	45,151,460
Single premium immediate annuity (SPIA) benefit reserves	297,724	324,264
Notes and loan payable	493,755	393,227
Subordinated debentures	241,853	241,452
Carrying Amount [Member] | Interest Rate Caps [Member]
Assets
Interest rate derivative assets	1,082	1,410
Carrying Amount [Member] | Interest Rate Swap [Member]
Liabilities
Interest rate derivative liabilities	2,113	3,139
Carrying Amount [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	41,060,494	36,421,839
Held for investment	76,825	76,622
Fair Value [Member]
Assets
Mortgage loans on real estate	2,522,035	2,471,864
Derivative assets	830,519	337,256
Other investments	300,918	297,903
Cash and cash equivalents	791,266	397,749
Coinsurance deposits	4,150,792	2,860,882
Counterparty collateral	145,693	82,312
Liabilities
Policy benefit reserves	43,104,183	38,435,515
Single premium immediate annuity (SPIA) benefit reserves	308,028	336,066
Notes and loan payable	519,440	417,752
Subordinated debentures	225,106	216,933
Fair Value [Member] | Interest Rate Caps [Member]
Assets
Interest rate derivative assets	1,082	1,410
Fair Value [Member] | Interest Rate Swap [Member]
Liabilities
Interest rate derivative liabilities	2,113	3,139
Fair Value [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	41,060,494	36,421,839
Held for investment	$ 68,766	$ 65,377

XML

Fair Values of Financial Instruments (Assets and Liabilities Measured on a Recurring Basis by Fair Value Hierarchy) (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Assets
Derivative assets	$ 830,519	$ 337,256
Cash and cash equivalents	791,266	397,749
Counterparty collateral	145,693	82,312
Assets	42,837,054	37,248,394
Liabilities
Fixed index annuities - embedded derivatives	6,563,288	5,983,622
Liabilities	6,565,401	5,986,761
Interest Rate Caps [Member]
Assets
Interest rate derivative assets	1,082	1,410
Interest Rate Swap [Member]
Liabilities
Interest rate derivative liabilities	2,113	3,139
Other Investments: Equity Securities, Available For Sale [Member]
Assets
Available for sale securities	8,000	7,828
United States Government Full Faith and Credit [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	11,805	471,256
United States Government Sponsored Agencies [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	1,344,787	1,398,611
United States Municipalities, States and Territories [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	3,926,950	3,755,367
Foreign Government Obligations [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	232,233	212,565
Corporate Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	27,118,526	23,802,394
Residential Mortgage Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	1,254,835	1,462,072
Commercial Mortgage Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	5,365,235	4,174,396
Other Asset Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	1,806,123	1,145,178
Quoted Prices in Active Markets (Level 1) [Member]
Assets
Derivative assets	0	0
Cash and cash equivalents	791,266	397,749
Counterparty collateral	0	0
Assets	796,653	836,468
Liabilities
Fixed index annuities - embedded derivatives	0	0
Liabilities	0	0
Quoted Prices in Active Markets (Level 1) [Member] | Interest Rate Caps [Member]
Assets
Interest rate derivative assets	0	0
Quoted Prices in Active Markets (Level 1) [Member] | Interest Rate Swap [Member]
Liabilities
Interest rate derivative liabilities	0	0
Quoted Prices in Active Markets (Level 1) [Member] | Other Investments: Equity Securities, Available For Sale [Member]
Assets
Available for sale securities	0	0
Quoted Prices in Active Markets (Level 1) [Member] | United States Government Full Faith and Credit [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	5,381	438,598
Quoted Prices in Active Markets (Level 1) [Member] | United States Government Sponsored Agencies [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Quoted Prices in Active Markets (Level 1) [Member] | United States Municipalities, States and Territories [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Quoted Prices in Active Markets (Level 1) [Member] | Foreign Government Obligations [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Quoted Prices in Active Markets (Level 1) [Member] | Corporate Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	6	121
Quoted Prices in Active Markets (Level 1) [Member] | Residential Mortgage Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Quoted Prices in Active Markets (Level 1) [Member] | Commercial Mortgage Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Quoted Prices in Active Markets (Level 1) [Member] | Other Asset Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Significant Other Observable Inputs (Level 2) [Member]
Assets
Derivative assets	830,519	337,256
Cash and cash equivalents	0	0
Counterparty collateral	145,693	82,312
Assets	42,040,401	36,411,926
Liabilities
Fixed index annuities - embedded derivatives	0	0
Liabilities	2,113	3,139
Significant Other Observable Inputs (Level 2) [Member] | Interest Rate Caps [Member]
Assets
Interest rate derivative assets	1,082	1,410
Significant Other Observable Inputs (Level 2) [Member] | Interest Rate Swap [Member]
Liabilities
Interest rate derivative liabilities	2,113	3,139
Significant Other Observable Inputs (Level 2) [Member] | Other Investments: Equity Securities, Available For Sale [Member]
Assets
Available for sale securities	8,000	7,828
Significant Other Observable Inputs (Level 2) [Member] | United States Government Full Faith and Credit [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	6,424	32,658
Significant Other Observable Inputs (Level 2) [Member] | United States Government Sponsored Agencies [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	1,344,787	1,398,611
Significant Other Observable Inputs (Level 2) [Member] | United States Municipalities, States and Territories [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	3,926,950	3,755,367
Significant Other Observable Inputs (Level 2) [Member] | Foreign Government Obligations [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	232,233	212,565
Significant Other Observable Inputs (Level 2) [Member] | Corporate Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	27,118,520	23,802,273
Significant Other Observable Inputs (Level 2) [Member] | Residential Mortgage Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	1,254,835	1,462,072
Significant Other Observable Inputs (Level 2) [Member] | Commercial Mortgage Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	5,365,235	4,174,396
Significant Other Observable Inputs (Level 2) [Member] | Other Asset Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	1,806,123	1,145,178
Significant Unobservable Inputs (Level 3) [Member]
Assets
Derivative assets	0	0
Cash and cash equivalents	0	0
Counterparty collateral	0	0
Assets	0	0
Liabilities
Fixed index annuities - embedded derivatives	6,563,288	5,983,622
Liabilities	6,563,288	5,983,622
Significant Unobservable Inputs (Level 3) [Member] | Interest Rate Caps [Member]
Assets
Interest rate derivative assets	0	0
Significant Unobservable Inputs (Level 3) [Member] | Interest Rate Swap [Member]
Liabilities
Interest rate derivative liabilities	0	0
Significant Unobservable Inputs (Level 3) [Member] | Other Investments: Equity Securities, Available For Sale [Member]
Assets
Available for sale securities	0	0
Significant Unobservable Inputs (Level 3) [Member] | United States Government Full Faith and Credit [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Significant Unobservable Inputs (Level 3) [Member] | United States Government Sponsored Agencies [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Significant Unobservable Inputs (Level 3) [Member] | United States Municipalities, States and Territories [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Significant Unobservable Inputs (Level 3) [Member] | Foreign Government Obligations [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Significant Unobservable Inputs (Level 3) [Member] | Corporate Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Significant Unobservable Inputs (Level 3) [Member] | Residential Mortgage Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Significant Unobservable Inputs (Level 3) [Member] | Commercial Mortgage Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	0	0
Significant Unobservable Inputs (Level 3) [Member] | Other Asset Backed Securities [Member] | Fixed Maturity Securities [Member]
Assets
Available for sale securities	$ 0	$ 0

XML

Fair Values of Financial Instruments (Assumptions Used in Estimating Fair Value) (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Expected cost of annual call options	3.10%	3.10%
Mortality rate assumption	65.00%
Fixed Index Annuities [Member] | Minimum [Member] | Contract Duration (Years), Group 1 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Contract duration (years)	1 year	1 year
Fixed Index Annuities [Member] | Minimum [Member] | Contract Duration (Years), Group 2 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Contract duration (years)	6 years	6 years
Fixed Index Annuities [Member] | Minimum [Member] | Contract Duration (Years), Group 3 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Contract duration (years)	11 years	11 years
Fixed Index Annuities [Member] | Minimum [Member] | Contract Duration (Years), Group 4 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Contract duration (years)	16 years	16 years
Fixed Index Annuities [Member] | Minimum [Member] | Contract Duration (Years), Group 5 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Contract duration (years)	20 years	20 years
Fixed Index Annuities [Member] | Maximum [Member] | Contract Duration (Years), Group 1 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Contract duration (years)	5 years	5 years
Fixed Index Annuities [Member] | Maximum [Member] | Contract Duration (Years), Group 2 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Contract duration (years)	10 years	10 years
Fixed Index Annuities [Member] | Maximum [Member] | Contract Duration (Years), Group 3 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Contract duration (years)	15 years	15 years
Fixed Index Annuities [Member] | Maximum [Member] | Contract Duration (Years), Group 4 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Contract duration (years)	20 years	20 years
Fixed Index Annuities [Member] | Weighted Average [Member] | Contract Duration (Years), Group 1 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Average lapse rates	1.76%	1.58%
Average partial withdrawal rates	3.30%	3.08%
Fixed Index Annuities [Member] | Weighted Average [Member] | Contract Duration (Years), Group 2 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Average lapse rates	6.58%	8.55%
Average partial withdrawal rates	3.30%	3.55%
Fixed Index Annuities [Member] | Weighted Average [Member] | Contract Duration (Years), Group 3 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Average lapse rates	11.25%	12.01%
Average partial withdrawal rates	3.32%	3.59%
Fixed Index Annuities [Member] | Weighted Average [Member] | Contract Duration (Years), Group 4 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Average lapse rates	12.04%	12.99%
Average partial withdrawal rates	3.18%	3.22%
Fixed Index Annuities [Member] | Weighted Average [Member] | Contract Duration (Years), Group 5 [Member]
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Average lapse rates	11.68%	12.54%
Average partial withdrawal rates	3.18%	3.22%

XML

Fair Values of Financial Instruments (Reconciliation of Beginning and Ending Balances of Level 3 Liabilities) (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 5,983,622	$ 5,574,653
Premiums less benefits	434,621	1,234,637
Change in fair value, net	145,045	(825,668)
Ending balance	$ 6,563,288	$ 5,983,622

XML

Investments (Narrative) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2016 USD ($) Securities	Dec. 31, 2015 USD ($) Securities	Dec. 31, 2014 USD ($)
Investments [Abstract]
Fixed income securities with call features, percentage	35.00%
Fixed income securities with call features, currently callable, percentage	0.10%
Fixed income securities with call features, currently callable, amount	$ 55,700
Fixed income securities with call features, callable during next 12 months, percentage	3.10%
Fixed income securities with call features, callable during next 12 months, amount	$ 1,300,000
Fixed income securities with call features, not callable until within 6 months of stated maturity, percentage	70.00%
Percentage of fixed maturity portfolio rated investment grade based on NAIC designations	97.00%	98.00%
Number of securities in unrealized loss position | Securities	1,514	1,246
Percentage of unrealized losses on fixed maturity securities where securities are rated investment grade	86.00%	84.00%
Assets held by insurance regulators	$ 43,500,000	$ 38,300,000
Investment Holdings [Line Items]
Principal repayments, calls and tenders of available for sale securities	$ 2,746,510	1,612,121	$ 1,490,906
Stockholders' Equity, Total [Member]
Investment Holdings [Line Items]
Threshold for disclosure percentage	10.00%
Investment Type Concentration Risk [Member]
Investment Holdings [Line Items]
Fair value, concentration of risk, investments	$ 0	0
Fixed Maturity Securities [Member]
Investment Holdings [Line Items]
Principal repayments, calls and tenders of available for sale securities	1,700,000	1,200,000	1,300,000
Available For Sale [Member]
Investment Holdings [Line Items]
Proceeds from sales of available for sale securities	$ 1,000,000	$ 400,000	$ 200,000

XML

Investments (Schedule of Fixed Maturity Securities) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Investment Holdings [Line Items]
Held for investment, amortized cost	$ 76,825	$ 76,622
Held for investment, fair value	68,766	65,377
Fixed Maturity Securities [Member] | Available For Sale [Member]
Investment Holdings [Line Items]
Available for sale securities, amortized cost	39,953,955	35,823,710
Available for sale securities, gross unrealized gains	1,691,257	1,443,474
Available for sale securities, gross unrealized losses	(584,718)	(845,345)
Available for sale securities, fair value	41,060,494	36,421,839
Equity Securities [Member] | Available For Sale [Member]
Investment Holdings [Line Items]
Available for sale securities, amortized cost	7,521	7,515
Available for sale securities, gross unrealized gains	479	313
Available for sale securities, gross unrealized losses	0	0
Available for sale securities, fair value	8,000	7,828
United States Government Full Faith and Credit [Member] | Fixed Maturity Securities [Member] | Available For Sale [Member]
Investment Holdings [Line Items]
Available for sale securities, amortized cost	11,864	470,567
Available for sale securities, gross unrealized gains	229	988
Available for sale securities, gross unrealized losses	(288)	(299)
Available for sale securities, fair value	11,805	471,256
United States Government Sponsored Agencies [Member] | Fixed Maturity Securities [Member] | Available For Sale [Member]
Investment Holdings [Line Items]
Available for sale securities, amortized cost	1,368,340	1,386,219
Available for sale securities, gross unrealized gains	23,360	26,801
Available for sale securities, gross unrealized losses	(46,913)	(14,409)
Available for sale securities, fair value	1,344,787	1,398,611
United States Municipalities, States and Territories [Member] | Fixed Maturity Securities [Member] | Available For Sale [Member]
Investment Holdings [Line Items]
Available for sale securities, amortized cost	3,626,395	3,422,667
Available for sale securities, gross unrealized gains	322,948	341,328
Available for sale securities, gross unrealized losses	(22,393)	(8,628)
Available for sale securities, fair value	3,926,950	3,755,367
Foreign Government Obligations [Member] | Fixed Maturity Securities [Member] | Available For Sale [Member]
Investment Holdings [Line Items]
Available for sale securities, amortized cost	224,588	210,953
Available for sale securities, gross unrealized gains	12,725	12,547
Available for sale securities, gross unrealized losses	(5,080)	(10,935)
Available for sale securities, fair value	232,233	212,565
Corporate Securities [Member] | Fixed Maturity Securities [Member] | Available For Sale [Member]
Investment Holdings [Line Items]
Available for sale securities, amortized cost	26,338,214	23,597,530
Available for sale securities, gross unrealized gains	1,149,085	887,288
Available for sale securities, gross unrealized losses	(368,773)	(682,424)
Available for sale securities, fair value	27,118,526	23,802,394
Corporate Securities [Member] | Fixed Maturity Securities [Member] | Held For Investment [Member]
Investment Holdings [Line Items]
Held for investment, amortized cost	76,825	76,622
Held for investment, gross unrealized gains	0	0
Held for investment, gross unrealized losses	(8,059)	(11,245)
Held for investment, fair value	68,766	65,377
Residential Mortgage Backed Securities [Member] | Fixed Maturity Securities [Member] | Available For Sale [Member]
Investment Holdings [Line Items]
Available for sale securities, amortized cost	1,166,944	1,366,985
Available for sale securities, gross unrealized gains	91,445	98,576
Available for sale securities, gross unrealized losses	(3,554)	(3,489)
Available for sale securities, fair value	1,254,835	1,462,072
Commercial Mortgage Backed Securities [Member] | Fixed Maturity Securities [Member] | Available For Sale [Member]
Investment Holdings [Line Items]
Available for sale securities, amortized cost	5,422,255	4,238,265
Available for sale securities, gross unrealized gains	59,994	41,412
Available for sale securities, gross unrealized losses	(117,014)	(105,281)
Available for sale securities, fair value	5,365,235	4,174,396
Other Asset Backed Securities [Member] | Fixed Maturity Securities [Member] | Available For Sale [Member]
Investment Holdings [Line Items]
Available for sale securities, amortized cost	1,795,355	1,130,524
Available for sale securities, gross unrealized gains	31,471	34,534
Available for sale securities, gross unrealized losses	(20,703)	(19,880)
Available for sale securities, fair value	$ 1,806,123	$ 1,145,178

XML

Investments (Fixed Maturity Securities by Contractual Maturity) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis [Abstract]
Available for sale, due in one year or less, amortized cost	$ 236,707
Available for sale, due after one year through five years, amortized cost	2,824,776
Available for sale, due after five years through ten years, amortized cost	11,659,762
Available for sale, due after ten years through twenty years, amortized cost	8,792,470
Available for sale, due after twenty years, amortized cost	8,055,686
Available for sale, securities with a single maturity date, amortized cost	31,569,401
Available for sale, amortized cost	39,953,955	$ 35,823,710
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract]
Available for sale, due in one year or less, fair value	241,934
Available for sale, due after one year through five years, fair value	2,979,768
Available for sale, due after five years through ten years, fair value	11,738,156
Available for sale, due after ten years through twenty years, fair value	9,284,726
Available for sale, due after twenty years, fair value	8,389,717
Available for sale, securities with a single maturity date, fair value	32,634,301
Available for sale, fair value	41,060,494	36,421,839
Held-to-maturity Securities, Debt Maturities, Net Carrying Amount [Abstract]
Held for investment, due in one year or less, amortized cost	0
Held for investment, due after one year through five years, amortized cost	0
Held for investment, due after five years through ten years, amortized cost	0
Held for investment, due after ten years through twenty years, amortized cost	0
Held for investment, due after twenty years, amortized cost	76,825
Held for investment, securities with a single maturity date, amortized cost	76,825
Held for investment, amortized cost	76,825	76,622
Held-to-maturity Securities, Debt Maturities, Fair Value [Abstract]
Held for investment, due in one year or less, fair value	0
Held for investment, due after one year through five years, fair value	0
Held for investment, due after five years through ten years, fair value	0
Held for investment, due after ten years through twenty years, fair value	0
Held for investment, due after twenty years, fair value	68,766
Held for investment, securities with a single maturity date, fair value	68,766
Held for investment, fair value	68,766	$ 65,377
Residential Mortgage Backed Securities [Member]
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis [Abstract]
Available for sale, securities without a single maturity date, amortized cost	1,166,944
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract]
Available for sale, securities without a single maturity date, fair value	1,254,835
Held-to-maturity Securities, Debt Maturities, Net Carrying Amount [Abstract]
Held for investment, securities without a single maturity date, amortized cost	0
Held-to-maturity Securities, Debt Maturities, Fair Value [Abstract]
Held for investment, securities without a single maturity date, fair value	0
Commercial Mortgage Backed Securities [Member]
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis [Abstract]
Available for sale, securities without a single maturity date, amortized cost	5,422,255
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract]
Available for sale, securities without a single maturity date, fair value	5,365,235
Held-to-maturity Securities, Debt Maturities, Net Carrying Amount [Abstract]
Held for investment, securities without a single maturity date, amortized cost	0
Held-to-maturity Securities, Debt Maturities, Fair Value [Abstract]
Held for investment, securities without a single maturity date, fair value	0
Other Asset Backed Securities [Member]
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis [Abstract]
Available for sale, securities without a single maturity date, amortized cost	1,795,355
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract]
Available for sale, securities without a single maturity date, fair value	1,806,123
Held-to-maturity Securities, Debt Maturities, Net Carrying Amount [Abstract]
Held for investment, securities without a single maturity date, amortized cost	0
Held-to-maturity Securities, Debt Maturities, Fair Value [Abstract]
Held for investment, securities without a single maturity date, fair value	$ 0

XML

Investments (Net Unrealized Gains on Available for Sale Fixed Maturity and Equity Securities Reported as a Seperate Component of Stockholders' Equity) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Investments [Abstract]
Net unrealized gains on available for sale fixed maturity securities and equity securities	$ 1,107,018	$ 598,442
Adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements	(618,661)	(322,859)
Deferred income tax valuation allowance reversal	22,534	22,534
Deferred income tax expense	(170,925)	(96,454)
Net unrealized gains reported as accumulated other comprehensive income	$ 339,966	$ 201,663

XML

Investments (Credit Quality of Fixed Maturity Security Portfolio by NAIC Designation) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Investment Holdings [Line Items]
Amortized cost	$ 40,030,780	$ 35,900,332
Fair value	41,129,260	36,487,216
NAIC, Class 1 Designation [Member]
Investment Holdings [Line Items]
Amortized cost	25,607,268	23,363,259
Fair value	26,507,798	24,207,801
NAIC, Class 2 Designation [Member]
Investment Holdings [Line Items]
Amortized cost	13,037,592	11,709,730
Fair value	13,295,648	11,589,325
NAIC, Class 3 Designation [Member]
Investment Holdings [Line Items]
Amortized cost	1,201,059	758,531
Fair value	1,155,702	643,293
NAIC, Class 4 Designation [Member]
Investment Holdings [Line Items]
Amortized cost	154,226	60,480
Fair value	137,188	44,312
NAIC, Class 5 Designation [Member]
Investment Holdings [Line Items]
Amortized cost	17,475	0
Fair value	24,664	0
NAIC, Class 6 Designation [Member]
Investment Holdings [Line Items]
Amortized cost	13,160	8,332
Fair value	$ 8,260	$ 2,485

XML

Investments (Gross Unrealized Losses on Investments, By Category and Length of Time) (Details) - Fixed Maturity Securities [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	$ 13,195,027	$ 13,944,810
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(454,013)	(646,288)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	1,368,974	676,956
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	(130,705)	(199,057)
Available for sale, continuous unrealized loss position, total, fair value	14,564,001	14,621,766
Available for sale, continuous unrealized loss position, total, unrealized losses	(584,718)	(845,345)
United States Government Full Faith and Credit [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	7,405	37,730
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(288)	(299)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	0	0
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	0	0
Available for sale, continuous unrealized loss position, total, fair value	7,405	37,730
Available for sale, continuous unrealized loss position, total, unrealized losses	(288)	(299)
United States Government Sponsored Agencies [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	995,548	957,053
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(46,913)	(14,409)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	0	0
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	0	0
Available for sale, continuous unrealized loss position, total, fair value	995,548	957,053
Available for sale, continuous unrealized loss position, total, unrealized losses	(46,913)	(14,409)
United States Municipalities, States and Territories [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	463,409	261,823
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(22,393)	(8,474)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	0	2,846
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	0	(154)
Available for sale, continuous unrealized loss position, total, fair value	463,409	264,669
Available for sale, continuous unrealized loss position, total, unrealized losses	(22,393)	(8,628)
Foreign Government Obligations [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	29,158	42,966
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(913)	(1,762)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	20,388	15,463
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	(4,167)	(9,173)
Available for sale, continuous unrealized loss position, total, fair value	49,546	58,429
Available for sale, continuous unrealized loss position, total, unrealized losses	(5,080)	(10,935)
Corporate Securities [Member] | Finance, Insurance and Real Estate [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	2,302,103	2,077,223
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(79,077)	(59,607)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	110,730	49,912
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	(9,834)	(14,855)
Available for sale, continuous unrealized loss position, total, fair value	2,412,833	2,127,135
Available for sale, continuous unrealized loss position, total, unrealized losses	(88,911)	(74,462)
Corporate Securities [Member] | Manufacturing, Construction and Mining [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	2,556,147	3,517,967
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(74,144)	(246,456)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	702,978	376,229
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	(74,382)	(131,003)
Available for sale, continuous unrealized loss position, total, fair value	3,259,125	3,894,196
Available for sale, continuous unrealized loss position, total, unrealized losses	(148,526)	(377,459)
Corporate Securities [Member] | Utilities and Related Sectors [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	1,605,742	2,240,652
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(53,055)	(138,940)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	196,085	97,184
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	(16,208)	(22,565)
Available for sale, continuous unrealized loss position, total, fair value	1,801,827	2,337,836
Available for sale, continuous unrealized loss position, total, unrealized losses	(69,263)	(161,505)
Corporate Securities [Member] | Wholesale/Retail Trade [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	396,310	473,050
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(9,433)	(17,863)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	57,708	38,682
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	(5,739)	(8,125)
Available for sale, continuous unrealized loss position, total, fair value	454,018	511,732
Available for sale, continuous unrealized loss position, total, unrealized losses	(15,172)	(25,988)
Corporate Securities [Member] | Services, Media and Other [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	857,515	1,037,011
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(35,107)	(39,937)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	132,170	32,050
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	(11,794)	(3,073)
Available for sale, continuous unrealized loss position, total, fair value	989,685	1,069,061
Available for sale, continuous unrealized loss position, total, unrealized losses	(46,901)	(43,010)
Corporate Securities [Member] | Insurance [Member]
Held-to-maturity Securities, Continuous Unrealized Loss Position [Abstract]
Held for investment, continuous unrealized loss position, less than 12 months, fair value	0	65,377
Held for investment, continuous unrealized loss position, less than 12 months, unrealized losses	0	(11,245)
Held for investment, continuous unrealized loss position, 12 months or more, fair value	68,766	0
Held for investment, continuous unrealized loss position, 12 months or more, unrealized losses	(8,059)	0
Held for investment, continuous unrealized loss position, total, fair value	68,766	65,377
Held for investment, continuous unrealized loss position, total, unrealized losses	(8,059)	(11,245)
Residential Mortgage Backed Securities [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	81,762	162,770
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(3,463)	(2,958)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	1,853	6,438
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	(91)	(531)
Available for sale, continuous unrealized loss position, total, fair value	83,615	169,208
Available for sale, continuous unrealized loss position, total, unrealized losses	(3,554)	(3,489)
Commercial Mortgage Backed Securities [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	3,148,395	2,679,510
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(116,938)	(105,002)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	895	11,495
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	(76)	(279)
Available for sale, continuous unrealized loss position, total, fair value	3,149,290	2,691,005
Available for sale, continuous unrealized loss position, total, unrealized losses	(117,014)	(105,281)
Other Asset Backed Securities [Member]
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract]
Available for sale, continuous unrealized loss position, less than 12 months, fair value	751,533	457,055
Available for sale, continuous unrealized loss position, less than 12 months, unrealized losses	(12,289)	(10,581)
Available for sale, continuous unrealized loss position, 12 months or more, fair value	146,167	46,657
Available for sale, continuous unrealized loss position, 12 months or more, unrealized losses	(8,414)	(9,299)
Available for sale, continuous unrealized loss position, total, fair value	897,700	503,712
Available for sale, continuous unrealized loss position, total, unrealized losses	$ (20,703)	$ (19,880)

XML

Investments (Changes in Net Unrealized Gains/Losses on Investments) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Investment Holdings [Line Items]
Fixed maturity securities held for investment carried at amortized cost	$ 3,186	$ (10,651)	$ 14,821
Investments carried at fair value	508,576	(1,642,010)	2,157,460
Adjustment for effect on other balance sheet accounts:
Deferred policy acquisition costs and deferred sales inducements	(295,802)	842,412	(1,118,683)
Deferred income tax asset/liability	(74,471)	279,860	(363,572)
Total adjustment for effect on other balance sheet accounts	(370,273)	1,122,272	(1,482,255)
Change in net unrealized gains on investments carried at fair value	138,303	(519,738)	675,205
Fixed Maturity Securities [Member]
Investment Holdings [Line Items]
Investments carried at fair value	508,410	(1,642,027)	2,157,439
Equity Securities [Member]
Investment Holdings [Line Items]
Investments carried at fair value	$ 166	$ 17	$ 21

XML

Investments (Components of Net Investment Income) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Net Investment Income [Line Items]
Investment income, gross									$ 1,861,392	$ 1,704,201	$ 1,545,892
Less investment expenses									(11,520)	(12,009)	(14,225)
Net investment income	$ 475,633	$ 463,583	$ 459,830	$ 450,826	$ 438,262	$ 436,085	$ 418,176	$ 399,669	1,849,872	1,692,192	1,531,667
Fixed Maturity Securities [Member]
Net Investment Income [Line Items]
Investment income, gross									1,729,176	1,566,409	1,394,301
Equity Securities [Member]
Net Investment Income [Line Items]
Investment income, gross									531	441	404
Mortgage Loans on Real Estate [Member]
Net Investment Income [Line Items]
Investment income, gross									122,985	131,892	143,998
Cash and Cash Equivalents [Member]
Net Investment Income [Line Items]
Investment income, gross									3,201	601	286
Other [Member]
Net Investment Income [Line Items]
Investment income, gross									$ 5,499	$ 4,858	$ 6,903

XML

Investments (Net Realized Gains (Losses) on Invesments) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Gain (Loss) on Investments [Line Items]
Net realized gains (losses) on investments, excluding other than temporary impairment (OTTI) losses	$ 844	$ 5,256	$ 2,737	$ 2,687	$ (151)	$ 1,159	$ 4,324	$ 4,879	$ 11,524	$ 10,211	$ (4,003)
Fixed Maturity Securities [Member]
Gain (Loss) on Investments [Line Items]
Available for sale fixed maturity securities: gross realized gains									14,132	7,230	3,273
Available for sale fixed maturity securities: gross realized losses									(4,036)	(5,787)	(1,006)
Available for sale fixed maturity securities: gross realized gains (losses), excluding other than temporary impairments									10,096	1,443	2,267
Other Investments [Member]
Gain (Loss) on Investments [Line Items]
Other investments: gain on sale of real estate									884	4,194	2,454
Other investments: loss on sale of real estate									(93)	(575)	(231)
Other investments: impairment losses on real estate									0	(1,297)	(2,441)
Gain (loss) on other investments									791	2,322	(218)
Mortgage Loans on Real Estate [Member]
Gain (Loss) on Investments [Line Items]
Mortgage loans on real estate: decrease (increase) in allowance for credit losses									(4,846)	1,018	(6,052)
Mortgage loans on real estate: recovery of specific allowance									5,483	5,428	0
Mortgage loans on real estate: change in allowance for provision and recoveries									$ 637	$ 6,446	$ (6,052)

XML

Investments (Non-Income Producing Investments) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Investment Holdings [Line Items]
Non-income producing investments	$ 1,651	$ 1,810
Fixed Maturity Securities [Member]
Investment Holdings [Line Items]
Non-income producing investments	1,651	10
Real Estate Owned [Member]
Investment Holdings [Line Items]
Non-income producing investments	$ 0	$ 1,800

XML

Investments (Significant Assumptions Used to Determine the Credit Loss Component of Other Than Temporary Impariment on Residential Mortgage Backed Securities) (Details) - Residential Mortgage Backed Securities [Member]	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Prime Sector [Member] | Vintage Year 2005 [Member] | Minimum [Member]
Schedule of Available-for-sale Securities [Line Items]
Discount rate	7.70%
Default rate	8.00%
Loss severity	50.00%
Prime Sector [Member] | Vintage Year 2005 [Member] | Maximum [Member]
Schedule of Available-for-sale Securities [Line Items]
Discount rate	7.70%
Default rate	14.00%
Loss severity	50.00%
Prime Sector [Member] | Vintage Year 2006 [Member] | Minimum [Member]
Schedule of Available-for-sale Securities [Line Items]
Discount rate	6.50%	6.50%
Default rate	12.00%	12.00%
Loss severity	40.00%	40.00%
Prime Sector [Member] | Vintage Year 2006 [Member] | Maximum [Member]
Schedule of Available-for-sale Securities [Line Items]
Discount rate	7.30%	7.40%
Default rate	13.00%	14.00%
Loss severity	50.00%	50.00%
Prime Sector [Member] | Vintage Year 2007 [Member] | Minimum [Member]
Schedule of Available-for-sale Securities [Line Items]
Discount rate	6.20%	5.80%
Default rate	18.00%	15.00%
Loss severity	50.00%	45.00%
Prime Sector [Member] | Vintage Year 2007 [Member] | Maximum [Member]
Schedule of Available-for-sale Securities [Line Items]
Discount rate	6.40%	7.00%
Default rate	31.00%	25.00%
Loss severity	55.00%	55.00%
Alt-A Sector [Member] | Vintage Year 2005 [Member] | Minimum [Member]
Schedule of Available-for-sale Securities [Line Items]
Discount rate	7.40%	5.60%
Default rate	11.00%	13.00%
Loss severity	60.00%	2.00%
Alt-A Sector [Member] | Vintage Year 2005 [Member] | Maximum [Member]
Schedule of Available-for-sale Securities [Line Items]
Discount rate	7.40%	7.40%
Default rate	11.00%	99.00%
Loss severity	60.00%	50.00%

XML

Investments (Other Than Temporary Impairment by Asset Type) (Details) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016 USD ($)	Sep. 30, 2016 USD ($)	Jun. 30, 2016 USD ($)	Mar. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Sep. 30, 2015 USD ($)	Jun. 30, 2015 USD ($)	Mar. 31, 2015 USD ($)	Dec. 31, 2016 USD ($) Securities	Dec. 31, 2015 USD ($) Securities	Dec. 31, 2014 USD ($) Securities
Gain (Loss) on Investments [Line Items]
Other than temporary impairment, number of securities | Securities									22	14
Total OTTI losses									$ (21,349)	$ (25,547)	$ 0
Portion of OTTI losses recognized in (from) other comprehensive income									(1,330)	6,011	(2,627)
Net OTTI losses recognized in operations	$ (9,560)	$ (2,979)	$ (4,446)	$ (5,694)	$ (13,347)	$ (5,229)	$ (828)	$ (132)	$ (22,679)	$ (19,536)	$ (2,627)
Corporate Securities [Member] | Energy [Member]
Gain (Loss) on Investments [Line Items]
Other than temporary impairment, number of securities | Securities									2
Total OTTI losses									$ (642)
Portion of OTTI losses recognized in (from) other comprehensive income									0
Net OTTI losses recognized in operations									$ (642)
Corporate Securities [Member] | Materials [Member]
Gain (Loss) on Investments [Line Items]
Other than temporary impairment, number of securities | Securities									1
Total OTTI losses									$ (4,554)
Portion of OTTI losses recognized in (from) other comprehensive income									1,575
Net OTTI losses recognized in operations									$ (2,979)
Corporate Securities [Member] | Telecommunications [Member]
Gain (Loss) on Investments [Line Items]
Other than temporary impairment, number of securities | Securities									1
Total OTTI losses									$ (4,462)
Portion of OTTI losses recognized in (from) other comprehensive income									562
Net OTTI losses recognized in operations									$ (3,900)
Corporate Securities [Member] | Utilities [Member]
Gain (Loss) on Investments [Line Items]
Other than temporary impairment, number of securities | Securities									2
Total OTTI losses									$ (6,961)
Portion of OTTI losses recognized in (from) other comprehensive income									798
Net OTTI losses recognized in operations									$ (6,163)
Corporate Securities [Member] | Industrial [Member]
Gain (Loss) on Investments [Line Items]
Other than temporary impairment, number of securities | Securities										2
Total OTTI losses										$ (15,414)
Portion of OTTI losses recognized in (from) other comprehensive income										2,975
Net OTTI losses recognized in operations										$ (12,439)
Residential Mortgage Backed Securities [Member]
Gain (Loss) on Investments [Line Items]
Other than temporary impairment, number of securities | Securities									9	11	7
Total OTTI losses									$ 0	$ (133)	$ 0
Portion of OTTI losses recognized in (from) other comprehensive income									(783)	(2,089)	(2,627)
Net OTTI losses recognized in operations									$ (783)	$ (2,222)	$ (2,627)
Commercial Mortgage Backed Securities [Member]
Gain (Loss) on Investments [Line Items]
Other than temporary impairment, number of securities | Securities									5
Total OTTI losses									$ (1,540)
Portion of OTTI losses recognized in (from) other comprehensive income									0
Net OTTI losses recognized in operations									$ (1,540)
Other Asset Backed Securities [Member]
Gain (Loss) on Investments [Line Items]
Other than temporary impairment, number of securities | Securities									2	1
Total OTTI losses									$ (3,190)	$ (10,000)
Portion of OTTI losses recognized in (from) other comprehensive income									(3,482)	5,125
Net OTTI losses recognized in operations									$ (6,672)	$ (4,875)

XML

Investments (Other Than Temporary Impairment, Credit Losses Recognized in Earnings) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Line Items]
Cumulative credit loss at beginning of year	$ (145,824)	$ (127,050)
Credit losses on securities for which OTTI has not previously been recognized	(18,414)	(17,447)
Additional credit losses on securities for which OTTI has previously been recognized	(4,265)	(2,089)
Accumulated losses on securities that were disposed of during the period	2,128	762
Cumulative credit loss at end of year	$ (166,375)	$ (145,824)

XML

Investments (Schedule of Other Than Temporary Impairment Losses, Investments) (Details) - Fixed Maturity Securities [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Investment Holdings [Line Items]
Amortized cost	$ 399,690	$ 481,421
OTTI recognized in other comprehensive income	(177,494)	(178,824)
Change in fair value since OTTI was recognized	217,747	198,605
Fair value	439,943	501,202
Corporate Securities [Member]
Investment Holdings [Line Items]
Amortized cost	17,549	6,396
OTTI recognized in other comprehensive income	(5,910)	(2,975)
Change in fair value since OTTI was recognized	13,566	9
Fair value	25,205	3,430
Residential Mortgage Backed Securities [Member]
Investment Holdings [Line Items]
Amortized cost	368,862	466,871
OTTI recognized in other comprehensive income	(169,941)	(170,724)
Change in fair value since OTTI was recognized	205,854	199,149
Fair value	404,775	495,296
Commercial Mortgage Backed Securities [Member]
Investment Holdings [Line Items]
Amortized cost	6,596
OTTI recognized in other comprehensive income	0
Change in fair value since OTTI was recognized	(107)
Fair value	6,489
Other Asset Backed Securities [Member]
Investment Holdings [Line Items]
Amortized cost	6,683	8,154
OTTI recognized in other comprehensive income	(1,643)	(5,125)
Change in fair value since OTTI was recognized	(1,566)	(553)
Fair value	$ 3,474	$ 2,476

XML

Mortgage Loans on Real Estate (Narrative) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2016 USD ($) portfolio_segment	Dec. 31, 2014 loans	Dec. 31, 2015 USD ($)
Mortgage Loans on Real Estate [Abstract]
Number of portfolio segments that make up financing receivables | portfolio_segment	1
Number of loans satisfied by foreclosure | loans		7
Impaired mortgage loans, workout terms, interest only payments, six month terms	6 months
Impaired mortgage loans, workout terms, interest only payments, twelve month terms	12 months
Impaired mortgage loans, workout terms, cash flow sweep, number of months	12 months
Number of days past due, non-accrual status	90 days
Non-accrual loans	$ 0		$ 0
Minimum [Member]
Mortgage Loans on Real Estate [Line Items]
Number of days past due, delinquent status	60 days
Commercial Real Estate Portfolio Segment [Member]
Mortgage Loans on Real Estate [Line Items]
Commitments outstanding	$ 75,500

XML

Mortgage Loans on Real Estate (Summary of Mortgage Loan Portfolio) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Loans and Leases Receivable Disclosure [Line Items]
Principal outstanding	$ 2,490,619	$ 2,449,909	$ 2,457,721
Mortgage loans on real estate	2,480,956	2,435,257
Commercial Real Estate Portfolio Segment [Member]
Loans and Leases Receivable Disclosure [Line Items]
Principal outstanding	2,490,619	2,449,909
Loan loss allowance	(8,427)	(14,142)
Deferred prepayment fees	(1,236)	(510)
Mortgage loans on real estate	$ 2,480,956	$ 2,435,257

XML

Mortgage Loans on Real Estate (Mortgage Loan Portfolio Summarized by Geographic Region and Property Type) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 2,490,619	$ 2,449,909	$ 2,457,721
Percent	100.00%	100.00%
Office [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 308,578	$ 396,154
Percent	12.40%	16.20%
Medical Office [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 50,780	$ 77,438
Percent	2.10%	3.20%
Retail [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 886,942	$ 790,158
Percent	35.60%	32.20%
Industrial/Warehouse [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 700,644	$ 686,400
Percent	28.10%	28.00%
Hotel [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 0	$ 3,361
Percent	0.00%	0.10%
Apartment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 375,837	$ 352,971
Percent	15.10%	14.40%
Mixed Use/Other [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 167,838	$ 143,427
Percent	6.70%	5.90%
East [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 635,434	$ 698,113
Percent	25.50%	28.50%
Middle Atlantic [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 151,640	$ 160,261
Percent	6.10%	6.60%
Mountain [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 235,932	$ 252,442
Percent	9.50%	10.30%
New England [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 12,724	$ 13,161
Percent	0.50%	0.50%
Pacific [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 385,683	$ 355,268
Percent	15.50%	14.50%
South Atlantic [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 519,065	$ 456,227
Percent	20.80%	18.60%
West North Central [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 325,447	$ 313,120
Percent	13.10%	12.80%
West South Central [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 224,694	$ 201,317
Percent	9.00%	8.20%

XML

Mortgage Loans on Real Estate (Rollforward of Allowance for Loan Losses) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Specific Allowance [Member]
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Beginning allowance balance	$ (7,842)	$ (12,333)	$ (16,847)
Charge-offs	5,078	2,045	9,211
Recoveries	5,483	5,428	255
Change in provision for credit losses	(4,046)	(2,982)	(4,952)
Ending allowance balance	(1,327)	(7,842)	(12,333)
General Allowance [Member]
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Beginning allowance balance	(6,300)	(10,300)	(9,200)
Charge-offs	0	0	0
Recoveries	0	0	0
Change in provision for credit losses	(800)	4,000	(1,100)
Ending allowance balance	$ (7,100)	$ (6,300)	$ (10,300)

XML

Mortgage Loans on Real Estate (Impaired Mortgage Loans on Real Estate By Basis of Impairment) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Mortgage Loans on Real Estate [Abstract]
Individually evaluated for impairment	$ 4,640	$ 21,277	$ 29,116
Collectively evaluated for impairment	2,485,979	2,428,632	2,428,605
Principal outstanding	$ 2,490,619	$ 2,449,909	$ 2,457,721

XML

Mortgage Loans on Real Estate (Real Estate Owned) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Mortgage Loans on Real Estate [Abstract]
Real estate owned at beginning of period	$ 6,485	$ 20,238	$ 22,844
Real estate acquired in satisfaction of mortgage loans	0	0	14,555
Additions	0	121	0
Sales	(6,444)	(12,322)	(14,134)
Impairments	0	(1,297)	(2,441)
Depreciation	(41)	(255)	(586)
Real estate owned at end of period	$ 0	$ 6,485	$ 20,238

XML

Mortgage Loans on Real Estate (Mortgage Loans by Credit Quality Indicator) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Mortgage Loans on Real Estate [Abstract]
Performing	$ 2,489,028	$ 2,438,341
In workout	1,591	11,568
Delinquent	0	0
Collateral dependent	0	0
Principal outstanding	$ 2,490,619	$ 2,449,909	$ 2,457,721

XML

Mortgage Loans on Real Estate (Aging of Financing Receivables) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Financing Receivable, Recorded Investment, Past Due [Line Items]
Commercial mortgage loans, past due	$ 2,737	$ 0
Commercial mortgage loans, current	2,487,882	2,449,909
Commercial mortgage loans, collateral dependent receivables	0	0
Principal outstanding	2,490,619	2,449,909	$ 2,457,721
30 to 59 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Commercial mortgage loans, past due	2,737	0
60 to 89 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Commercial mortgage loans, past due	0	0
90 Days and Over Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Commercial mortgage loans, past due	$ 0	$ 0

XML

Mortgage Loans on Real Estate (Impaired Financing Receivables) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Financing Receivable, Impaired [Line Items]
Mortgage loans with an allowance, recorded investment	$ 3,313	$ 13,435
Mortgage loans with no related allowance, recorded investment	1,591	8,859
Impaired mortgage loans, recorded investment	4,904	22,294
Mortgage loans with an allowance, unpaid principal balance	4,640	21,277
Mortgage loans with no related allowance, unpaid principal balance	1,591	8,859
Impaired mortgage loans, unpaid principal balance	6,231	30,136
Mortgage loans with an allowance, related allowance	(1,327)	(7,842)
Mortgage loans with an allowance, average recorded investment	3,398	13,893	$ 18,465
Mortgage loans with no related allowance, average recorded investment	1,665	8,930	2,656
Impaired mortgage loans, average recorded investment	5,063	22,823	21,121
Mortgage loans with an allowance, interest income recognized	301	1,117	1,797
Mortgage loans with no related allowance, interest income recognized	73	584	43
Impaired mortgage loans, interest income recognized	$ 374	$ 1,701	$ 1,840

XML

Mortgage Loans on Real Estate (Troubled Debt Restructurings) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2016 USD ($) loans	Dec. 31, 2015 USD ($) loans
Financing Receivable, Modifications [Line Items]
Number of TDRs | loans	2	9
Principal balance outstanding	$ 5,024	$ 20,374
Specific loan loss allowance	(467)	(3,459)
Net carrying amount	$ 4,557	$ 16,915
South Atlantic [Member]
Financing Receivable, Modifications [Line Items]
Number of TDRs | loans	1	6
Principal balance outstanding	$ 3,004	$ 11,155
Specific loan loss allowance	0	(2,992)
Net carrying amount	$ 3,004	$ 8,163
East North Central [Member]
Financing Receivable, Modifications [Line Items]
Number of TDRs | loans	1	2
Principal balance outstanding	$ 2,020	$ 3,306
Specific loan loss allowance	(467)	(467)
Net carrying amount	$ 1,553	$ 2,839
West North Central [Member]
Financing Receivable, Modifications [Line Items]
Number of TDRs | loans		1
Principal balance outstanding		$ 5,913
Specific loan loss allowance		0
Net carrying amount		$ 5,913

XML

Derivative Instruments (Narrative) (Details) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended								12 Months Ended			13 Months Ended
	Sep. 15, 2015 USD ($)	Sep. 30, 2010 USD ($) counterparties $ / shares shares	Dec. 31, 2016 USD ($)	Sep. 30, 2016 USD ($)	Jun. 30, 2016 USD ($)	Mar. 31, 2016 USD ($)	Dec. 31, 2015 USD ($) shares	Sep. 30, 2015 USD ($)	Jun. 30, 2015 USD ($)	Mar. 31, 2015 USD ($)	Dec. 31, 2016 USD ($) shares	Dec. 31, 2015 USD ($) $ / shares shares	Dec. 31, 2014 USD ($) partial_unwind_agreement	Dec. 31, 2016 USD ($) shares
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative collateral			$ 827,800				$ 349,800				$ 827,800	$ 349,800		$ 827,800
Credit risk, maximum exposure											55,500	36,900
Number of partial unwind agreements | partial_unwind_agreement													5
Net cash received from counterparties for settlement of call options and warrants													$ 16,600
Warrants reclassified from equity to a derivative liability, at fair value													(51,257)
Derivative [Line Items]
Change in fair value of embedded derivatives											(543,465)	464,698	(32,321)
Net income			120,796	$ (7,420)	$ 14,708	$ (44,841)	$ 33,776	$ 97,306	$ 82,845	$ 5,903	$ 83,243	$ 219,830	126,023
Shares of common stock issued to settle warrants that have reached their expiration | shares											92,998	47,868		140,866
2015 Notes Hedges [Member]
Derivative [Line Items]
Number of counterparties | counterparties		2
Conversion spread, shares of common stock | shares		16,000,000
Derivative asset, strike price | $ / shares		$ 12.50
Derivative asset, cash received to settle	$ 25,800
2015 Notes Embedded Conversion Derivative [Member]
Derivative [Line Items]
Change in fair value of embedded derivatives											$ 0	$ 4,516	19,036
Derivative liability, cash paid to settle conversion premium	$ 25,800
2015 Warrants [Member]
Derivative [Line Items]
Number of securities called by warrants | shares		16,000,000					1,600,000					1,600,000
Warrants, exercise price | $ / shares		$ 16.00										$ 15.59
Proceeds from issuance of warrants		$ 15,600
September 2015 Notes [Member]
Derivative [Line Items]
Debt instrument, face amount		$ 200,000
Interest rate		3.50%
SunTrust [Member] | Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Collateral on deposit			$ 700								$ 700			$ 700
SunTrust [Member] | Not Designated as Hedging Instrument [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Derivative, term of contract											7 years
SunTrust [Member] | Not Designated as Hedging Instrument [Member] | Interest Rate Caps [Member]
Derivative [Line Items]
Derivative, term of contract											7 years
SunTrust [Member] | Three Month London Interbank Offered Rate (LIBOR) [Member] | Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Cap rate			2.50%								2.50%			2.50%
Change in Assumptions for Fair Value [Member]
Derivative [Line Items]
Change in fair value of embedded derivatives													(62,600)
Net income													$ 14,800
Call Options [Member]
Derivative [Line Items]
Investment maturity period											1 year

XML

Derivative Instruments (Fair Value of Derivative Instruments as Presented in the Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Derivatives, Fair Value [Line Items]
Derivative assets	$ 830,519	$ 337,256
Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative assets	831,601	338,666
Derivative liabilities	6,565,401	5,986,761
Call Options [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative assets	830,519	337,256
Interest Rate Caps [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative assets	1,082	1,410
Fixed Index Annuities - Embedded Derivatives [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative liabilities	6,563,288	5,983,622
Interest Rate Swap [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative liabilities	$ 2,113	$ 3,139

XML

Derivative Instruments (Change in Fair Value of Derivative Instruments) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of derivatives	$ 164,219	$ (336,146)	$ 504,825
Change in fair value of embedded derivatives	543,465	(464,698)	32,321
Call Options [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of derivatives	165,029	(327,921)	521,947
2015 Notes Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of derivatives	0	(4,516)	(8,934)
Interest Rate Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of derivatives	(482)	(2,341)	(4,863)
Interest Rate Caps [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of derivatives	(328)	(1,368)	(3,325)
Fixed Index Annuities - Embedded Derivatives [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of embedded derivatives	145,045	(825,668)	(532,337)
Other Changes in Difference Between Policy Benefit Reserves Computed Using Derivative Accounting Vs. Long-Duration Contracts Accounting [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of embedded derivatives	398,420	365,486	579,885
2015 Notes Embedded Conversion Derivative [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of embedded derivatives	0	(4,516)	(19,036)
2029 Notes Embedded Conversion Derivative [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of embedded derivatives	$ 0	$ 0	$ 3,809

XML

Derivative Instruments (Schedule of Call Options by Counterparty) (Details) - Call Options [Member] - Not Designated as Hedging Instrument [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Derivative [Line Items]
Notional amount	$ 31,048,082	$ 29,277,569
Fair value	830,519	337,256
Bank of America [Member]
Derivative [Line Items]
Notional amount	5,958,884	6,257,861
Fair value	178,477	67,662
Barclays [Member]
Derivative [Line Items]
Notional amount	3,441,832	2,463,768
Fair value	89,721	35,273
BNP Paribas [Member]
Derivative [Line Items]
Notional amount	1,199,265	1,520,710
Fair value	19,598	16,944
Citibank, N.A. [Member]
Derivative [Line Items]
Notional amount	4,038,528	3,786,498
Fair value	97,094	23,587
Credit Suisse [Member]
Derivative [Line Items]
Notional amount	2,130,710	1,278,492
Fair value	44,242	12,508
Deutsche Bank [Member]
Derivative [Line Items]
Notional amount	25,935	1,349,002
Fair value	892	10,704
J.P. Morgan [Member]
Derivative [Line Items]
Notional amount	1,785,583	838,982
Fair value	19,645	5,283
Morgan Stanley [Member]
Derivative [Line Items]
Notional amount	2,543,421	3,465,457
Fair value	64,425	33,171
Royal Bank of Canada [Member]
Derivative [Line Items]
Notional amount	3,384,310	2,820,410
Fair value	103,510	48,654
SunTrust [Member]
Derivative [Line Items]
Notional amount	2,375,418	1,308,434
Fair value	72,990	20,028
Wells Fargo [Member]
Derivative [Line Items]
Notional amount	3,850,842	4,187,955
Fair value	130,545	63,442
Exchange Traded [Member]
Derivative [Line Items]
Notional amount	313,354	0
Fair value	$ 9,380	$ 0

XML

Derivative Instruments (Interest Rate Swaps) (Details) - Interest Rate Swaps, Maturity Date, March 15, 2021, 2.415% [Member] - Interest Rate Swap [Member] - SunTrust [Member] - Not Designated as Hedging Instrument [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Derivative [Line Items]
Notional amount	$ 85,500
Pay rate	2.415%
Derivative liabilities	$ (2,113)	$ (3,139)

XML

Derivative Instruments (Interest Rate Caps) (Details) - Interest Rate Caps [Member] - SunTrust [Member] - Not Designated as Hedging Instrument [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Derivative [Line Items]
Notional amount	$ 79,000
Derivative assets	1,082	$ 1,410
Interest Rate Caps, Maturity Date, July 7, 2021, 2.50% [Member]
Derivative [Line Items]
Notional amount	$ 40,000
Cap rate	2.50%
Derivative assets	$ 542	708
Interest Rate Caps, Maturity Date, July 8, 2021, 2.50% [Member]
Derivative [Line Items]
Notional amount	$ 12,000
Cap rate	2.50%
Derivative assets	$ 163	212
Interest Rate Caps, Maturity Date, July 29, 2021, 2.50% [Member]
Derivative [Line Items]
Notional amount	$ 27,000
Cap rate	2.50%
Derivative assets	$ 377	$ 490

XML

Deferred Policy Acquisition Costs and Deferred Sales Inducements (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Insurance [Abstract]
Deferred policy acquisition costs, increase (decrease) in amortization due to unlocking adjustment	$ 48.2	$ (11.0)	$ (35.5)
Deferred sales inducements, increase (decrease) in amortization due to unlocking adjustment	$ 35.8	$ (5.6)	$ (12.6)

XML

Deferred Policy Acquisition Costs and Deferred Sales Inducements (Deferred Policy Acquisition Costs) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance at beginning of year	$ 2,905,136	$ 2,058,556	$ 2,426,652
Costs deferred during the year: commissions	538,863	651,094	421,802
Costs deferred during the year: policy issue costs	4,462	6,545	5,080
Amortization	(374,012)	(286,114)	(163,578)
Effect of net unrealized gains/losses	(169,072)	475,055	(631,400)
Balance at end of year	$ 2,905,377	$ 2,905,136	$ 2,058,556

XML

Deferred Policy Acquisition Costs and Deferred Sales Inducements (Deferred Sales Inducements) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Movement in Deferred Sales Inducements [Roll Forward]
Balance at beginning of year	$ 2,232,148	$ 1,587,257	$ 1,875,880
Costs deferred during the year	353,966	486,924	330,079
Amortization	(251,166)	(209,390)	(131,419)
Effect of net unrealized gains/losses	(126,730)	367,357	(487,283)
Balance at end of year	$ 2,208,218	$ 2,232,148	$ 1,587,257

XML

Reinsurance and Policy Provisions (Equitrust Coinsurance Agreements) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2016 USD ($) coinsurance_agreement	Dec. 31, 2015 USD ($)
Ceded Credit Risk [Line Items]
Coinsurance deposits	$ 4,639,492	$ 3,187,470
Equitrust Coinsurance Agreements, All Periods [Member]
Ceded Credit Risk [Line Items]
Number of coinsurance agreements | coinsurance_agreement	2
Coinsurance deposits	$ 700,000	800,000
Reinsurance payable	$ 9,700	$ 2,500
Equitrust Coinsurance Agreement, August 1, 2001 to December 31, 2001 [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	70.00%
Equitrust Coinsurance Agreement, January 1, 2002 to December 31, 2003 [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	40.00%
Equitrust Coinsurance Agreement, January 1, 2004 to July 31, 2004 [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	20.00%

XML

Reinsurance and Policy Provisions (Athene Coinsurance Agreements) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2016 USD ($) coinsurance_agreement	Dec. 31, 2015 USD ($)
Ceded Credit Risk [Line Items]
Coinsurance deposits	$ 4,639,492	$ 3,187,470
Athene Coinsurance Agreements, All Periods [Member]
Ceded Credit Risk [Line Items]
Number of coinsurance agreements | coinsurance_agreement	3
Coinsurance deposits	$ 3,900,000	2,400,000
Reinsurance payable	$ 45,800	$ 12,700
Fixed Index Annuities [Member] | American Equity Life [Member] | Athene, 1st Coinsurance Agreement, January 1, 2009 to March 31, 2010 [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	20.00%
Years until eligibility for recapture	7 years
Fixed Index Annuities [Member] | American Equity Life [Member] | Athene, 3rd Coinsurance Agreement, August 1, 2016 to December 31, 2016 [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	80.00%
Fixed Index Annuities [Member] | Eagle Life [Member] | Athene, 3rd Coinsurance Agreement, January 1, 2014 Going Forward [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	80.00%
Fixed Index Annuities [Member] | Eagle Life [Member] | Athene, 3rd Coinsurance Agreement, January 1, 2017 to December 31, 2018 [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	50.00%
Fixed Index Annuities [Member] | Eagle Life [Member] | Athene, 3rd Coinsurance Agreement, January 1, 2019 Going Forward [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	20.00%
Multi-Year Rate Guaranteed Annuities [Member] | American Equity Life [Member] | Athene, 2nd Coinsurance Agreement, July 1, 2009 to December 31, 2013 [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	80.00%
Multi-Year Rate Guaranteed Annuities [Member] | American Equity Life [Member] | Athene, 3rd Coinsurance Agreement, January 1, 2014 Going Forward [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	80.00%
Multi-Year Rate Guaranteed Annuities [Member] | Eagle Life [Member] | Athene, 2nd Coinsurance Agreement, November 20, 2013 to December 31, 2013 [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	80.00%
Multi-Year Rate Guaranteed Annuities [Member] | Eagle Life [Member] | Athene, 3rd Coinsurance Agreement, January 1, 2014 Going Forward [Member]
Ceded Credit Risk [Line Items]
Coninsurance percentage on certain annuities	80.00%

XML

Reinsurance and Policy Provisions (Amounts Ceded to Equitrust and Athene, Impact on Consolidated Statements of Operations and Consolidated Statements of Cash Flows) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Effects of Reinsurance [Line Items]
Annuity product charges									$ 173,579	$ 136,168	$ 118,990
Change in fair value of derivatives	$ 95,391	$ 103,794	$ 39,099	$ (74,065)	$ 69,338	$ (351,360)	$ (23,024)	$ (31,100)	164,219	(336,146)	504,825
Interest sensitive and index product benefits									725,472	968,053	1,473,700
Change in fair value of embedded derivatives									543,465	(464,698)	32,321
Other operating costs and expenses									102,231	96,218	81,584
Coinsurance deposits									(1,317,555)	(80,777)	109,184
Coinsurance Agreements, EquiTrust and Athene [Member]
Effects of Reinsurance [Line Items]
Annuity product charges									5,366	5,427	5,956
Change in fair value of derivatives									18,446	(14,360)	31,076
Coinsurance, revenues included in consolidated statement of operations									23,812	(8,933)	37,032
Interest sensitive and index product benefits									93,487	88,923	122,666
Change in fair value of embedded derivatives									23,848	(22,616)	35,820
Other operating costs and expenses									24,039	9,922	9,241
Coinsurance, benefits and expenses included in the consolidated statement of operations									141,374	76,229	167,727
Annuity deposits									(1,736,054)	(471,822)	(171,124)
Cash payments to policyholders									418,499	391,045	280,308
Coinsurance deposits									$ (1,317,555)	$ (80,777)	$ 109,184

XML

Reinsurance and Policy Provisions (Hannover Financing Arrangements) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
2013 Hannover Reinsurance Agreement [Member]
Ceded Credit Risk [Line Items]
Waived surrender charges on penalty free withdrawals and deaths on certain business, percentage	45.60%
Reserve credit	$ 638.1	$ 480.7
Risk charges	$ 27.7	21.0
2011 Hannover Reinsurance Agreement [Member]
Ceded Credit Risk [Line Items]
Risk charge rate	1.25%
Risk charges		0.3	$ 0.8
Net pretax statutory surplus benefit	$ 49.2
Reduction in pretax statutory surplus, current period		$ 10.3	$ 10.8

XML

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Statutory federal income tax rate	35.00%
Deferred tax assets, valuation allowance	$ 0	$ 0
Non-Life Subsidiaries [Member] | Internal Revenue Service (IRS) [Member]
Non-life net operating loss carryforwards	0
Deferred Tax Asset, Valuation Allowance, Unrealized Losses on Available For Sale Fixed Maturity Securities [Member]
Deferred tax assets, valuation allowance	$ 0

XML

Income Taxes (Components of Income Tax Expense) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Consolidated statements of operations:
Current income taxes	$ 57,412	$ 75,568	$ 116,545
Deferred income taxes (benefits)	(10,408)	41,916	(46,504)
Total income tax expense included in consolidated statements of operations	47,004	117,484	70,041
Stockholders' equity:
Expense (benefit) relating to: change in net unrealized investment losses	74,471	(279,860)	363,572
Expense (benefit) relating to: share-based compensation	(527)	(3,649)	(5,716)
Expense (benefit) relating to: extinguishment of convertible debt	0	0	(9,284)
Total income tax expense (benefit) included in consolidated financial statements	$ 120,948	$ (166,025)	$ 418,613

XML

Income Taxes (Effective Income Tax Rate Reconciliation) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income before income taxes	$ 130,247	$ 337,314	$ 196,064
Income tax expense on income before income taxes	45,586	118,060	68,622
Tax effect of: state income taxes	2,559	2,924	1,145
Tax effect of: tax exempt net investment income	(2,167)	(3,834)	(3,669)
Tax effect of: extinguishment of convertible debt	0	0	4,202
Tax effect of: other	1,026	334	(259)
Total income tax expense included in consolidated statements of operations	$ 47,004	$ 117,484	$ 70,041
Effective tax rate	36.10%	34.80%	35.70%

XML

Income Taxes (Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Deferred income tax assets:
Policy benefit reserves	$ 2,354,786	$ 2,092,731
Other than temporary impairments	15,681	7,801
Derivative instruments	0	91,638
Amounts due reinsurer	1,321	0
Other policyholder funds	6,474	6,861
Litigation settlement accrual	1,709	7,100
Deferred compensation	7,963	8,346
Share-based compensation	5,407	5,286
Net operating loss carryforwards	3,745	6,637
Other	9,658	8,031
Gross deferred tax assets	2,406,744	2,234,431
Deferred income tax liabilities:
Deferred policy acquisition costs and deferred sales inducements	(1,951,333)	(1,860,722)
Net unrealized gains on available for sale fixed maturity and equity securities	(170,925)	(96,454)
Derivative instruments	(75,405)	0
Amounts due reinsurer	0	(9,677)
Investment income items	(39,118)	(32,466)
Other	(1,385)	(2,429)
Gross deferred tax liabilities	(2,238,166)	(2,001,748)
Net deferred income tax asset	$ 168,578	$ 232,683

XML

Notes and Loan Payable and Amounts Due Under Repurchase Agreements (Schedule of Notes and Loan Payable) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015	Jul. 17, 2013
Debt Instrument [Line Items]
Notes and loan payable	$ 493,755		$ 393,227
July 2021 Notes [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	400,000		400,000	$ 400,000
Unamortized debt issue costs	(5,733)		(6,773)
Term Loan [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	100,000	$ 100,000	0
Unamortized debt issue costs	$ (512)		$ 0

XML

Notes and Loan Payable and Amounts Due Under Repurchase Agreements (2021 Notes Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2016	Dec. 31, 2015	Jul. 17, 2013
2011 Line of Credit [Member]
Debt Instrument [Line Items]
Repayments of line of credit	$ 15,000
July 2021 Notes [Member]
Debt Instrument [Line Items]
Debt instrument, face amount		$ 400,000	$ 400,000	$ 400,000
Interest rate		6.625%
Deferred financing costs		$ 9,000

XML

Notes and Loan Payable and Amounts Due Under Repurchase Agreements (2015 Notes, 2015 Notes Hedges and 2015 Warrants Narrative) (Details) - USD ($) $ in Thousands		12 Months Ended
	Sep. 15, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Sep. 30, 2010
Debt Instrument [Line Items]
Interest expense on convertible notes		$ 28,248	$ 28,849	$ 36,370
Convertible Debt [Member]
Debt Instrument [Line Items]
Interest expense on convertible notes			$ 1,400	9,000
2015 Notes Embedded Conversion Derivative [Member]
Debt Instrument [Line Items]
Derivative, liability, fair value at issuance					$ 37,000
Derivative liability, cash paid to settle conversion premium	$ 25,800
September 2015 Notes [Member]
Debt Instrument [Line Items]
Debt instrument, face amount					$ 200,000
Interest rate					3.50%
Deferred financing costs					$ 6,800
Extinguishment of debt, cash paid	48,200
Extinguishment of debt, amount	$ 22,400
Interest rate, effective percentage			8.90%
September 2015 Notes [Member] | Private Exchange Offers [Member]
Debt Instrument [Line Items]
Extinguishment of debt, cash paid				82,900
Extinguishment of debt, amount				69,600
Extinguishment of debt, cash paid for shares of common stock				$ 48,200
Extinguishment of debt, shares issued				2,115,055
Extinguishment of debt, carrying value at extinguishment				$ 66,000
Extinguishment of debt, gain (loss), net of tax				$ (4,800)

XML

Notes and Loan Payable and Amounts Due Under Repurchase Agreements (2029 Notes Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2009
Debt Instrument [Line Items]
Change in fair value of embedded derivatives	$ (543,465)	$ 464,698	$ (32,321)
Interest expense on convertible notes	28,248	28,849	36,370
2029 Notes Embedded Conversion Derivative [Member]
Debt Instrument [Line Items]
Change in fair value of embedded derivatives	$ 0	0	(3,809)
Convertible Debt [Member]
Debt Instrument [Line Items]
Interest expense on convertible notes		$ 1,400	9,000
Mandatory Redemption [Member] | 2029 Notes Embedded Conversion Derivative [Member]
Debt Instrument [Line Items]
Change in fair value of embedded derivatives			(3,800)
December 2029 Notes [Member]
Debt Instrument [Line Items]
Debt instrument, face amount				$ 115,800
Adjustments to additional paid in capital, equity component of convertible debt				15,600
Deferred income tax liability, equity component of convertible debt				$ 11,000
Interest rate				5.25%
Interest rate, effective percentage		11.90%
December 2029 Notes [Member] | Private Exchange Offers [Member]
Debt Instrument [Line Items]
Extinguishment of debt, amount			36,200
Extinguishment of debt, cash paid			66,700
Extinguishment of debt, cash paid for shares of common stock			$ 23,200
Extinguishment of debt, shares issued			946,793
Extinguishment of debt, carrying value at extinguishment			$ 34,600
Extinguishment of debt, gain (loss), net of tax			(2,500)
December 2029 Notes [Member] | Mandatory Redemption [Member]
Debt Instrument [Line Items]
Extinguishment of debt, amount			32,100
Extinguishment of debt, cash paid			69,400
Extinguishment of debt, cash paid for shares of common stock			$ 24,600
Extinguishment of debt, shares issued			897,548
Equity reclassified to an embedded derivative liability			$ 58,100

XML

Notes and Loan Payable and Amounts Due Under Repurchase Agreements (Line of Credit and Term Loan Narrative) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2016 USD ($) guarantor banks occasions	Sep. 30, 2016 USD ($)	Dec. 31, 2015 USD ($)
2016 Line of Credit [Member]
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity	$ 150,000
Line of credit, unused capacity, commitment fee percentage	0.275%
Line of credit, number of occasions borrowing capacity can be increased | occasions	3
Line of credit, additional borrowing capacity, aggregate amount	$ 50,000
Line of credit, duration of maturity date extension available, years	1 year
Line of credit, amount outstanding	$ 0
2013 Line of Credit [Member]
Debt Instrument [Line Items]
Credit agreement, number of banks in the agreement | banks	5
Line of credit, maximum borrowing capacity	$ 140,000
Term Loan [Member]
Debt Instrument [Line Items]
Term loan	$ 100,000	$ 100,000	$ 0
Interest rate, effective percentage	2.625%
September 30, 2016 Credit Agreement [Member]
Debt Instrument [Line Items]
Credit agreement, number of banks in the agreement | banks	6
Credit agreement, interest rate, floating, applicable margin	0.75%
Credit agreement, interest rate, floating, adjusted LIBOR	1.75%
Minimum risk-based capital ratio	275.00%
Maximum debt to capital ratio	0.35
Minimum capital to be retained	80.00%
Minimum portion of net income to be retained	50.00%
Minimum capital contributions to be retained	50.00%
Credit agreement, number of guarantors | guarantor	0
Cash in excess of amount required by covenants	$ 575,600

XML

Notes and Loan Payable and Amounts Due Under Repurchase Agreements (Repurchase Agreements Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Debt Disclosure [Abstract]
Repurchase agreement, maximum amount borrowed	$ 113.0	$ 40.6	$ 138.7
Repurchase agreement, average borrowings	$ 4.5	$ 0.5	$ 9.2
Repurchase agreement, weighted average interest rate	0.66%	0.39%	0.19%

XML

Subordinated Debentures (Narrative) (Details) - American Equity Capital Trust II [Member] $ in Millions	Dec. 31, 2016 USD ($)
Subordinated Borrowing [Line Items]
Debt instrument, face amount	$ 100.0
Subordinated debentures, fair value at issuance	$ 74.7
Interest rate, effective percentage	6.80%
Ownership percentage, Iowa Farm Bureau Federation	50.00%

XML

Subordinated Debentures (Summary of Subordinated Debt Obligations to the Trusts) (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015
American Equity Capital Trust II [Member]
Subordinated Borrowing [Line Items]
Interest rate		5.00%
Subordinated borrowing, due date		Jun. 01, 2047
American Equity Capital Trust III [Member]
Subordinated Borrowing [Line Items]
Description of variable rate basis	[1]	*LIBOR +
Basis spread on variable rate		3.90%
Subordinated borrowing, due date		Apr. 29, 2034
American Equity Capital Trust IV [Member]
Subordinated Borrowing [Line Items]
Description of variable rate basis	[1]	*LIBOR +
Basis spread on variable rate		4.00%
Subordinated borrowing, due date		Jan. 08, 2034
American Equity Capital Trust VII [Member]
Subordinated Borrowing [Line Items]
Description of variable rate basis	[1]	*LIBOR +
Basis spread on variable rate		3.75%
Subordinated borrowing, due date		Dec. 14, 2034
American Equity Capital Trust VIII [Member]
Subordinated Borrowing [Line Items]
Description of variable rate basis	[1]	*LIBOR +
Basis spread on variable rate		3.75%
Subordinated borrowing, due date		Dec. 15, 2034
American Equity Capital Trust IX [Member]
Subordinated Borrowing [Line Items]
Description of variable rate basis	[1]	*LIBOR +
Basis spread on variable rate		3.65%
Subordinated borrowing, due date		Jun. 15, 2035
American Equity Capital Trust X [Member]
Subordinated Borrowing [Line Items]
Description of variable rate basis	[1]	*LIBOR +
Basis spread on variable rate		3.65%
Subordinated borrowing, due date		Sep. 15, 2035
American Equity Capital Trust XI [Member]
Subordinated Borrowing [Line Items]
Description of variable rate basis	[1]	*LIBOR +
Basis spread on variable rate		3.65%
Subordinated borrowing, due date		Dec. 15, 2035
American Equity Capital Trust XII [Member]
Subordinated Borrowing [Line Items]
Description of variable rate basis	[1]	*LIBOR +
Basis spread on variable rate		3.50%
Subordinated borrowing, due date		Apr. 07, 2036
Subordinated Debentures [Member]
Subordinated Borrowing [Line Items]
Subordinated debentures, gross		$ 246,671	$ 246,450
Unamortized debt issue costs		(4,818)	(4,998)
Subordinated debentures		241,853	241,452
Subordinated Debentures [Member] | American Equity Capital Trust II [Member]
Subordinated Borrowing [Line Items]
Subordinated debentures, gross		77,061	76,840
Subordinated Debentures [Member] | American Equity Capital Trust III [Member]
Subordinated Borrowing [Line Items]
Subordinated debentures, gross		27,840	27,840
Subordinated Debentures [Member] | American Equity Capital Trust IV [Member]
Subordinated Borrowing [Line Items]
Subordinated debentures, gross		12,372	12,372
Subordinated Debentures [Member] | American Equity Capital Trust VII [Member]
Subordinated Borrowing [Line Items]
Subordinated debentures, gross		10,830	10,830
Subordinated Debentures [Member] | American Equity Capital Trust VIII [Member]
Subordinated Borrowing [Line Items]
Subordinated debentures, gross		20,620	20,620
Subordinated Debentures [Member] | American Equity Capital Trust IX [Member]
Subordinated Borrowing [Line Items]
Subordinated debentures, gross		15,470	15,470
Subordinated Debentures [Member] | American Equity Capital Trust X [Member]
Subordinated Borrowing [Line Items]
Subordinated debentures, gross		20,620	20,620
Subordinated Debentures [Member] | American Equity Capital Trust XI [Member]
Subordinated Borrowing [Line Items]
Subordinated debentures, gross		20,620	20,620
Subordinated Debentures [Member] | American Equity Capital Trust XII [Member]
Subordinated Borrowing [Line Items]
Subordinated debentures, gross		$ 41,238	$ 41,238

[1] three month London Interbank Offered Rate

XML

Retirement and Share-based Compensation Plans (Defined Contribution Plan) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Defined contribution plan, maximum annual employee contribution	$ 18,000	$ 18,000	$ 17,500
Defined contribution plan, employer plan contributions	$ 1,300,000	$ 400,000	$ 400,000

XML

Retirement and Share-based Compensation Plans (Share-based Compensation Expense By Plan) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
ESOP, compensation expense	$ 2,522	$ 2,604	$ 2,486
Compensation expense	4,414	5,128	4,581
Employee Incentive Plans [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	1,207	1,911	1,306
Director Equity And Incentive Plan And Stock Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 685	$ 613	$ 789

XML

Retirement and Share-based Compensation Plans (Employee Stock Ownership Plan) (Details)	12 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
ESOP, requisite service period	6 months
ESOP, vesting percentage	100.00%
ESOP, vesting period	2 years

XML

Retirement and Share-based Compensation Plans (Incentive Plans) (Details) - shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
2016 Employee Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	2,500,000
Number of shares available for future grant	2,226,256
2009 Employee Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	2,500,000
Duration of award	10 years
Award vesting period	3 years
2009 Employee Incentive Plan [Member] | March 2010 Option Grant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Duration of award	6 years
Employee Incentive Plans [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Shares issued in period	43,373	25,784	18,239
Participant age for full vesting	65 years
Requisite service period for full vesting	10 years
Employee Incentive Plans [Member] | 2016 Replacement Award Grant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued in period	21,806
Employee Incentive Plans [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Equity instruments granted	208,565	60,947	54,718
Duration used to measure performance and threshold goals	3 years
Employee Incentive Plans [Member] | Restricted Stock Units [Member] | Threshold Goals, Vesting Percentage [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	50.00%
Employee Incentive Plans [Member] | Restricted Stock Units [Member] | Target Performance Goals, Vesting Percentage [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	100.00%
Employee Incentive Plans [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued in period	43,373	23,062	14,869
2013 Director Equity And Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	250,000
Number of shares available for future grant	116,500
Award vesting period	1 year
2013 Director Equity And Incentive Plan [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued in period	47,500	22,000	24,000

XML

Retirement and Share-based Compensation Plans (Stock Option Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, intrinsic value	$ 21.3
Options vested and expected to vest, intrinsic value	21.3
Proceeds from stock options exercised	5.0	$ 8.1	$ 13.7
Tax benefit from stock options exercised	$ 0.0	0.0	1.0
Stock Option Plans, 1996 Stock Option Plan, 2000 Employee Stock Option Plan, 2000 Directors Stock Option Plan, 2011 Directors Stock Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	3,475,000
Duration of award	10 years
Stock Option Plans, 1996 Stock Option Plan, 2000 Employee Stock Option Plan, 2000 Directors Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	6 months
Stock Option Plans, 2011 Director Stock Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Number of shares available for future grant	18,000
Stock Option Plans, Independent Insurance Agent Stock Option Plans [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	8,000,000
Stock Option Plans, All Stock Option Plans For Officers, Directors And Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options exercised in period, total intrinsic value	$ 4.0	$ 1.4	$ 5.4

XML

Retirement and Share-based Compensation Plans (2014 Independent Insurance Agent Restricted Stock and Restricted Stock Unit Plan) (Details) - 2014 Independent Insurance Agent Restricted Stock and Restricted Stock Unit Plan [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	1,800,000
Restricted Stock Units [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	20.00%
Award vesting period	1 year
Retirement Eligible Agent [Member] | Restricted Stock Units [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	80.00%
Award vesting period	4 years
Non-Retirement Eligible Agent [Member] | Restricted Stock Units [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	80.00%
Non-Retirement Eligible Agent [Member] | Restricted Stock Units [Member] | Maximum [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	5 years
2016 American Equity Life Agent Grant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Commission expense	$ 2.6
2016 American Equity Life Agent Grant [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments granted	363,624
2015 American Equity Life Agent Grant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Commission expense	$ 1.7	$ 3.5
2015 American Equity Life Agent Grant [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments granted		650,683
Award vested in period	246,532
2014 American Equity Life Agent Grant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Commission expense	$ 0.6	$ 1.3	$ 1.9
2014 American Equity Life Agent Grant [Member] | Retirement Eligible Agent [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments granted			27,985
2014 American Equity Life Agent Grant [Member] | Non-Retirement Eligible Agent [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments granted			221,489
Award vested in period	36,609	85,104
2014 American Equity Life Agent Grant [Member] | Non-Retirement Eligible Agent [Member] | Restricted Stock Units [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	20.00%
Award vesting period	1 year
2014 American Equity Life Agent Grant [Member] | Non-Retirement Eligible Agent [Member] | Restricted Stock Units [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	80.00%
2014 American Equity Life Agent Grant [Member] | Non-Retirement Eligible Agent [Member] | Restricted Stock Units [Member] | Maximum [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	5 years

XML

Retirement and Share-based Compensation Plans (Changes in the Number of Stock Options Outstanding) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Outstanding, number of shares	2,918,946	3,443,991	4,044,175	3,976,725
Outstanding, weighted-average exercise price per share	$ 16.06	$ 15.17	$ 15.02	$ 10.86
Outstanding, total exercise price	$ 46,885	$ 52,240	$ 60,760	$ 43,171
Granted, number of shares	0	0	1,277,650
Granted, weighted-average exercise price per share	$ 0.00	$ 0.00	$ 24.79
Granted, total exercise price	$ 0	$ 0	$ 31,673
Canceled, number of shares	(24,700)	(47,300)	(35,400)
Canceled, weighted-average exercise price per share	$ 14.83	$ 10.54	$ 11.64
Canceled, total exercise price	$ (366)	$ (499)	$ (412)
Exercised, number of shares	(500,345)	(552,884)	(1,174,800)
Exercised, weighted-average exercise price per share	$ 9.97	$ 14.51	$ 11.64
Exercised, total exercise price	$ (4,989)	$ (8,021)	$ (13,672)

XML

Retirement and Share-based Compensation Plans (Schedule of Stock Options Outstanding, By Exercise Price Range) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock options outstanding, number of awards	2,918,946	3,443,991	4,044,175	3,976,725
Stock options outstanding, weighted-average exercise price per share	$ 16.06	$ 15.17	$ 15.02	$ 10.86
Exercise Price Range I [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit	5.07
Exercise price range, upper range limit	$ 8.02
Stock options outstanding, number of awards	248,225
Stock options outstanding, remaining life (yrs)	1 year 8 months 27 days
Stock options outstanding, weighted-average exercise price per share	$ 7.16
Stock options vested, number of awards	248,225
Stock options vested, remaining life (yrs)	1 year 8 months 27 days
Stock options vested, weighted-average exercise price per share	$ 7.16
Exercise Price Range II [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit	9.27
Exercise price range, upper range limit	$ 11.35
Stock options outstanding, number of awards	752,150
Stock options outstanding, remaining life (yrs)	2 years 7 months 29 days
Stock options outstanding, weighted-average exercise price per share	$ 10.19
Stock options vested, number of awards	752,150
Stock options vested, remaining life (yrs)	2 years 7 months 29 days
Stock options vested, weighted-average exercise price per share	$ 10.19
Exercise Price Range III [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit	12.04
Exercise price range, upper range limit	$ 24.79
Stock options outstanding, number of awards	1,918,571
Stock options outstanding, remaining life (yrs)	3 years 2 months 28 days
Stock options outstanding, weighted-average exercise price per share	$ 19.52
Stock options vested, number of awards	1,918,571
Stock options vested, remaining life (yrs)	3 years 2 months 28 days
Stock options vested, weighted-average exercise price per share	$ 19.52
Exercise Price Range, All Options [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower range limit	5.07
Exercise price range, upper range limit	$ 24.79
Stock options outstanding, number of awards	2,918,946
Stock options outstanding, remaining life (yrs)	2 years 11 months 20 days
Stock options outstanding, weighted-average exercise price per share	$ 16.06
Stock options vested, number of awards	2,918,946
Stock options vested, remaining life (yrs)	2 years 11 months 20 days
Stock options vested, weighted-average exercise price per share	$ 16.06

XML

Retirement and Share-based Compensation Plans (Deferred Compensation Arrangements) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Deferred Compensation Plans, Certain Officers, Directors and Consultants [Member]
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Shares earned and reserved for future issuance	364,000	366,072
Share-based compensation expense		$ 102,000	$ 127,000
Deferred Compensation Plans, Officer Rabbi Trust [Member]
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Deferred compensation liability	$ 3,500,000	$ 3,700,000
Shares held	102,932	103,251
Deferred Compensation Plans, NMO Deferred Compensation Plan [Member]
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Award vesting period	9 years
Undistributed vested shares	0	223,454
Deferred Compensation Plans, NMO Trust [Member]
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Shares held	15,058	230,012
Shares distributed	215,273	313,108	349,568

XML

Statutory Financial Information and Dividend Restrictions (Narrative and Statutory Accounting Practices Tables) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Insurance [Abstract]
American Equity Life, statutory net income	$ 75,035	$ 131,452	$ 340,000
American Equity Life, statutory capital and surplus balance	2,726,664	2,415,419
Total adjusted capital	2,933,193	2,593,472
Company Action Level RBC	$ 857,321	$ 771,293
Ratio of adjusted capital to Company Action Level RBC	342.00%	336.00%
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments [Abstract]
Statutory amount available for dividend payments without regulatory approval	$ 272,700
Dividends paid by insurance subsidiaries	$ 0	$ 0	$ 0

XML

Commitments and Contingencies (Narrative and Schedule of Future Minimum Rental Payments for Operating Leases) (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Rent expense			$ 2,800	$ 2,700	$ 2,700
Aggregate future minimum lease payments due	$ 16,900		16,900
2017	1,890		1,890
2018	1,915		1,915
2019	1,898		1,898
2020	1,950		1,950
2021	1,754		1,754
2022 and thereafter	7,464		7,464
Change in estimated litigation liability	(4,100)	$ (6,400)
Legal fees paid	4,100	1,800
Loss contingency reclassified to policy benefit reserves		(1,800)
Loss contingency accrual, decrease due to additional information on claims and based on the terms of the settlement		$ (2,800)
Estimated litigation liability	600		600
Unfunded commitments to limited partnerships	48,400		48,400
Unfunded commitments to secured bank loans	$ 34,300		$ 34,300

XML

Earnings Per Share and Stockholders' Equity (Schedule of Earnings Per Share, Basic and Diluted) (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended								12 Months Ended
		Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Earnings Per Share, Basic and Diluted [Line Items]
Net income—numerator for earnings per common share		$ 120,796	$ (7,420)	$ 14,708	$ (44,841)	$ 33,776	$ 97,306	$ 82,845	$ 5,903	$ 83,243	$ 219,830	$ 126,023
Weighted average common shares outstanding (shares)	[1]									84,793,151	78,936,828	74,431,087
Effect of dilutive securities: convertible senior notes (shares)										0	0	2,657,158
Effect of dilutive securities: equity forward sale agreements (shares)										0	67,575	0
Effect of dilutive securities: 2015 warrants (shares)										15,136	759,723	1,559,646
Denominator for earnings per common share - assuming dilution (shares)										85,605,169	80,960,568	79,893,600
Earnings per common share		$ 1.37	$ (0.09)	$ 0.18	$ (0.55)	$ 0.41	$ 1.22	$ 1.07	$ 0.08	$ 0.98	$ 2.78	$ 1.69
Earnings per common share - assuming dilution		$ 1.35	$ (0.09)	$ 0.18	$ (0.55)	$ 0.40	$ 1.19	$ 1.05	$ 0.07	$ 0.97	$ 2.72	$ 1.58
Stock Options And Deferred Compensation Agreements [Member]
Earnings Per Share, Basic and Diluted [Line Items]
Effect of dilutive securities: share-based payment agreements (shares)										456,236	1,040,922	1,178,783
Restricted Stock And Restricted Stock Units [Member]
Earnings Per Share, Basic and Diluted [Line Items]
Effect of dilutive securities: share-based payment agreements (shares)										340,646	155,520	66,926

[1] Weighted average common shares outstanding include shares vested under the NMO Deferred Compensation Plan and exclude unallocated shares held by the ESOP.

XML

Earnings Per Share and Stockholders' Equity (Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share) (Details) - Stock Options [Member] - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of shares	1,054,091	1,061,541	1,215,450
Minimum [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Range of exercise prices	$ 24.79	$ 24.79	$ 24.79
Maximum [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Range of exercise prices	$ 24.79	$ 24.79	$ 24.79

XML

Earnings Per Share and Stockholders' Equity (Stockholders' Equity Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended	12 Months Ended
	Aug. 01, 2016	Aug. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Earnings Per Share [Abstract]
Public offering related to equity forward transaction, shares		8,600,000
Forward rate per share		$ 25.25
Shares subject to forward sale agreement		4,300,000
Optional shares available to underwriters		1,290,000
Stock issued during period, shares	5,590,000
Proceeds from issuance of common stock	$ 134,700		$ 139,654	$ 112,481	$ 13,681

XML

Quarterly Financial Information (Unaudited) (Schedule of Quarterly Financial Information) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Premiums and product charges	$ 60,508	$ 60,406	$ 52,582	$ 43,850	$ 47,781	$ 46,310	$ 42,446	$ 35,679
Net investment income	475,633	463,583	459,830	450,826	438,262	436,085	418,176	399,669	$ 1,849,872	$ 1,692,192	$ 1,531,667
Change in fair value of derivatives	95,391	103,794	39,099	(74,065)	69,338	(351,360)	(23,024)	(31,100)	164,219	(336,146)	504,825
Net realized gains (losses) on investments, excluding other than temporary impairment (OTTI) losses	844	5,256	2,737	2,687	(151)	1,159	4,324	4,879	11,524	10,211	(4,003)
Net OTTI losses recognized in operations	(9,560)	(2,979)	(4,446)	(5,694)	(13,347)	(5,229)	(828)	(132)	(22,679)	(19,536)	(2,627)
Total revenues	622,816	630,060	549,802	417,604	541,883	126,965	441,094	408,995	2,220,282	1,518,937	2,168,973
Net income	$ 120,796	$ (7,420)	$ 14,708	$ (44,841)	$ 33,776	$ 97,306	$ 82,845	$ 5,903	$ 83,243	$ 219,830	$ 126,023
Earnings (loss) per common share	$ 1.37	$ (0.09)	$ 0.18	$ (0.55)	$ 0.41	$ 1.22	$ 1.07	$ 0.08	$ 0.98	$ 2.78	$ 1.69
Earnings (loss) per common share—assuming dilution	$ 1.35	$ (0.09)	$ 0.18	$ (0.55)	$ 0.40	$ 1.19	$ 1.05	$ 0.07	$ 0.97	$ 2.72	$ 1.58

XML

Quarterly Financial Information (Unaudited) (Comparability of Net Income, Impact of Fair Value Accounting to Fixed Index Annuity Business) (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015
Quarterly Financial Information Disclosure [Abstract]
Fixed index annuity derivatives, fair value accounting impact on comparability of net income (loss)	$ (66,618)	$ 6,054	$ 34,215	$ 62,822	$ 11,091	$ (53,716)	$ (28,596)	$ 42,849

XML

Schedule I - Summary of Investments - Other Than Investments in Related Parties (Details) $ in Thousands	Dec. 31, 2016 USD ($)
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	$ 43,133,761	[1]
Amount at which shown in the balance sheet	44,757,568
Fixed Maturity Securities [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	40,030,780	[1]
Fair value	41,129,260
Amount at which shown in the balance sheet	41,137,319
Fixed Maturity Securities [Member] | Available For Sale [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	39,953,955	[1]
Fair value	41,060,494
Amount at which shown in the balance sheet	41,060,494
United States Government Full Faith and Credit [Member] | Available For Sale [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	11,864	[1]
Fair value	11,805
Amount at which shown in the balance sheet	11,805
United States Government Sponsored Agencies [Member] | Available For Sale [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	1,368,340	[1]
Fair value	1,344,787
Amount at which shown in the balance sheet	1,344,787
United States Municipalities, States and Territories [Member] | Available For Sale [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	3,626,395	[1]
Fair value	3,926,950
Amount at which shown in the balance sheet	3,926,950
Foreign Government Obligations [Member] | Available For Sale [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	224,588	[1]
Fair value	232,233
Amount at which shown in the balance sheet	232,233
Corporate Securities [Member] | Available For Sale [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	26,338,214	[1]
Fair value	27,118,526
Amount at which shown in the balance sheet	27,118,526
Corporate Securities [Member] | Held For Investment [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	76,825	[1]
Fair value	68,766
Amount at which shown in the balance sheet	76,825
Residential Mortgage Backed Securities [Member] | Available For Sale [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	1,166,944	[1]
Fair value	1,254,835
Amount at which shown in the balance sheet	1,254,835
Commercial Mortgage Backed Securities [Member] | Available For Sale [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	5,422,255	[1]
Fair value	5,365,235
Amount at which shown in the balance sheet	5,365,235
Other Asset Backed Securities [Member] | Available For Sale [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	1,795,355	[1]
Fair value	1,806,123
Amount at which shown in the balance sheet	1,806,123
Mortgage Loans on Real Estate [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	2,480,956	[1]
Fair value	2,522,035
Amount at which shown in the balance sheet	2,480,956
Derivative Instruments [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	313,729	[1]
Fair value	830,519
Amount at which shown in the balance sheet	830,519
Other Investments [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost	308,296	[1]
Amount at which shown in the balance sheet	$ 308,774

[1] On the basis of cost adjusted for other than temporary impairments, repayments and amortization of premiums and accrual of discounts for fixed maturity securities and short-term investments, original cost for derivative instruments and unpaid principal balance less allowance for credit losses for mortgage loans.

XML

Schedule II - Condensed Financial Information of Registrant (Condensed Balance Sheets) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Assets
Cash and cash equivalents	$ 791,266	$ 397,749	$ 701,514	$ 897,529
Other assets	173,726	112,171
Total assets	56,053,472	49,029,392
Liabilities:
Notes and loan payable	493,755	393,227
Other liabilities	1,090,896	629,897
Total liabilities	53,761,877	47,084,857
Stockholders' equity:
Common stock	88,001	81,354
Additional paid-in capital	770,344	630,367
Accumulated other comprehensive income	339,966	201,663
Retained earnings	1,093,284	1,031,151
Total stockholders' equity	2,291,595	1,944,535	2,139,876	1,384,687
Total liabilities and stockholders' equity	56,053,472	49,029,392
Parent Company [Member]
Assets
Cash and cash equivalents	36,394	38,903	$ 61,139	$ 252,541
Equity securities of subsidiary trusts	7,422	7,415
Receivable from subsidiaries	182	207
Deferred income taxes	9,528	11,645
Federal income tax recoverable, including amount from subsidiaries	0	7,747
Other assets	2,540	2,270
Total assets, excluding investment in and advances to subsidiaries	56,066	68,187
Investment in and advances to subsidiaries	2,992,217	2,526,972
Total assets	3,048,283	2,595,159
Liabilities:
Notes and loan payable	493,755	393,227
Subordinated debentures payable to subsidiary trusts	241,853	241,452
Federal income tax payable	3,614	0
Other liabilities	17,466	15,945
Total liabilities	756,688	650,624
Stockholders' equity:
Common stock	88,001	81,354
Additional paid-in capital	770,344	630,367
Accumulated other comprehensive income	339,966	201,663
Retained earnings	1,093,284	1,031,151
Total stockholders' equity	2,291,595	1,944,535
Total liabilities and stockholders' equity	$ 3,048,283	$ 2,595,159

XML

Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Operations) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenues:
Net investment income	$ 475,633	$ 463,583	$ 459,830	$ 450,826	$ 438,262	$ 436,085	$ 418,176	$ 399,669	$ 1,849,872	$ 1,692,192	$ 1,531,667
Change in fair value of derivatives	95,391	103,794	39,099	(74,065)	69,338	(351,360)	(23,024)	(31,100)	164,219	(336,146)	504,825
Loss on extinguishment of debt									0	0	(12,502)
Total revenues	622,816	630,060	549,802	417,604	541,883	126,965	441,094	408,995	2,220,282	1,518,937	2,168,973
Expenses:
Change in fair value of embedded derivatives									543,465	(464,698)	32,321
Interest expense on notes and loan payable									28,248	28,849	36,370
Interest expense on subordinated debentures issued to subsidiary trusts									12,958	12,239	12,122
Other operating costs and expenses									102,231	96,218	81,584
Total benefits and expenses									2,090,035	1,181,623	1,972,909
Income tax expense									47,004	117,484	70,041
Net income	$ 120,796	$ (7,420)	$ 14,708	$ (44,841)	$ 33,776	$ 97,306	$ 82,845	$ 5,903	83,243	219,830	126,023
Parent Company [Member]
Revenues:
Net investment income									78	62	130
Dividends from subsidiary trusts									384	363	360
Investment advisory fees									75,706	65,957	58,044
Surplus note interest from subsidiary									4,080	4,080	4,080
Change in fair value of derivatives									(810)	(8,225)	(17,122)
Loss on extinguishment of debt									0	0	(12,502)
Total revenues									79,438	62,237	32,990
Expenses:
Change in fair value of embedded derivatives									0	(4,516)	(15,227)
Interest expense on notes and loan payable									28,248	28,849	36,370
Interest expense on subordinated debentures issued to subsidiary trusts									12,958	12,239	12,122
Other operating costs and expenses									8,551	8,195	7,928
Total benefits and expenses									49,757	44,767	41,193
Income (loss) before income taxes and equity in undistributed income of subsidiaries									29,681	17,470	(8,203)
Income tax expense									12,073	7,338	664
Income (loss) before equity in undistributed income of subsidiaries									17,608	10,132	(8,867)
Equity in undistributed income of subsidiaries									65,635	209,698	134,890
Net income									$ 83,243	$ 219,830	$ 126,023

XML

Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Cash Flows) (Details) - USD ($) $ in Thousands		3 Months Ended								12 Months Ended
	Aug. 01, 2016	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Operating activities
Net income		$ 120,796	$ (7,420)	$ 14,708	$ (44,841)	$ 33,776	$ 97,306	$ 82,845	$ 5,903	$ 83,243	$ 219,830	$ 126,023
Adjustments to reconcile net income to net cash provided by operating activities:
Change in fair value of 2015 notes embedded conversion derivative										543,465	(464,698)	32,321
Change in fair value of derivatives										(165,727)	334,300	(506,328)
Loss on extinguishment of debt										0	0	12,502
Share-based compensation										6,692	7,373	3,544
ESOP compensation										2,522	2,604	2,486
Deferred income taxes										(10,408)	41,916	(46,504)
Other										(14,089)	(15,962)	(8,948)
Changes in operating assets and liabilities:
Other assets										1,812	71	(2,771)
Other liabilities										(55,940)	75,794	(51,008)
Net cash provided by operating activities										1,414,322	504,804	707,786
Investing activities
Purchases of property, plant and equipment										(1,197)	(1,313)	(1,352)
Net cash used in investing activities										(4,499,045)	(5,577,205)	(2,947,749)
Financing activities
Financing fees incurred and deferred										(1,456)	0	(100)
Repayment of notes payable										0	(48,152)	(219,094)
Net proceeds from settlement of notes hedges and warrants										0	25,775	16,558
Proceeds from issuance of debt										100,000	0	0
Excess tax benefits realized from share-based compensation plans										527	3,649	5,184
Proceeds from issuance of common stock	$ 134,700									139,654	112,481	13,681
Dividends paid										(21,110)	(17,874)	(15,015)
Net cash provided by (used in) financing activities										3,478,240	4,768,636	2,043,948
Increase (decrease) in cash and cash equivalents										393,517	(303,765)	(196,015)
Cash and cash equivalents at beginning of year					397,749				701,514	397,749	701,514	897,529
Cash and cash equivalents at end of year		791,266				397,749				791,266	397,749	701,514
Cash paid during the year for interest:
Interest paid										39,647	39,118	42,989
Common Stock Issued in Extinguishment of Debt [Member]
Non-cash financing activity:
Common stock issued										0	0	95,993
Common Stock Issued to Settle Warrants That Have Expired [Member]
Non-cash financing activity:
Common stock issued										93	48	0
Parent Company [Member]
Operating activities
Net income										83,243	219,830	126,023
Adjustments to reconcile net income to net cash provided by operating activities:
Change in fair value of 2015 notes embedded conversion derivative										0	(4,516)	(15,227)
Provision for depreciation and amortization										1,946	1,613	2,081
Accrual of discount on equity security										(7)	(6)	(6)
Equity in undistributed income of subsidiaries										(65,635)	(209,698)	(134,890)
Accrual of discount on contingent convertible notes										0	698	4,417
Change in fair value of derivatives										(698)	6,377	15,619
Loss on extinguishment of debt										0	0	12,502
Accrual of discount on debenture issued to subsidiary trust										221	207	193
Share-based compensation										818	1,026	1,141
ESOP compensation										0	0	82
Deferred income taxes										2,117	8,967	6,439
Other										0	0	(2,235)
Changes in operating assets and liabilities:
Receivable from subsidiaries										(125)	93	2,208
Federal income tax recoverable										11,361	2,683	1,121
Other assets										(326)	(4)	378
Other liabilities										2,546	(1,664)	(7,256)
Net cash provided by operating activities										35,461	25,606	12,590
Investing activities
Capital contributions to subsidiaries										(255,000)	(120,000)	0
Purchases of property, plant and equipment										(54)	0	0
Net cash used in investing activities										(255,054)	(120,000)	0
Financing activities
Financing fees incurred and deferred										(1,456)	0	(100)
Repayment of notes payable										0	(48,152)	(219,094)
Net proceeds from settlement of notes hedges and warrants										0	25,775	16,558
Proceeds from issuance of debt										100,000	0	0
Excess tax benefits realized from share-based compensation plans										0	0	184
Proceeds from issuance of common stock										139,654	112,481	13,681
Dividends paid										(21,114)	(17,946)	(15,221)
Net cash provided by (used in) financing activities										217,084	72,158	(203,992)
Increase (decrease) in cash and cash equivalents										(2,509)	(22,236)	(191,402)
Cash and cash equivalents at beginning of year					$ 38,903				$ 61,139	38,903	61,139	252,541
Cash and cash equivalents at end of year		$ 36,394				$ 38,903				36,394	38,903	61,139
Parent Company [Member] | Common Stock Issued in Extinguishment of Debt [Member]
Non-cash financing activity:
Common stock issued										0	0	95,993
Parent Company [Member] | Common Stock Issued to Settle Warrants That Have Expired [Member]
Non-cash financing activity:
Common stock issued										93	48	0
Parent Company [Member] | Notes and Loans Payable [Member]
Cash paid during the year for interest:
Interest paid										27,164	27,283	31,206
Parent Company [Member] | Subordinated Debentures [Member]
Cash paid during the year for interest:
Interest paid										$ 12,454	$ 11,833	$ 11,765

XML

Schedule III - Supplementary Insurance Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Supplementary Insurance Information [Abstract]
Deferred policy acquisition costs	$ 2,905,377	$ 2,905,136	$ 2,058,556
Future policy benefits, losses, claims and loss expenses	51,637,026	45,495,431	39,802,861
Unearned premiums	0	0	0
Other policy claims and benefits payable	298,347	324,850	365,819
Premium revenue	217,346	172,216	151,613
Net investment income	1,849,872	1,692,192	1,531,667
Benefits, claims, losses and settlement expenses	1,572,586	758,203	1,679,255
Amortization of deferred policy acquisition costs	374,012	286,114	163,578
Other operating expenses	$ 143,437	$ 137,306	$ 130,076

XML

Schedule IV - Reinsurance (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Gross amount, life insurance in force	$ 1,996,446	$ 2,036,690	$ 2,171,426
Ceded to other companies, life insurance in force	10,045	10,677	11,548
Assumed from other companies, life insurance in force	57,849	56,882	56,509
Net amount, life insurance in force	2,044,250	2,082,895	2,216,387
Net amount, insurance premiums and other considerations	$ 43,767	$ 36,048	$ 32,623
Percent of amount assumed to net, life insurance in force	2.83%	2.73%	2.55%
Insurance Premiums and Other Considerations [Member]
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Gross amount, insurance premiums and other considerations	$ 222,466	$ 177,310	$ 157,254
Ceded to other companies, insurance premiums and other considerations	5,617	5,683	6,292
Assumed from other companies, insurance premiums and other considerations	497	589	651
Net amount, insurance premiums and other considerations	$ 217,346	$ 172,216	$ 151,613
Percent of amount assumed to net, insurance premiums and other considerations	0.23%	0.34%	0.43%
Annuity Product Charges [Member]
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Gross amount, insurance premiums and other considerations	$ 178,945	$ 141,595	$ 124,946
Ceded to other companies, insurance premiums and other considerations	5,366	5,427	5,956
Assumed from other companies, insurance premiums and other considerations	0	0	0
Net amount, insurance premiums and other considerations	$ 173,579	$ 136,168	$ 118,990
Percent of amount assumed to net, insurance premiums and other considerations	0.00%	0.00%	0.00%
Traditional Life, Accident and Health Insurance, and Life Contingent Immediate Annuity Premiums [Member]
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Gross amount, insurance premiums and other considerations	$ 43,521	$ 35,715	$ 32,308
Ceded to other companies, insurance premiums and other considerations	251	256	336
Assumed from other companies, insurance premiums and other considerations	497	589	651
Net amount, insurance premiums and other considerations	$ 43,767	$ 36,048	$ 32,623
Percent of amount assumed to net, insurance premiums and other considerations	1.14%	1.63%	2.00%

XML

Schedule V - Valuation and Qualifying Accounts (Details) - Valuation Allowance on Mortgage Loans [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning balance	$ (14,142)	$ (22,633)	$ (26,047)
Charged to costs and expenses	(4,846)	1,018	(6,052)
Translation adjustment	0	0	0
Write-offs/payments/other	10,561	7,473	9,466
Ending balance	$ (8,427)	$ (14,142)	$ (22,633)